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-  i l l  -
"¥e m ust have c l i n i c i a n s  who keep  in  c lo se  
to u ch  w ith  p h y s io lo g y , p a th o lo g y  and c h e m is try , 
and who a r e  p re p a re d  to  t r a n s f e r  to  th e  wards 
th ro u g h  p ro p e r  ch an n e ls  th e  knowledge o f  th e  
l a b o ra to r y .  The o rg an iz ed  m édical c l i n i c  i s  a  
c le a r in g h o u se  f o r  th e  s c i e n t i f i c  t r a d e r s  who 
a re  d o in g  b u s in e s s  in  a l l  p a r t s  o f  th e  body 
c o rp o ra te ,  and th e  a p p l ic a t io n  o f  new f a c t s  to  
m edicine must come th ro u g h  i t ,  o r  th ro u g h  t h a t  
sm a ll b u t h a p p ily  in c re a s in g  group o f  men who 
f in d  tim e amid th e  d a i ly  c a re s  o f p r a c t i c e .
One th in g  i s  c e r t a in ;  we c l i n i c i a n s  must go to  
th e  p h y s io lo g i s t s ,  th e  p a th o lo g is ts  and th e  
c h em is ts  -  th e y  no lo n g e r  come to  u s ."
S i r  W illiam  O sie r  (1849-1919)
-  I V  -
I
PREFACE
The work p re s e n te d  in  t h i s  t h e s i s  r e p r e s e n ts  seven y e a rs
c l i n i c a l  and b a s ic  s c ie n c e  e x p e rie n c e  w ith  th e  a n t i - a r t h r i t i c  g o ld
.com plexes. I  f i r s t  became in t e r e s t e d  in  th e  rh eu m a tic  d is e a s e s  in  
1973 d u r in g  my s ix  months a s  a  s e n io r  house o f f i c e r  in  p a th o lo g y  
w ith  P ro fe s s o r  John A nderson a t  th e  W estern In f i rm a ry ,  Glasgow. 
F o llow ing  th e  com ple tion  o f  my t r a i n in g  in  i n t e r n a l  m ed ic in e , in  
1976 , I  p u rsued  my i n t e r e s t  i n  rheum ato logy  by e n te r in g  th e •I
S p e c ia l ty  T ra in in g  Programme in  th e  Rheum atic D isease  U n it a t
i
Q ueen 's U n iv e r s i ty ,  K in g s to n , O n ta rio  under th e  d i r e c t io n  o f P ro f ­
e s s o r  T assos P . A n a s ta s s ia d e s .  I t  was a t  t h i s  tim e th a t  I  became 
aware o f  th e  la c k  o f knowledge r e g a rd in g  th e  c h e m is try , th e  b io lo g ­
i c a l  mechanisms and th e  c l i n i c a l  a p p l ic a t io n  o f  th e  a n t i - a r t h r i t i c  
g o ld  com plexes.
.I n  1980 I  was a p p o in te d  to  th e  F a c u lty  o f H ea lth  S c ie n c e ,
McMaster U n iv e r s i ty ,  H am ilton , O n ta r io  a s  an A s s is ta n t  P ro fe s so r  
in  th e  Rheum atic D isease  U n it u n d er th e  cha irm an sh ip  o f  P ro fe s s o r  
W. Watson Buchanan,
.3
I t  became obv ious from  my c l i n i c a l  s tu d ie s  w ith  go ld  sodium Ith io m a la te  in  th e  tre a tm e n t of rheum ato id  a r t h r i t i s ,  t h a t  much co u ld  
be g a in ed  by in v e s t ig a t in g  th e  t r u e  in t e r a c t io n s  o f th e  go ld  com­
pounds a t  a  c e l l u l a r  and m o lecu la r l e v e l .  To t h i s  end I  was f o r tu n a te  
to  b eg in  c o l la b o r a t iv e  work w ith  P ro fe s s o r  C o lin  J .L .  Lock, P ro fe s s o r
-  V  -
o f C hem istry , I n s t i t u t e  f o r  M a te r ia ls  R esearch , McMaster U n iv e r s i ty  
and to  s e t  up my i n i t i a l  l a b o ra to r y  base  a t  McMaster U n iv e r s i ty  
un d er th e  d i r e c t io n  o f  P ro f e s s o r  J , F r a s e r  M ustard (P ro fe s s o r  o f  
P a th o lo g y , V ic e -P re s id e n t o f  H e a lth  S c ie n c e s ) .
An o u t l in e  o f  th e  h i s to r y  o f  go ld  in  m ed icine  and th e  
subseq u en t s e r e n d ip i to u s  e v o lu tio n  o f th e  u se  o f g o ld  com plexes in  
th e  tre a tm e n t o f  rheum ato id  d is e a s e  i s  o u t l in e d  to  i l l u s t r a t e  m an 's 
i n t e r a c t io n  w ith  g o ld  th ro u g h  th e  c e n tu r ie s  a s  a  h e a l in g  a g e n t .  The 
c l i n i c a l  s tu d ie s  in  c h a p te r s  I I I ,  IV  and V in c lu d e  p a t i e n t s  from 
b o th  Q ueen 's  U n iv e r s i ty ,  K in g sto n , O n ta rio  and McMaster U n iv e r s i ty ,  
H am ilton , O n ta r io , Rheum atic D isease  U n its .  These s tu d ie s  were 
d e s ig n e d  to  i d e n t i f y  th e  c l i n i c a l  r i s k s  and b e n e f i t s  in  th e  u se  o f  
g o ld  sodium th io m a la te  in  th e  t r e a tm e n t o f  rheum ato id  a r t h r i t i s . I t  
i s  hoped t h a t  th e  in fo rm a tio n  conveyed in  th e se  c h a p te r s  and my c o r r e s ­
ponding p u b l ic a t io n s  in  th e  m ed ica l l i t e r a t u r e  w i l l  se rv e  a s  a  g u ide  
to  p r a c t i s in g  c l i n i c i a n s  in  th e  u se  o f  th e  a n t i - a r t h r i t i c  g o ld  com­
pounds .
The chem ical s t r u c t u r e  o f th e  commonly u sed  a n t i - a r t h r i t i c  
g o ld  compounds, g o ld  sodium th io m a la te  and go ld  th io g lu c o s e  have 
n e v e r  been d e te rm in e d : a  f a c t o r ,  n o t r e l a t e d  to  la c k  o f  i n t e r e s t  on 
th e  p a r t  o f  c h e m is ts , b u t  r a t h e r  to  th e  com plex ity  o f  go ld  c h e m is try . 
C h ap te r VI o u t l in e s  some o f  th e s e  f a c t o r s .  C le a r ly  th e  mechanism o f 
a c t io n  o f th e  b e n e f i t s  and t o x i c i t i e s  r e l a t e d  to  th e  g o ld  compounds 
co u ld  be more e a s i l y  u n d e rs to o d  i f  t h e i r  chem ical s t r u c tu r e  and sub­
s e q u e n tly  t h e i r  b io -m o le c u la r  i n t e r a c t io n s  were known.
-  V I
The l a s t  two c h a p te rs  c o n ta in  two co m p le te ly  new o b s e rv a tio n s  
p e r ta in in g  to  th e  fo rm u la tio n  and mechanism o f a c t io n  o f g o ld  sodium 
th io m a la te .  C hap ter VII i l l u s t r a t e s  my f in d in g s  which d em o n stra te  
t h a t  g o ld  sodium th io m a la te  a s  c u r r e n t ly  m arketed i s  a  m ix tu re .
S e p a ra tio n  of th e  com ponents o f  t h i s  m ix tu re  cou ld  p o t e n t i a l l y  r e s u l t  
in  th e  p ro d u c tio n  o f  a  compound w hich i s  l e s s  to x ic  o r  perh ap s even 
more e f f e c t i v e .  I n  c h a p te r  VTII I  have d e s c r ib e d  my o b s e rv a tio n s  on 
th e  in h i b i to r y  e f f e c t  o f g o ld  sodium th io m a la te  on th e  throm bin  enzyme.
T h is  f in d in g  cou ld  have p o t e n t i a l l y  f a r  re a c h in g  im p lic a t io n s  in  th e
.management o f th rom bo-em bolic d is e a s e s ,  lu p u s  n e p h r i t i s  and th ro m b o tic
-v a s c u l i t i c  d i s o r d e r s .
I  hope t h a t  th e  c o n te n t o f  t h i s  t h e s i s  w i l l  enhance th e  c u r r e n t  
knowledge o f th e  c l i n i c a l  u se  o f  g o ld  compounds in  a r t h r i t i s  and a ls o  
p ro v id e  some f u r t h e r  i n s ig h t  in t o  u n d e rs ta n d in g  th e  b io lo g ic a l  a c t io n  
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SUMMARY
The d is c o v e ry  t h a t  g o ld  compounds a re  b e n e f i c i a l  in  th e  
tre a tm e n t o f  rheum ato id  a r t h r i t i s  i s  p o s s ib ly  th e  g r e a t e s t  b re a k ­
th ro u g h  in  th e  management o f  t h i s  d e v a s ta t in g  c r ip p l in g  d is e a s e  
w hich we w i l l  w itn e ss  in  t h i s  c e n tu ry .  T h is  t h e s i s  d e s c r ib e s  |
my c l i n i c a l  and r e s e a r c h  e x p e rie n c e  w ith  g o ld  compounds ov er th e  
p a s t  seven  y e a rs  and a l s o  c o n ta in s  my a tte m p ts  to  u n d e rs ta n d  some 
o f  th e  c l i n i c a l ,  chem ica l and b io lo g ic a l  a c t io n s  o f th e  a n t i -  
a r t h r i t i c  g o ld  com plexes, in  th e  hope t h a t  my o b s e rv a tio n s  may 
prove b e n e f i c i a l  to  th e  management o f  p a t i e n t s  w ith  rheum ato id  
a r t h r i t i s .
C h ap te r I  and I I  d e s c r ib e  th e  h i s to r y  o f  g o ld  in  m edicine 
and i t s  subseq u en t u se  a s  an a g e n t i n  th e  t re a tm e n t o f  rheum ato id  
d is e a s e .  G o l d ' s  presum ed m ag ica l q u a l i t i e s  and i t s  resem blance 
to  th e  "esse n ce"  o f th e  sun made i t  a  n a tu r a l  ch o ice  a s  a  h e a l in g  
a g e n t by p r i e s t s  and shamen. The " sc ie n c e "  o f  alchem y re v o lv e d  
around  th e  s e a rc h  f o r  th e  " q u in ta  e ssen ce"  o r  p h i lo s o p h e r 's  s to n e , 
w hich would tu r n  base  m e ta ls  i n to  g o ld  o r  d iv u lg e  th e  s e c r e t  f o r  
th e  e l i x i r  o f  l i f e ,  Moses b u rn in g  o f  th e  Golden C a lf  and f o r c in g  
th e  C h ild ren  o f  I s r a e l  to  d r in k  a  p o tio n  made o f  th e  a sh e s  i s  
p ro b ab ly  one o f th e  e a r l i e s t  a c c o u n ts  o f  th e  p r a c t ic e  o f alchem y 
in v o lv in g  g o ld . S ig n i f i c a n t  m ile s to n e s  in  th e  c h em is try  o f  g o ld  
were p ro b a b ly  Y a b ir 's  d e s c r ip t io n  in  th e  8 th  c e n tu ry  o f  aqua r e g ia
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and Roger B aco n 's  d e s c r ip t io n  in  th e  1 3 th  c e n tu ry  o f go ld  c h lo r id e  
and i t s  u se  in  le p ro s y .  The f i r s t  a tte m p t in  modem tim e s  to  r e l a t e  
th e  m ed ica l u se  o f a  g o ld  compound to  i t s  ch e m is try  was th e  d e s c r ip ­
t i o n  in  1811 by two F rench  P ro fe s s o r s ,  P ie r r e  F ig u ie r  and Andre-  
Jean  G h re s tie n , o f th e  u se  of go ld  sodium c h lo r id e  in  s y p h i l i s  and 
tu b e r c u lo s i s .  Koch ' s  o b s e rv a tio n  in  I 89O t h a t  g o ld  cy an id e  in h ib i t e d  
th e  grow th o f  tu b e rc le  b a c i l l i  in  v i t r o  h e ra ld e d  th e  u se  o f  g o ld  
compounds in  th e  t r e a tm e n t o f  tu b e rc u lo s is  ov er th e  n e x t 40 y e a r s .
I t  was Jacque  F o r e s t i e r 's  e rro n eo u s  assum ption  t h a t  tu b e rc u lo s is  and 
rheum ato id  d is e a s e  had s im i la r  p a th o g e n e s is , t h a t  le d  to  th e  u se  o f 
g o ld  compounds in  th e  tre a tm e n t o f  rheum ato id  a r t h r i t i s .  I n  1933»
S i r  S ta n le y  D avidson o f  E d inburgh , Chairman o f  th e  S c i e n t i f i c  A dvisory  
Committee o f th e  Empire Rheumatism C o u n c il, p roposed  a  m u l t i - c e n tr e  
c o n t ro l le d  double b l in d  t r i a l  to  in v e s t ig a te  th e  u se  o f go ld  sodium 
th io m a la te  in  rheu m ato id  a r t h r i t i s .  World War I I  d is ru p te d  th e  
su c c e ss  o f  t h i s  i n i t i a l  p ro p o sa l b u t th e  l a t e  D r. Thomas N. F ra s e r  
o f Glasgow re p o r te d  h i s  s e c t io n  o f  th e  m u l t i - c e n tr e  t i a l .  D r. F r a s e r 's  
t r i a l  which was th e  f i r s t  p u b lish e d  d o u b le -b lin d  c o n t ro l le d  t i d a l  o f  
any a n t i - rh e u m a tic  d ru g , d em o n stra ted  t h a t  g o ld  sodium th io m a la te  was 
e f f ic a c io u s  in  82^ o f h i s  p a t i e n t s .  The Empire Rheumatism C ouncil 
T r i a l  was e v e n tu a l ly  p u b lish e d  in  196O and confirm ed  D r . F i a s e r ' s  
f in d i n g s .
U n fo r tu n a te ly  g o ld  th e ra p y  r e s u l t s  in  t o x i c i t y  in  a t  l e a s t  
30^  o f  p a t i e n t s .  I t  was to  i d e n t i f y  some o f  th e s e  r i s k  t h a t  I  
engaged in  th e  c l i n i c a l  s tu d ie s  re p o r te d  in  c h a p te rs  I I I ,  IV and V.
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p r io r  g o ld  th e ra p y  in f lu e n c e  th e  subsequen t outcome in  p a t i e n t s  
t r e a t e d  w ith  D -p e n ic i lla m in e . The r e s u l t s  in d ic a te d  t h a t  th e r e  was 
no s ig n i f i c a n t  d i f f e r e n c e  in  outcome o f  p a t i e n t s  t r e a t e d  w ith
My f in d in g s  in d ic a te d  t h a t  s i d e - e f f e c t s  such a s  r a s h ,  mouth u lc e r
and p r o te in u r ia  had p r e d ic ta b le  p a t t e r n s  o f developm ent, a l l  p re ­
d o m in an tly  o c c u rr in g  w ith in  th e  f i r s t  y e a r ,  w hereas th rom bocy topen ia  
and low w h ite  b lo o d  c e l l  coun t co u ld  appear a t  any tim e . No p r e -  
d ic t iv e  c o r r e l a t e s  cou ld  be e s ta b l i s h e d  f o r  p a t i e n t s  who had gone 
in t o  s u s ta in e d  re m is s io n , b u t th e  d a ta  s t r o n g ly  su g g es ted  t h a t  
p a t i e n t s  who improve w ith in  s ix  m onths may c o n tin u e  g o ld  th e ra p y  f o r  
up to  th r e e  y e a rs  w ith  an in c r e a s in g  m argin o f  s a f e ty  f o r  m ucocuta- 
neous and r e n a l  t o x i c i t y .  I n  c h a p te r  IV my s tu d ie s  in d ic a te  t h a t  
th e  e ld e r ly  rheum ato id  p a t i e n t  (>60 y e a rs )  re sp o n d s  j u s t  a s  w e ll to  
g o ld  sodium th io m a la te  a s  h is  o r h e r  younger c o u n te rp a r t  and t h a t  
th e  t o x i c i t y  r a t e  i s  s im i la r  in  th e  two age g ro u p s . A n o te  o f c a u t io n  
i s  r e q u ire d  how ever, a s  i t  was d em o n stra ted  t h a t  se id o u s  haem ato- 
l o g i c a l  a b n o rm a lity  o c c u rre d  on ly  in  paÆ ients o v e r 47 y e a r s ,  and 
n e p h ro tic  syndrome o c c u rre d  o n ly  in  p a t i e n t s  o ld e r  th a n  52  y e a r s .
I n  c h a p te r  V th e  c l i n i c a l  s tu d y  d is c u s s e s  th e  q u e s t io n ,  does
I
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D -p e n ic i l la m in e , w ith  r e s p e c t  to  t o x i c i t y ,  w hether th e y  had. pre^/ious 
g o ld  t o x i c i t y ,  p re v io u s  g o ld  b u t no t o x i c i t y  o r  no p re v io u s  g o ld  
th e ra p y . T p ta l  g o ld  compound re c e iv e d  had no e f f e c t  on th e  e v e n tu a l 
outcome o f  D -p e n ic illa m in e  t r e a tm e n t .  The d is c u s s io n  in  c h a p te r  V 
e x p la in s  t h a t  D -p e n ic illa m in e  i s  n o t  a  c h e la t in g  a g en t f o r  th e  Au( l )  




D -p e n ic illa m in e  and A u (l)  in  v ivo  sh o u ld  n o t he r e f e r r e d  to  
a s  such .
P erhaps one m ajor re a so n  a s  to  why th e  mechanism o f  a c t io n  
o f th e  g o ld  com plexes have n o t been id e n t i f i e d  i s  th e  f a c t  t h a t  
th e  s t r u c t u r e  o f  th e  two most commonly used  go ld  compounds, g o ld  
sodium th io m a la te  and g o ld  th io g lu c o s e  a re  unknown. Both o f  th e se  
compounds have go ld  i n  th e  A u (l) o x id a tio n  s t a t e  and because  o f 
th e  known ch e m is try  o f  g o ld , b o th  a re  p ro b ab ly  polym ers a rran g ed  
th ro u g h  r e c u r r in g  g o ld -s u lp h u r  bonds.
My e a r ly  r e s e a r c h  w ith  go ld  sodium th io m a la te  le d  to  th e  
o b se rv a tio n  t h a t  g o ld  sodium th io m a la te  co u ld  e x i s t  a s  b o th  a  
c o lo u r le s s  and a  y e llo w  s o lu t io n .  I f  go ld  sodium th io m a la te  ( s o l id )  
i s  added to  w a te r , a  c o lo u r le s s  s o lu t io n  i s  p roduced ; how ever, i f  
t h i s  s o lu t io n  i s  h e a te d  a t  100°C f o r  30 m inu tes a s  in  th e  s ta n d a rd  
m ark e tin g  p ro c e d u re , a  y e llo w  s o lu t io n  a p p e a rs . I t  i s  t h i s  yellow  
s o lu t io n  which i s  g iv e n  to  p a t i e n t s  w ith  rheum ato id  a r t h r i t i s .
Hydrogen-1  n u c le a r  m agnetic  re so n an ce  s p e c t r a  show no d if f e r e n c e  
betw een th e  two s o lu t io n s .  Both th e  c o lo u r le s s  and y e llo w  s o lu t io n  
i n h ib i t e d  th e  mixed lym phocyte c u l tu r e  r e a c t io n  and a ls o  th e  a c t io n  
o f th rom bin  on human p l a t e l e t s .  However, u l t r a - v i o l e t - v i s i b l e  
sp e c tro sc o p y  re v e a le d  t h a t  th e re  was a  d i f f e r e n c e  in  th e  two s o lu ­
t i o n s  w ith  an abso rbance  in  th e  300-450 nm ran g e  a c c o u n tin g  f o r  
th e  y e llo w  c o lo u r .  I n  t h e i r  d i r e c t  i n t e r a c t io n  w ith  human p l a t e ­
l e t s  th e  ye llow  s o lu t io n  in d u ced  an ADP dependen t p l a t e l e t  a g g re g a tio n . 
The c o lo u r le s s  s o lu t io n  d id  n o t a f f e c t  th e  p l a t e l e t s .  E le c tro n
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m icroscopy and energy  d is p e r s iv e  a n a ly s i s  a l s o  re c o rd e d  a  d i f f e r e n c e  
in  t h a t  p l a t e l e t s  t r e a t e d  w ith  th e  yellow  s o lu t io n  c o n ta in e d  p a r t i ­
c u la te  m a te r ia l  IOO-7OO nm in  le n g th  which was phagocy tosed  w ith in  
th e  ly so so m es. P l a t e l e t s  t r e a t e d  w ith  th e  c o lo u r le s s  s o lu t io n  a ls o  
c o n ta in e d  a  p a r t i c u l a t e  component h u t th e se  were < 40 nm. The 
p a r t i c l e s  from  p l a t e l e t s  t r e a t e d  w ith  bo th  th e  c o lo u r le s s  and yellow  
s o lu t io n  c o n ta in e d  g o ld  and s u lp h u r .  The above f in d in g s  in d ic a te  
t h a t  g o ld  sodium th io m a la te  (y e llo w  s o lu t io n )  a s  c u r r e n t ly  m arketed 
f o r  human u s e ,  i s  a  m ix tu re . I f  th e  b e n e f i c ia l  and to x ic  p r o p e r t i e s  
o f t h i s  compound can be i d e n t i f i e d  and s e p a ra te d  t h i s  cou ld  r e s u l t  
i n  a  m ajor advance in  th e  th e r a p e u t i c s  o f rheum ato id  d is e a s e .  I n  
c o l la b o r a t io n  w ith  my c o lle a g u e s  a  s e p a ra t io n  p ro c e s s  f o r  th e  comp­
o n en ts  o f  g o ld  sodium th io m a la te  h as  been e s ta b l i s h e d  and i n i t i a l  
b io lo g ic a l  ex p erim en ts  have been com pleted . D e ta i l s  o f t h i s  i n f o r ­
m ation  i s  n o t  conveyed in  t h i s  t h e s i s  a s  i t  i s  th e  s u b je c t  o f  a  
p a te n t  a p p l ic a t io n  su b m itted  in  Canada and th e  U .S .A . by McMaster 
U n iv e rs i ty  on b e h a lf  o f P ro fe s s o r  C o lin  J .L ,  Lock (P ro fe s s o r  o f 
C h em is try ) , M iss D ebra Harvey (Ph .D . s tu d e n t -  g o ld  ch e m is try )  and 
m y se lf .
F in a l ly ,  i n  C h ap te r V III my o b se rv a tio n s  t h a t  g o ld  sodium 
th io m a la te  i n h i b i t s  th e  s e r in e  e s te r a s e  th rom bin  i n  v i t r o  and in  
v ivo  i s  d e s c r ib e d .  Gold sodium th io m a la te  i n h i b i t s  th e  a c t io n  o f  
th rom bin  on washed human p l a t e l e t s  and th e  throm bin  c l o t t i n g  tim e 
o f  p l a t e l e t  r i c h  p lasm a and p l a t e l e t  poor p lasm a. U sing  an e x p e r i ­
m en tal model o f  e x p e r im e n ta lly  induced  th ro m b o sis  i t  was shown t h a t  
r a b b i t s  t r e a t e d  w ith  p h a rm aco lo g ica l c o n c e n tra tio n s  o f  g o ld  sodium 
th io m a la te  had s i g n i f i c a n t l y  reduced  throm bus w eigh t compared to
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c o n t r o l s .  Gold sodium th io m a la te  had no e f f e c t  on f i b r i n o l y s i s  
n o r  p l a t e l e t  s u r v iv a l ,  th e r e f o r e  th e  re d u c t io n  in  throm bus 
w eigh t was most l i k e l y  due to  th e  d i r e c t  i n h i b i t i o n  o f  th e  throm bin  
a s  was observed  v i t r o . C le a r ly  such a  f in d in g  cou ld  have f a r
re a c h in g  consequences in  th e  t r e a tm e n t o f v a s c u l i t i s ,  lu p u s  
g lo m e ru lo n e p h r i t is , co ro n ary  a r t e r y  d is e a s e  and c e re b ro -v a s c u la r  
d i s e a s e .
T h is  t h e s i s  i s  n o t an end to  th e  work d e s c r ib e d  h e re in  
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"The h i s t o r y  o f  s c ie n c e  i s  
s c ie n c e  i t s e l f  . . .  "
Johann Wolfgang Von G oethe (1749-1832)
enhancing  b e a u ty  and p e rp e tu a t in g  s la v e ry .  M an's l u s t  f o r  go ld  
a s  a  so u rce  o f  w e a lth  and b e a u ty  a ls o  in flam ed  h is  sav ag e ry  demon­
s t r a t e d  by th e  c r u e l ty  o f  th e  sw eat p i t s  in  th e  a n c ie n t  N ubian, 
E g y p tia n , A rab ian  and European g o ld  m ines.
. . .  "But g o ld  s h in e s  l i k e  f i r e  
b la z in g  in  th e  n ig h t ,  supreme of 
l o r d l y  w e a lth ."
P in d a r  ( c i r c a  518-438 B .C .)
Olympian Odes I  l i n e  i .
M an's w orsh ip  has made "Gold" th e  g r e a t e s t  m o n o th e is tic
d e i ty  in  th e  h i s to r y  o f c i v i l i s a t i o n .  The d a z z le  and a l l u r e  o f  i t s
b r i l l i a n c e  has e n th r a l le d  men s in c e  th e  dawn o f t im e . Gold i s  th e
lo d e s to n e  o f th e  eyes and th e  h e a r t ,  g ra n tin g  p eace , waging w ar. I
G o ld 's  r a r i t y  and u n iq u e  s t a b i l i t y  i s  th e  b a s is  o f  i t s  v a lu e . 
S o la r  s p e c t r a l  a n a ly s i s  in d i c a te s  t h a t  w h ile  g o ld  i s  p re s e n t  a t  0 .0 4  
p a r t s  p e r  m il l io n  in  th e  su n , in  th e  E a r t h 's  c r u s t  i t  i s  o n ly  app rox ­
im a te ly  0 .0 0 4  p a r t s  p e r  m i l l io n  ( l ) , I t  e x i s t s  as  th e  m e ta l o r  in  
m in e ra l fo rm , e i t h e r  a s  T e l lu r id e s ,  such  a s  c a l a v e r i t e  o r k r e n n e r i te  
o r  to  a  l e s s e r  e x te n t  a s  a u r i f e r o u s  su lp h id e s  ( l , 2 ) .  The go ld  known 1
to  a n c ie n t  man, how ever, was o b v io u s ly  th e  f a m i l i a r  a l l u v i a l  o r  p la c e r  
d e p o s i t s  o f  g o ld  n u g g e ts  o r  g ra n u le s  (F ig u re  1 ) .  We can on ly  su rm ise  
th e  awe and wonder b eh e ld  by th e  d is c o v e re r  when th e  f i r s t  h a i ry  human­
o id  hand g rasp ed  t h a t  heavy g l i t t e r i n g  t r e a s u r e  from  th e  sandy s tre a m .
"G old; G old; G old; G old;
B rig h t and y e llo w , h a rd  and c o ld ."
Thomas Hood (1799-1845)
-  10 -
FIGURE 1 ; Electrum; A n a tu r a lly  occurring a l lo y  
o f 80^ go ld  and 20^ s i l v e r .
Gold: Gold nugget which occurs alm ost
in  pure form in  n atu re.
3 ; t i
- 1 1  -
Who th e  f i r s t  g o ld m in ers  and g o ld sm ith s  w ere, we s h a l l  n e v e r  
know (F ig u re  2 ) .  Gold was c e r t a i n l y  known to  th e  a n c ie n t  peop le  o f  
B u lg a r ia .  The o ld e s t  g o ld  t r e a s u r e  known a t  p re s e n t  i s  th e  Varna 
t r e a s u r e  o f ap p ro x im a te ly  2 ,000  g o ld  p ie c e s  w eighing 5*5 k ilo g ra m s , 
A ccording to  D r. T .P . Mohide ( 2 ) ,  t h i s  t r e a s u r e  i s  t r a c e a b le  to  th e  
T ra n sy lv a n ia n  g o ld  m ines o f Romania and p ro b ab ly  Mount Pangion in  
Thrace (now B u lg a r ia ) .
The e a r l i e s t  form s o f o rg an iz ed  r e t r i e v a l  o f g o ld  was from  
a l l u v i a l  beds by g le a n in g , w ashing o r  s t r i p  m in in g . I n  th e  a l l u v i a l
s tre a m s , th e  s i l t  and sand was washed th ro u g h  anim al h id e s  such a s  
sh e e p sk in . The h id e  was a llo w ed  to  d ry  and th e  go ld  p a r t i c l e s  
s e p a ra te d .  These a n c ie n t  crude  methods were p ro b ab ly  th e  b a s is  o f 
th e  le g en d  o f th e  Golden F le e c e ,  I n  th e  le g e n d , Ja so n  o f  T h e ssa ly  
and h i s  A rgonauts s e t  s a i l  to  C o lc h is  (now in  th e  S o v ie t  R epub lic  o f  
G eo rg ia) to  s t e a l  th e  Golden F le e c e  ( 3) (F ig u re  3 ) •  The myth was 
p ro b ab ly  based  on a  G reek e x p e d itio n  to  s t e a l  some o f  th e  g o ld  b e in g  
r e t id e v e d  from  th e  sh o re s  o f  th e  B lack S ea .
I
:■
As w ith  many o th e r  a s p e c ts  o f  c i v i l i s a t i o n ,  th e  e a r ly  p eo p les
_
of th e  e a r ly  Mesopotamion c u l tu r e s  developed  s k i l l s  in  m e ta l w ork ing .
Legend su g g e s ts  t h a t  when A t la n t i s  was b e in g  e n g u lfe d  by th e  waves
■ 'ii(now th o u g h t to  be th e  d e s t r u c t io n  o f  th e  Minoan c i v i l i s a t i o n  on C re te  
by th e  tsunam i c r e a te d  by th e  v o lc a n ic  d e s t r u c t io n  o f  T hera o r  
S a n to r in i )  th e  p eo p le  s e t  s a i l  i n  g r e a t  b o a ts  in  s e a rc h  o f la n d .  Were 
th e se  t a l l  d a rk  h a i r e d  Sum erians (F ig u re  4) who a r r iv e d  on th e  sh o re s
-  12 -
FIGURE 2; Metal sm ith u s in g  blowpipe to  in t e n s ify
the heat in  h is  fo r g e . In  h is  r ig h t  hand 
he u ses  fo rcep s  to  hold metal p ie c e s  over  
the glow ing c o a ls .  His trade and t o o ls  have 
not ap p reciab ly  changed fo r  5 ,000 y ea rs .





C0Tji—1 0in O x : d•H W) -p 0 1Æ üO 0 I—j 0 cH1—4 cd 0 3O -p 0 U 0ü -P Ü NW) 03 ■PCh C o
WO O-P -Ptjû AG CD •P
W a g -P 0rHX3 0 03-pa cd 3 &
a 03 3•H O(H ÊO 0 3 d 30 O 3 0
0 % X 03-P d 0x : •P U 3tjû 3 03 bO -P 03
ê  s Ch0 S '4:3■d f—t 3^ • 5nJ o 0 00) -p X i 0 ü-d •P X 3<0 -p -p cd£ W)S X  o03 3 -p03 (d Ch0) U o4^ d0) 0 d Chü bO 3 0 (HA 3 3 H êO •H (0 Ch03 P40 (d0 cd<33 0 0Æ iH -p d 3E-t 03 0 O03 £c i cdU d 003 g•H03 1d §3 1
jG 3 «H OA 0 OO d cd oü 0 0 d 03




FIGURE 4 ; F r ieze  ( c ir c a  8th  century B .C .) from
the p a lace  o f  King Sargon I I , in  Khorsahad.
I t  d e p ic ts  two Sumerian p r ie s t s .  The 
f i r s t  i s  carry ing  a g a z e l le  and ho ld in g  a 
mandrake flo w er  in  h is  hand; the second i s  
hold in g  poppy se e d s .
(Musee du Louvre, P a r is , A n tiq u ités  O r ien ta les)
15 -
o f  th e  "Land o f  th e  Two R iv e rs"  r e a l l y  th e  s k i l l e d  m eta l sm ith s  
o f A t la n t i s  (4 )?  Over 4000 y e a rs  ago th e  b u s t l i n g  c i t i e s  o f L agash, 
Urafc, Sumer and Ur (F ig u re  5 ,6 )  were renowned f o r  t h e i r  m e ta l-w o rk in g . 
These a n c e s to r s  o f  th e  A ssy ro -B ab y lo n ian s  in v e n te d  th e  w heel and 
produced  th e  e x q u i s i t e ly  f i n e  je w e l l r y  and cerem o n ia l weaponry found 
i n  th e  d ig g in g s  o f U r ( 2 ,4 ,5 ) .  W ith th e  r i s e  o f  th e  P h aro an ic
c i v i l i s a t i o n  in  lo w er E gyp t, many o f  th e  s k i l l s  o f  th e  o th e r  a re a s  of
th e  M iddle E a s te rn  c u l tu r e s  were im p o rted  in to  th e  N ile  D e l ta .  Gold 
was c e r t a in l y  known to  th e  a n c ie n t  E g y p tian s  from  a s  e a r ly  a s  4000 B .C. 
D e sp ite  th e  s p e c ta c u la r  t r e a s u r e s  of Tutankharaun’s g ia v e  (F ig u re  7 ,8 ,9 )  
w hich d e p ic t  th e  u n b e l ie v a b le  w e a lth  and m a g n if ic e n t m e ta l c ra ftsm a n ­
s h ip  o f a n c ie n t  Egypt (F ig u re  lO ) , i t  i s  o f i n t e r e s t  t h a t  Gordon (5)
in  h i s  t r e a t i s e  on M edicine T h ro u g h o u t. A n tiq u ity  makes no m ention o f 
th e  m e d ic in a l u se  o f  g o ld  by  th e  E g y p tia n s .
A lthough th e  span  of th e  y e a rs  betw een known e v e n ts  in  th e  
dawn o f  c i v i l i s a t i o n  i s  m inim ised by d is ta n c e ,  i t  i s  p e rh ap s  n o t s u r ­
p r i s in g  t h a t  by th e  tim e  2000 y e a rs  had e la p se d , m eta l w orking s k i l l s  
and knowledge o f g o ld  m in ing  te c h n iq u e s  had sp read  from  th e  M iddle E a s t 
to  th e  most w e s te r ly  s h o re s  o f Europe and to  th e  Shang c i v i l i s a t i o n  in  
th e  Y angtse v a l le y  in  E a s te rn  C hina . The a n c ie n t  peop le  o f  I r e la n d  o r  
P r o to - C e l ts ,  were g o ld m in ers  and g o ld sm ith s  a s  e a r ly  a s  2000 B.C. and 
numerous t r e a s u r e s  e x i s t  in  th e  N a tio n a l Museum o f I r e l a n d ,  th e  Royal 
I r i s h  Academy and T r i n i t y  C o lleg e  in  D ub lin  ( 2 ) .
E a r ly  man p ro b a b ly  b e l ie v e d  t h a t  g o ld  p o sse sse d  m ag ica l and 
even d iv in e  p r o p e r t i e s .  I t  i s  n a tu r a l  to  im agine how man’s  f a n a t i c a l  
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FIGURE 6 t CITY OF UR.
A shepherd and h is  f lo c k  pass the ru in s  o f  the  
C ity  o f  Ur (foreground) w ith the Z iggarut in  
the background (se e  Figure 5 ) •  The d ig g in g s  o f  
Ur have rev ea led  the c i t y ' s  fou n d ation s, 
in c lu d in g  r e s id e n t ia l  and commercial c en tre s  
composed around a network o f la n e s ,  which lin k ed  
s c h o o ls , shops, d w e llin g s  and p la ce s  o f  w orship.
— 18 —
FIGURE 7 ! Gold p la ted  mask o f the famous 
Tutankhamun sarcophagus.
-  19 -
FIGURE 8 ! T his sp len d id  scene i s  carved on the
back o f  King Tutankhamun' s golden th ro n e . 
I t  probably d e p ic ts  h is  coron ation , w ith  
Ankhesenamun, h is  Queen, an o in tin g  him 
w ith  perfume.
1-  20 -
, FIGURE 9 ; Dagger h i l t  from the treasu re o f Tutankhamun ' s
tomb. The a r t i s t r y  in  go ld  i s  known as gran u lation , 
The diamond and z ig za g  p a ttern s are made o f minute 
gold  spheres the s iz e  o f poppy se e d s .
-  21 -
FIGURE 1 0 ; Gold s ta tu e  o f  Amen, lo c a l  d e ity  o f  Thebes 
e lev a ted  to  ru lin g  god o f Egyptian pharoahs, 
whose tem ple p r ie s t s  included  h e a le r s .  
(M etropolitan  Museum o f  A rt, New York)
2 2
"esse n ce"  o r " s p i r i t u a l i t y "  o f t h i s  s h in in g  m e ta l.  The a n c ie n t  
c u l tu r e s  u s u a l ly  a s c r ib e d  c o r p o r e a l i ty  to  n a tu r a l  e v e n ts  such  as  
f lo o d s ,  e a r th q u a k e s , d e a th  and d i s e a s e .  I l l n e s s  was th o u g h t to  
r e s u l t  from  s in  and cou ld  on ly  be r e l i e v e d  by w orsh ip  o r  th e  in c a n ­
t a t i o n s  o f  a  p r i e s t  o r  shaman (F ig u re  l l ) , I t  w i l l  n ev e r be known 
which c u l tu r e  f i r s t  u sed  g o ld  a s  a  h e a l in g  a g e n t ,  b u t W eigleb 
re c o rd s  t h a t  th e  e a r l i e s t  a t t r i b u t a b l e  u se  o f  go ld  a s  a  m e d ic in a l 
ag en t was by th e  C hinese ( 6 ) .  I n  H is to r is c h - K r i t i s c h e  U ntersuchang  P e r  
Alchemie he s t a t e s  t h a t  in  th e  w r i t in g s  o f th e  n in th  p ro v in ce  and th e  
te n th  c i t y  o f  th e  same name, a  la r g e  b lo c k  o f  g o ld  e x is te d  which had 
been used  s in c e  2500 B .C. to  cu re  s ic k n e s s  and i l l s .
To a n c ie n t  man, g o ld  was th e  sun on e a r th .  With th e  r i s e  of 
th e  Greek c i v i l i s a t i o n  and th e  te a c h in g s  o f A r i s t o t l e , t h a t  a l l  sub­
s ta n c e s  a r e  on ly  d i f f e r e n t  form s o f  th e  same fundam ental su b s ta n c e , 
came th e  a lc h e m is t 's  h y p o th e s is  t h a t  base  m e ta ls  cou ld  be tu rn e d  in to  
g o ld  i f  one co u ld  command th e  m a g is te ry  over th e  fo u r  e lem en ts  o r  
e s s e n c e s , a i r ,  e a r th ,  f i r e  and w a te r . M an ipu la tion  o f  t h i s  p r in c ip le  
r e q u ire d  th e  knowledge o f  th e  Q u in ta  e ssen ce  o r p h i lo s o p h e r 's  s to n e .
I t  i s  e asy  to  im agine how in c a n ta t io n s  o f  th e  a n c ie n t  p r i e s t s  in  se a rc h  
o f  th e  q u in te s se n c e  le d  to  th e  b i r t h  o f alchem y and th u s  a l s o  to  th e  
u se  o f g o ld  a s  a  h e a l in g  a g e n t .
The a u ra  o f re v e re n c e  bequea thed  on th e  m e ta l go ld  by th e  
a n c ie n t  c u l tu r e s  and r e l i g io n s  i s  e x e m p lif ie d  in  The Holy B ib le .
Exodus, C hap ter 25 where God g iv e s  Moses i n s t r u c t io n s  f o r  th e  c o n s tru c ­
t i o n  of th e  Ark o f th e  C ovenant, now b eh e ld  a s  th e  most s a c re d  symbol
I
-  23 -
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FIGURE 11 :
Form ula on a  m edico-m agical p ap y ru s . Magic in c a n ta t io n  
o r  fo rm u la  used  by an E gy p tian  p r i e s t .  The t e x t  d a te s  
from  th e  tim e o f Rameses I I  ( c i r c a  1250 B .C .) .  The 
p a t i e n t  who has re c e iv e d  a  head wound, i s  i d e n t i f i e d  w ith  
Horus ' t h e  av en g er o f h i s  f a t h e r ' ( O s i r i s ) .  'He i s  H orus, 
o gods, th e  Lord o f  L i f e ,  who r i g h t f u l l y  ap p roaches th e  
house o f h i s  f a th e r '.  T hat no god o r  goddess, n e i th e r  male 
no r fem ale s p i r i t ,  n e i t h e r  dead man n o r dead woman, n o r 
any e v i l  b e in g , male o r  fe m a le , s h a l l  be a b le  to  ta k e  
p o sse ss io n  o f  th e  lim b s  o f  th e  son o f any woman, whomsoever 
he may b e , t o  p e r p e t r a te  a n y th in g  e v i l  o r b a d . '
Then w r i t te n  in  re d  in k :  "To be u t t e r e d  over th e  ta lo n s
o f  a  f a lc o n ,  over th e  s h e l l  o f a  t o r t o i s e .  B o il i t  and p u t 
i t  i n  o i l .  A noin t a  wounded man (w ith  i t )  on th e  s i t e  o f 
h i s  wounds. No e v i l  o r bad w i l l  b e f a l l  him . A r e l i a b l e  
rem edy, proven a  m i l l io n  tim es  o v e r ,"
(R ijk s  Museum Van Oudheden, Leyden, H o lla n d ).
-  25
o f  G od 's  p resen ce  among th e  Hebrew p e o p le .
"And th e y  s h a l l  make an a rk  o f s h i t t im  
wood; two c u b i t s  and a  h a l f  s h a l l  be 
th e  le n g th  th e r e o f ,  and a  c u b i t  and a  
h a l f  th e  b re a d th  th e r e o f ,  and a  c u b i t  
and a  h a l f  th e  h e ig h t th e r e o f .
And th o u  s h a l t  o v e r la y  i t  w ith  pure 
g o ld , w ith in  and w ith o u t s h a l t  though 
o v e r la y  i t ,  and s h a l t  make upon i t  a  
crown o f g o ld  round  a b o u t ."  (? )  (F ig u re  12)
The f re q u e n t r e f e r e n c e s  to  th e  u se  o f go ld  in  Exodus, may 
n o t be m erely  a s s o c ia te d  w ith  enhancing  th e  b eau ty  o f d iv in e  o b je c ts .  
D oberer (4 ) s u g g e s ts  t h a t  th e  Hebrew p ro p h e t Moses ( c i r c a  1500 B .C .) 
was p ro b ab ly  an accom plished  m ag ic ian  and had a  knowledge o f alchem y. 
I n  th e  B ib le ,  M oses' d e m o n stra tio n  o f th e se  t a l e n t s  i s  re c o rd e d  i n  
th e  d ra m a tic  acco u n t o f  th e  d e s t r u c t io n  o f  th e  Golden C a lf  (F ig u re  13 )
"And he to o k  th e  c a l f  which th e y  had made, 
and b u rn t  i t  i n  th e  f i r e ,  and ground i t  
to  pow der, and s traw ed  i t  upon th e  w a te r , 
and made th e  c h i ld r e n  o f I s r a e l  d r in k  o f 
i t . "  (8)
W hether Moses in te n d e d  th e  g o ld  s o lu t io n  a s  a  punishm ent o r 
a  th e r a p e u t ic  purge i s  n o t  r e a d i ly  i n t e r p r e ta b le  b u t he d id  convince 
th e  "c lea n se d "  to  engage in  w h o le sa le  s la u g h te r  o f th o se  I s r a e l i t e  
b re th re n  who d id  n o t  ad o p t th e  new Commandments (8 , 9 ) .  I n  O bserva- 
t io n e s  Q hvm ico-Phvsico-M edical. S ta h l  (lO ) (F ig u re  l4 )  s u g g e s ts  t h a t  
th e  g o ld  s o lu t io n  made by Moses was p ro b ab ly  a  g o ld -s u lp h u r  compound 
made from  a lk a l in e  wood a s h , s u lp h u r  and g o ld . T his a c t  perform ed 
by Moses su p p o rts  th e  co n cep t t h a t  he was an accom plished  a lc h e m is t 
(4) and p e rh ap s one o f th e  e a r l i e s t  o f t h a t  " f a c u l ty "  o f s c ie n c e .
— 26 —
FIGURE 1 ^ : "And they s h a l l  make an ark o f sh itt im
wood .............. And thou sh a lt  overlay  i t  w ith
pure go ld ."
Exodus 25 v e r se s  10 ,11 .
Even in  very  dry p la c e s , such as the S in a i 
d eser t and the lands around the Dead Sea, 
a ca c ia s  (or S h ittim  wood) s t i l l  th r iv e  and 
bear d e l ic a te  y e llo w  blossom s. Because the  
wood o f th is  thorny tr e e  i s  c lo s e  grained and 
hard, i t  has always been prized  by ca b in et­
makers -  hence i t s  s e le c t io n  for the Ark of  
the Covenant.
-  27 -
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FIGURE 13 ; GOLDEN CALFHeretical idol fashioned by Aaron for the Children of Israel, This gold coated bronze bull, 15 inches long, comes from the City of Byblos (circa 2000 B.C.).
(Musee Du Louvre, Paris)
— 28 —
figure 14; Dr. GEORG ERNST STAHL (l660-1734)
In Obervationes Chvmico-Phvsico-Medical Stahl suggests that the gold solution made by Moses from the burnt remains of the golden calf, was probably a gold-sulphur compound, made from the alkaline wood ash, sulphur and gold,
-  29 -
Alchemy, r e l i g i o n ,  h e a l in g  and p h ilo so p h y  were en tw ined  in  
an in s e p a ra b le  mesh. Almost e v e ry  a n c ie n t r e l i g io n  encom passes each  
o f  th e s e  fo u r  " s c ie n c e s " .  C irc a  600 B.C. th e r e  a ro se  in  C hina th e  
r e l ig io n -p h i lo s o p h y  o f  Taoism ( l i t e r a l l y  -  The Way), b ased  on th e  
te a c h in g s  of L a o - tse  ( c i r c a  604-531 B . C . ) .  L a o -tse  was a  p h ilo s o ­
pher who ad v o ca ted  th e  p r in c ip le s  o f  sim ple  h o n es t e x is te n c e  coupled  
w ith  n o n - in te r f e re n c e  w ith  th e  co u rse  o f  l i f e  ( l l ,1 2 ) o  However, one 
would c o n s id e r  th e  l a t t e r  p r in c i p le  c o n tra d ic te d  by th e  T a o is t  p h y s i­
c ia n s  who m a in ta in ed  t h a t  th e  m e d ic in a l p r o p e r t i e s  o f g o ld  u sed  in  
p o tio n s  and a s  c o a t in g s  f o r  p i l l s  co u ld  p ro lo n g  l i f e ,  cu re  i l l n e s s  
and c o n fe r  im m o r ta l i ty . L ike  th e  g o ld  ch e m is try  o f th e  European 
M iddle A ges, C hinese alchem y o f  th e  T a o is t  p h ilo so p h y  f e l l  in to  a  
d i s a r r a y  o f  m y s tic a l and a l l e g o r i c a l  th in k in g  in  th e  s e a rc h  f o r  th e  
e l i x i r  o f l i f e  (13 ) .
M ention of th e  m e d ic in a l u se  o f g o ld  appeared  in  th e  Roman 
and G reek l i t e r a t u r e  by th e  f i r s t  c e n tu ry  Anno Domini. P l in iu s  
Secundus (P lin y  th e  E ld e r ,  23 o r  24-79 A. D. ) ,  who d ie d  a t  S ta b ia e  
(C a s te llm a re  in  th e  Bay of N ap les) from  s u lp h u r  fumes d u r in g  th e  
e ru p tio n  o f V esuvius;,. d e s c r ib e d  th e  u se  o f g o ld  p o tio n s  a s  a  cure 
f o r  a l l  i l l s  from  s k in  r a s h  to  haem orrho ids in  book 33 o f  h i s  H is to r ia  
N a tu r a l is  ( l 4 ) . The Greek p h y s ic ia n ,  Pedonius D io sc o rid e s  ( c i r c a  
50 A.D.)  was a  s c i e n t i s t  and p h a rm a co lo g is t (F ig u re  I 5 ) who se rv ed  
in  N e r o ' s  army. D uring army e x p e d it io n s  to  S p a in , N orth  A fr ic a  and 
S y r ia ,  D io sc o rid e s  p ro b ab ly  a c q u ire d  th e  e x te n s iv e  knowledge to  
com pile De M ate ria  M edica which became a  le a d in g  p h arm aco lo g ica l t e x t  
f o r  s ix te e n  c e n tu r ie s .  I n  t h i s  work he su g g e s ts  th e  u se  o f g o ld  a s  a  
m e d ic in a l a g en t (15 ) .
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FIGURE 1 5 ; Heure s i s  hands over th e Mandragora to  
the Greek p h y sic ia n , D io sco r id es .
(O sterr e ich isch e  N a tio n a lb ib lio th e k , Vienna)
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P r io r  to  modem tim e s ,  s c i e n t i f i c  r e s e a r c h  was r a r e l y  used  
to  s tu d y  m ed ical p rob lem s. The f i r s t  b io lo g ic a l  experim en t i n  th e  
use o f g o ld  can p ro b ab ly  be a s c r ib e d  to  Wei Po-yang ( c i r c a  15O A.D.) 
who was a  Tao a lc h e m is t -p h y s ic ia n . He was re p o r te d  to  have had 
10 ,000 fo rm u lae  f o r  th e  p ro lo n g a tio n  o f l i f e ,  some o f  w hich c o n ta in e d  
g o ld . He r e a l i s e d  t h a t  h i s  g o ld  s o lu t io n s  d id  n o t alw ays p ro v id e  
b io lo g ic a l ly  r e p ro d u c ib le  r e s u l t s ,  th e r e f o r e  he would t e s t  h is  p o tio n s  
on dogs b e fo re  a d m in is te r in g  them t o  h i s  p a t i e n t s  (13 ) .
F o llow ing  th e  decay  o f th e  Roman c i v i l i s a t i o n ,  th e  s e a t  o f 
power g ra d u a l ly  r e tu rn e d  to  th e  M iddle E a s t .  By th e  y th  and 8 th  
c e n tu r ie s  Anno Domini th e  A rabs had e s ta b l i s h e d  t h e i r  r u l e  in  th e  N ear 
E a s t ,  P e r s i a ,  p a r t  o f  th e  M iddle E a s t and N orth  A f r ic a ,  S p a in , S i c i l y  
and I n d ia  a s  f a r  a s  th e  Malay A rc h ip e la g o . By t h i s  tim e a  s o p h is t ic a te d  
m ed ical and p h a rm a c e u tic a l e d u c a tio n  system  had been e s ta b l i s h e d  in  
P e r s ia  by th e  N e s to r ia n  C h r i s t i a n s . Three c e n tu r ie s  e a r l i e r , because  
o f r e l i g io u s  p e rs e c u t io n  from  r i v a l  C h r i s t i a n s ,  th e y  had em ig ra ted  
from  S y r ia  and e s ta b l i s h e d  h o s p i t a l s  and m ed ica l sch o o ls  in  th e  P e rs ia n  
c i t i e s  o f N is ib is  and G ondeschapur (16 ) . I t  was in  th e s e  i n s t i t u t i o n s  
t h a t  A rab ian  pharmacy and m edicine were b o rn . One o f  th e  most n o ta b le  
a lc h e m is ts  o f th e  p e r io d  was Abu Musa, Ib n  Hayyan, Y ab ir ( c i r c a  722-815 
A.D.)  a l s o  known a s  G eber. H is f a th e r  Hayyan, was a  p h a rm a c is t in  th e  
town o f K ufa, now a  sm a ll town in  I r a q .  Hayyan was a  fo llo w e r  o f  th e  
A bbasides and th u s  p o l i t i c a l l y  opposed to  th e  C a lip h , Y aaid I I .  F o r 
t h i s  he l o s t  h is  l i f e  b u t n o t b e fo re  f a th e r in g  a  son who was t o  become 
known a s  th e  f a th e r  o f modem pharmacy (17 ) . Sometimes r e f e r r e d  to  a s  
Abu Musa th e  W ise, Y ab ir was a  s c i e n t i s t  r a t h e r  th an  a  s c o r c e r e r .
D oberer a t t r i b u t e s  th e  fo llo w in g  p h i lo s o p h ic a l  s ta te m e n t to  Y a b ir : -
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"He who makes no ex p erim en ts  w i l l  a t t a i n  n o th in g . 
The r e s e a r c h e r  does n o t d e l ig h t  in  q u a n t i t a t iv e  
e x p e rim en ts ; what he i s  concerned  f o r  i s  th e  
q u a l i ty  o f th e  r e s u l t  a t t a i n e d I " (17 )
I n  h i s  s e a rc h  f o r  aurum p o ta b i le  Y abir d isc o v e re d  aqua r e g ia  
th e  s o lv e n t f o r  th e  k in g  o f  m e ta ls .  D o b e re r 's  i n t e r p r e t a t i o n  of 
Y a b ir ' s  r e c ip e  f o r  aqua r e g i a  i s  a s  f o l lo w s : -
"Mix a  pound o f  v i t r i o l  w ith  a  pound o f 
s a l t p e t r e  and a  q u a r te r  o f a  pound o f alum 
from  Yemen and d i s t i l  i f  thou  d i s s o l ­
ve s t  t h e r i n  th e  f o u r th  p a r t  o f  salam m oniac, 
f o r  th e n  i t  d i s s o lv e th ,  g o ld  su lp h u r  and 
s i l v e r . "
D e sp ite  h i s  f a t h e r 's  p o l i t i c a l  antagonism  to  Umayyad C a lip h  
Y aaid I I , Y ab ir became th e  fav o u red  c o u r t  s c i e n t i s t  and p h y s ic ia n  
t o  th e  o ld  C a l ip h 's  so n , th e  g r e a t  Haroun a l  R ash id , C a lip h  o f 
Bagdad, c i t y  o f th e  "Thousand and One N ig h ts " , At t h i s  tim e , th e  
Arab w orld was th e  c e n t r e  o f w orld  power, c u l tu r e ,  r e l i g io n  and 
sc ie n c e  (18 ) . Over th e  n e x t two hundred y e a rs  th e re  fo llo w ed  a  
su c c e ss io n  o f  g r e a t  A rab ian  s c i e n t i s t s  and p h y s ic ia n s :  A li ib n  A bbasi 
(d ie d  994 A.D. ) ;  Ib n  S ah l a l - t a b a r i ,  S inon b in  s u b i t  q u rra h  (d ie d  942 
A.D. ) ;  A l-R hazi o r Rhazes (850-932 A.D, ) ;  Bar Judens and one o f th e  
f a t h e r s  o f modem m edicine Abu A l i ,  A l-H usa in , Ib n  A bdu llah , Ib n  
S in n a  o r A vicenna (980-1037 A.D.)  ( l 9 , 2 0 ) .  R hazes, b o m  in  Rayy 
n e a r  Teheran was one o f th e  g r e a t e s t  Arab p h y s ic ia n s .  He worked in  
th e  Baghdad h o s p i t a l s  and ta u g h t  c l i n i c a l  m edicine b ased  on t r a d i ­
t i o n a l  knowledge and h is  own o b s e rv a tio n s .  H is m ajor work was A l-haw i 
-  th e  s to re h o u se  which was p u b lish e d  in  L a t in  in  th e  1 2 th  c e n tu ry
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u n d er th e  t i t l e  L ih e r  C on tinens ( l 6 ) , A vicenna s tu d ie d  under 
th e  N e s to r ia n s ,  Ahu S ah e l M osichi and Ab N asr A lfa rab i. in  Baghdad,
He n o t o n ly  became a  g r e a t  p h y s ic ia n  b u t a  p h ilo so p h e r  and an 
a u th o r .  H is m ajor work Al-Qanum f i ' l - T i b b  ( Canon M ed ic in a l)
(F ig u re  l6 )  was a  sy n o p s is  o f  G reek m edicine p ro b ab ly  a c q u ire d  
th ro u g h  th e  t r a n s l a t i o n s  o f th e  N e s to r ia n  C h r is t ia n s  ( l6 )  . He 
b e l ie v e d  g o ld  to  be p u r i f i e r  o f  th e  b lo o d  and p re s c r ib e d  p i l l s  
co a ted  w ith  s i l v e r  and g o ld . Al-Qanum became th e  b a s is  o f m ed ical 
te a c h in g  f o r  th e  n e x t f iv e  hundred  y e a r s ( l6 ,2 0 ) . M oorish s c h o la r s  
o f  th e  1 0 th  c e n tu ry  sp re a d  t h e i r  knowledge o f m ed icines and alchem y 
th ro u g h  S pain  and in to  E urope. An exam ple o f t h i s  p e rp e tu a l  ch a in  
o f  knowledge was th e  t e x t  A l-T a s r i f  by A l-Zahraw i a ls o  known as  
A lb u c a s is  o f Cordoba ( c i r c a  940-1000 A . D. ) .  T h is was a  comprehen­
s iv e  en cy c lo p aed ia  o f  m ed ic in e , s u rg e ry  and pharm acy. The s u r g ic a l  
s e c t io n  was t r a n s l a t e d  in to  L a t in  by G erhard  o f Cremona in  th e  
famous Toledo sch o o l o f t r a n s l a t o r s .  Such sc h o o ls  were r e s p o n s ib le  
f o r  t r a n s m i t t in g  th e  c u l tu r e  and p h ilo so p h y  o f th e  Arab w orld to  
Europe and th e  B r i t i s h  I s l e s  in  th e  e a r ly  M iddle Ages ( 2 l ) .
The F ra n c is c a n  s c h o la r  Roger Bacon ( c i r c a  1214-1292 A.D.) 
(F ig u re  17) i s  p ro b ab ly  th e  f i r s t  known g o ld  r e s e a r c h e r  in  B r i t a in .  
He s u f f e r e d  f o r  h i s  s c i e n t i f i c  c a l l i n g ,  and was tw ice  p e rs e c u te d  by 
h i s  own r e l i g io u s  O rder f o r  h i s  " h e re sy " . He se rv ed  two s e p a ra te  
p r is o n  te rm s , one o f 10 y e a rs  ( c i r c a  1255-1265 A.D.) u n t i l  r e le a s e d  
by Pope Clement IV , and a  second o f l 4  y e a rs  ( c i r c a  1278-1292), 
a lth o u g h  i t  i s  s t a t e d  t h a t  th e  l a s t  few y e a rs  o f  h i s  l i f e  were sp e n t
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FIGURE 1 6 1 A page from Al-Qanum f i ' l - T ib b  o f Avicenna,
d e p ic t in g  a pharmacy. I n s e t s  show sunbathing; 
th ree  bath ing scen es; cupping; b leed in g  and 
th o r a c ic  puncture,
(Hebrew B ib lio te c a , U n iv e r s ita r ia  Di Bologna)
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FIGURE 17 ; The Franciscan  sch o la r  ROGER BACON (l2 l4 -1 2 9 2  A.D.)
i s  probably th e f i r s t  known go ld  research er  in  the  
B r it is h  I s l e s .  He i s  sa id  to  have f i r s t  used gold  
ch lo r id e  in  th e treatm ent o f le p r o sy .
■ :% :;3S
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" in  freedom  a t  Oxford in  a  l i t t l e  room in  th e  sq u a t tow er o f th e  
gatew ay a t  F o l ly  B ridge" (2 2 ,2 3 ) .  B acon 's  c o n t r ib u t io n  to  go ld  
th e ra p y  in  m edicine was h i s  u se  o f  a u r ic  c h lo r id e  f o r  th e  tre a tm e n t 
o f  le p ro s y  (2 4 ) .  T h is  aurum p o ta b i le  o f  go ld  c h lo r id e  was p re p a re d  
by d is s o lv in g  g o ld  in  aqua r e g ia  and n e u t r a l i s in g  th e  s o lu t io n  w ith  
ca lc iu m  c a rb o n a te  (c h a lk )  ( 23) .
"Malte a  d i l i g e n t  p u r i f i c a t i o n  o f  th e  Calx 
w ith  th e  w a te r  o f  A lk a l i ,  and o th e r  a c u te  
w a te rs ,  g r in d  i t  by s e v e ra l  c o n t r i t io n s  
w ith  th e  s a l t s ,  and b u m  i t  w ith  many 
a s s a t i o n s ,  t h a t  th e  e a r th  may be p e r f e c t ly  
s e p a ra te d  from  o th e r  e lem en ts  . . . "  ( 23)
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E x p lo i ta t io n  of th e  peop le  by u n sc ru p u lo u s  p h y s ic ia n s  
a d v o c a tin g  th e  v a lu e  o f g o ld  d ru g s was w idesp read  th ro u g h o u t E urope. 
C haucer (F ig u re  I 8) c a p tu re s  t h i s  a n c ie n t  and modem v ic e  o f 
d o c to rs  in  h i s  s a t i r e ,  th e  C an te rb u ry  T a le s
"And y e t  he was b u t e sy  o f  d isp e n se .
He k e p t t h a t  he wan in  p e s t i l e n c e .
F or g o ld  i s  p h is ik  in  a  c o r d ia l ;  
th e r e f o r e  he lo v e d e  g o ld  in  s p e c ia l . "  ( 25)
As w ith  h i s  o th e r  c h a r a c te r s ,  Chaucer i s  a b le  to  c a p tu re  th e  p ro fe s ­
s io n a l  and p r e s c r ib in g  h a b i t s  o f  th e  p h y s ic ia n  o f h i s  day , many o f
'whom were no more th a n  c h a r la ta n s  and qu ack s.
W itc h c ra f t ,  s o rc e ry  and cheap t r i c k e r y  were n e v e r  f a r  
removed from  th e  p r a c t ic e  o f alchem y. The dogm atic b e l i e f  in  th e  
q u in te s se n c e  and th e " P h i lo s o p h e r 's  S tone" p rev en ted  alchem y from  
e v e r  becoming a  t r u e  sc ie n c e  based  on s te p  l o g i c .  S o rc e re r s  such  a s
s
i'iI
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FIGURE 18 : GEOFFREY CHAUCER (l3 4 0 -l4 0 0 )
C elebrated  E n g lish  poet noted fo r  h is  n a rra tiv e  
s k i l l s ,  humour and in s ig h t .  His awareness of  
the unscrupulous p r a c t ic e s  o f p h ysic ian s and th e ir  
lo v e  fo r  go ld  i s  captured in  the Prologue to  
Canterbury T a les:
"For go ld  i s  ÿ i i s i k  in  a co rd ia l;  
th ere fo re  he lovede gold  in  s p e c ia l ."
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F ic in u s  ( l4 3 3 “l499  A .D .) n o t o n ly  recommended g o ld  a s  an  e l i x i r  
o f l i f e  b u t ad v ise d  th a t  p i l l s  c o n ta in in g  g o ld  be made a t  th e  
c o n ju n c tio n  of J u p i t e r  and Venus to  se c u re  t h e i r  p o te n cy . To
«?
F ic in u s  i s  a l s o  a s c r ib e d  th e  b iz a r r e  lo g i c  t h a t  e t e r n a l  you th  can If
be ach iev ed  by d r in k in g  th e  b lood  o f c h i ld re n  -  a  d ia b o l i c a l  concep t 
adop ted  by C o n s ta n tin e  and L ou is  XI to  re c o v e r  new v i t a l  energy  ( 26) .
C h a r la ta n s  and s o r c e r e r s  such  a s  F ic in u s  d e s tro y e d  any hope o f :|!
e s ta b l i s h in g  s c i e n t i f i c  f a c t .  The M iddle Ages was a  p e r io d  o f  r e p r e s -  | .
f:s iv e  dogm atism . A ll new r e l i g i o u s ,  p h i lo s o p h ic a l  and s c i e n t i f i c
f#th o u g h t was met w ith  s u sp ic io n  and f e a r .  The Church re g a rd e d  th e
w r i t in g s  and te a c h in g s  o f th e  a lc h e m is ts  a s  th e  works o f th e  D ev il ■ IfIand th e  h e ra ld  of th e  A n t i c h r i s t .  While one can condemn t h i s  dogm atic 
r e s t r a i n t  on th e  advancem ent o f  s c ie n c e  a s  i t  was a p p l ie d  to  Roger 
Bacon ( 23) ,  th e  j u s t i f i c a t i o n  o f  such  t e n e t  was p e rh ap s n e c e ssa ry  
to  su p p re ss  th e  w i tc h c r a f t  and s o rc e ry  o f  c h a r la ta n s  such  a s  F ic in u s
( 26) ,  L ike  Bacon, n o t a l l  academ ics o f th e  M iddle Ages were q u ack s . 
Raymond L u l l  (1235- 1315) ( 27) th e  physician-m onfc, and h i s  f r ie n d  
A rnold o f  V illa n o v a  ( l2 3 5 ~ 1 3 H ) (28) i n  t h e i r  s e a rc h  f o r  th e  p h i lo ­
s o p h e r 's  s tone., l a i d  th e  fo u n d a tio n s  f o r  th e  embryo o f th e  R enais­
sance  w hich was to  a p p ea r 200 y e a rs  l a t e r .  A rnold o f V illa n o v a  was 
a  p r o l i f i c  w r i t e r  and one o f  th e  most famed p h y s ic ia n s  o f  h i s  day 
( 28) .  He was an accom plished  a lc h e m is t and was re p u te d  to  have i n t r o ­
duced brandy in to  th e  pharm acopeia a s  an aurum p o ta b i le .  A rno ld , a  
d o c to r  o f th e o lo g y , law , p h ilo so p h y  and m ed ic in e , was c o n s u l ta n t  to
I
39 .  -
P e te r  I I I  of Aragon and a l s o  to  B oniface V III whom he had t r e a te d  
f o r  r e n a l  c a lc u lu s  (2 9 ) .  The I n q u i s i t i o n  was s u sp ic io u s  o f  A rn o ld ’s 
p r a c t ic e  o f alchem y and h i s  " h e r e t i c a l "  w r i t in g s .  He sough t th e  
p r o te c t io n  o f  B on iface  V III w hich r e s u l t e d  in  th e  l a t t e r  a ls o  
b e in g  su sp e c te d  o f  h e re s y . B o n ifa c e ’s " so u l"  was o n ly  r e s to r e d  to  
th e  Church a f t e r  h i s  d e a th  by Clement V ( 29) .  However, A rn o ld 's  
s e a rc h  f o r  th e  e l i x i r  o f  l i f e  and o th e r  th e o lo g ic a l  h e r e s ie s  r e s u l ­
te d  i n  h i s  excom m unication a f t e r  d e a th  (2 8 ) .
S earch  f o r  th e  p h i lo s o p h e r 's  s to n e ,  aurum p o ta b i le  and th e  
e l i x i r  o f l i f e  in t r ig u e d  th e  ro y a l  f a m i l ie s  o f Europe th ro u g h o u t 
th e  M iddle A ges. James IV o f S c o tla n d  ( l4 7 3 “I5 I3 )  (F ig u re  19) was 
f a s c in a te d  by m edicine and alchem y and was lau d ed  a s  an a s tu te  
p h y s ic ia n  and su rgeon  ( 30) .
. . .  " In  th e  meane tyme t h i s  n o b i l l  
King James th e  f o u r t  was w e i l l  
l e i m i t  i n  th e  a r t  o f  m ediecein  
and a l s o  one cun ing  so ru g en ar 
t h a t  nane in  h i s  rea lm e t h a t  
w ss t t h a t  c r a f t  b o t wald ta k  h i s  
c o u n s a ll  in  a l l  p r o c e id in g is ."  ( 31)
James IV  n o t on ly  p r a c t i s e d  s u rg e ry  b u t encouraged  p a t i e n t s ,  
d o c to rs  and a lc h e m is ts  a t  h i s  c o u r t .  He was th e  p a tro n  o f John 
Damian th e  F rench  (o r  I t a l i a n )  a lc h e m is t and p ro v id ed  f o r  h is  la b o ­
r a to r y  a t  S t i r l i n g  C a s tle  ( 32) D am ian 's f u t i l e  s e a rc h  f o r  th e  q u in t ­
e ssen ce  and th e  p ro d u c tio n  o f g o ld  from  base  m e ta ls  i s  overshadowed 
by h i s  s p e c ta c u la r  experim en t where he a ttem p ted  to  f l y  w ith  th e  a id  
o f  a r t i f i c i a l  w ings from  th e  w a lls  o f  S t i r l i n g  C a s t le ;  an experim en t 
which r e s u l t e d  i n  him f r a c t u r in g  h i s  fem ur (33 )•
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FIGURE 1 9 ; KING JAMES IV OF SCOTLAND (l4 7 3 “1513)
"King James th e fo u r t was w e il l  l e i m i t  
in  the a r t  o f  m ediecein and a lso  one 
cuning sorugenar."
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A S c o t t i s h  a lc h e m is t who s u f fe re d  f o r  h is  knowledge a t  
th e  hands o f th e  n o b i l i t y  was A lexander Seton  (32 , 34) (A lexander 
S e to n iu s  o r  S c o tu s , c i r c a  1 5 50 -l604  A .D .) , S co tu s  was re p u te d  
to  have d em o n stra ted  th e  tra n sm u ta tio n , o f  le a d  in to  g o ld  a t  th e  
home o f Jakob H anssen in  E nkhu izen , H olland  on March 1 3 th , l6 0 2  
(34)0 He re v e a le d  t h i s  experim en t to  D r. Johann Wolfgang Dienheim 
and D r. Jakob Zwinger and l a t e r  in  I 603 to  A ndreas B le tz .  He a l s o  
perform ed  h i s  experim en t f o r  P h i l i p  Jakob G ustenhO fer, a  S tra sb o u rg  
g o ld sm ith  and Hans Leondorp a  g o ld sm ith . S co tu s  to l d  th e  S c o t t i s h  
Surgeon i n  Cologne "M e is te r  G eorg", t h a t  he had a  remedy ( h i s  g o ld  
making powder) " th a t  e a t s  away r o t t e n  f l e s h  and le a v e s  h e a l th y  
sinew s a lo n e"  (3 4 ) .  T his m arv e llo u s  s e c r e t  d id  n o t go u n n o tic e d .
S co tu s  was a r r e s t e d  and to r tu r e d  by th e  E le c to r  C h r is t i a n  I I  b u t 
was re sc u e d  by h i s  p u p il  and f r i e n d  M ichael S end ivog ius (b o m  1556 
Cracow) b e fo re  he r e v e a le d  th e  s e c r e t .  U n fo r tu n a te ly  S c o tu s  d ie d  
o f  h i s  i n j u r i e s  (3 2 ,3 ^ ) .  Even th e n  h i s  p e rs e c u t io n  was n o t o v e r.
Not knowing S co tu s  was d ead , Duke F re d e r ic k  o f  W urttenberg  s e n t  
a  l e t t e r  to  James VI o f S c o tla n d  (Jam es I  o f England) on March 1 0 th , 
1605 demanding th e  e x t r a d i t i o n  o f  S co tu s  on th e  grounds t h a t  S co tu s  
had prom ised  to  r e v e a l  a l l  h i s  s e c r e t s  b u t had absconded (3 4 ) .
The Emperor Rudolph I I  o f  Germany (1576- I 612) was th e  
a rc h  p a tro n  o f  alchem y in  th e  l 6 t h  c e n tu ry . I n  h is  q u e s t f o r  th e  
p h i lo s o p h e r 's  s to n e  he f i l l e d  th e  H radsch in  p a lace  in  P rague w ith  ev e ry  
s o r c e r e r ,  a lc h e m is t ,  p h y s ic ia n  and c h e a t who claim ed a  knowledge o f
-  42
s c i e n t i s t ,  le a d in g  to  su b seq u en t a l l e g a t io n s  t h a t  he was no more th a n  
a  c h a r la ta n  and a  quack .
Î
th e  q u in te s s e n c e . Thus am b itio u s  a lc h e m is ts  se e k in g  c o u r t  fa v o u rs  
and r ic h e s  would f lo c k  to  th e  "Gold A lle y " . F a i lu r e  to  f u l f i l  
ex p ec ted  p ro m ise s , how ever, u s u a l ly  r e s u l t e d  in  d e a th  by e x e c u tio n
(35).
The Sw iss p h y s ic ia n  T heo p h rastu s  Bombastus von Hohenheim
(1493- 15^1 )# a ls o  known a s  P h il ip p u s  A ureo lus P a ra c e ls u s  (F ig u re  ] 
b e l ie v e d  g o ld  was a  u n iv e r s a l  pan acea . He i s  s a id  to  have f i r s t  u sed  
g o ld  in  th e  tre a tm e n t o f tu b e r c u lo s is  and was co n s id e re d  by many a s  
th e  fo u n d e r o f e x p e rim e n ta l th e r a p e u t i c s  (3 6 ,3 ? ) .  U n fo r tu n a te ly  h i s  
r e c o n d i te  th e o r i e s  o f  p h y s io lo g y  and p a th o lo g y  p o r tra y e d  in  h i s  e x te n ­
s iv e  w r i t in g s  (F ig u re  21) have c a s t  doub t on h i s  t r u e  a b i l i t y  a s  a
A s im i la r  s o c ia l  f a t e  b e f e l l  th e  Englishm an F ra n c is  Anthony 
(1550-1623  A .D .) ( 38 ) .  Anthony was a  M aster o f A r ts  from  Cambridge
(1574) and s tu d ie d  c h e m is try  and p h y s ic s  a t  t h a t  u n iv e r s i ty  f o r  20 y e a r s .  
A lthough he d id  n o t p o s se ss  a  m ed ica l l i c e n s e  he p r a c t i s e d  a s  a  g e n e ra l 
p h y s ic ia n  and came u n d er th e  w ra th  o f  th e  Royal C o lleg e  o f  P h y s ic ia n s  
when he p u b lish e d  Panacea A urea 8 eu De Auro P o ta b i l i  i n  1598. Anthony 
b e l ie v e d  vehem ently  i n  th e  p r o p e r t i e s  o f h i s  g o ld  p o tio n  and c laim ed  
t h a t  i t  was an arcanum cap ab le  o f  c u r in g  a l l  d is e a s e s .  The Royal 
C o llege  o f  P h y s ic ia n s  d u ly  com pelled  him to  undergo an exam ination  which 
he f a i l e d  so m ise ra b ly  t h a t  he was in t e r d i c t e d  from  p r a c t i c e .  He d i s ­
obeyed t h i s  r u l i n g ,  was f in e d  f iv e  pounds and s e n t to  p r is o n .  However, 
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FIGURE 20 ; THEOPHRASTUS BOMBASTUS VON HOHENHEIM
PHILIPPUS AUREOLUS PARACEISUS ( l4 9 3 -1 5 4 l)
He i s  reputed to  have f i r s t  used a gold  
in  th e treatm ent o f tu b e r c u lo s is  and was 
con sid ered  by many as the founder o f  
experim ental th e r a p e u tic s .
— 44 —
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%D w indling h e a l th  b u d g e ts  in  th e  l a s t  400 y e a rs  have no doub t made 
e x te n s iv e  use  o f  t h i s  in v e n tio n  o b s o le sc e n t!
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months b e fo re  b e in g  r e le a s e d  in  l 602  on a  p le a  o f  p o v e r ty  by h i s  
w ife . Undaunted he im m ed ia te ly  resum ed p r a c t ic e  and i s  s a id  to  have 
am assed a  c o n s id e ra b le  fo r tu n e  from  th e  p r e s c r ib in g  and d is p e n s in g  
o f  h i s  g o ld  c u re s .  I n  I 6IO he p u b lish e d  a  t r e a t i s e  M edicinae Ghvmical 
E t V eri A uri P o ta b i l i s  A s s e r t io . A n thony 's  work was s e v e re ly  c r i t i -  
c is e d  by many n o ta b le  s c i e n t i s t s  and p h y s ic ia n s  o f h i s  such a s  
D r. John C otton  o f  N ortham pton, and Matthew Gwi.nne, f i r s t  p ro fe s s o r  
o f  Gresham C o lle g e . I n  r e p ly  to  th e s e  " a t ta c k s "  Anthony p u b lish e d  
A pologie Or D efense Of A V e r i ty  H e re to fo re  P u b lish e d  Goncemine: A 
M edicine C a lle d  Aurum P o ta b i l e . in  I 6 1 6 , which acc o rd in g  to  Evans i s  
i n  th e  l i b r a r y  o f th e  Royal C o lleg e  o f  P h y s ic ia n s  in  London ( 38) .
Anthony recommended h i s  aurum p o ta b i le  " f o r  th e  s t re n g th e n in g  and 
co m fo rtin g  o f th e  h e a r t  and v i t a l  s p i r i t s " . T h is  s p i r i t u a l  b e l i e f  by 
Anthony -  an u n lic e n s e d  p h y s ic ia n  -  o f  th e  a l l  encom passing q u a l i t i e s  
o f  aurum p o ta b i le  p ro b ab ly  se rv e d  a s  succou r d u rin g  th e  p e r io d s  o f 
a ttem p ted  pogrom on h i s  p anacea  by th e  m ed ica l p ro fe s s io n .
Not a l l  u s e s  o f  g o ld  in  m edicine was by p o tio n s  and p i l l s .
The in d e s t r u c ta b le  p r o p e r t i e s  o f  g o ld  le d  th e  in g e n io u s  F rench  surgeon IAmbrose P are  to  u se  g o ld  w ire  o r  F unctus Aureus a s  a  l i g a t u r e  f o r
Min g u in a l  h e rn ia .
" I f  th e  R upture w i l l  n o t be cu red  by a l l  
th e s e  m eanes, by re a so n  o f  th e  g r e a t  f o lu t io n  
o f  th e  c o n t in u i ty  o f  th e  r e l a x t  o r  broken 
P erito n aeu m , and th e  P a t ie n t  by th e  co n fen t 
o f  h i s  f r i e n d s  th e r e  p r e f e n t ,  i s  re a d y  to  
undergo  th e  d an g er in  hope o f  re c o v e ry ; th e  
cu re  f h a l l  be a tte m p te d  by th a t  which th e y  c a l l  
th e  P u n c tu s  A ureus o r  Golden t i e " .  ( 39)
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The u se  o f  g o ld  f i l l i n g s  in  d e n ta l  su rg e ry  h as  been w idely  
u sed  f o r  th e  p a s t  100 y e a r s .  However, to o th  m u t i la t io n  f o r  d e c o r -
l a t e  17t h  and e a r ly  19t h  c e n tu ry  a  handsome go ld -h ead ed  cane became 
th e  symbol o f  p r o s p e r i ty  f o r  i t s  s ix  m a ste rs  (42 , 43 , 4 4 , 4 5 ) .
D r. W illiam  MacMichael who was a  R a d c l if fe  t r a v e l l i n g  s c h o la r ,  w rote 
a  l i g h t  h e a r te d  acco u n t o f th e  c a n e ' s  m a ste rs  t o ld  from  th e  p o in t  o f 
view  o f th e  cane (4 5 ) .  The cane was o r ig in a l ly  owned by D r. John
Î
Ï
a t iv e  p u rp o ses  was w ide ly  p r a c t i s e d  by th e  a n c ie n t  Mayan c i v i l i -
tis a t io n  ( c i r c a  3OO-8OO A .D .) and by o th e r  South  American p eo p les  
( 4 o ) . I n  1913 M.H. 8a v i l i e  ( 4 l )  d e s c r ib e d  a  most f a s c in a t in g  exam­
p le  o f  " d e n ta l a r t "  w ith  g o ld  i n  a  specim en o f m andible from  La P ie d ra  
in  E cuador (F ig u re  2 2 ) . The c e n t r a l  in c i s o r s  were i n l a i d  w ith Ic i r c u l a r  f i l l i n g s  o f g o ld . T h is  specim en i s  now in  th e  Museum o f 
th e  American In d ia n ,  Heye F o u n d a tio n , New York. The h o r r i f i c  s t o r ­
i e s  o f  th e  a n c ie n t  South  American r e l i g io u s  s a c r i f i c i a l  p r a c t ic e s  
(F ig u re  23) i s  s h a rp ly  c o n t ra s te d  by t h e i r  m a g n if ic a n t g o ld  a r t i s t r y  
(F ig u re  24, 25, 26) and th e  advanced m ed ica l and s u r g ic a l  c a p a b i l i ­
t i e s  o f th e s e  p e o p le s .
The a s s o c ia t io n  o f g o ld  w ith  m edicine has n o t  alw ays been
■ 1o f  th e r a p e u t ic  i n t e r e s t ,  a t  l e a s t  n o t to  th e  p a t i e n t .  Between th e
■S
3R a d c l i f f e ,  whose e s t a t e  funded  th e  R a d c l if f e  L ib ra ry ,  R a d c l if fe
:#In f i rm a ry ,  th e  R a d c l if f e  O b se rv a to ry  and th e  R a d c l if fe  T ra v e ll in g  i?
F e llo w sh ip  (4 2 ) . The second owner o f  th e  go ld -h ead ed  cane was e q u a l ly  
s u c c e s s fu l  -  D r. R ichard  Mead who a t te n d e d  Queen Anne on h e r  d ea th b ed .
He became th e  most p ro p se ro u s  p r a c t i t i o n e r  o f h i s  tim e , e a rn in g  a s  t
much a s £ 7 ,0 0 0  in  one y e a r .  The go ld -h ead ed  cane , now a  symbol o f
w ea lth  and su c c e ss  in  th e  m ed ical p ro fe s s io n ,  was p assed  onto  D rs .
: : l-I
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FIGURE 2 4 : Panamanian go ld  a r t i f a c t  o f  Veraguas
d es ig n , o f  a monkey pendant. The p iece  
i s  hollow  c a s t  and i s  th ree  in ch es  h igh  
(U n iv ers ity  Museum, U n iv e r s ity  of 
P en n sy lv a n ia ).
-  5 0 -
FIGURE 2 5  : Peruvian go ld  work o f  Chavin period  (1200-400 B.C.)  
Nine and a h a lf  inch  h i# i  columnar crown o f  
beaten g o ld , embossed w ith c a t - l ik e  f ig u r e s .
(Museum o f  American In d ian , New York C i t y ) .
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FIGURE 26 : A Fantasy in Gold. This cast figure of aGod is a Taironia Indian Specimen which dates from the 13th century A.D. Despite the elaborate work, the figure measures only 
5Î-" high.
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Askew, W illiam  and D avid P i t c a i r n  (F ig u re  27) and Matthew B a i l l i e 
(F ig u re  2 8 ) . D r. Askew owned a  la v i s h  house in  Q ueen 's  Square 
where he housed h i s  enormous l i b r a r y  o f  f in e  books. These he 
t r e a s u r e d  so  much t h a t  he d id  n o t  p e rm it h i s  f r ie n d s  to  to u ch  them . 
The Scotsm an, Matthew B a i l l i e ,  nephew o f W illiam  and John H unter 
(46) was th e  l a s t  ow ner. F o llo w in g  h i s  d e a th  in  1823, h i s  widow 
p re s e n te d  th e  cane to  th e  Royal C o lleg e  o f  P h y s ic ia n s  where i t  i s  
now on d is p la y  in  th e  l i b r a r y  (4 2 ) .
Although alchemy, sorcery and p ractice  o f the occu lt were 
rampant in  the early  17th  century, the emergence of s c ie n t is t s  such 
as Johann Glauber ( l6 0 4 - l6 7 9 ) , Thomas W illis  (162I - 1675) , Robert 
Boyle (1627- 1687) , John Mayow (l6 4 3 -l6 7 9 ) and N icolas Lemery (l6 4 5 -  
1715) (47) brought the evo lu tion  o f a n a ly tic a l chem istry, physio­
logy  and anatomy to  the fo r e . Glauber, Boyle and Lemery a l l  d is p e l­
le d  the alchem ical b e l ie f  th at aurum p otab ile  had l i f e  g iv in g  prop­
e r t ie s .  This new era o f r a tio n a l th inking produced the framework 
fo r  the development o f s c i e n t i f i c  m edicine. The Dutch physician  
Herman Boerhaave (1668- I 738) (Figure 29) refuted  the m edicinal value 
of aurum p otab ile  in  one o f h is  le c tu r er s  (48) and in  1778 (49) 
the Scotsman Dr. Donald Monro published "A T reatise on M edicinal and 
Pharmaceutical Chvmistrv and the Materia Medica in  which he sta ted
th at although gold was long acclaimed to  be a panacea, t h is  b e l ie f
was i l l  founded and th at gold was o f no m edicinal va lue,
"Gold, and some preparations made from i t ,  were long b elieved  to  be possessed of
great v ir tu e s , and to be powerful remedies
in  many d isorders; but th is  has been found 
to  be a m istake, and they are now never 
used as m edicines," (49)
-  53 -
D a v i d  P i t c a i r n  ( 1 7 4 9 - 1 8 0 9 )
FIGURE 27 : DAVID PITCAIRN (l749-l809)
One of the six owners of the Gold Headed Cane.
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M a t t h e w  B a i l l i e  ( 1 7 6 1 - 1 8  2 3 )
FIGURE 28 ; S c o t t is h  p h ysic ian  MATTHEW BAILLIE ( 1 7 6 I - I 8 2 3 ) , 
nephew o f W illiam  and John Hunter and l a s t  
owner o f  the Gold Headed Cane.
■I
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FIGURE 29 ; HERMAN BOERHAAVE ( l6 6 8 -1 7 3 8 ) , famous Dutch 
p h ysic ian  o f th e  Renaissance P eriod . In  
one o f h is  le c t u r e s ,  Boerhaave re fu ted  the  
m edicinal value o f  aurum p o ta b ile .
t h e i r  t im e ) .
famous G u illaum e-L ou is F ig u ie r  ( l8 l9 - l8 9 4 )  e d i to r  o f La P re s s e ,  was 
a l s o  a  p h a rm a c is t and l i k e  h i s  b r o th e r ,  f a th e r  and u n c le  c o n tr ib u te d  
to  th e  l i t e r a t u r e  on g o ld  c h e m is try  w ith  R echerches s u r  l e s  Combin­
a is o n s  Qxygenees de l 'O r ,  l e  P o u rp re  de C ass iu s  e t  l 'O r  F u lm inan t (53 ) 
and O b se rv a tio n s  S ur La P r é c ip i t a t i o n  De L'Oxvde D 'O r (5 4 ) .
The r e v iv a l  o r r e - in t r o d u c t io n  o f  th e  u se  o f go ld  compounds 
in to  m edicine  can p ro b ab ly  be a t t r i b u t e d  to  two F rench  p ro fe s s o rs  a t  
th e  U n iv e r s i ty  o f  M o n tp e l l ie r ,  P ie r r e  F ig u ie r  (1765- I 8I 7 ) ,  P ro fe s s o r  
of C hem istry  and h i s  f r i e n d  A ndre-Jean  C h re s tie n  th e  P ro fe s s o r  o f 
M edicine ( 50 ) . I n  1811 C h re s tie n  p u b lish e d  De La Methods I n t r a l e u t i a u e  
(50 ) in  which th e  l a s t  100 pages were based  on th e  use  o f  g o ld  comp­
ounds i n  s e v e ra l  d is e a s e s  among w hich were s y p h i l i s  and tu b e r c u lo s i s .
.1I
Ï
,(On t h i s  a c c o u n t, b o th  F ig u ie r  and C h re s tie n  were 100 y e a rs  ahead o f
I
I n  o rd e r  to  enhance th e  q u a l i t y  o f h i s  p u b l ic a t io n  C h re s tie n  
asked  F ig u ie r  to  p ro v id e  a  d e t a i l e d  s c i e n t i f i c  acco u n t o f  th e  go ld  
compounds he had d is c u s s e d .  T h is  he p u b lish e d  a s ,  S u r Les P re p a ra t io n s  
D 'O r. P roposées  P a r  Le D octeu r C h re s t ie n .  P ro fe s s e u r  A L 'U n iv e r s i té  De 
Medecine De M o n tn e llie r  ( 5 l ) • Among th e  p r e p a ra t io n s  d e s c r ib e d ,
IF ig u ie r  o u t l in e d  th e  p re p a ra t io n  o f  sodium g o ld  c h lo r id e  which was 
recommended by C h re s tie n  (50 ) .  O th er members o f  F ig u ie r ' s  d is t in g u is h e d  
fa m ily  c o n tr ib u te d  to  th e  go ld  l i t e r a t u r e .  H is younger b r o th e r  Jean  
F ig u ie r  (1776-1824) a ls o  a  p h a rm a c is t,  p u b lish e d  a  p ap er on go ld  sodium 
c h lo r id e  i n  1820 (52 ) .  J e a n 's  e l d e s t  son P ie r re -O s c a r  F ig u ie r  (1805-
■1879) p u b lish e d  a  sm a ll book e n t i t l e d ,  N ouvelles  O b se rv a tio n s  S u r La 





Knowledge o f Andre-Jean C hrestien 's work quickly spread and 
according to  Hlgby (4 8 ) , Dr. Samuel L. M itchell of New York sen t h is  
co lleagu es at the New York H ospital a copy of Chrestien*s book. 
Researchers a t the New York H ospital were in v e stig a tin g  the use o f  
sodium gold chloride in  the treatment of s y p h il is .  In I 8I I  John G. 
Gheesman, a student o f Dr. Valentine Seaman at Queen's C ollege in  
New York, wrote h is  M.D. th e s is  on the use o f muriate o f gold  in  the 
treatment of sy p h ilis  (55) (Figure 30) , Gheesman referred  to  h is  
drug as gold chloride but according to  the method of preparation (55) 
i t  was obviously the sodium gold ch loride described by F igu ier  (51) , 
Although Gheesman claimed success w ith h is  use of sodium gold  chloride  
in  the treatment o f s y p h il is  h is  study was only based on seven p a tien ts  
(55)• Further scepticism  as to  the v a lid ity  o f the e f f e c t  o f sodium 
gold chloride in  the treatment of s y p h il is  i s  found in  the c r it ic ism  
o f C hrestien 's o r ig in a l work by an anonymous Edinburgh ph ysician , who 
claimed he was unable to  reproduce the b e n e fic ia l e f f e c t s  o f the drug 
in  h is  own p a tien ts  (56) .
By the early  18th  century when medical science began to  evolve  
from the empiricism of alchemy, the time was r ip e  fo r  revolutionary  
thought in  the treatment o f d is e a se . C hristian F riedrick Samuel 
Hahnemann (1755-1843) introduced severa l unique d octrin es in  medical 
th inking which are embodied in  h is  work, Organon Per Rationellum  
Heilkunde (18IO) (5 7 )« Some o f Hahnemann's doctrines such as S im ilia  
Sim ilibu s Curantur whereby d isea se s  are cured by drugs which produce 
sim ilar  symptoms were somewhat ir r a t io n a l in  thought, but he did  
advocate the in troduction  o f the "small dose" a lb e it  based on the 
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FIGURE 30 : T it le  page o f doctorate th e s is  by John Gumming
Gheesman on the use of gold ch loride in  the 
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o f  lo g i c  was sco rned  and p ro c la im ed  a s  quack ery  by th e  m a jo r i ty  
o f th e  m ed ica l p ro f e s s io n .  I n  an a d d re s s  a t  th e  New Z ealand  P a r l i a ­
ment in  i 860, th e  p h y s ic ia n  S i r  D avid Monro (1813- I 871) s a id  o f 
homeopathy -
"that most absurd im position  
on the face  o f the earth , 
p e r fe c tly  in cred ib le  and monstrous". (58)
N everth eless , the therapeutic n ih ilism  of miniature dosage of drugs 
was welcomed by the public  who had long been exposed to  the ia tro g en ic  
d isea ses  induced by the a lch em ists, charlatans and quacks fo r  centu­
r ie s .  Hahnemann cer ta in ly  found fame in  h is  p ra ctices  and when he 
died in  1843 at age 88 years he was a m illio n a ire  (5 9 ). Throughout 
the ninetheenth and ea r ly  tw entieth  century, homeopaths advocated the 
use of gold le a f  and aqua reg ia  as almost u n iversa l treatm ents.
M. F religh  in  h is  te x t  Homeo-pathie P ractice  o f Medicine 1868 (60) 
l i s t s  Aurum-Foliat (gold  le a f )  and Aurum Nitro-M uriat (gold-aqua reg ia  
so lu tio n ) in  the chapter on h is  d ispensary. Throughout the te x t  
Aurum alone or in  combination with other preparations appears as the 
recommended treatment fo r  numerous unrelated d isorders from catarrh , 
cancer and congestion of the blood to  s y p h il is ,  scrofu la  and melan­
choly o f the mind. U nfortunately t h is  almost random ap p lica tion  of 
drugs to  symptoms and s ign s formed very l i t t l e  b a s is  from which to  
develop a s c ie n t i f i c  approach to  th erap eu tics .
Hahnemann's e r a  (1755-1843) o v e rlap p ed  w ith  th e  g r e a t  p e r io d  
o f  m ed ical and s c i e n t i f i c  " re v o lu t io n "  in  B r i t a i n .  G rad u a tes  o f 
Glasgow U n iv e r s i ty  were among th e  most n o ta b le  p io n e e rs  -  W illiam  
S m e llie  (1697- 1763) O b s te t r ic ia n  (F ig u re  31) , W illiam  C u llen  (17I I -  
1790) P ro fe s s o r  o f M edicine (F ig u re  3%), Jo sep h  B lack (1728-1799)
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W i l l i a m  S m e l l i e  ( 1 6 9  7 - 1 7 6 3 )  
Portrait painted by himself in 1719
fCiriinnnl in  ikn PfiVoA CoUéfê o f  SutÊêOtU* Ëd^nbun
FIGURE 31 ; WILLIAM SMELLIE (1 6 9 6 - I 7 6 3 )
Glasgow graduate and p ion eer o f  
modem o b s te t r ic a l  p r a c t ic e .
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FIGURE 32 : WILLIAM CULLEN. 1710-1790. Bom a t  Ham ilton.
He was a stud en t a t  Glasgow U n iv e r s ity , but d id  h is  m edical 
s tu d ie s  in  Edinburgh (1734, 1735, 1 7 3 6 ). He took h is  M.D. 
a t  Glasgow in  1740 and gave le c tu r e s  on C lin ic a l  M edicine and 
Chemistry a t  Glasgow (Joseph Black was one o f h is  p u p i ls ) .
In  1 7 5 1  he became P ro fe sso r  o f  M edicine a t  Glasgow: 1755 he 
was appointed P ro fe sso r  o f Chem istry, U n iv ers ity  o f  Edinburgh; 
in  1 7 6 6  he became P ro fe sso r  o f  P h ysio logy  a t  th e  U n iv e r s ity  
o f  Edinburgh, and in  1733 he was awarded the Chair in  Medicine 
a t  th e U n iv e r s ity  o f  Edinburgh a t  the age o f  6 3 .
“  6 2
Professor of Medicine and Chemist (Figure 3 3 ) , William Hunter 
(1718- 1783) Surgeon Anatomist (Figure 34, 35) and John Hunter (1728- 
1793) Surgeon (Figure 36 ) (4 6 , 6 1 , 62 ) .  Although homeopathy in tro ­
duced an almost p h ilosop h ica l approach to  medical therapy, i t  did  
introduce a considerable balance of sa fe ty , countering the ia tr o ­
gen ic havoc wreaked among the populace by alchem ists and quacks 
(Figure 3 7 ) • One contemporary o f th is  tr a n s it io n a l era was Robert 
Bums (1759- 1796) .  Bums' fa te  a t the hands of the medical p rofes­
sion  i s  described by J . Thomson (63 ) .
"I proclaim th a t Robert Burns died the 
d o ctor 's martyr . , . ,  The truth stands 
thus -  The Physician of Robert Burns 
( i . e .  Dr. William Maxwell) b e lieved  that 
h is  l iv e r  was d iseased , and placed him 
under a course o f mercury. In th ese days 
a mercurial course was extremely severe  
. . . .  Among the la s t  words I ever heard 
him speak were, 'W ell, the doctor has 
made a f in is h  of i t  now’ ."
There i s  considerable evidence that the much maligned Bums 
did not d ie  at the hands o f an avenging Bacchus or Venus but indeed  
was a "doctor's martyr" (6 4 ) .  Lenihan and colleagues in  Glasgow 
(65 ) examined a lock  o f Bum s’ h a ir  by neutron a c tiv a tio n  a n a lysis  
and found i t  to  contain 8 .02  parts per m illion  of mercury -  a higher  
than normal le v e l  but not n e c essa r ily  r e f le c t in g  an acute dosage. 
Bearing in  mind th at ha ir  grows a t 20 centim etres per year, the 
mercurial a n a ly s is  of the hair  sample may not r e f le c t  unacceptably  
high le v e l s  in  l iv e r ,  brain and renal tubules (6 4 ) .  Bums' premoni­
tio n  o f h is  fa te  i s  ap tly  expressed in  Death and Dr. Hombrook where 
he s a t ir iz e s  ia tro g en ic  d isease
"Whare I k i l le d  ane, a f a ir  strae  death,
By lo s s  0 ’ blood o f want or breath, 
t h is  n igh t I'm  free  to take my a ith .
That Hornbrook's s k i l l
Has clad a score i '  th e ir  l a s t  c la ith ,
By drop an p i l l ."  (Figure 38)
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FIGURE 33 : JOSEPH BLACK (1728-1799), physician, chemistand physicist. Joseph Black is known for his original definition of "specific heat", "capacity for heat" and "latent heat". He also noted that "fixed air" given off by quickened lime and alkalis is also present in expired air.
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FIGURE 3 4  ; WILLIAM HUNTER ( 1 7 I 8 - I 7 8 3 ) surgeon, anatom ist 
and o b s te tr ic ia n ,  W illiam  Hunter fo llow ed  the 
examples o f h is  tea ch ers  S m ellie  and D ouglass 
and s ta r te d , in  1746, a  course o f p r iv a te  
le c tu r e s  on d is s e c t in g ,  op erative  surgery , and 
bandaging. H is famous le c tu r e  th ea tre  and 
museum in  Great Windmill S tr e e t in  London was 
to  become the tr a in in g  ground fo r  the b est  
surgeons and anatom ists o f  th a t era .
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FIGURE 35 :
P a in t in g  by Johann Z offany  o f W illiam  H unter d e m o n stra tin g  
to  members o f th e  R oyal Academy in  London, H unter was 
ap p o in ted  a s  P ro fe s s o r  o f Anatomy to  th e  Royal Academy a t  
i t s  in a u g u ra tio n  in  1769-70• The P re s id e n t  o f th e  Royal 
Academy, S i r  Jo sh u a  R eynolds, can be i d e n t i f i e d  by h i s  lo n g  
e a r  tru m p e t. I t  i s  n o t re c o rd e d  what S i r  Jo sh u a  th o u g h t o f
Z o ffa n y 's  p a in t in g ,  e s p e c ia l ly  a s  th e  s k e le to n  h as  13 p a i r s  
o f r i b s l  I n  h i s  f i r s t  D isc o u rse  a s  P re s id e n t to  th e  Royal 
Academy, S i r  J o sh u a  u rg ed  s tu d e n t s ,  a s  b e g in n in e r s , to  l e a m  
how to  make p r e c is e  d raw in g s . "He who endeavours to  copy 
n ic e ly  th e  f ig u r e  b e fo re  him , n o t  on ly  a c q u ire s  a  h a b i t  o f 
e x a c tn e s s  and p r e c i s io n ,  b u t i s  c o n t in u a l ly  advanc ing  in  h i s
knowledge o f  th e  human f ig u r e ,  and though he seems to  su p e r -
;C
f i c i a l  o b se rv e rs  to  make a  s lo w er p ro g re s s ,  he w i l l  be found 
a t  l a s t  cap ab le  o f  ad d ing  (w ith o u t ru n n in g  in t o  c a p r ic io u s  
w ild n e ss )  t h a t  g race  and b e a u ty , which i s  n e c e s sa ry  to  be 
g iv en  to  h i s  more f in i s h e d  w orks, and which can n o t be g o t by 
th e  m odem s, a s  i t  was n o t a c q u ire d  by th e  a n c ie n ts ,  b u t by 
an a t t e n t i v e  and w e ll compared s tu d y  o f  th e  human fo rm ."
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FIGURE3 6  ; JOHN HUNTER (1728-1793) Surgeon.
With the advent o f John Hunter, surgery ceased  
to  be regarded as  a mere te c h n ic a l mode o f  
treatm en t, and began to  take i t s  p la ce  as a 
branch o f  s c i e n t i f i c  m edicine, f ir m ly  grounded 






FIGURE 37 : The T heriac Vendor or ’ Quack Medicine Man ' ,  
m odelled by Simon F e iln e r  1752. From the  
P eter  P e tr i C o lle c t io n , Bahnhof-Apotheke, 
Offenbach a . m. ,  Germany.

















In  th e  e ig h te e n th  c e n tu ry  homeopathy p ro v id ed  a  new m argin 
o f  s a f e ty  f o r  d rug  a d m in is t r a t io n ,  and a t te m p ts  a t  d is e a s e  c a te g o r ­
i s a t i o n  by p eo p le  l i k e  C u llen  (6 l )  l a i d  th e  fo u n d a tio n  f o r  t r u e  
s c i e n t i f i c  d ia g n o s t ic  and th e r a p e u t i c  a p p l ic a t io n .
I n  th e  l a t e  n in e te e n th  c e n tu ry  a  unique th e r a p e u t ic  a p p l i ­
c a t io n  o f  a  g o ld  compound appea red  -  th e  tre a tm e n t o f i n e b r i e ty  by 
sodium g o ld  c h lo r id e .  Higby (48) c r e d i t s  D r. L e s l ie  I .  K eeley o f 
D w ight, I l l i n o i s  a s  th e  p io n e e r  o f t h i s  form  o f th e ra p y  (4 8 ) . As 
a  young p h y s ic ia n  se rv in g  in  th e  Union Army d u r in g  th e  American C iv i l  
War, K eeley  was a p p a l le d  to  see  th e  s o c ia l  and p h y s ic a l  d e s t r u c t io n  
caused  by a lc o h o l in  th e  d e p re sse d  s o l d i e r s .  D r. K eeley  and a  
p h a rm a c is t c o l le a g u e , John R. Oughton sp e n t 12 y e a rs  re s e a rc h in g  a  
cu re  f o r  a lc h o lis m  and e v e n tu a l ly  p ro c la im ed  sodium g o ld  c h lo r id e  a s  
a  "c u re "  f o r  d ru n k en n ess . K eeley  opened h i s  f i r s t  san a to riu m  i n  1880 
and news o f  h i s  su ccess  q u ic k ly  sp re a d . H is l i f e  s to r y  was r e c e n t ly  
rev iew ed  by G.A. B arc lay  in  th e  J o u rn a l o f th e  I l l i n o i s  S ta te  H is to ­
r i c a l  S o c ie ty  (6 6 ) .  S a t e l l i t e  b ran ch e s  o f K eeley*s " I n s t i t u t e :  
opened in  o th e r  s t a t e s  and by th e  1890* s ov er 30,000  fo rm er p a t i e n t s  
had e s ta b l i s h e d  th e  "B i-C h lo rid e  o f  Gold Club" p ro v id in g  s e rv ic e s  much 
l i k e  A lcoho lics Anonymous do to d a y  (6 6 ) .  D r. K eeley  was a p p a re n tly  
v e ry  s e c r e t iv e  w ith  re g a rd  t o  h i s  tr e a tm e n t sch ed u le s  and d ie d  w ith o u t 
r e v e a l in g  th e  dosages he u s e d . Use o f  sodium g o ld  c h lo r id e  a s  a  t r e a t ­
ment o f d runkenness was a l s o  r e f e r r e d  to  i n  th e  Canadian l i t e r a t u r e  (6? 
6 8 ) . D r. O liv e r  Edwards o f  O ttawa p re se n te d  h i s  p ap e r on th e  tre a tm e n t 
o f in e b r i e ty  to  th e  M ontreal M ed ico -G h iru rg ica l S o c ie ty  in  1896. He
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presum ably  u sed  s im i la r  methods to  K eeley  and d e t a i l e d  in s t r u c t io n s  
f o r  th e  a d m in is tr a t io n  o f  th e  sodium g o ld  c h lo r id e  a re  g iv en  in  th e  
t e x t  : -
" 1 s t ,  Wyeth’s  Hypodermic t a b l e t s  o f c h lo r id e  o f Gold and 
S odium ,the l / 2 0 t h  o f a  g r a in  o f 3 o r  4  tim es  a  day f o r  2 o r 3 d ay s . 
Then d rop  to  th e  l / 4 0 t h  o f a  g r a in  ( t h a t  i s ,  one t a b l e t  w i l l  do f o r  
2 i n j e c t i o n s ) , and c o n tin u e  th a t  3 tim e s  a  day f o r  a t  l e a s t  3 aJid 
someümes 4 w eeks. Use a  sy r in g e  w ith  a  s o l id  p is to n  a s  s o ld  by 
Chapman o f M o n trea l, and u se  alw ays a  p la tin u m  n e e d le .  A f te r  a  day 
o r  two you may have some lo c a l  hyperaem ia -  use  l a n o l in  o r  c a rb o -  
l i z e d  v a s e l in e ,  and shower th e  arm w ith  h o t w a te r morning.,.and even ing , 
T h is  does n o t u s u a l ly  l a s t  beyond th e  second w eek."
D r. Edwards a ls o  ad v o ca ted  concom itan t u se  o f  v e g e ta b le  
b i t t e r  to n ic s  p ro v id ed  th e y  were n o n a lc o h o lic  and t h i r d l y  in d u c tio n  
o f  a  r e f r e s h in g  s le e p  w ith  "brom ide o f sodium and c h lo ra l"  f o r  1 o r  
2 n ig h t s .  D e sp ite  th e  a p p a re n t su c c e ss  o f th e se  "cu re s"  f o r  d runken­
n e s s ,  th e  p o p u la r i ty  o f  th e  th e ra p y  d id  n o t p e r s i s t  in to  th e  20 th  
c e n tu ry  and c e r t a in l y  no m ention o f  t h i s  appeared  in  O s i e r 's  T ex t­
book ( 69 ) .
W ith th e  approach  o f th e  tw e n t ie th  c e n tu ry , a  new e r a  o f  g o ld  
th e ra p y  was ab o u t to  b e g in . On March 24, 1882 b e fo re  th e  B e r l in  
P h y s io lo g ic a l  S o c ie ty ,  R obert Koch (F ig u re  39»4o) astounded  th e  w orld 
o f  s c ie n c e  w ith  h i s  announcement t h a t  a  b a c i l lu s  was re s p o n s ib le  f o r  
th e  d readed  d is e a s e ,  tu b e r c u lo s i s .  E ig h t y e a rs  l a t e r  in  I 89O a t  
th e  1 0 th  I n t e r n a t io n a l  M edical C ongress in  B e r l in  he announced t h a t
-  72 -
FIGURE 39 ; Dr. ROBERT KOCH (1843-1910), Nobel Laureate I 9 0 5 .
Koch astounded the world o f sc ie n c e  in  1882 w ith  
h is  announcement o f  the id e n t i f ic a t io n  o f a 
b a c il lu s  as the cause o f tubercu losis.
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tu b e rc u l in  was o f b e n e f i t  f o r  tu b e rc u lo s is  s u f f e r e r s .  T his s t a t e -
i n t e r n a t i o n a l  M edical C ongress he d id  make an announcement t h a t
Î
■i!:;
ment was p rem atu re  a s  a lth o u g h  tu b e rc u l in  had a  marked e f f e c t ,  i t
was n o t  a  cu re  and many hopes were d ash ed . However, a t  th e  same
was to  h e ra ld  th e  modem management o f rheum ato id  d is e a s e .  He
re p o r te d  t h a t  g o ld  cyan ide  was e f f e c t iv e  a g a in s t  tu b e rc le  b a c i l l i  
in  v i t r o  ( ? 0 ) . T h is  p u b l ic a t io n  n o t  on ly  le d  to  th e  u se  o f g o ld  
compounds in  th e  tre a tm e n t o f tu b e rc u lo s is  b u t a l s o  by a  s e r e n d ip i -  
dous ro u te  paved th e  way f o r  th e  u se  o f go ld  compounds in  th e  t r e a t -
:ment o f  rheu m ato id  a r t h r i t i s . H is r e s u l t s  d em o n stra ted  t h a t  go ld
cyan ide  added to  c u l tu r e  p la te s  o f tu b e rc le  b a c i l l u s  in h ib i te d
.grow th o f  th e  organism  in  v i t r o  b u t n o t in  v ivo  in  la b o ra to r y  a n i ­
m als (70 ) .  I t  i s  n o t known why Koch e le c te d  to  u se  g o ld  cyan ide n o r 
d id  he e x p la in  w hether i t  was th e  g o ld  o r th e  cyan ide m oiety  which
produced th e  b io lo g ic a l  e f f e c t s .  I n  view o f  th e  f in d in g s  o f  Koch,
p h y s ic ia n s  began to  u se  g o ld  compounds in  th e  tre a tm e n t o f  tu b e rc u -
,l o s i s .  F e l d t ’ s o b s e rv a tio n s  d i f f e r e d  from Koch’s ,  in  t h a t ,  F e ld t
'observed  b e n e f i c i a l  e f f e c t s  o f  go ld  compounds a g a in s t  tu b e rc le
b a c i l l i  in  la b o ra to r y  an im a ls  (71 ) • As w e ll a s  th e  r e p o r t s  by F e ld t
.
(7 1 , 72 ) ,  Bruck and G lück (73) and Ju n k e r (74) p u b lish e d  on th e  
e f f e c t  o f  g o ld  cyan ide  compounds on human tu b e r c u lo s i s .  I n  1925, 
th e  D anish v e te r in a r i a n  H olger M Ollgard re p o r te d  on th e  u se  o f th e
,compound g o ld  sodium th io s u lp h a te  in  bovine tu b e rc u lo s is  (75* Over 
th e  succeed in g  decade numerous p u b lic a t io n s  r e p o r t in g  th e  b e n e f i c i a l  
e f f e c t  o f go ld  compounds a g a in s t  tu b e rc u lo s is  ap p ea red  in  th e
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European l i t e r a t u r e  (76 ) . However, th e  rev iew  by W ells and Long 
con firm s t h a t  th e  e f f e c t iv e n e s s  o f  th e  v a r io u s  g o ld  compounds in  
tu b e rc u lo s is  was i f  a n y th in g  m inim al (76 ) ,  I n  1927 D r. K. Lande 
re p o r te d  on th e  u se  o f  a u ro th io g lu c o se  in  39 p a t i e n t s  w ith  i l l -  
d e f in e d  c o n d i t io n s ,  w hich p ro b ab ly  in c lu d e d  rh eu m a tic  f e v e r  and 
b a c t e r i a l  e n d o c a rd i t i s  (7 7 ) .  H is u se  o f  a u ro th io g lu c o se  was based  
on th e  p rem ise t h a t  g o ld  was a  n o n - s p e c if ic  a n t i s e p t i c  su b s ta n c e . 
The f o r tu i to u s  b u t e rro n e u s  h y p o th e s is ,  t h a t  rheum ato id  a r t h r i t i s  
was a  ch ro n ic  in f e c t io u s  p ro c e ss  s im i la r  to  tu b e r c u lo s i s ,  le d  
D r. J .  F o r e s t i e r  to  s t a r t  t r e a t i n g  h i s  p a t ie n t s  w ith  in flam m ato ry  
rheum ato id  d is e a s e  w ith  g o ld  th io p ro p a n o l sodium su lp h o n a te  in  May 
1928 (78 ) .  F o r e s t i e r ’s  a p p l ic a t io n  o f go ld  th e ra p y  to  p a t i e n t s  
w ith  a r t h r i t i s  th u s  s t a r t e d  a  new e r a  o f  g o ld  th e ra p y  in  m edicine 




E lem en ta l g o ld  h as  been known to  man s in c e  th e  dawn of 
c i v i l i s a t i o n .  The l u s t r e  and permanence coupled  w ith  i t s  r a r i t y  
has  le d  to  th e  w orsh ip  a f fo rd e d  t h i s  m e ta l th ro u g h o u t h i s to r y .  
G o ld 's  presumed m ag ical q u a l i t i e s  and i t s  resem blance to  th e  
"e sse n c e ” o f  th e  sun made i t  a  n a tu r a l  ch o ice  by p r i e s t s ,  h e a le r s  
and shaman. A lthough r e fe re n c e  had been made to  th e  m e d ic in a l u se  
o f g o ld  by th e  C hinese c i r c a  25OO B. C. ,  th e  d ram a tic  acco u n t o f  
Moses b u rn in g  th e  go lden  c a l f ,  p re p a r in g  a  p o tio n  from  th e  a sh e s ,
I
and f o r c in g  th e  C h ild re n  o f I s r a e l  to  " . . .  d r in k  o f  i t " ,  i s  p ro b ab ly  
one o f  th e  e a r l i e s t  a c c o u n ts  o f th e  p r a c t ic e  o f alchem y in v o lv in g
■g o ld . R eference to  th e  m e d ic in a l u se  o f  g o ld  i s  a l s o  a t t r i b u t e d  
to  th e  T a o is t  p h ilo so p h e rs  o f  a n c ie n t  China c i r c a  6OO B.C.  and in  
l a t e r  l i t e r a t u r e ,  P l in y  th e  E ld e r  and B io sc o r id e s  re c o rd  th e  u se  
o f  g o ld  a s  a  m e d ic in a l a g e n t .  I n  th e  g r e a t  P e rs ia n  m ed ica l sc h o o ls  
i n i t i a t e d  by th e  N e s to r ia n  C h r i s t i a n s ,  p h a rm a c is t-p h y s ic ia n s  such 
a s  Y ab ir, A vicenna and Rhazes a l l  advoca ted  th e  use  o f g o ld  comp­
ounds a s  p an ac eas . M edical T each ing  between th e  t h i r d  and n in th  
c e n tu r ie s  sp read  a c ro s s  N orth  A f r ic a  and in to  S pain  w ith  th e  swoop 
o f  th e  Arab C a l ip h a te s ,  T h is  m ed ica l knowledge sp re a d  in to  o th e r  
p a r t s  o f Europe and th e  B r i t i s h  I s l e s  by th e  1 1 th  and 1 2 th  c e n tu r ie s .  
P erhaps th e  f i r s t  g o ld  r e s e a r c h e r  i n  th e  B r i t i s h  I s l e s  was th e  
F ra n c isc a n  s c h o la r  Roger Bacon ( c i r c a  1214-1292 A , D. ) ,  A ccording 
to  S ta h l ,  Bacon gave one o f th e  f i r s t  known d e s c r ip t io n s  o f  g o ld  
c h lo r id e .  The r e p r e s s iv e  r e l ig io u s ;a n d  s c i e n t i f i c  a t t i tu d e s  o f th e  
M iddle Ages p rev en ted  th e  developm ent o f  any t r u e  s c ie n c e  b u t on
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th e  c o n tra ry  r e s u l t e d  in  th e  f l o u r i s h  o f quack ery , s o rc e ry  and 
w i tc h c r a f t .  I n  th e  s e a rc h  f o r  th e  " P h ilo s o p h e r 's  S tone" and th e  
q u in ta  e s se n c e , alchem y was p a tro n is e d  by th e  n o b le  houses o f 
Europe in c lu d in g  th e  c o u r t  o f James IV  o f S c o tla n d  ( l4 7 3 “”1 5 1 3 ) , 
th e  Emperor Rudolph I I  o f Germany ( l5 7 6 0 l6 l2 )  and Duke F re d e r ic k  
o f  W urtenberg , a l l  hoping  to  d is c o v e r  th e  knowledge f o r  e t e r n a l  
l i f e  and th e  s e c r e t  o f  tra n s m u ta tio n  o f base  m e ta ls  in to  g o ld .
I n  th e  R enaissance  p e r io d  th e  w r i t in g  and work o f  P a ra c e ls u s  was 
to  g r e a t ly  in f lu e n c e  th e  p r a c t ic e  o f m ed ic ine . He ad v o ca ted  go ld  
a s  a  u n iv e r s a l  pan acea . A s im i la r  p ro c lam atio n  th a t  h i s  g o ld
p o tio n  was an arcanum came from  th e  Englishm an F ra n c is  Anthony 
(155O -I023 ) . Anthony was n o t a  p h y s ic ia n  b u t d id  s tu d y  c h em is try  
and p h y s ic s  a t  Cam bridge. He was im piâsoned  on a t  l e a s t  two o cca -
.
s io n s  f o r  q u ack ery , and s u b je c te d  to  "exam ination" by th e  Royal
■C ollege  o f P h y s ic ia n s  -  an e x e rc is e  w hich he f a i l e d  m ise ra b ly .
I n  d e fe n se  o f  h i s  g o ld  panacea Anthony engaged in  a  l i t e r a r y  i n t e r ­
change w ith  th e  m ed ica l g r e a t  o f h i s  day . D e sp ite  t h e i r  c r i t i c i s m
he co n tin u ed  to  p r e s c r ib e  h is  g o ld  p o tio n  to  h i s  w i l l in g  p a t i e n t s  
th ro u g h o u t h i s  l i f e t i m e .
Unique a s s o c ia t io n  o f  g o ld  w ith  m edical p r a c t ic e  have been 
re c o rd e d . Among th e  more n o ta b le  i s  th e  re c o rd  by th e  famous F rench  
su rg eo n , Ambrose P a re , o f  th e  u se  o f  a  go ld  l i g a t u r e  in  th e  t r e a t ­
ment o f  r e c u r r e n t  in g u in a l  h e rn ia .
A lthough g o ld  has been u sed  in  d e n ta l  su rg e ry  f o r  a lm ost 
100 y e a r s ,  d e c o ra tiv e  d e n t i s t r y  was p r a c t i s e d  by th e  a n c ie n t  South
; i'
78 -
American c i v i l i s a t i o n  more th a n  1000 y e a rs  ago , A specim en o f a  
m andible w ith  c i r c u l a r  g o ld  in la y s  in  th e  in c i s o r s  was d isc o v e re d  
by th e  A n th ro p o lo g is t M.H. Sa v i l i e  in  Ecuador in  1913 and i s  now 
in  th e  Museum o f  th e  American In d ia n  in  New York C ity .
The a s s o c ia t io n  o f  go ld  w ith  m edicine has n o t alw ays been 
o f  th e r a p e u t ic  i n t e r e s t .  From th e  end o f  th e  1 7 th  c e n tu ry  to  th e  
b e g in n in g  o f th e  19 t h  c e n tu ry  a  handsome g o ld  headed cane was th e  
p r iz e d  p o s se s s io n  o f  a  s e r i e s  o f  s ix  n o ta b le  p h y s ic ia n s .  The cane 
was o r ig i n a l l y  owned by D r. John R a d c l i f f e ,  b e n e fa c to r  o f th e  now 
famous Oxford h o s p i ta l  and l i b r a r y .  D r. R a d c l if fe  p assed  th e  cane 
to  D r. R ichard  Mead, who was an e q u a l ly  em inent and s u c c e s s fu l
p h y s ic ia n .  The cane was th e n  s u c c e s s iv e ly  owned by D rs . Askew, 
W illiam  and D avid P i t c a i r n ,  and f i n a l l y  by D r. Matthew B a i l l i e th e  
nephew o f  W illiam  and John H u n te r. The cane i s  now on d is p la y  in  
th e  l i b r a r y  o f th e  R oyal C o llege  o f P h y s ic ia n s  in  London,
The emergence o f m edicine and c h em is try  a s  t r u e  s c ie n c e s  
p ro b ab ly  began in  th e  e a r ly  1 7 th  c e n tu ry  w ith  such peop le  a s  John 
G lau b er ( l6 0 4 - l6 7 9 ) , R obert Boyle (1627- I 687) and N ic o la s  Lemery 
(1645- 1715) • Around t h i s  tim e th e  famous Dutch p h y s ic ia n  Herman 
Boerhaave (1668- 1738) and th e  Scotsm an D r. Donald Monro r e je c te d  
th e  id e a  t h a t  aurum p o ta b i le  was o f  any m ed ic in a l v a lu e .  The 
r e v iv a l  o f g o ld  compounds in  m edicine o ccu rred  in  th e  e a r ly  19 t h  
c e n tu ry  due to  th e  work o f  A ndre-Jean  C h re s tie n  and P ie r r e  F ig u ie r  
(1765- 1817) ,  two p ro fe s s o rs  a t  th e  U n iv e rs i ty  o f M o n tp e llie r .
_
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I n  th e  p a s t  15O y e a r s ,  p e rh ap s  th e  most un ique  a p p l ic a t io n  
o f  a  g o ld  compound was th e  u se  o f g o ld  sodium c h lo r id e  by D r. L e s l ie  
I .  K eeley  (1832- I 9OO) o f D w ight, I l l i n o i s  and D r. O liv e r  Edwards 
o f  O ttawa in  th e  tre a tm e n t o f i n e b r i e ty .  D r. Edwards p re s e n te d  h i s  
p ap e r to  th e  M ontreal M ed ico -G h iru rg ica l S o c ie ty  i n  I 8 9 6 . D esp ite  
th e  la u d ed  rem arks o f t h i s  tre a tm e n t b o th  by th e  p a t i e n t s  and th e  
p h y s ic ia n s ,  no r e c o rd  o f i t s  use  e x i s t s  in  c u r re n t  te x tb o o k s  o f 
m edicine and th e re  was no m ention in  O s i e r 's  T extbook.
F ig u ie r ,  a  p h a rm a c is t, p ro v id ed  th e  chem ica l fo rm u la tio n  f o r  th e  
g o ld  compounds, in  p a r t i c u l a r  g o ld  sodium c h lo r id e ,  w hich C h re s tie n  
ad v o ca ted  a s  o f  v a lu e  in  th e  tre a tm e n t o f tu b e rc u lo s is  and s y p h i l i s .
The f i r s t  reco id . o f  th e  u se  o f  g o ld  compounds i n  modem 
m ed icine  in  th e  U n ite d  S ta t e s  was th e  t h e s i s  by John G. Cheesman 
on th e  u se  o f g o ld  sodium c h lo r id e  in  th e  tre a tm e n t o f  s y p h i l i s .
The 18 t h  c e n tu ry  was th e  p e r io d  o f  th e  g r e a t  pharm acolo-
1
g ic a l  r e v o lu t io n  when hom eopaths such a s  F r ie d r ic k  Hahnemann 
re sc u e d  th e  popu lace  from  th e  ia t r o g e n ic  rav ag e s  o f  th e  a lc h e m ic a l 
fo rm u lae  by in t ro d u c in g  th e  "m in i-d o se " . The homeopath M. F re l ig h  
l i s t s  g o ld  l e a f  and a  g o ld -aq u a  r e g ia  s o lu t io n  a s  a  recommended i-
t r e a tm e n t f o r  a  wide v a r ie ty  o f  u n r e la te d  d is o r d e r s ,  a lth o u g h  no
r a t i o n a l  a s s o c ia t io n  o f th e se  d is e a s e s  i s  a p p a re n t.  N e v e r th e le s s ,  
th e  ad v en t o f homeopathy c o in c id e d  w ith  th e  developm ent o f  s t r u c ­
t u r a l  m edical p r a c t ic e  a s  ad v o ca ted  by W illiam  C u llen  (1711-1790) 
and Josep h  B lack  (1728-1799), b o th  Glasgow U n iv e rs i ty  g ra d u a te s .
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The h e ra ld  o f th e  modem use  o f go ld  compounds i n  m edicine 
s t a r t s  w ith  th e  o b se rv a tio n  by D r. R obert Koch th a t  g o ld  cyan ide 
was b a c t e r i c i d a l  in  v i t r o  to  tu b e rc le  b a c i l l i .  European s c i e n t i s t s  
an d  p h y s ic ia n s  ov er th e  n e x t 40 y e a rs  experim en ted  w ith  th e  u se  o f 
g o ld  com plexes i n  th e  tre a tm e n t o f  human and bovine tu b e r c u lo s i s .  
The e rro n eo u s  b u t s e re n d ip i to u s  assum ption  by D r. Jacq u es  F o r e s t i e r  
t h a t  rheum ato id  d is e a s e  was an in f e c t io u s  d is e a s e  an a logous to  
tu b e r c u lo s i s ,  le d  him to  u se  g o ld  th io p ro p a n o l sodium su lp h o n a te  
on 15 p a t i e n t s  w ith  in flam m ato ry  rheum ato id  d is e a s e .  The su c c e ss  
o f  t h i s  i n i t i a l  experim en t was th e  seed  which has le d  r e s e a r c h e r s  
ov er th e  p a s t  50 y e a rs  to  in v e s t ig a t e  b o th  th e  b e n e f i c i a l  and th e  










CHAPTER I I  
GOLD THERAPY IN RHEUMTCOCD DISEASE
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"We do n o t what we ough tj 
What we ought n o t ,  we do;
And le a n  upon th e  th o u g h t
T hat chance w i l l  b r in g  u s  th ro u g h ."
Matthew A rnold (1822-1888)
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L 'an a lo g u e  de l 'é v o l u t i o n  c l in iq u e  de 
c e r t a in e s  form es g ra v e s  de rheum atism s ch ron ique  
avec c e l l e  de l a  m alad ie  tu b e rc u le u s e ;  é v o lu tio n  
f e b r i l e ,  avec p o u ssé es  f lu x o n n a ire s  au l i è v r e  
c o n tin u e , a t t e i n t e  de 1 ' é t a t  g é n é ra l ,  anem ie, 
le u c o c y to s e , e t c . ,  nous on t f a i t  p e n se r  que l e s  
s e l s  d ' o r  em ployes dans l a  tu b e rc u lo s e  p o u r ra ie n t  
re n d re  de t r è s  g ran d s  s e rv ic e  aux rh e u m a tis a n ts  . . . . "  (78 )
The l a t e  D r. Jacq u es  F o r e s t i e r  (F ig u re  .41 ) th u s  h y p o th e s ise d  
t h a t  s in c e  th e  m a n ife s ta t io n s  o f  rheum ato id  a r t h r i t i s  were so s im i la r  
to  th o se  o f tu b e r c u lo s i s ,  g o ld  compounds shown t o  be o f  b e n e f i t  
a g a in s t  th e  d read ed  b a c i l l u s  cou ld  be e f f e c t iv e l y  employed a g a in s t  
a  d is e a s e  o f s im i la r  e v o lu t io n ,  c h ro n ic  rheum ato id  a r t h r i t i s .  I n  h i s  
o r ig in a l  s e r i e s ,  F o r e s t i e r  t r e a t e d  11 women and fo u r  men o f mean age 
42 y e a r s ,  w ith  25O mgs o f g o ld  th io p ro p a n o l sodium su lp h o n a te  a s  
w eekly in tra m u s c u la r  i n j e c t i o n s .  The g o ld  compound suspended in  
sodium c h lo r id e  was g iv e n  e v e ry  f iv e  to  seven days depending  on how 
w e ll i t  was t o l e r a t e d .  A co u rse  o f g o ld  th e ra p y  was d e f in e d  a s  10 o r  
12 i n j e c t i o n s .  I n  some c a se s  a  second co u rse  was commenced a f t e r  a  
one month " r e s t"  p e r io d .  I n  t o t a l  I 65 in j e c t i o n s  were g iven  to  th e  
15  p a t i e n t s  w ith  a  ran g e  o f  betw een two to  24 p e r  p a t i e n t .  F iv e  
p a t i e n t s  had an e x c e l le n t  re sp o n se , f i v e  p a t i e n t s  were much im proved 
and two were re c o rd e d  a s  h av in g  a  m inim al re sp o n se . I n  th r e e  p a t i e n t s  
i n s u f f i c i e n t  knowledge was a v a i la b le  b u t acc o rd in g  to  th e  a u th o r ,  
none o f them was w orse . S ig n i f i c a n t  improvement was reco rd ed  in  l o c a l  
and g e n e ra l f e a tu r e s  o f  a  h i t h e r to f o r e  p ro g re s s iv e ,  d e s t r u c t iv e  
d is e a s e .  P a t i e n ts  were re c o rd e d  a s  hav ing  a  d e c re a se  in  sy n o v ia l
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FIGURE 4 l  ; Dr. JACQUES FORESTIER (1890-1978)
P ioneer in  the use o f  gold compounds in  the  
treatm ent o f rheumatoid a r t h r i t i s .
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s w e llin g  and e f fu s io n  a s  w e ll a s  a  d e c re a se  in  j o i n t  p a in  and 
s t i f f n e s s .  P e r i a r t i c u l a r  te n d e rn e s s  and muscle cramps d isa p p e a re d , 
s le e p  p a t te r n  im proved and p a t i e n t s  r e q u ire d  l e s s  a n a lg e s ic s j
e s p e c ia l ly  a s p i r i n . !
II
I n  h i s  o r ig in a l  15 p a t i e n t s  F o r e s t i e r  d id  re c o rd  s id e  e f f e c t s  j
h u t in  g e n e ra l th e s e  were n o t s e r io u s .  E ig h t p a t i e n t s  had f e b r i l e  j
ir e a c t io n s  on two o r  th r e e  o c c a s io n s  b u t none was s u s ta in e d  above !
!
38°G, a lth o u g h  in  s ix  p a t i e n t s  a  t r a n s i e n t  r i s e  to  40^G was re c o rd e d . |
!
Four o f  th e  p a t i e n t s  had d ia r rh o e a  and vom iting  and one o f  th e  g roup j
a l s o  had a  g e n e ra l is e d  m o rb ill ifo rm  erythem a w ith  desquam ation . I n  I
Ione p a t i e n t  who was f e b r i l e ,  th e  te m p e ra tu re  e le v a t io n  was accom panied |
- I
by a  t r a n s i e n t  g e n e ra l is e d  lym phadenopathy , T h is  was n o t p e r s i s t e n t  
and f u r th e r  th e ra p y  was n o t  w ith h e ld . Three p a t i e n t s  had s e r io u s  
ad v e rse  e f f e c t s .  Two had a  g e n e ra l is e d  erythem a w ith  p u s tu le s  and 
one p a t i e n t  had erythem a and mouth u l c e r s .
T h is  o r ig in a l  work by F o r e s t i e r  s e t  in  m otion a  new e r a  in  
th e  tre a tm e n t o f  rheum ato id  a r t h r i t i s  by in tro d u c in g  a  drug  which 
m arkedly  im proved th e  d is e a s e  s t a t e .  F o r e s t i e r  had shown th a t  g o ld  
th io p ro p a n o l sodium su lp h o n a te  was e f f e c t iv e  in  th e  tre a tm e n t o f rheum­
a to id  a r t h r i t i s  b u t he was w ise enough to  c a u tio n  t h a t  i t  d id  induce 
a d v e rse  e f f e c t s  and th u s  th e ra p y  had to  be m onito red  from  s t a r t  to  
f i n i s h .
A f te r  more th a n  50 y e a rs  o f g o ld  th e ra p y  in  th e  tre a tm e n t o f  
rheum ato id  d is e a s e ,  w ith  no mechanism o f  a c t io n  hav ing  y e t been d e t e r ­
m ined, i t  i s  i n t e r e s t i n g  to  n o te  F o r e s t i e r ' s  s p e c u la tio n  a s  to  th e  mode
— 8 6  —
o f  a c t io n  o f th e  g o ld  t h i o l  compounds in  th e  tre a tm e n t o f  rheum ato id  
a r t h r i t i s .
sym m etrica l in flam m ato ry  p o l y a r t h r i t i s  which he b e l ie v e d  to  be consi*
A lthough Jacq u es  F o r e s t i e r  i s  lau d ed  a s  th e  p io n e e r  o f g o ld  
th e ra p y  in  rheum ato id  a r t h r i t i s ,  i t  sh o u ld  be n o te d  th a t  h i s  f a t h e r ,  
th e  l a t e  D r. H enri F o r e s t i e r ,  fo u n d e r o f  La L igue I n t e r n a t io n a l  C ontre
1
F!
" . . . .  Nous pensons que l ' a c t i o n  p r in c ip le  r é s id e  
dans l a  com binaison d l ' o r  avec l 'a to m e  de 
so u fre  e t  que ce compose d o i t  a v o i r  une a c t io n  
b a c te r ic id e  in  v ivo  s u r  l e  ou l e s  a g e n ts  m icro­
b ie n s  q u i c o rd e n t l e s  form es de p o ly a r t h r i t e s  
i n f e c t i e u s e s  que nous avons t r a i t é e s , "  (78 )
In  F eb ru a ry  1930 (79) Ja cq u es  F o r e s t i e r  su p p o rted  h i s  i n i t i a l  
f in d in g s  (78 ) by r e p o r t in g  th e  outcome o f  a  f u r t h e r  33 p a t i e n t s  w ith
s t e n t  w ith  rheum ato id  a r t h r i t i s .  The outcome o f t h i s  second s tu d y
confirm ed  th e  e f f ic a c y  and t o x i c i t y  d a ta  o f  th e  f i r s t  b u t a l s o  showed 
t h a t  th e  u se  o f 100 mg o f  g o ld  th io p ro p a n o l sodium su lp h o n a te  w eekly 
was p ro b ab ly  l e s s  to x ic  and e q u a l ly  e f f e c t iv e  to  th e  o r ig in a l  h ig h e r  
dose o f  250 mg w eek ly . F o r e s t i e r  adds a  n o te  o f c a u tio n  to  p o te n t i a l  
p r e s c r ib e r s  o f t h i s  compound t h a t  b e n e f i t  from  th e  d rug  i s  n o t seen  
u n t i l  a t  l e a s t  th r e e  months o f  th e ra p y  have e la p se d . He recommended 
t h a t  th e ra p y  be s t a r t e d  w ith  th r e e  i n j e c t i o n s  o f 50 mg in t r a m u s c u la r ly  
1 week a p a r t  fo llo w ed  by 100 mg w eekly u n t i l  a  t o t a l  o f  1 ,0  to  I .5  
grams have been g iv e n . R epeat c o u rse s  o f  th e  g o ld  compound cou ld  be 
g iv en  p ro v id ed  an i n t e r v a l  o f  s ix  w eeks.had e la p se d  s in c e  th e  
p re v io u s  c o u rse . I t  i s  o f i n t e r e s t  t h a t  t h i s  second p u b lic a t io n  on 
th e  u se  o f g o ld  compounds by F o r e s t i e r  was th e  b a s is  f o r  th e  e m p ir ic a l 
d osag e  sch ed u le  now u sed  f o r  g o ld  sodium th io m a la te .
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Le Rhumatisme (80) (F ig u re  42) a s s i s t e d  h i s  son in  th e  o r ig in a l  
c l i n i c a l  exp erim en ts  w ith  go ld  compounds in  th e  tre a tm e n t o f rheuma­
to id  a r t h r i t i s  (7 8 ,81 ) ,
"Les p rem ie re  a p p l ic a t io n s  th é ra p e u tiq u e  
d es  s e l s  d ' o r  aux rheum atism ss ch ro n iq u es  
p r o g r e s s i f s  d 'o r ig in e  in f e c t ie u s e  f a i t e s  
p a r  l e  D r. Jacq u es  F o r e s t i e r ,  mon f i l s  e t  
moi-même d e f in s  1928 a u t  donné d es  r é s u l t a t s  
t r è s  s a t i s f a i s a n t s . "  (82)
F ra n c o is  F o r e s t i e r  (F ig u re  43) son o f  Jacq u es  F o r e s t i e r  i s  
p r e s e n t ly  a  p h y s ic ia n  in  A ix -L es-B ains and i s  th e  V ic e -P re s id e n t de 
l a  S o c ié té  F ra n ç a ise  d 'h y d ro lo g ie  m é d ica le . A lthough he i s  n o t 
c u r r e n t ly  engaged in  c l i n i c a l  r e s e a r c h  w ith  g o ld , he has p u b lish e d  
on th e  s u b je c t  in  c o l la b o r a t io n  w ith  h i s  f a th e r  (8 3 , 84 ) ,
The f i r s t  p u b l ic a t io n  on g o ld  th e ra p y  in  E n g lish  by Jacq u es  
F o r e s t i e r  was p u b lish e d  i n  L an ce t in  1932 (85 ) .  T h is  was a  summary 
o f h i s  o r ig i n a l  o b s e rv a tio n s  p u b lish e d  in  th e  F rench  l i t e r a t u r e  (7 8 , 
79 ) .  I n  1934 , in  th e  H u n te ria n  A ddress (86) F o r e s t i e r  p re s e n te d  th e  
r e s u l t s  o f 500 p a t i e n t s  w ith  rheum ato id  a r t h r i t i s ,  t r e a te d  w ith  g o ld  
compounds. He re c o rd e d  a  70 to  80^ su c c e ss  r a t e .  F i f t y  p e r  c e n t o f 
p a t i e n t s  t r e a t e d  e a r ly  in  th e  d is e a s e  s t a t e  were perm anen tly  im proved 
compared to  o n ly  25^  o f  p a t i e n t s  w ith  d is e a s e  o f  two o r more y e a r s ' 
d u r a t io n .  I n  h i s  d is c u s s io n  o f  g o ld  compounds F o r e s t i e r  s t a t e d  t h a t  
g o ld  sodium th io m a la te  and g o ld  th io g lu c o s e  were th e  most u s e f u l  
a g e n ts .  I n  t h i s  p u b l ic a t io n .  F o r e s t i e r  r e c o r ie d  a  f a t a l  case  o f a g ra n ­
u lo c y to s i s ,  which was h i s  f i r s t  d e a th  due to  g o ld  th e ra p y . I n  a  
subsequen t p ap e r (87 ) he s t a t e d  t h a t  s e d im e n ta tio n  r a t e  was th e  most
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FIGURE4^ D r. HENRI FORESTIER (l86l-1945)Foundateur de La Ligue Internationale Centre Le Rhumatisme. Father of Jacques Forestier and co-pioneer with his son in the use of gold compounds in the treatment of rheumatoid arthritis
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FIGURE 43; Dr. FRANCOIS FORESTIER (Bom  19 2 6 ).
V ice-P resid en t de l a  S o c ié té  Française  
d 'h y d ro lo g ie  m éd ica le . Co-author w ith  
h is  fa th e r  Jacques F o r e s t ie r  on s tu d ie s  
in  the use o f  g o ld  compounds in  the  
treatm ent of rheumatoid a r t h r i t i s .
Dr. Francois F o r e s t ie r  i s  a ph ysician  in  
A ix -le s -B a in s  in  France.
ao
important check on treatment and th at monthly blood counts and 
u r in a ly s is  were an important means of d etectin g  in c ip ien t to x ic  
rea c tio n s. He a lso  sta ted  th at every p atien t trea ted  with gold
treatment i s  started  in  order to  id e n t ify  those p a tien ts  su scep tib le  
to  the development o f purpura.
d isease  appeared in  the l i t e r a tu r e .  In a s e r ie s  o f 3 pu b lication s  
between 1935 and 1937» H artfa ll and co lleagu es recorded th e ir  obser­
vations of b en efit and to x ic i t y  due to  gold therapy in  p a tien ts  with  
rheumatoid a r th r it is  (9 3 ,9 4 ,9 5 )• The f in a l  a r t ic le  which described
to x ic i ty  occurred in  4 ^  o f ca ses , although only 6% were severe. The 
relap se rate was 21^ and the authors sta ted  that relap se was le s s  
common i f  two courses of gold therapy were g iven . Seven deaths due 
to  gold therapy were recorded in  th is  s e r ie s  of p a tien ts; three cases  
of haemorrhagic purpura; one case o f agranulocytosis; two cases of
H a r t f a l l  and c o lle a g u e s  a l s o  s t a t e d  t h a t  g o ld  th e ra p y  was o f d o u b tfu l
i
therapy should have a coagulation time and a bleeding time before
In v estig a to rs  in  the United Kingdom (8 8 ), Germany (8 9 ), 
the United S ta tes  (9 0 ,9 l)  and A u stra lia  (92) confirmed F o r e s t ie r 's
■fin d in gs th at in jec ta b le  gold compounds were e f fe c t iv e  in  rheumatoid 
a r th r it is  but were not without s ig n if ic a n t  t o x ic i t y .  Over the next 





the outcome o f 750 p a tien ts  was the la r g es t  s e r ie s  so fa r  recorded (95)• 
S trik in g  improvement was noted in  approximately 70% of p a tien ts  and
■f
subacute n ecrosis  o f the l iv e r ,  and one case o f e x fo lia t iv e  d erm a tit is .
v a lu e  in  o th e r  form s o f a r t h r i t i s .  T h is  s ta te m e n t has n ev e r been
9.1
c h a lle n g e d  by a  s e r i e s  o f c o n t ro l le d  c l i n i c a l  t r i a l s  a lth o u g h  in  
1978 D o rm rt e t  a l  (96 ) r e p o r te d  a  com parative  t r i a l  o f go ld  th e ra p y  
w ith  e i t h e r  g o ld  sodium th io m a la te  o r  g o ld  th io g lu c o s e  in  p a t i e n t s  
w ith  p s o r i a t i c  a r t h r i t i s  compared to  p a t i e n t s  w ith  rheum ato id  
a r t h r i t i s .  The a u th o rs  re c o rd e d  t h a t  th e  l 4  p a t i e n t s  w ith  p s o r i a t i c  
a r t h r i t i s  had g r e a t e r  b e n e f i t  and l e s s  t o x i c i t y  th a n  th e  42 p a t i e n t s  
w ith  rheum ato id  a r t h r i t i s .  E xcept f o r  t h i s  s tu d y  and t h a t  o f Brewer 
e t  a l  ( 97) on th e  u se  o f g o ld  th e ra p y  in  ju v e n ile  rheum atism , no 
o th e r  c o n t ro l le d  s tu d y  o f g o ld  th e ra p y  has been done to  examine 
e f f ic a c y  n o r t o x i c i t y  in  th e  o th e r  rh eu m a tic  d is e a s e s .
U n c o n tro lle d  s tu d ie s  on th e  u se  o f go ld  th e ra p y  in  rheum ato id
d is e a s e  su g g es ted  th a t  th e s e  d rugs were o f  b e n e f i t  i n  between 50^
( 98) to  80% ( 99- 101) o f  p a t i e n t s  g iv e n  th e s e  compounds b u t t h a t  a  
wide range  o f ad v e rse  e f f e c t s  o ccu rred  which co u ld  be s e r io u s  (7 8 ,7 9 ,
85-95» 98- 101) and even f a t a l  (8 6 ,9 5 ,1 0 2 ) .  There was c l e a r ly  a  need  
f o r  a  s t r i c t  e v a lu a tio n  o f  e f f ic a c y  and t o x i c i t y  o f  a t  l e a s t  one o f 
th e  g o ld  compounds w ith  re g a rd s  to  i t s  u se  in  rheum ato id  a r t h r i t i s .
I n  1939 S i r  S ta n le y  D avidson , Chairman o f  th e  S c i e n t i f i c  A dvisory  
Committee o f  th e  Empire Rheumatism C ouncil p roposed  a  m u l t i - c e n tr e  
c o n t ro l le d  doub le  b l in d  t r i a l  to  in v e s t ig a t e  th e  compound g o ld  sodium 
th io m a la te  in  rheum ato id  a r t h r i t i s .  World War I I  d is ru p te d  th e  
su c c e ss  o f  t h i s  i n i t i a l  p ro p o sa l b u t th e  l a t e  D r. Thomas N. F ra s e r  
o f Glasgow (F ig u re  44) com pleted  h i s  s e c t io n  o f th e  m u l t ic e n tre  t r i a l  
a t  th e  W estern In f irm a ry  o f Glasgow (F ig u re  45) and p u b lish e d  h i s  
r e s u l t s  in d e p e n d e n tly  in  th e  A nnals o f  th e  Rheumatic D iseases  in  1945 
(103) .  F r a s e r 's  t r i a l  was th e  f i r s t  p u b lish e d  d o u b le -b lin d  c o n t ro l le d
i
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FIGURE 4 4 ; Dr. THOMAS N. FRASER (1910-1976)
Author o f the f i r s t  d ou b le-b lin d  co n tro lled  
t r i a l  in  th e  use o f  go ld  therapy in  th e  t r e a t ­
ment o f rheumatoid a r t h r i t i s , fo r  which he 
graduated M.D. w ith  honours from Glasgow 
U n iv e r s ity  in  1948. This was the f i r s t  double­
b lin d  c o n tr o lle d  t r i a l  o f any an ti-rh eu m atic drug.
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th io g lu c o s e  d u r in g  th e  f i r s t  y e a r  o f  t h e i r  d is e a s e .  The t o t a l  compound
Ï
t r i a l  o f  any a n t i - rh e u m a tic  d ru g . I t  confirm ed F o r e s t i e r ' s  o r ig i n a l  
f in d in g s  (78 ) and d em o n stra ted  an e f f ic a c y  r a t e  o f  82^ in  th e  p a t i e n t s
who re c e iv e d  g o ld  sodium th io m a la te  compared to  45^ o f  th e  c o n t ro l  
p a t i e n t s .  F r a s e r  d id ,  how ever, c a u t io n  t h a t  i n t e r p r e t a t i o n  o f  th e  
r e s u l t s  sh o u ld  o n ly  be made w ith in  th e  c o n f in e s  o f th e  s tu d y  g ro u p .
H is c o n t ro l  g roup  had a  marked im provem ent r a t e  w hich was a p p a re n tly  
u n ex p ec ted . F r a s e r  e x p la in e d  f i r s t l y  t h a t  a l l  s tu d y  p a t i e n t s  re c e iv e d  
p h y s io th e ra p y  and se c o n d ly  t h a t  some spon taneous re m is s io n s  m ight have 
o c c u rre d . I f  t h i s  a l s o  acco u n ted  f o r  some improvement in  th e  m y o c ris in  
g ro u p , th e r e f o r e  im provem ent a t t r i b u t a b l e  to  g o ld  th e ra p y  would be 
red u ced  to  4 2 ^ . I t  i s  im p o rta n t to  n o te  t h a t  Y2% of th e  c o n t ro l  g roup  
re c o rd e d  a  s u b je c t iv e  im provement a lth o u g h  f o r  th e  purpose o f th e  
s tu d y , im provement was o n ly  re c o rd e d  w ith  4 ^  who showed o b je c t iv e  
im provement (IO3 ) . T h is  s u g g e s ts  t h a t  a  c o n s id e ra b le  p s y c h o lo g ic a l 
f a c t o r  may have been o p e r a t iv e .  Subsequen t to  F r a s e r 's  work f i r t h e r  
t r i a l s  were re p o r te d  b u t th e s e  were p o o r ly  c o n t r o l le d ,  ( l0 4 ,  105)»
I n  1947 Maine and c o lle a g u e s  ( l0 4 )  r e p o r te d  on 58 p a t i e n t s
t r e a t e d  w ith  e i t h e r  g o ld  sodium th io m a la te  o r  g o ld  th io s u lp h a te .  A ll
p a t i e n t s  re c e iv e d  a  minimum o f 5OO mg w ith  an av erag e  t o t a l  dose of
1600 mg. The a u th o rs  r e p o r te d  a  s ig n i f i c a n t  improvement in  57% o f
th e  t r e a t e d  group compared to  29S^  o f  c o n t r o l s .  However, th e  c o n t ro ls  
.were a  g roup  o f  62 rh eu m ato id  a r t h r i t i s  p a t i e n t s  t r e a t e d  w ith  o n ly  
" su p p o r tiv e "  th e ra p y  and d id  n o t  r e c e iv e  a  p laceb o  in j e c t i o n .
I n  1950 Adams and C e c il (105) r e p o r te d  on IO6 p a t i e n t s  w ith  
rheum ato id  d is e a s e  who e i t h e r  re c e iv e d  g o ld  sodium th io m a la te  o r  a u ro -
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g iv e n  was betw een 1000 mg and 1500 mg. The a u th o rs  re c o rd e d  a  66% 
r a t e  o f " rem iss io n "  by t h e i r  d e f in i t i o n  i n  th e  go ld  t r e a t e d  group 
compared to  on ly  24 .1^  re m is s io n  r a t e  in  th e  c o n t ro l  p a t i e n t s .
However, th e  c o n t ro l  g roup  o n ly  re c e iv e d  c o n v e n tio n a l th e ra p y  and 
no p laceb o  in j e c t i o n ,  th u s  making th e s e  f ig u r e s  n o n -com parab le .
R em ission o ccu rred  on av erag e  10 months l a t e r  in  th e  c o n t ro l  g roup  
th a n  in  th e  g o ld  t r e a t e d  g roup ( l 7 months and seven  months r e s p e c ­
t i v e l y  ) .  The av erag e  tim e  from  re m is s io n  to  r e la p s e  was 27 m onths.
The a u th o rs  th u s  concluded  th a t  g o ld  th e ra p y  in c r e a s e s  th e  in c id e n c e  
and a c c e le r a te s  th e  app ea ran ce  o f re m is s io n  i f  g iv e n  d u rin g  th e  f i r s t  
y e a r  o f th e  d is e a s e  (105) .
I n  c o n t r a s t  to  th e  b e n e f i c i a l  e f f e c t s  o f  i n j e c t a b l e  g o ld  
th e ra p y  over c o n v e n tio n a l th e ra p y  q u o ted  by a l l  a u th o rs  so f a r  c i t e d ,  
M e rlis s  and c o l le a g u e s  (106 ) found a u r o th io g ly c o la n i l id e  (Lauron) 
g iv e n  over s ix  months to  27 p a t i e n t s ,  to  be no b e t t e r  th a n  s a l i n e  o r  
serum in j e c t i o n s  g iv en  to  44 c o n t ro l  p a t i e n t s  over a  s im i la r  p e r io d  
of tim e . S im i la r ly  Brown and C u rr ie  (107 ) found t h a t  g o ld  sodium t h i o ­
m a la te  g iven  a s  a  t o t a l  dose o f  800 mg -1 0 0 0  mg was no b e t t e r  th a n  
co p p er, s a l in e  n o r  a r s e n ic  in j e c t i o n s  and no b e t t e r  th a n  p h y s io th e ­
ra p y  o r  o r a l  a s p i r i n  when p a t i e n t s  were a s s e s se d  a t  th e  end o f  th e  
co u rse  o f g o ld , and a t  th r e e  months and 12 months l a t e r .
Lack o f f irm  s t a t i s t i c a l  ev id en ce  a s  to  th e  e f f ic a c y  o f i n j e c ­
t a b le  go ld  compounds le d  th e  Empire Rheumatism C ouncil in  1957 to  p la n  
a  second m u l t i - c e n tr e  t r i a l .  T h is  was c a r r i e d  ou t in  24 c e n t r e s  th ro u g h ­
o u t th e  U n ited  Kingdom and th e  r e s u l t s  were p u b lish e d  in  I 96O and
50  mg w eekly g o ld  sodium th io m a la te ,  th e r e  was p ro g re s s iv e  im prove­
ment in  a  number o f  o b je c t iv e  v a r i a b le s ,  in c lu d in g  th e  number o f 
j o i n t s  c l i n i c a l l y  inflam m ed, g r ip  s t r e n g th  and se d im e n ta tio n  r a t e .
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1961  (1 0 8 ,109 ) .  One hundred and n in e ty -n in e  p a t i e n t s  s t a r t e d  th e  
t r i a l .  The 99 p a t i e n t s  in  th e  t r e a t e d  group re c e iv e d  1000 mg o f g o ld  
sodium th io m a la te  a s  50 mg w eekly i n j e c t i o n s  over 20 weeks. The 
c o n t ro l  group were g iv en  0 .0 1  mg o f  g o ld  sodium th io m a la te  a s
-60 .5  yg w eekly over a  20 week p e r io d  ( i . e .  th e y  r e c e iv e d  1 x 10 
th e  q u a n t i ty  o f  g o ld  compound re c e iv e d  by th e  t r e a t e d  group) . I t  
was u n e q u iv o c a lly  d em p n stra ted  t h a t  in  most p a t i e n t s  g iv en  th e
A lthough g o ld  th e ra p y  was s to p p ed  a f t e r  20 weeks (lOOO mg o f  com- 
po u n d ), im provem ent p e r s i s t e d  f o r  up to  12 months in  many p a t i e n t s  
and was g e n e r a l ly  m a in ta in ed  up to  18 m onths. However, by month 
30 ( i . e .  two y e a rs  a f t e r  g o ld  th e ra p y  had been d is c o n tin u e d )  l i t t l e  
i f  any advan tage  was re c o rd e d  in  th e  o r ig in a l  g o ld  t r e a t e d  group
compared to  controls (109 ) . I n  1973 th e  C o o p era tin g  C l in ic s  Committee 
o f  th e  American Rheumatism A ss o c ia tio n  ( llO )  r e p o r te d  t h e i r  d o u b le ­
b l i n d  t r i a l  o f 68 p a t i e n t s  w ith  d e f i n i t e  o r  c l a s s i c a l  rheum ato id  
a r t h r i t i s  ( i l l ) . The i n i t i a l  phase o f  t h i s  s tu d y  compared 36 
p a t i e n t s  who re c e iv e d  g o ld  sodium th io m a la te  50 mg w eekly f o r  s ix  
months and a  c o n t ro l  g roup  o f  J2 p a t i e n t s  who re c e iv e d  s t e r i l e  w a te r
v e h ic le  ov er th e  same p e r io d .  Twelve p a t i e n t s  i n  th e  g o ld  group
■dropped o u t because  o f a d v e rse  e f f e c t s  and e ig h t  p a t i e n t s  in  th e  
p laceb o  group dropped ou t because o f  no b e n e f i t .  The go ld  t r e a t e d  







m easured, a lth o u g h  on ly  th e  change in  s e d im e n ta tio n  r a t e  was s t a t i s ­
t i c a l l y  s i g n i f i c a n t .  I n  th e  second phase o f th e  s tu d y , d e s ig n ed  to  
compare th e  r e s u l t s  o f m ain tenance th e ra p y ,  p a t i e n t s  re c e iv e d  s ix  
50 mg doses  a t  two-week i n t e r v a l s ,  s ix  d o ses  a t  th ree -w ee k  i n t e r -
:v a i s  and th e n  a t  fou r-w eek  i n t e r v a l s  u n t i l  a  t o t a l  o f  two y e a rs  o f  
t r e a tm e n t had been g iv e n . C o n tro l p a t i e n t s  re c e iv e d  th e  s t e r i l e  
w a te r  v e h ic le  in  th e  same f a s h io n .  I n  phase two th e  g o ld  group 
showed no in c re a s e  in  th e  number o f  in v o lv e d  j o i n t s ,  im proved t h e i r  
g r ip  s t r e n g th  and had a  f a l l  i n  s e d im e n ta tio n  r a t e .  D uring  th e  same ' .
tim e  p e r io d ,  th e  c o n t ro l  group  d e t e r io r a t e d  in  a l l  o f  th e se  m easure­
m en ts . The a u th o rs  commented t h a t  th e  r e s u l t s  o f th e  C oopera ting  
C l in ic s  Committee T r i a l  ( l lO )  confirm ed  th e  r e s u l t s  o f  th e  Empire 
Rheumatism C ouncil T r i a l  ( l0 8 ,1 0 9 )  and s t a t e d  t h a t  th e  l a r g e r  sample 
s iz e  o f  th e  l a t t e r  a llo w ed  th e  d i f f e r e n c e s  re c o rd e d  f o r  g r ip  s t r e n g th  
an d  number o f  a c t iv e  j o i n t s  t o  re a c h  s t a t i s t i c a l  s ig n if ic a n c e  a s  had 
been  ach iev ed  by th e  se d im e n ta tio n  r a t e .  I t  sh o u ld  be n o te d  t h a t
a lth o u g h  th e  Empire Rheumatism C ouncil T r i a l  p a t i e n t s  and C o o p era tin g  
.C lin ic s  Committee T r i a l  p a t i e n t s  w ere com parable in  a lm o st a l l  r e s p e c t s ,  
th e r e  were marked d i f f e r e n c e s  i n  th e  c a te g o ry  o f d u ra t io n  o f  d is e a s e  
p r i o r  to  th e ra p y . The m a jo r i ty  o f Empire Rheumatism C ouncil T r i a l  
p a t i e n t s  had d is e a s e  o f l e s s  th a n  th r e e  y e a rs  d u ra t io n  and had an 
u p p er l i m i t  o f f iv e  y e a r s ,  w hereas th e  C o o p era tin g  C l in ic s  Committee 
T r i a l  p a t i e n t s  had no d is e a s e  d u ra t io n  l i m i t  and a lm o st one t h i r d  o f 
th e  p a t i e n t s  had rheu m ato id  a r t h r i t i s  f o r  lo n g e r  th a n  f iv e  y e a r s .  I f  
go ld  works b e t t e r  when g iv e n  e a r ly  in  th e  d is e a s e  p ro c e s s ,  t h i s  would
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C ouncil T r i a l  r e s u l t s .  However, one must c o n s id e r  t h a t  g o ld  
th e ra p y  may n o t he a s  e f f e c t i v e  a s  i s  g e n e ra l ly  th o u g h t and th e  
r e s u l t s  o f th e  C oo p era tin g  C l in ic s  Committee T r i a l  a r e  a  t r u e  
r e f l e c t i o n  o f  i t s  e f f ic a c y .
Two subseq u en t d o u b le -b l in d  t r i a l s  have added f u r th e r  
u s e f u l  knowledge to  th e  management o f  rheum ato id  d is e a s e  w ith  
i n j e c t a b l e  g o ld  compounds. The f i r s t  i s  t h a t  o f  D r. John M. S ig le r  
and c o lle a g u e s  ( l l 2 )  and th e  second i s  t h a t  o f  D .E. P u r s t  and 
c o lle a g u e s  ( I I 3) •
IS ig l e r  and c o lle a g u e s  ( l l 2 )  r e p o r te d  a  two y e a r  d o u b le ­
b l in d  s tu d y  o f 13 p a t i e n t s  who re c e iv e d  g o ld  sodium th io m a la te  
compared to  l 4  p a t i e n t s  who re c e iv e d  p laceb o  i d e n t i c a l  in  ap p e a r­
ance to  th e  g o ld  compound. S ig n i f i c a n t  improvement in  r e l a t i o n  to  
g lo b a l  m easurem ent, r in g  s i z e s  and g r ip  s t r e n g th  was re c o rd e d  in  
th e  g o ld - t r e a te d  g roup . However, th e  most s t r i k i n g  f in d in g  was 
th e  c la im  by th e  a u th o rs  t h a t  r a d io lo g ic a l  exam in a tio n  showed 
a r r e s t  o f  bone and c a r t i l a g e  d e s t r u c t io n  in  s e v e ra l  p a t i e n t s  and 
t h a t  th e  mean p ro g re s s io n  r a t e  o f  d e s t r u c t io n  was s i g n i f i c a n t l y
'slow ed f o r  th e  t r e a t e d  g ro u p . I n  th e  C o o p era tin g  C l in ic s  Committee 
T r i a l  ( llO )  p o s te r o a n te r io r  ra d io g ra p h s  o f  th e  hands were ta k en  a t  
th e  b eg in n in g  and end o f phase  one (0 -27  w eek s). The r e s u l t s  
o b ta in e d  by a  s in g le  o b se rv e r  in  b l in d f o ld  fa s h io n  d e te c te d  d e t e r ­
i o r a t i o n  i n  n in e  o f  19 c o n t r o l s  and th r e e  o f 20 g o ld  t r e a te d  p a t i e n t s .  
The d i f f e r e n c e  (P « O.O6 ) was n o t s ig n i f i c a n t  b u t fav o u red  g o ld  
th e ra p y  a s  b e in g  p o s s ib ly  b e n e f i c i a l .  I n  th e  Empire Rheumatism
__A
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C ouncil T r i a l  (108 ,109) no s i g n i f i c a n t  r a d io lo g ic a l  d i f f e r e n c e s  
were d e te c te d  betw een th e  g o ld  t r e a t e d  and th e  c o n t ro l  g ro u p s in  
te rm s  of j o i n t  n a rro w in g , developm ent o f new e ro s io n s  o r  e x te n s io n '
o f  new e ro s io n s  in  any p e r io d  o f  th e  t r i a l .  The m inim al d i f f e r e n c e s
(115) o However, i t  does su g g e s t t h a t  e i t h e r  g o ld  th e ra p y  i n h i b i t s  
th e  d is e a s e  p ro c e s s  s u f f i c i e n t l y  w e ll t o  a llo w  norm al t i s s u e  r e p a i r  
t o  ta k e  p la c e  o r  t h a t  g o ld  th e ra p y  enhances t i s s u e  r e p a i r .
IIt h a t  d id  o ccu r were in  fa v o u r  o f  th e  g o ld  t r e a t e d  group  (109) <.
T h is  a p p a re n t a r r e s t  o r  even r e g r e s s io n  o f  r a d io lo g ic a l  changes 
re c o rd e d  by S ig l e r  e t  a l  h a s  a l s o  been confirm ed  in  a  much l a r g e r  
b u t u n c o n tro l le d  s tu d y  by Luukhainen e t  a l  ( l l 4 ) .
I t  i s  d i f f i c u l t  to  compare th e  r e s u l t s  o f th e  r a d io lo g ic a l  
s tu d ie s  in  th e  a fo rem en tio n ed  t r i a l s  (108- I IO , 112 , l l 4 )  because o f 
th e  known in te r o b s e r v e r  v a r i a b i l i t y  i n  ra d io g ra p h ic  i n t e r p r e t a t i o n
,1
The p rece d in g  d o u b le -b l in d  t r i a l s  (IO8 , 109 , 110 , 112) 
confirm ed  t h a t  g o ld  th e ra p y  was o f v a lu e  in  th e  tre a tm e n t o f rheu m at- 
b id  d is e a s e ,  b u t dosage sch ed u le  had been ach iev ed  by e m p ir ic a l means 
based  on d e s c r ip t iv e  a n a ly se s  (79) and p o o rly  c o n t ro l le d  com parative  
s tu d ie s  (101 ) .  The q u e s tio n  was r a i s e d  a s  to  w hether 50mg o f  g o ld  
sodium th io ra a la te  w eekly was e q u a l ly  e f f ic a c io u s  and l e s s  to x ic  to
'h ig h e r  d o s e s . F u r s t  and c o l le a g u e s  ( I I 3 ) a tte m p te d  to  answ er th e  
q u e s tio n  by com paring th e  outcome o f  23 p a t i e n t s  who were g iv en  50 mg 
o f  g o ld  sodium th io m a la te  w eekly , to  a  group  o f 24- p a t i e n t s  who were 
g iv e n  150 mg w eekly . Drug a d m in is t r a t io n  and e v a lu a t io n s  were c a r r i e d  
o u t doub le  b l in d .  Serum g o ld  c o n c e n tr a t io n s  were re c o rd e d  b u t d id
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n o t c o r r e l a t e  w ith  e f f ic a c y  n o r  w ith  t o x i c i t y .  The co n v e n tio n a l 
dose -  50 mg w eekly was j u s t  a s  e f f ic a c io u s  a s  th e  h ig h  dose -  
150 mg w eekly . However, s id e  e f f e c t s  were more f re q u e n t and se v e re  
in  th e  h ig h  dose group (113) « These f in d in g s  a re  i d e n t i c a l  to  th o se  
observed  by F o r e s t i e r  i n  h i s  second p u b l ic a t io n  on th e  u se  o f g o ld  
th io p ro p a n o l sodium su lp h o n a te  (7 9 )•
S in ce  th e  r e s u l t s  o f F r a s e r 's  t r i a l  (103 ) and subseq u en t 
c o n firm a tio n  by th e  Empire Rheumatism C ouncil T r i a l ,  (108 ,109) go ld  
sodium th io m a la te  has become th e  most w id e ly  u sed  in j e c ta b le  go ld  
compound in  th e  t re a tm e n t o f  rheum ato id  a r t h r i t i s  a lth o u g h  go ld  
th io g lu c o s e  i s  u sed  in  th e  U n ited  S ta t e s  and g o ld  th io s u lp h a te  i s  
s t i l l  u sed  in  H olland  and Denmark. I n  1972 S u tto n  and c o lle a g u e s
(116 ) r e p o r te d  t h a t  o r a l l y  a d m in is te re d  a lk y lp h o sp h in e  g o ld  co­
o rd in a t io n  com plexes e x h ib i te d  a n ti- in f la m m a to ry  p r o p e r t i e s  when 
a d m in is te re d  to  a d ju v a n t a r t h r i t i c  r a t s  and in  th e  same y e a r  th e  
same group ( I I 7 ) r e p o r te d  t h a t  t r ie th y lp h o s p h in e  g o ld  c h lo r id e  was 
e q u ip o te n t to  p a r e n t e r a l l y  a d m in is te re d  g o ld  sodium th io m a la te  in  
su p p re s s in g  th e  in flam m ato ry  l e s i o n s  o f  a d ju v a n t a r t h r i t i s ,  T r i ­
e th y lp h o sp h in e  g o ld  c h lo r id e  i s  e x tre m e ly  to x ic  in  man and f u r t h e r  
s tu d ie s  were n o t e v a lu a te d .  However, a  r e l a t e d  compound 2 ,3 ,^ ,6  -  
T e tra  -  2  -  a c e ty l  -  1 -  th i o  -  £ -  D -  g lu c o p y ra n o sa to  -  5 -  
( t r ie th y lp h o s p h in e )  g o ld  h as  been shown to  e x h ib i t  p o te n t a n t i -  
a r t h r i t i c  p r o p e r t i e s  (118 ) . Subsequent s tu d ie s  have shown th a t  t h i s  
compound m arketed a s  A u ra n o f in ^  (Sm ith  K lin e  and F ren ch , P h i la d e lp h ia )  
i s  e f f e c t iv e  i n  human s tu d ie s  o f  rheum ato id  a r t h r i t i s  ( l l 9 , 1 2 0 ,1 2 1 ),
  ’“ ÎWKÏ
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E x ten s iv e  s tu d ie s  a re  c u r r e n t ly  b e in g  conducted w orld  wide by 
S m ith  K line  and F rench  to  in v e s t ig a t e  th e  b io lo g ic a l ,  pharmaco­
lo g i c a l  and c l i n i c a l  p r o p e r t i e s  o f  A u ra n o f in ^  w ith  a  view to  
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Summary;
Based on th e  assum ption  th a t  rheum ato id  d is e a s e  was an 
in f e c t io u s  d is e a s e  analogous to  tu b e r c u lo s i s ,  Jacq u es  F o r e s t i e r  ( 78 ) 
in tro d u c e d  g o ld  th e ra p y  in  th e  tr e a tm e n t  o f  rheum ato id  a r t h r i t i s .  
T h is  somewhat s e r e n d ip i to u s  d is c o v e ry  i s  to d a y  p e rh ap s i r o n i c a l l y  
c lo se  to  th e  t r u t h , i n  view o f  th e  r e c e n t  i n t e r e s t  in  th e  r o le  o f 
th e  E p s te in -B a rr  v i r u s  ( l2 2 )  and g a s t r o - i n t e s t i n a l  commensals (123 ) 
a s  i n f e c t io u s  a g e n ts  which p la y  a  r o l e  in  th e  p a th o g e n e s is  o f 
rheum ato id  d i s e a s e .  F o llo w in g  F o r e s t i e r ' s  i n i t i a l  p u b l ic a t io n s  
(7 8 , 7 9 » 83 - 8 7 ) numerous d e s c r ip t iv e  a n a ly se s  a t t e s t e d  to  th e  e f f i ­
cacy o f  g o ld  compounds in  rheu m ato id  a r t h r i t i s  b u t a ls o  d em o n stra ted  
t h a t  p o t e n t i a l l y  s e r io u s  t o x i c i t y  was a  m ajor d is a d v a n ta g e . The 
d o u b le -b lin d  t r i a l  by F r a s e r  (103 ) and th e  su b seq u en t Empire 
Rheumatism C ouncil T r i a l  ( l0 8 ,1 0 9 )  and C o o p era tin g  C l in ic s  Committee 
T r i a l  ( l lO )  f i n a l l y  e s ta b l i s h e d  th a t  in j e c t a b l e  g o ld  compounds were 
e f f ic a c io u s  in  th e  tre a tm e n t o f  rheum ato id  a r t h r i t i s .  I n  an a tte m p t 
to  produce an o r a l  g o ld  compound. Sm ith  K line  and F ren ch , P h i la d e l ­
p h ia  in v e s t ig a te d  th e  e f f e c t iv e n e s s  o f  a lk y lp h o sp h in e  go ld  compounds 
(116- 118 ) ,  2 ,3 ,4 ,6  -  T e t r a  -  2  “ a c e ty l  -  1 -  t h io  -  |  -  D -  g lu c o ­
p y ran o sa to  -  S -  ( t r ie th y lp h o s p h in e )  g o ld  has proven to  be an e f f e c ­
t i v e  ag e n t c l i n i c a l l y  (119-121) and e x te n s iv e  t r i a l s  a re  underway on 
a  w orld  wide b a s i s  p r i o r  t o  p ro b ab le  m ark e tin g .
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CHAPTER I I I
GURIGAL STUDIES OH GOLD THERAPY 
LONG TERM INJECTABLE GOLD THERAPY; INCIDENCE OF EFFICACY 
AND TOXICITY DUKENG SEQUENTIAL TIME PERIODS
-  INTRODUCTION






"Man can le a r n  n o th in g  u n le s s  he 
p ro ceed s  from  th e  known to  th e  unknown,"
C laude B ernard  (1813- I 878)
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INTRODUCTION :
As a l re a d y  d is c u s s e d  in  c h a p te r  I I ,  th e  e f f ic a c y  o f go ld  
th e ra p y  w ith  g o ld  sodium th io m a la te  i n  th e  tre a tm e n t o f rheum ato id  
a r t h r i t i s  i s  w e ll e s ta b l i s h e d  (IO8 - I IO , 1 1 2 ). However, u n t i l  1979 
(124 ) th e r e  were no c l e a r  g u id e l in e s  on how lo n g  g o ld  com plexes 
sh o u ld  c o n tin u e  to  be a d m in is te re d  to  p a t i e n t s  who a p p a re n tly  
resp o n d  to  and t o l e r a t e  th e  d ru g . F u rth erm o re , a c c u ra te  d a ta  on 
th e  in c id e n c e  o f v a r io u s  form s o f  t o x i c i t y  d u rin g  in c r e a s in g  tim e 
i n t e r v a l s  o f g o ld  tre a tm e n t were la c k in g ,  even though some a u th o rs  
su g g es ted  t h a t  p ro lo n g ed  a d m in is t r a t io n  was u s u a l ly  w e ll t o l e r a t e d
(1 2 5 , 126) .
The fo llo w in g  s tu d y  d e s c r ib e s  my e x p e rien ce  w ith  lo n g  term  
g o ld  sodium th io m a la te  a d m in is tr a t io n  w hile  s tu d y in g  a s  a  rheuma.- 
to lo g y  t r a i n in g  fe l lo w  a t  Q ueen 's  U n iv e r s i ty ,  K in g sto n , O n ta rio  
u n d e r th e  d i r e c to r s h ip  o f D r. T .P . A n a s ta s s ia d e s  ( l 2 4 ) . The s tu d y  
was conducted  a t  Q ueen 's  U n iv e r s i ty ,  Rheumatic D isease  U n it in  a  
s p e c ia l  Gold T herapy C l in ic  (127) . I t  was th e re f o r e  p o s s ib le  to  
document v i r t u a l l y  a l l  o f  th e  t o x i c i t y  t h a t  o ccu rred  w ith in  one 
c l i n i c  s e t t i n g .  R e l ia b le  c a l c u la t io n s  f o r  bo th  th e  freq u en cy  and 
in c id e n c e  o f  t o x i c i t y  co u ld  th e r e f o r e  be made f o r  p e r io d s  o f  c o n t in ­
uous tre a tm e n t ra n g in g  from  ze ro  to  72 m onths. D ata  was a ls o  o b ta in e d  
on th e  outcome o f s u s ta in e d  re m is s io n s  fo llo w in g  th e  d is c o n t in u a t io n  
o f lo n g  te rm  g o ld  tr e a tm e n t .
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PAHENTS AND METHODS;
The m ethodology o f a ssessm en t and m o n ito rin g  were e s ta b ­
l i s h e d  in  1971 by D r. T .P . A n a s ta s s ia d e s  p r io r  to  th e  commencement 
o f  th e  s tu d y . I  jo in e d  h i s  u n i t  on J u ly  1 s t ,  1976 and to o k  charge 
o f th e  assignm ent u s in g  e x a c t ly  th e  same m ethodology.
The s tu d y  group  c o n s is te d  o f  94 p a t i e n t s  who r e c e iv e d  100 
c o u rse s  o f g o ld  sodium th io m a la te  (M yochrisine) from  A p r il  1971 to  
June 1978 . There were 29 m ales and 65 fem a les  w ith  an average  age 
o f  5 2 .3  y e a rs  (ran g e  10-79) and 4 9 .9  y e a rs  (range  IO -69 ) ,  r e s p e c t i ­
v e ly .  Two m ales and fo u r  fem a le s  re c e iv e d  more th a n  one co u rse  o f 
g o ld  th e ra p y . A co u rse  i s  d e f in e d  a s  th e  in tra m u s c u la r  a d m in is tra ­
t i o n  o f g o ld  compound a t  w eekly to  m onthly p e r io d s  f o r  an in d e f i n i t e  
p e r io d  o f  tim e , A p a t i e n t  was c o n s id e re d  to  have r e c e iv e d  a  new 
co u rse  i f  more th a n  s ix  m onths had e la p se d  s in c e  th e  p re v io u s  
i n j e c t i o n .
A ll p a t i e n t s  had c l a s s i c  o r  d e f i n i t e  rheum ato id  a r t h r i t i s  by 
th e  American Rheumatism A ss o c ia tio n  c r i t e r i a  ( i l l )  an d .h ad  o b je c t iv e  
c l i n i c a l  in flam m atio n  o f  th e  j o i n t s  f o r  s ix  months o r  lo n g e r .  The 
d e c is io n  to  s t a r t  g o ld  th e ra p y  was made by a  p h y s ic ia n  s p e c ia l i z in g  
in  th e  rh eu m a tic  d is e a s e s  and was b ased  on th e  p re sen ce  o f a c t iv e  
rheum ato id  a r t h r i t i s  u n re sp o n s iv e  to  adeq u a te  th e ra p y  w ith  n o n s te r ­
o id a l  a n t i- in f la m m a to ry  d ru g s . In tra m u sc u la r  i n j e c t i o n s  o f  th e  g o ld  
compound were g iv e n  w eekly w ith  s t a r t i n g  d o ses  o f 10 mg and 25 mg in  
th e  f i r s t  two w eeks, fo llo w ed  by $0 mg w eekly u n t i l  a  t o t a l  o f  1000 mg 
had been g iv e n . M aintenance d o ses  o f  50 mg o f g o ld  were th e n  g iv e n  
ev e ry  two to  fo u r  w eeks. I f  t o x i c i t y  d ev e lo p ed , th e  dose was reduced
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o r s to p p ed  a t  th e  d i s c r e t io n  o f th e  p h y s ic ia n . Dosage o f g o ld , 
t o x i c i t y ,  haem oglobin , w h ite  b lood  c e l l  co u n t, d i f f e r e n t i a l  w h ite  
b lo o d  c e l l  c o u n t, p l a t e l e t  c o u n t, e ry th ro c y te  se d im e n ta tio n  r a t e ,  
and u r in e  p r o te in  were re c o rd e d  on each  p a t i e n t 's  h o s p i t a l  f i l e  on 
a  s p e c ia l  m o n ito rin g  s h e e t .  P l a t e l e t  co u n ts  were m easured in  th e  
h o s p i ta l  r o u t in e  haem atology la b o ra to r y  on a  T echnicon A u to an a ly ze r 
(m o d e l- lA )  by u s in g  f r e s h  b lo o d  c o l le c te d  in  EDTA, The norm al range  
was 1 5 0 , 000- 4 5 0 , 000/ mm  ^ and low  p l a t e l e t  coun ts  (< 5 0 , 000/mm^) were 
checked by a  C o u lte r  C oun ter ZBl.
Some p a t i e n t s  who l i v e d  a t  c o n s id e ra b le  d is ta n c e  from th e  
U n it were g iven  g o ld  in j e c t i o n s  by t h e i r  fa m ily  p h y s ic ia n s ,  fo llo w in g  
th e  d e s c r ib e d  s c h e d u le . Both th e  fa m ily  d o c to r  and th e  p a t i e n t  had 
d u p l ic a te  g o ld  m o n ito rin g  s h e e ts  i d e n t i c a l  to  th o se  in  th e  Gold 
Therapy  C l in ic ,  w ith  th e  in fo rm a tio n  b e in g  t r a n s c r ib e d  from  th e  
p a t i e n t 's  s h e e t  to  a  c l i n i c  m o n ito rin g  s h e e t  when th e  p a t i e n t  was seen  
a t  th e  Gold T herapy C l in ic .  I n  a d d i t io n ,  fa m ily  d o c to rs  u n d e r ta k in g  
g o ld  th e ra p y  were r o u t in e ly  p ro v id ed  w ith  w r i t te n  in fo rm a tio n  on g o ld  
t o x i c i t y  and e f f i c a c y .  The 26 p a t i e n t s  who were r e c e iv in g  in j e c t i o n s  
from  t h e i r  fa m ily  d o c to rs  were n o rm ally  seen  a t  th e  Gold Therapy C lin ic  
a p p ro x im a te ly  ev e ry  12 w eeks. The rem ain in g  68 p a t i e n t s  were fo llo w ed  
e n t i r e l y  a t  th e  Gold Therapy C l in ic .
P a t i e n t s  were asked  ab o u t th e  appearance o f  r a s h ,  p r u r i t i s ,  
o r  b r u is in g .  D epending on th e  h i s to r y  and s e v e r i ty  o f  th e  r a s h  o r 
p r u r i t i s ,  th e  g o ld  dosage was red u ce d , te m p o ra r ily  w ithdraw n, 
d is c o n tin u e d , o r  in  some in s ta n c e s  co n tin u ed  a t  th e  same d osage .
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was a l s o  w ithdraw n i f  th e  fo llo w in g  a b n o rm a li t ie s  were p r e s e n t ;  2+ 
p r o te in u r ia ,  th e  p e r s is te n c e  o f  1+ p r o te in u r ia  f o r  3 w eeks, o r  
1000 ng o f p r o te in  in  u r in e  p e r  24 h o u rs . F o llow ing  most ep iso d es  
o f  t o x i c i t y ,  g o ld  th e ra p y  was r e s t a r t e d  a t  reduced  dosage (25  mg). 
P ro v id ed  th e re  was no re c u rre n c e  o f t o x i c i t y ,  f u l l  dosage (50 mg) 
was resum ed on th e  n e x t o r su b seq u en t v i s i t .
oI f  th e  w h ite  b lood  c e l l  coun t f e l l  below  4 ,000  p e r  mm-^  o r  th e  p l a t e -  
l e t  coun t f e l l  below  150,000  p e r  mm , go ld  th e ra p y  was im m ed ia te ly  
d is c o n t in u e d . I f  th e r e  was a  downward tr e n d  o f  p l a t e l e t  c o u n t, th e
g o ld  th e ra p y  dosage was r e e v a lu a te d .  I f  th e  p l a t e l e t  coun t f e l l
3below  200,000/mm , th e  n e x t dosage o f go ld  was o m itte d . Gold th e ra p y
The re sp o n se  to  th e  d rug  was judged by two c r i t e r i a .  The
f i r s t  was th e  p a t i e n t 's  answ er to  th e  q u e s t io n ,  "How do you f e e l ,
r e l a t i v e  to  b e fo re  you r e c e iv e d  g o ld  th e ra p y ? "  ( l 2 8 ) . The second
.c r i t e r i o n  was th e  c l i n i c a l  e s t im a t io n  o f  d is e a s e  a c t i v i t y  based  on 
th e  t o t a l  number o f  a c t iv e  j o i n t s .  A j o i n t  was c o n s id e re d  a c t iv e  i f  
i t  was te n d e r  to  p a lp a t io n  o r  p a in fu l  a t  th e  ex trem es o f  range o f 
m otion , o r  i f  i t  d em o n stra ted  s o f t  t i s s u e  sw e llin g  o r  e f f u s io n .  I f  
th e r e  was a  s ig n i f i c a n t  d e c re a se  in  th e  number o f a c t iv e  j o i n t s  
s in c e  th e  p re v io u s  assessm en t (u s u a l ly  an improvement i n  a t  l e a s t  
5 j o i n t s ) ,  th e  p a t i e n t  was c o n s id e re d  " b e t t e r " ; i f  th e  j o i n t  coun t 
was a p p ro x im a te ly  th e  same, th e  p a t i e n t  was co n s id e re d  th e  "same"; 
and i f  th e re  was a  s i g n i f i c a n t  in c re a s e  in  th e  number o f a c t iv e
j o i n t s  s in c e  th e  p re v io u s  v i s i t ,  th e  p a t i e n t  was c o n s id e re d  "w orse".
R em ission was c l a s s i f i e d  a s  no c l i n i c a l  ev idence o f a c t iv e  j o i n t s  
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a r t h r i t i s .  O c c a s io n a lly , where th e  p a t i e n t 's  s u b je c t iv e  re sp o n se  
d i f f e r e d  from  th e  p h y s ic ia n 's  a s se s sm e n t, th e  l a t t e r  was ta k e n  a s  
th e  r e s u l t  f o r  in c lu s io n  in  t h i s  s tu d y . Response to  th e  d rug  was 
re c o rd e d  a t  th e  end o f  e ig h t  p e r io d s ;  3 m onths, 6 m onths, 12 m onths, 
24 m onths, 38 m onths, 48 m onths, 60 m onths, and ?2 m onths.
RESULTS;
E f f ic a c y  and Outcome. 
O v e ra ll outcom e.
Ten p a t i e n t s  were d is c o n tin u e d  from  go ld  th e ra p y  fo llo w in g
r e la p s e d .  The av erag e  tim e o f tr e a tm e n t when re m is s io n  was re c o rd e d  
was s im i la r  in  b o th  th e  p a t i e n t s  who m a in ta in ed  re m is s io n  and th o se  who 
e x p e rien ced  r e la p s e s ,  b u t th e  av erag e  dose r e q u ire d  to  g a in  re m is s io n
3
The c l i n i c a l  outcome o f  94 p a t i e n t s  r e c e iv in g  100 c o u rse s
o f g o ld  th e ra p y  i s  i l l u s t r a t e d  in  T ab le  1 ,  As d e s c r ib e d  in  P a t i e n t s  
a n d  M ethods, p a t i e n t s  were c a te g o r iz e d  a s  be in g  in  re m is s io n , b e t t e r ,  
sam e, o r  w orse . F o r th e  purpose o f  th e  s tu d y , outcome was reco rd ed  
ov er s e t  i n t e r v a l s  o f  tim e a s  shown in  Table 1 .  F o r th e  0 -3  month 
p e r io d ,  3 p a t i e n t s  were w ithdraw n fo llo w in g  im m ediate t o x i c i t y  to  th e  
d ru g , and t h e i r  re sp o n se  i s  n o t re c o rd e d  (see  M isce llan eo u s  T o x ic ity
.
b e lo w ), The number o f  p a t i e n t s  who showed a  fa v o ra b le  re sp o n se  
( re m iss io n  and b e t t e r )  was g r e a t e r  th a n  70^  f o r  each p e r io d  o f  t r e a t ­
ment a n a ly z e d .
Outcome o f  s u s ta in e d  re m is s io n s  and re a so n s  f o r  w ithd raw al o f th e ra p y .
s u s ta in e d  re m is s io n . The outcome a f t e r  d is c o n t in u a t io n  o f  th e ra p y  was 
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was h ig h e r  in  th e  group  who have m a in ta in ed  re m is s io n . The d u ra tio n  
o f m ain tenance th e ra p y  a f t e r  re m is s io n  was s h o r te r  in  6 p a t i e n t s  who 
rem ain  in  re m is s io n . Two o f  th e  4 who r e la p s e d  have been r e s t a r t e d  
on g o ld  th e ra p y . Both went in t o  re m is s io n  a g a in  a f t e r  4  months o f 
th e ra p y , and n e i th e r  h as  shown any ev id en ce  o f  t o x i c i t y .
The re a so n  f o r  w ithd raw al from  g o ld  th e ra p y  d u r in g  th e  
13 4 .4  y e a rs  o f  tre a tm e n t i s  shown i n  T able 2 . F o rty -tw o  p a t i e n t s  
were w ithdraw n because  o f  t o x i c i t y ,  19 because  o f no re s p o n s e , 10 
were in  s u s ta in e d  re m is s io n  (T ab le  2 ) ,  and 7 had m isc e lla n e o u s  r e a s o n s .  
One p a t i e n t  w ith  F e l t y 's  syndrome i s  in  th e  m isc e lla n e o u s  g roup , 
hav ing  been s to p p ed  because o f p e r s i s t e n t l y  low  w h ite  c e l l  count 
a f t e r  135 mg o f g o ld  th e ra p y .  He h as  s in c e  been r e s t a r t e d  and has 
had a  good re sp o n se  i n  te rm s o f d is e a s e  a c t i v i t y  w ith  d isa p p e a ra n c e  o f 
F e l t y 's  syndrome a f t e r  1 ,150  mg o f  M y o ch ris in e , One p a t i e n t  was 
d is c o n tin u e d  because  she  p lanned  to  become p re g n a n t. E leven  p a t i e n t s  
had more th a n  one re a so n  f o r  w ith d ra w a l.
T o x ic i ty .
O v e ra ll t o x i c i t y  (T ab le  3 )•
F o rty -tw o  p a t i e n t s  had to  be w ithdraw n from  g o ld  th e ra p y  
because  o f  t o x i c i t y .  E leven  p a t i e n t s  had more th a n  one to x ic  ep iso d e  
re c o rd e d  a s  a  re a so n  f o r  w ith d raw a l. Rash acco u n ted  f o r  45^ o f  th e  
w ith d raw a ls  in  th e  p a t i e n t s  w ith  to x ic  r e a c t io n s  b u t o n ly  26^  o f th e  
re a so n  f o r  w ith d raw al i n  th e  t o t a l  s tu d y  g ro u p . Mouth u lc e r s  accoun­
te d  f o r  20^ o f w ith d raw a ls  in  th e  p a t i e n t s  w ith  to x ic  r e a c t io n s  and







M -  C
II







-  113 -
I







<u o73O W)SI<u Ioz
§I1
gH
» 0  O  O s  O O  ( N  f N  Tj- (N ^ 8
O  C N COIT)
o01
ot03 a
l a P olîlîlÜ cdg
rqIH
:
. §Sr e]o o '% 'x3 S73 cdrM T)^'i
cdO h9
IO8
















12% o f  w ith d raw a ls  in  th e  s tu d y  g ro u p . P r o te in u r ia  acco u n ted  f o r  
19% of w ithd raw al in  th e  p a t i e n t s  w ith  to x ic  r e a c t io n s  and 11% of 
w ithd raw al in  th e  s tu d y  g ro u p .
in  p a t i e n t s  r e c e iv in g  more th a n  2 y e a rs  o f  th e ra p y  was uncommon, and
S ix te e n  e p iso d e s  o f  p r o te in u r ia  (a s  d e f in e d  i n  P a t i e n t s  and 
M ethods) in  1 3 4 .4  y e a rs  o f  tr e a tm e n t were observed  w hich g iv e s  an 
o v e r a l l  in c id e n c e  o f 0 .9  e p iso d e s  p e r  10 ,000  p a t i e n t s  p e r  month.
The av erag e  tim e o f  o n s e t o f a  to x ic  r e a c t io n  n e c e s s i t a t i n g  
w ith d raw al was 10 m onths. The av erag e  tim e o f o n se t o f r a s h ,  mouth 
u l c e r ,  and p r o te in u r ia  n e c e s s i t a t i n g  w ithdraw al was 11 m onths,
9 m onths, and 8 months r e s p e c t iv e ly .
R ash, mouth u l c e r ,  and p r o te i n u r ia  (T ab le 4 ) .
There were 59 e p iso d e s  o f  r a s h  in  th e  1 3 4 .4  y e a rs  o f t r e a t ­
ment o f  th e  s tu d y  g roup , g iv in g  an o v e r a l l  in c id e n c e  o f  3*6 e p iso d e s  
p e r  10 ,000  p a t i e n t s  p e r  m onth. Rash o ccu rred  most f r e q u e n t ly  i n  th e  
0-3  month p e r io d  w ith  an in c id e n c e  o f  9*8. The o ccu rren ce  o f r a s h
th e  in c id e n c e  a p p e a rs  to  d e c re a se  ov er p ro g re s s iv e  tim e i n t e r v a l s  o f
g o ld  th e ra p y  (T ab le  4 ) .
There were 23 e p iso d e s  o f  mouth u lc e r  in  th e  1 3 4 .4  y e a rs  o f  
tr e a tm e n t o f th e  s tu d y  g ro u p , w ith  an o v e r a l l  in c id e n c e  o f  1 .4  e p i s ­
odes p e r  10 ,000 p a t i e n t s  p e r  month. However, ag a in  th e  h ig h e s t  
in c id e n c e  was observed  d u r in g  th e  0 -3  month p e r io d ,  w ith  a  p ro g re s s iv e  
d e c re a se  over su b seq u en t tim e p e r io d s  so t h a t  th e  o ccu rren ce  o f  mouth 
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There were 5 e p iso d e s  o f  n e p h ro tic  syndrome a l l  o c c u r r in g  w ith in  
th e  f i r s t  12 m onths o f t r e a tm e n t .
Low P l a t e l e t s :  (T ab le  5)*
p l a t e l e t  c o u n ts  betw een 150,000 and 200,000 p e r  mm^. T h e ir  average
1 ,4 5 0  mg.
tim e had a  p l a t e l e t  coun t o f  l e s s  th a n  125,000  p e r  mm .^
The in c id e n c e  o f p r o te in u r ia  a l s o  ap p ea red  to  d e c re a se  ov er p ro g re s ­
s iv e  tim e i n t e r v a l s  o f  tr e a tm e n t and was uncommon a f t e r  12 m onths.
E p iso d es  o f  low p l a t e l e t s  d id  n o t fo llo w  a  p a t te r n  s im i la r  
to  th e  in c id e n c e  o f  r a s h ,  mouth u l c e r s ,  and p r o te in u r ia  :dLth r e s p e c t
to  p ro g re s s iv e  tim e i n t e r v a l s  o f  g o ld  th e ra p y . Throm bocytopenia a s  
d e f in e d  in  P a t i e n t s  and M ethods, o c c u rre d  when p l a t e l e t  co u n ts  were
3l e s s  th a n  150,000 p e r  mm-^ . The av erag e  d u ra tio n  o f th e ra p y  f o r  seven 
p a t i e n t s  who developed  th rom bo cy to p en ia  was 9*7 months (2 .5 "3 °1  month 
r a n g e ) , and th e  av erag e  dosage was 1 ,157  mg. Three p a t i e n t s  developed
*
d u ra t io n  o f th e ra p y  was l 4  m onths (6 -2 4 ) and t h e i r  av e rag e  dosage was
Two p a t i e n t s  had se v e re  th rom bocy topen ia  o f  l e s s  th a n  40 ,000  
and were g iv e n  p red n iso n e  th e ra p y  to  a s s i s t  re c o v e ry  o f  p l a t e l e t  c o u n t. 
Both p a t i e n t s  were g iv en  g o ld  i n j e c t i o n s  o u ts id e  th e  Gold Therapy 
C l in ic ,  I t  i s  i n t e r e s t i n g  to  n o te  t h a t  one o f  th e  seven  p a t i e n t s  
developed  h i s  th ro m b o cy to p en ia  two months a f t e r  g o ld  th e ra p y  had been 
s to p p ed  because  o f  sk in  r a s h  and p r o te in u r ia  o c c u rr in g  a t  s ix  months
(625  mg o f M y o c h r is in e ) . A ll p a t i e n t s  ex cep t th e  two w ith  se v e re  throm -
ob o c y to p en ia  ( l e s s  th a n  40 ,000  p e r  mm-^ ) had a  re c o v e ry  o f  t h e i r  p l a t e ­
l e t s  on w ithd raw al o f  g o ld . I n  seven  p a t i e n t s  th e  g o ld  was r e s t a r t e d i























Low w hite  b lood  c e l l  coun t (WBC)
One p a t i e n t  developed  a  f a l l  i n  WBG from  ^,000/mm to  
2,000/mm^ a f t e r  85  mg o f  M yochrisine» There was no ev id en ce  o f 
F e l t y 's  syndrom e, and bone marrow appearance was c o n s i s te n t  w ith  
g o ld  induced  marrow t o x i c i t y  (129 ) .
M isce llan eo u s  t o x i c i t y .
There w ere two e p iso d e s  o f  ja u n d ic e . One fem ale  p a t i e n t  
developed  c h o l e s t a t i c  ja u n d ic e  a f t e r  85 mg o f  M yochrisine  and a  
male p a t i e n t  d ev eloped  a  c h o l e s t a t i c  ja u n d ic e  a f t e r  75 mg o f 
M y o ch ris in e . L iv e r  b io p sy  in  th e  fem ale  p a t ie n t  was c o n s is te n t  
w ith  i n t r a h e p a t i c  c h o l e s t a s i s .  The re m is s io n  which developed  w ith ­
in  two weeks o f  th e  app earan ce  o f ja u n d ic e  has  c o n tin u e d . The male 
p a t i e n t 's  m ain tenance th e ra p y  was b e in g  g iven  o u ts id e  th e  Gold Therapy 
G lin ic .  A l i v e r  b io p sy  was n o t  perform ed and th e r e  were no r a d io lo g ic  
i n v e s t ig a t io n s .  H is ja u n d ic e  r e s o lv e d  a f t e r  s ix  weeks and g o ld  
th e ra p y  was r e s t a r t e d  12 weeks l a t e r .  There has been no re c u r re n c e  
o f ja u n d ic e  and th e  p a t i e n t  was re c o rd e d  a s  b e t t e r  by th e  c r i t e r i a  
o u t l in e d  in  P a t i e n t s  and M ethods a f t e r  2 y e a rs  o f th e ra p y .
Three p a t i e n t s  d ev eloped  im m ediate h y p e r s e n s i t i ' ' / i t y - l ik e  
r e a c t io n s  to  th e  M yochrisine  th e ra p y . These c o n s t i tu te d  f e v e r ,  
sw e a tin g , h ead ach e , and ta c h y c a rd ia .  Two p a t i e n t s  d is c o n tin u e d  th e  
drug  a f t e r  th e  t e s t  dose and one p a t i e n t  was a llow ed  to  co n tin u e  





The w e ll c o n t ro l le d  B r i t i s h  s tu d y  ( l0 8 ,  109) on th e  e f f ic a c y  
o f  t r e a tm e n t w ith  g o ld  sodium th io m a la te  was c a r r i e d  ou t f o r  p e r io d s  
o f up to  20 weeks, and a lth o u g h  th e  subseq u en t C o -o p e ra tin g  C lin ic s
, ,
Committee s tu d y  ( l i o )  had a  "phase 2" component f o r  a  lo n g e r  p e r io d  
o f  t im e , th e  numbers o f p a t i e n t s  t h a t  e n te re d  t h a t  phase were to o  
sm all f o r  m ean ingfu l comment ( l l O ) . However, subseq u en t s tu d ie s  have 
su g g es ted  th a t  lo n g  te rm  th e ra p y  w ith  g o ld  sodium th io m a la te  i s  
e f f ic a c io u s  (13O, I 31 ) and th e r e  a re  d e f i n i t e  in d ic a t io n s  t h a t  lo n g  
te rm  tre a tm e n t w ith  g o ld  sodium th io m a la te  d e c re a se s  th e  r a t e  o f 
p ro g re s s io n  o f  e ro s io n s  ( l l 2 ,  l l 4 ) .  N e v e r th e le s s , p re v io u s  s tu d ie s  
d id  n o t s y s te m a t ic a l ly  examine th e  in c id e n c e  o f t o x i c i t y  ;f i th  p ro ­
lo n g ed  a d m in is t r a t io n  o f g o ld , even though  some a u th o rs  re p o r te d  t h a t  
lo n g  te rm  th e ra p y  was u s u a l ly  w e ll  t o l e r a t e d  ( l2 5 ,  1 2 6 ) . U n t i l  now 
i t  h as  th e r e f o r e  n o t been  p o s s ib le  to  make a  r a t i o n a l  judgem ent a s  
to  th e  p r e c is e  r i s k  (and  th e r e f o r e  a d v i s a b i l i ty )  o f c o n tin u in g  t r e a t ­
ment w ith  g o ld  sodium th io m a la te  i n d e f i n i t e l y  in  p a t i e n t s  who have
I 
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responded  and who have n o t developed  t o x i c i t y .
II t  w i l l  be observed  from  T able 1 t h a t  th e  c l i n i c a l  resp o n se  
d u r in g  th e  f i r s t  two tim e  p e r io d s  s tu d ie d  i s  s im i la r  to  o th e r  s tu d ie s  
p u b lish e d  (IO8 -IIO ) o v e r s im i la r  tim e p e r io d s  ( i . e .  up to  6 m on ths).
As su g g e s te d  by F ra s e r  (103) in  h i s  s e r i e s ,  th e r e  i s  q u i te  l i k e l y  an 
im p o rta n t p laceb o  e f f e c t  (1 0 9 , 110 , I 32) in c lu d e d  in  th e  re sp o n se s  
o f p a t i e n t s  (who were seen  more f r e q u e n t ly  th a n  b e fo re  g o ld  t r e a t ­
ment was s t a r t e d ) , a lth o u g h  an a c c u ra te  e s t im a te  o f such  an e f f e c t
  j
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i s  c u r r e n t ly  n o t f e a s ib l e  because  i t  would in v o lv e  w ith h o ld in g  
p o te n t i a l l y  re m is s io n  in d u c in g  a g e n ts  such a s  th e  g o ld  com plexes,
D -p e n ic illa m in e  and 'ch lo roqu ine  f o r  p ro lo n g ed  p e r io d s  o f  tim e . I t  
i s  o f i n t e r e s t  to  n o te  t h a t  f o r  p r o g re s s iv e ly  lo n g e r  i n t e r v a l s  o f  
tim e , th e  " re m iss io n "  group has in c re a s e d  p r o p o r t io n a te ly  to  th e  
" b e t t e r "  g roup ( e .g .  compare 6-12  and 12-24  months i n t e r v a l  Table l ) . 
T h is  i s  l i k e l y  e x p la in e d  in  p a r t  by th e  p o l ic y  o f  th e  s tu d y  to  
co n tin u e  g o ld  th e ra p y  i n  p a t i e n t s  who went i n to  re m is s io n  b e fo re  
12 m onths o f g o ld  th e ra p y  f o r  p a s t  one y e a r ,  and in  p a r t  by a d d i­
t i o n a l  re m is s io n s  l a t e r  d u rin g  t r e a tm e n t .  However, a l s o  c o n t r ib u -
t i n g  t o  th e  d e c re a se d  p ro p o r tio n  o f  p a t i e n t s  do ing  " b e t t e r "  i s  an 
a p p a re n t in c re a s e  i n  th e  p ro p o r tio n  do ing  "w orse" betw een 1 and 2 
y e a r s .  A f te r  2 y e a rs  th e  number o f  " re m iss io n s"  on g o ld  dropped 
a s  some p a t i e n t s  r e v e r te d  to  an  a c t iv e  d is e a s e  s t a t u s ,  and in  o th e r s ,  
g o ld  was d is c o n tin u e d ; th e  l a t t e r  p a t i e n t s  do n o t ap p ea r in  T ab le 1 .
'
The q u e s tio n  o f  what happens to  p a t i e n t s  in  re m is s io n  whose 
g o ld  was d is c o n tin u e d  was a l s o  e x p lo re d . I t  i s  a p p a re n t t h a t  w h ile  
some p a t i e n t s  r e la p s e d  and o th e rs  have s ta y e d  in  re m is s io n  f o r  
p ro lo n g ed  p e r io d s  o f  t im e , th e  p a t i e n t s  who r e la p s e d  r e c e iv e d  on 
th e  a v e ra g e ,le s s  m ain tenance g o ld  o v er a  more p ro lo n g ed  p e r io d  o f 
t im e . However, th e s e  d i f f e r e n c e s  i n  m ain tenance th e ra p y  a re  n o t 
s t a t i s t i c a l l y  s ig n i f i c a n t  f o r  th e s e  sm a ll subg roups, so t h a t  no 
d e f i n i t e  s ta te m e n t can be made ab o u t th e  le n g th  o f m ain tenance th e ra p y  
o r  fre q u e n c y  o f  i n j e c t i o n  i n  p a t i e n t s  who have gone in t o  re m is s io n .
i
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Although the to t a l  ep isodes o f to x ic ity  as causes o f w ith- 
/ \drawal (Table 3) are of in te r e s t  in  g iv in g  an overview of the types 
of to x ic  reaction s th at are seen in  populations trea ted  with in je c ­
ta b le  gold therapy, they are o f l i t t l e  p red ictive value fo r  p a tien ts  
who continue on the drug. S tud ies in  both the more recent and the i|
older l ite r a tu r e  (103, 108-110) report to x ic ity  in  a fash ion  s im ilar
to  Table 3» or as a percentage of the whole population studied during
the to ta l  period of observation . In  view o f the lack  o f p red ictive  
value of to x ic i ty  reported as in  Table 3 certa in  adverse e f f e c t s  
(p a r t ia lly  because they co n stitu te  frequent occurrences) were subjec-
ted to  a more rigorous a n a ly s is  of incidence during seq u en tia l time 
in te r v a ls  o f prolonged therapy with gold sodium th iom alate, as i s  |-
shown in  Table 4 . I t  was deemed u se fu l to  ca lcu la te  incidence data ‘f
on the b asis  o f 10 ,000  p a tien ts  (Table 4) because the numbers derived
'Ican be conveniently re la ted  to  expected to x ic ity  in  large  populations. |
The data have a lso  been ca lcu la ted  as a frequency o f occurrence 
(ep isodes per u n it  tim e) s in ce  th is  serves a u se fu l way to  express 
to x ic i ty  when one i s  d ea lin g  with r e la t iv e ly  sm all numbers o f p a tien ts  
rece iv in g  gold  fo r  various periods o f time ( e . g .  Gold Therapy C lin ic s ) .
This approach a lso  has a cer ta in  p red ic tiv e  value. F or example, i t  
i s  apparent from Table 4 th at there i s  a progressive decrease in  
the frequency o f occurrence and the incidence of rash , mouth u lc e r ,
. :and proteinuria  during progressive time in terv a ls  o f in jec ta b le  gold
therapy. This decrease in  frequency and incidence i s  not l ik e ly  to  
be due to chance because there i s  a steady reduction in  the frequency
I
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and incidence in  a l l  three forms of t o x ic i t y .  Furthermore, in  
at le a s t  the f i r s t  f iv e  time periods of treatment (O-36 months 
in c lu s iv e )  each time period in clu d es a s izea b le  part of the study i
population and of treatment months (Table 4 ) .
One explanation fo r  th is  reduction in  the incidence of
certa in  t o x ic i t i e s  might be th a t the authors p rogressively  s e le c ­
ted  p a tien ts  who are b io lo g ic a lly  r e s is ta n t  to  th ese forms of 
to x ic ity  so th at as the duration o f gold treatment progresses in  
tim e, the proportion o f the "resistant"  population a lso  progres­
s iv e ly  in crea ses , s in ce  p a tien ts  who are prone to  develop to x ic ity  
gradually drop out. However, a n a ly s is  o f episodes o f rash occur­
rin g  in  p a tien ts  who have received  gold therapy fo r  prolonged 
periods of time suggests an a lte r n a tiv e  explanation. I f  one exam­
in es  the group of p a tien ts  who continued on with gold therapy, fo r  
the time in ter v a l o f two to  f iv e  years, one fin d s  th at the 22 
p a tien ts  who entered th a t group had experienced 12 episodes o f rash Iduring th e ir  to t a l  period o f observation , 11 of which had occurred
'1
a
before two years o f treatment; most o f these episodes occurred in  
the 3-6  months period . This g iv es  an o v era ll incidence o f 3 «5 
based on the to t a l  period o f treatm ent months fo r  th is  group of 
0-5  years, which i s  considerably higher than a ca lcu la ted  incidence  
of 0 ,2  fo r  rashes occurring during the 2-5 year in terv a l fo r  the
■SB
I
: igroup. I t  can th erefore be argued th at there i s  a group of p a tien ts  Sfi|
who tend to develop rashes ea r ly  (w ithin  6 months), but i f  gold  
treatment continues, they become "resistant"  to  the development of Î
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f u r t h e r  r a s h e s .  The p o s s i b i l i t y  t h a t  th e  p ro longed  g o ld  t r e a t ­
ment i t s e l f  may c o n fe r  such r e s i s t a n c e  r e p r e s e n ts  an i n t e r e s t i n g  
s p e c u la t io n .
I
I t  i s  e v id e n t from  T ab le  5 t h a t  th e  p a t te r n  o f  low p l a t e ­
l e t s  c o r r e la te d  to  th e  tim e o f  o b se rv a tio n  d u r in g  g o ld  tre a tm e n t 
i s  d i f f e r e n t  th a n  t h a t  o f  m ucocutaneous and r e n a l  t o x i c i t y .  I n  
f a c t ,  no p a t te r n  o f  tim e o f o ccu rren c e  f o r  low  p l a t e l e t s  co u ld  be 
i d e n t i f i e d  i n  t h i s  s e r i e s  o f  p a t i e n t s ,  a s  i s  in d ic a te d  by th e  wide 
range  o f  tim e s  when low  p l a t e l e t s  were observed  (see  R e s u l t s ) .
I t  would th e r e f o r e  ap p e a r t h a t  th e  d u ra t io n  o f in j e c ta b le  g o ld  
th e ra p y  b e a rs  no c o r r e l a t i o n  to  th e  in c id e n c e  o f th rom bocy topen ia ; 
th u s  th e  u s e f u l  approach  to  a n a ly s i s  o f  d a ta  a s  d is c u s s e d  f o r  th e  
o th e r  form s o f  t o x i c i t y  in  T ab le 4 h a s  no p r e d ic t iv e  v a lu e  f o r  
th ro m b o cy to p en ia . T h is  c o n c lu s io n  i s  in  agreem ent w ith  p re v io u s  
im p re s s io n s  w ith  r e s p e c t  to  th e  o ccu rren ce  o f  g o ld -a s s o c ia te d  
th rom bocy topen ia  (133» 1 3 4 ) . Throughout th e  s tu d y  c l i n i c a l l y  s ig n ­
i f i c a n t  th rom bocy topen ia  (o r  p l a t e l e t  co u n ts  l e s s  th a n  1 2 5 , 000/mm^) 
were n o t  seen  in  p a t i e n t s  who were fo llo w ed  e n t i r e l y  in  th e  Gold 
Therapy G lin ic  ( 7 ^  o f  a l l  p a t i e n t s  i n  th e  s tu d y ), where th e  g e n e ra l 
p o l ic y  had been to  d is c o n tin u e  g o ld  th e ra p y  a t  l e a s t  te m p o ra r ily  i f
I
th e  p l a t e l e t s  dropped below  200,000/mm^, and to  e v a lu a te  th e  s i t u a -
,  3t i o n  even i f  a  d e c re a s in g  t r e n d  was n o te d  to  l e v e l s  above 200,000/mm
( in  th e  absence o f p r e - e x i s t in g  th ro m b o c y to s is ) . The v a l i d i t y  o f
t h i s  p r a c t i c e ,  o f c o u rs e ,  depends on th e  r e l i a b i l i t y  o f  th e  p l a t e l e t,c o u n tin g  method and th e  method o f  h a n d lin g  th e  b lood  (se e  P a t i e n t s
ij
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and M ethods). Most l a b o r a to r i e s  s p e c ify  a  va lue  o f  150,000/mm^ as  
th e  low er l e v e l  o f  norm al f o r  t h e i r  p l a t e l e t  c o u n t. A p h y s ic ia n
p l a t e l e t  co u n t which h as  been  s te a d y  a t  400 ,000/im ^ to  210,000/mm^
p a t i e n t s  who may p o t e n t i a l l y  d ev e lo p  sudden th ro m b o cy to p en ia . I t
m o n ito rin g  in j e c ta b le  g o ld  th e ra p y , how ever, sho u ld  observe  a  
p l a t e l e t  coun t o f  l e s s  th a n  200,000/mm^ a s  an in d ic a t io n  to  w ith ­
h o ld  g o ld  th e ra p y . A f a l l i n g  p l a t e l e t  count even w ith in  th e  norm al 
ra n g e , may be e q u a l ly  om inous. Thus a  sudden change in  a  w eekly
■
behoves th e  p h y s ic ia n  to  w ith h o ld  g o ld  th e ra p y  u n t i l  a  r e p e a t  p l a t e -  
l e t  count con firm s a  s t a b l e  v a lu e  above 20 0 ,000/mm^ on a t  l e a s t  two 
o c c a s io n s  one week a p a r t .  When a  f a l l  in  p l a t e l e t  coun t r e s u l t s  
in  a  v a lu e  which i s  p e r s i s t e n t l y  l e s s  th an  200,000/mm^, extrem e 
c a u tio n  i s  ad v ise d  and , where a v a i l a b l e ,  b lood sh o u ld  be t e s t e d  f o r  
th e  p resen ce  o f  p l a t e l e t  a n t ib o d ie s  ( l3 5 f  136) .  K elton  and h i s  
c o lle a g u e s  ( l3 5 )  a t  McMaster U n iv e r s i ty  have shown a  100^ c o r r e l a -  
t i o n  between th e  p re sen ce  o f  IgG a n t ib o d ie s  on th e  s u r fa c e  o f  p l a t e -
.1;l e t s  and g o ld -in d u c e d  th ro m b o cy to p en ia . I t  i s  n o t known w hether 
th e s e  p l a t e l e t  a n t ib o d ie s  a re  p r e s e n t  in  th e  much r a r e r  th rom bocy to -
Ip e n ia  due to  marrow s u p p re s s io n . Throm bocytopenia due to  g o ldth e ra p y  has been s t a t e d  a s  o c c u rr in g  p r e c ip i to u s ly  w ith  no a p p a re n t
w arn ing . C lose o b s e rv a tio n  o f  changes in  p l a t e l e t  co u n t even f d th -  
.in  th e  norm al ra n g e , sh o u ld  r e s u l t  in  e a r ly  i d e n t i f i c a t i o n  o f some
i s  o f  i n t e r e s t ,  how ever, t h a t  th e  two c a se s  o f se v e re  th rom bocy to -
'
p e n ia  w ith  p l a t e l e t  c o u n ts  l e s s  th a n  4 0 , OOO/mm  ^ (T ab le  5) and a ls o  
th e  one case  o f  n e u tro p e n ia ,  were observed  among th e  26 p a t i e n t s
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whose g o ld  th e ra p y  and fo llo w -u p  were p r im a r i ly  m on ito red  by t h e i r  
fa m ily  p h y s ic ia n s ,  and who were seen  in  th e  Gold Therapy C lin ic  a t
■
l e s s  f re q u e n t i n t e r v a l s .  T hus, w h ile  th e  r i s k  o f  th rom bocy topen ia  
seems to  be p re s e n t  a t  any p e r io d  o f t r e a tm e n t,  th e  r i s k  o f  c l i n i ­
c a l l y  im p o rta n t th rom bocy topen ia  i s  p ro b ab ly  s i g n i f i c a n t l y  d e c re a se d  
by v e ry  c a r e f u l  fo llo w -u p , p r e f e r a b ly  a t  an o rg a n ise d  g o ld  th e ra p y  
c l i n i c .  The developm ent o f  th rom bocy topen ia  due to  g o ld  th e ra p y  
sho u ld  be re c o g n ise d  a s  an  a b s o lu te  c o n t ra in d ic a t io n  to  f u r t h e r  
go ld  th e ra p y . O ther form s o f  t o x i c i t y  were observed  a t  to o  low a  
freq u en cy  to  a tte m p t to  r e l a t e  them to  d u ra tio n  o f  in j e c t a b l e  go ld  
th e r a p y .
I t  would th e r e f o r e  ap p e a r t h a t  p a t i e n t s  who have shown 
s i g n i f i c a n t  c l i n i c a l  im provem ent ( o r  have gone in to  re m is s io n  and 
have t o l e r a t e d  w e ll ,  s i x  months o f g o ld  tre a tm e n t)  sh o u ld  be ad v ise d  
t h a t ,  depend ing  on t h e i r  g e n e ra l  d is e a s e  a c t i v i t y  and re s p o n s e , th e y  
may c o n tin u e  in j e c t a b l e  g o ld  th e r e f o r e  f o r  a t  l e a s t  th r e e  y e a rs  w ith  
an  in c re a s in g  m argin o f  s a f e ty  f o r  m ucocutaneous and r e n a l  t o x i c i t y .
However, c lo s e  m o n ito rin g  o f  h a e m a to lo g ic a l p a ram e te rs  rem ains 
e s s e n t i a l  th ro u g h o u t p ro lo n g ed  in j e c t a b l e  go ld  th e ra p y  (127) .
A d e t a i l e d  acco u n t o f  a d m in is tr a t io n  o f g o ld  th e ra p y  and 
te c h n iq u e s  o f m o n ito rin g  e f f ic a c y  and to x i c i t y  have n o t been g iv en  
in  t h i s  t h e s i s  a s  t h i s  in fo rm a tio n  i s  a v a i la b le  in  a l l  m ajor rheuma­
to lo g y  te x tb o o k s . I n  1981, I  was i n v i t e d  to  -write a  rev iew  on th e  
u se  o f g o ld  th e ra p y  in  th e  management o f  rheum ato id  a r t h r i t i s  f o r
' i i
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th e  p r a c t i s in g  p h y s ic ia n  ( l2 7 ) .  T h is  rev iew  was p u b lish e d  in  
Modem M edicine o f  Canada in  November 1981, and o u t l in e s  su g g es ted  
methods o f m o n ito rin g  e f f ic a c y  and t o x i c i t y  a s  w e ll a s  rev ie w in g  









The fre q u e n c y  and in c id e n c e  o f c e r t a in  form s o f t o x i c i t y
■in  p a t i e n t s  r e c e iv in g  lo n g  te rm  g o ld  th e ra p y  f o r  rheum ato id  
a r t h r i t i s  have been r e l i a b l y  c a lc u la te d  f o r  d e f in e d , s e q u e n t ia l  
tim e p e r io d s .  N in e ty -fo u r  p a t i e n t s  who re c e iv e d  100 c o u rse s  o f 
g o ld  th e ra p y  f o r  a  t o t a l  t r e a tm e n t p e r io d  o f 1 3 4 .4  p a t ie n t - y e a r s  
were fo llo w ed  a t  one g o ld  th e ra p y  c l i n i c .  F or th e  p e r io d  o f  0 -3  
m onths, th e  in c id e n c e  o f  r a s h ,  mouth u l c e r ,  and p r o te in u r ia  were 
9 .8 ,  4 .0 ,  and 1 .8  e p iso d e s  p e r  10 ,000  p a t ie n ts /m o n th , r e s p e c t iv e ly .
However, th e  in c id e n c e  o f  th e s e  form s o f t o x i c i t y  d e c re a se d  p ro g re s ­
s iv e ly  in  su b seq u en t tim e p e r io d s  o f  co n tin u ed  g o ld  th e ra p y . No
s im i la r  d e c re a se  was n o te d  in  th e  in c id e n c e  o f th ro m b o cy to p en ia , 
b u t i t  would ap p ea r t h a t  th e  m ethodology used  in  m o n ito rin g , s i g n i ­
f i c a n t l y  a f f e c t s  th e  in c id e n c e  o f  c l i n i c a l l y  im p o rta n t th rom bocyto­
p e n ia .  No p r e d ic t iv e  c o r r e l a t e s  c o u ld  be d e te rm in ed  f o r  p a t i e n t s Iwho had gone in to  s u s ta in e d  re m is s io n . However, th e  d a ta  s t r o n g ly  
su g g e s t t h a t  p a t i e n t s  who im prove w ith in  s ix  months may co n tin u e  
g o ld  th e ra p y  f o r  a t  l e a s t  up to  th r e e  y e a rs  w ith  an in c re a s in g  m argin 
o f  s a f e ty  f o r  m ucocutaneous and r e n a l  t o x i c i t y .  No p a t i e n t  shou ld  
be t r e a te d  w ith  g o ld  th e ra p y  w ith o u t a  s t r i c t  m o n ito rin g  system  
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"L et o b se rv a tio n  w ith  e x te n s iv e  view 
S urvey  m ankind, from  C hina to  P e ru ,"
Samuel Johnson (1709-1784)
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I n  th e  p a s t  20 y e a rs  g o ld  and p e n ic il la m in e  th e ra p y  have 
re c e iv e d  e x te n s iv e  coverage in  th e  rh eum ato log i c a l  l i t e r a t u r e  w ith  
r e s p e c t  to  t h e i r  v a lu e  in  th e  tre a tm e n t o f rheum ato id  d is e a s e .
'H
INTRODUGHON
I n  view o f th e  v a lu e  o f in je c ta b le  g o ld  th e ra p y  in  th e  
t r e a tm e n t o f  rheu m ato id  a r t h r i t i s ,  th e  n ex t c l i n i c a l  s tu d y  which 
I  in v e s t ig a te d  was w hether th e  e f f ic a c y  and t o x i c i t y  o f  g o ld  sodium 
th io m a la te  was e q u a l ly  a p p l ie d  th ro u g h o u t th e  a d u l t  p o p u la t io n , in  
p a r t i c u l a r  in  th e  e l d e r l y .  T h is  s tu d y  was u n d e rta k en  u s in g  d a ta  
c o l le c te d  from  my y e a rs  a t  Q ueen 's  U n iv e r s i ty ,  K in g sto n , O n ta rio  
a l re a d y  r e f e r r e d  to  i n  C hap ter I I I , and d a ta  c o l le c te d  s in c e  s t a r ­
t i n g  my appo in tm en t a s  a  f a c u l ty  member a t  McMaster U n iv e r s i ty  in  
H am ilton , O n ta rio  i n  March 1980, w ith  P ro fe s s o r  W, Watson Buchanan, 
P ro fe s s o r  and R eg ional C o -o rd in a to r  o f Rheuiaatology.
At th e  p re s e n t  t im e , th e  approx im ate p e rc e n ta g e  o f th e  
C anadian p o p u la tio n  o v e r th e  age o f  65 i s  9 ^ . By th e  y e a r  2001 I
th e  p ro je c te d  e s tim a te  by S t a t i s t i c s  Canada i s  t h a t  t h i s  age group Îw il l  com prise  12^ o f  28 m ill io n  p o p u la tio n  ( l 3 7 ) . S im i la r ly  f ig u r e s  
a v a i la b le  f o r  th e  U n ite d  S ta t e s  e s tim a te  t h a t  th e  p o p u la tio n  over 
age 60 y e a rs  a t  th e  p r e s e n t  tim e i s  o f 231 m i l l io n  and w i l l  be 
o f 287 m i l l io n  peo p le  by th e  y e a r  2000 (138) I f  th e  assumed 
p rev a len ce  o f rheum ato id  a r t h r i t i s  rem ains a t  1.%, th e r e  w i l l  be 
33,600 C anadians o v e r 65  y e a rs  and 401,800 A m ericans ov er 60 y e a rs  
w ith  rheu m ato id  a r t h r i t i s .  S im i la r  t r e n d s  a re  e v id e n t in  most 






However, l i t t l e  in fo rm a tio n  i s  a v a i la b le  a s  a  gu ide  to  th e  p o s s ib le  
e f f ic a c y  and t o x i c i t y  p a t te r n s  in  th e  e ld e r ly  rheum ato id  p a t i e n t .
I t  was o r ig in a lly  sta ted  th at D -penicillam ine therapy 
resu lted  in  increased  to x ic ity  (l3 9 ) and a decreased e ff ic a c y  in  
the e ld e r ly  compared to  the young rheumatoid p a tien t. However, two 
subsequent stu d ies  from our u n it fa i le d  to  confirm th ese fin d in gs  
( l4 0 , l 4 l ) .
In  1975 B ill in g s  e t  a l  reported a prospective d escr ip tiv e  
a n a ly s is  of 22 p a tien ts  rece iv in g  in jec ta b le  gold therapy. The 
authors sta ted  th at the p a tien ts  with no improvement c l in ic a l ly  had 
a higher mean age (53 years) compared to  those with moderate improve­
ment (46 years) and/or major improvement as a ssessed  by th e ir  func­
t io n a l in d ic e s . These d if fe re n c e s , however, were not s t a t i s t i c a l ly  
s ig n if ic a n t  but the authors sta ted  in  th e ir  "Discussion" th at 
advancing age appeared to  be a ssoc ia ted  with a l e s s  favourable out­
come (142) ,  Debosset and B itte r  reported in  abstract form a prospec- 
t iv e ,  d escr ip tiv e  a n a ly s is  of 24 p a tien ts  rece iv in g  in jec ta b le  gold  
therapy fo r  rheumatoid a r t h r i t i s . Although no b asic  data i s  i l l u s ­
tra ted  in  the a b stra c t, the authors sta ted  that rem ission and drug 
to lerance were l e s s  in  the 45-65 years age group, and thus questioned  
the in d ica tio n  fo r  the use o f gold in  the e ld er ly  ( l4 3 ) . Thus no
Î
good evidence e x is t s  a t present as to  the e ff ic a c y  or to x ic ity  of 
in jec ta b le  gold compounds used in  the e ld e r ly . In  view o f our
experience with D -penicillam ine in  the e ld e r ly  we th erefore report 
a comparative study of the e f f ic a c y  and to x ic ity  patterns of e ld e r ly  
and young p a tien ts  rece iv in g  in jec ta b le  gold therapy over prolonged 




One hundred and fo r ty -o n e  p a t i e n t s  w ith  c l a s s i c a l  o r  
d e f i n i t e  rheum ato id  d is e a s e  ( i l l )  were fo llo w ed  p ro s p e c t iv e ly  
betw een A p r il  1971 and A p r il  1982 in  o rd e r  to  m o n ito r t h e i r  
t o x i c i t y  p a t t e r n  to  g o ld  sodium th io m a la te  th e ra p y  (M y o c h ry s in e ^ ,
g r e a t e r  and a  younger group l e s s  th a n  60 y e a rs  o f ag e .
y e a rs  o r  g r e a t e r  ex ce p t 2 fem a les  aged 10 y e a r s .  Both g i r l s  were
TM*
R hone-Poulenc, Q uebec). F o r th e  pu rpose  o f t h i s  s tu d y , p a t i e n t s  
were d iv id e d  in to  two c o h o r ts ,  an e l d e r ly  group o f  60 y e a rs  and
PATIENTS -  Young Group:
I n  th e  young group  th e re  were 28 m l e s  and 73 fem a les  
w ith  a  mean age o f  44 (ran g e  10-59) y e a r s .  A ll p a t i e n t s  were l6
Î
I
-s e r o p o s i t iv e  and s in c e  t h i s  age g roup w ith  c l a s s i c a l  o r  d e f i n i t e  
rheum ato id  d is e a s e  ( i l l )  resp o n d  to  g o ld  in  a  s im i la r  manner to  
th e  ad .u lt p o p u la tio n  ( 97 ) ,  th e y  were in c lu d e d  in  th e  a n a l y s i s .
The median f u n c t io n a l  c l a s s  was 2 , and th e  d u ra tio n  o f  d is e a s e  p r io r  
to  th e ra p y  was 4 .4  y e a r s .  The mean d u ra tio n  o f th e ra p y  was 1 5 .6  
m onths. The mean t o t a l  g o ld  sodium th io m a la te  dosage r e c e iv e d  was 
1392 mg p e r  p a t i e n t  (T ab le  6 ) .
I n  o rd e r  to  d e te rm in e  e f f ic a c y  and t o x i c i t y  w ith in  and 
betw een g ro u p s , th e  s tu d y  p o p u la tio n  was su b -d iv id e d  in to  4 a r b i t r a r y  
age g ro u p s , A, B, G and D. (T ab le  7 )
Group A com prised  l 4  fem a les  and 2 m ales betw een 10 and 












LO LO U ) C MO P p i pOA oA o oV A
CO COlO P pr - r — CM
ccUJO
p N  CO
§
CO m0 0 r s







































COF -O .X_  3
d Ugl
S ' S










o > p s o >
o C O O+1 +1 +1p s r - p sC O CM L O
C O00 S2+1 ^CM
O )
910
C O p s L O
O 'T “ O+1 +1 +1
C O L O p sL O t — "dp
O ?
5  T
6C O  ( O  C O
C O c o
C O+1 o+1






















































LUc  oil*D  Cc S 
8 ?
z i%  w
-  135 -
o f  d is e a s e  p r io r  to  th e ra p y  was 3*9 y e a rs  ± 0 .6  SEM. • Mean d u ra tio n  
o f th e ra p y  was 1 5 .9  months + 3 * 5  SEM. T o ta l g o ld  compound re c e iv e d  
was 1254 mg ± 187 SEM,
Group B com prised  17 fem a les  and 6 m ales in  th e  age group
30-44 y e a rs  in c lu s iv e .  The mean age was 36.7  y e a rs  ± 1 . 9  SEM, The
mean d u ra t io n  o f  d is e a s e  p r io r  to  th e ra p y  was 3-8  y e a rs  ± 0 . 6  SEM.
The mean d u ra t io n  o f th e ra p y  was 17 months ± 3 * 6  SEM. The t o t a l  go ld  
compound re c e iv e d  was 1473 mg ± 234 SEM,
Group G com prised  42 fem a les  and 20 m ales in  th e  age group
45-59  year's i n c lu s iv e .  The mean age was 53 y e a rs  ± 0 , 6  SEM. The
mean d u ra t io n  o f  d is e a s e  p r io r  to  th e ra p y  was 4 .7  y e a rs  ± 0 , 5  SEM.
The mean d u ra tio n  o f th e ra p y  was 15 months ± 1 . 7  SEM. The mean t o t a l  
g o ld  compound re c e iv e d  was 1459 ± 127 SEM.
PATIENTS -  E ld e r ly  Group;
The e ld e r ly  group was d e s ig n a te d  a s  g roup D, I n  th e  e ld e r ly
group th e r e  were I 7 m ales and 23 fem a les  w ith  a  mean age o f 67 y e a rs
± 0 .9  SEM. The median A .E.A , f u n c t io n a l  c l a s s  was 2, and th e  d u ra ­
t i o n  o f  th e ra p y  was 21 m onths. The mean t o t a l  g o ld  sodium th io m a la te
a d m in is te re d  was I 861 mg p e r  p a t i e n t . (T ab le  6 and T able 7 )
T here was no s i g n i f i c a n t  d i f f e r e n c e  among th e  g roups f o r  
d u ra t io n  o f d is e a s e  p r io r  to  th e ra p y  (A v e rsu s  B t  = 0 .1 1 , p >  0 .0 5 ;
A v e rsu s  G t  = 1 .0 2 , p > 0 .0 5 ; A v e rs u s  D t  = 1 .6 6 , p > 0 .0 5 ; B v e rsu s  
G t  = 1 . 4 l ,  p > 0 .0 5 ; B v e rsu s  D t  = 1 .7 5 , P > 0 .0 5 ; 0 v e rsu s  D t  =
0 . 9 8 , p > 0 .0 5  a l l  n o t s i g n i f i c a n t ) .  There was no s i g n i f i c a n t  d i f f ­
e ren c e  among th e  g roups f o r  d u ra t io n  o f  th e ra p y  (A v e rsu s  B t  * 0 .2 1 7 ,
I
-  136
p > 0 .0 5 ; A v e rsu s  G t  = 0 .2 3 , p > 0 .0 5 ; A v e rsu s  D t  = 1 .0 0 , 
p > 0 .0 5 ; B v e rsu s  G t  = 0 .5 ,  p > 0 .0 5 ; B v e rsu s  D t  = 0 .7 8 ,
p > 0 .0 5 ; G v e rsu s  D t  = 1 .4 7 , P > 0 .0 5 ) .  There was no s i g n i f i ­
ca n t d i f f e r e n c e  among th e  g roups in  te rm s o f mean t o t a l  go ld  dosage 
(a v e rsu s  B t  = 0 .7 3 , P > 0 .0 5 ; A v e rsu s  0 t  = 0 .9 0 , p > 0 .0 5 ;
B v e rsu s  G t  = 0 .0 5 , P > 0 .0 5 ; B v e rsu s  D t  = 1 .1 5 , P > 0 .0 5 ;
G v e rsu s  D t  = 1 .4 7 , P > 0 .0 5 ) ex ce p t f o r  group A (<  30 y e a rs )
and group D (>  60 y e a r s ) , where th e  t o t a l  mean g o ld  dosage was 1254 
mg and l 86l  mg r e s p e c t iv e ly  ( t  = 1 .9 7 9 , P < 0 .0 5 , > 0 .0 2 ) (T ab le 7 ) .
Thus th e  4 subgroups were com parable f o r  d is e a s e  d u ra tio n  
p r io r  to  th e ra p y , d u ra t io n  o f th e ra p y  and t o t a l  g o ld  dosage e x c e p t 
group  A (< 30 y e a rs )  and group D (>  60 y e a rs )  where th e  e ld e r ly  
group had r e c e iv e d  s i g n i f i c a n t l y  more g o ld  compound (T ab le  7 ) .
METHODS ;
A ll p a t i e n t s  w ith  in flam m ato ry  rheum ato id  d is e a s e  n o t 
re s p o n s iv e  to  n o n - s te r o id a l  a n ti- in f la m m a to ry  d ru g s  were co n s id e re d  
e l i g i b l e  to  be s t a r t e d  on go ld  sodium th io m a la te ,  A co u rse  o f  t r e a t ­
ment was d e f in e d  a s  g o ld  sodium th io m a la te  th e ra p y  f o r  1 month o r  
g r e a t e r .  The drug  was g iv e n  a s  a  10 mg t e s t  dose in t ra m u s c u la r ly  
fo llo w ed  in  1 week by a  25 mg t e s t  d o se , and th e n  50 mg p e r  week f o r  
20 weeks and su b se q u e n tly  a t  2 -4  week i n t e r v a l s  f o r  an in d e f i n i t e  
p e r io d .
Im m unosuppressive d ru g s , c h lo ro q u in e  and D -p e n ic i l la m in e , 
were n o t used  d u r in g  g o ld  sodium th io m a la te  th e ra p y . E q u iv a le n t
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number o f p a t i e n t s  (< lOfo) i n  each  group  were r e c e iv in g  p red n iso n e  
a t  l e s s  th a n  10 m g/day.
C l in ic a l  re sp o n se  was re c o rd e d  by rh e u m a to lo g is ts  a t  a  
s p e c ia l  g o ld  th e ra p y  c l i n i c  on a  p ro s p e c tiv e  b a s i s  u s in g  th e  s u b je c ­
t i v e  and o b je c t iv e  a ssessm en t o r ig i n a l l y  d ev ised  by A n a s ta s s ia d e s  
( l 2 4 ) . The s u b je c t iv e  a ssessm en t was based  on th e  p a t i e n t ' s  answ er 
to  th e  q u e s t io n ,  "How do you f e e l  now, r e l a t i v e  to  b e fo re  s t a r t i n g  
go ld  sodium th io m a la te  t r e a tm e n t ,  -  b e t t e r ,  same o r  w orse?" The 
o b je c t iv e  a ssessm en t was based  on th e  a c t iv e  j o i n t  c o u n t. A j o i n t  
was co n s id e re d  a c t iv e  i f  i t  e x h ib i te d  te n d e rn e s s  to  p a lp a t io n ,  
te n d e rn e s s  on ran g e  o f m o tion , e f f u s io n ,  in c re a s e d  te m p e ra tu re  o r  
s o f t  t i s s u e  s w e ll in g .  I f  th e re  was a  d e c re a se  in  j o i n t  coun t o f 5 
j o i n t s  o r  more, th e  p a t i e n t  was a s s e s s e d  a s  " b e t t e r " ;  i f  th e r e  was 
an in c re a s e  i n  j o i n t  coun t o f 5 j o i n t s  o r  more th e  p a t i e n t  was con­
s id e re d  "w orse" . I f  th e  s u b je c t iv e  assessm en t d i f f e r e d  from  th e  
o b je c t iv e  a n a ly s i s ,  th e  l a t t e r  was ta k e n  a s  th e  r e s u l t  re c o rd e d  in  
th e  s tu d y . The re sp o n se  to  th e ra p y  was reco rd ed  a t  s e q u e n t ia l  tim e 
p e r io d s  o f  3 , 6 , 12 , 24 and 36 m onths. Rem ission was c l a s s i f i e d  a s  
no ev id en ce  o f a c t iv e  j o i n t s  and no ev id en ce  o f th e  e x t r a  a r t i c u l a r  
m a n ife s ta t io n s  o f rheum ato id  a r t h r i t i s .
Drug t o x i c i t y  was m on ito red  by a  p h y s ic ia n  a t  each  p a t i e n t  
v i s i t .  P a t i e n t s  were q u e s tio n e d  d i r e c t l y  re g a rd in g  p r u r i t i s , r a s h ,  
b r u i s in g ,  mouth u lc e r s  and j o i n t  p a in .  L a b o ra to ry  v a lu e s  were a s s e s ­
sed  a t  each  v i s i t  f o r  hem oglobin , w h ite  b lood  c e l l  c o u n t, d i f f e r e n ­
t i a l  w h ite  b lood  c e l l  c o u n t, p l a t e l e t  c o u n t, e ry th ro c y te  sed im en ta ­
t i o n  r a t e  and u r i n a l y s i s .
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F or th e  pu rpose  o f  t h i s  s tu d y  a  sk in  r a s h  was any e ru p tio n  
which was co n s id e re d  to  be r e l a t e d  to  th e  go ld  sodium th io m a la te .
Mouth u lc e r s  were d e f in e d  a s  l e s io n s  s im i la r  in  appearance  to  
aph th o u s u lc e r s  o c c u rr in g  in  th e  mucous membrane o f  th e  mouth. 
P r o te in u r ia  was re c o rd e d  a s  th e  p re sen ce  o f 2+ on d ip s t i c k  on one 
o c c a s io n , o r  1+ on 2 c o n se c u tiv e  specim ens one week a p a r t .  Abormal 
u r in a r y  sed im en t was c o n s id e re d  a s  any o f  th e  fo llo w in g : th e  p resen ce  
o f r e d  c e l l s  >10 p e r  h ig h  power f i e l d ,  w hite  c e l l s  >10 p e r  h ig h  
power f i e l d ,  re d  c e l l  c a s t s ,  w h ite  c e l l  c a s ts  o r  h y a lin e  c a s t s .  
Throm bocytopenia was re c o rd e d  a s  any d rop  in  p l a t e l e t  count below 
1 5 0 , 000/cu.mm and le u k o p e n ia  a s  any d rop  in  w hite  c e l l  coun t below  
4 , 000/cu.mm. A f a l l  i n  polym orph count below 50^ a n d /o r  a  r i s e  in  
monocyte coun t above 10^ was re c o rd e d  a s  a  W.B.G. t o x i c i t y .  A f a l l  
i n  p l a t e l e t  coun t o f g r e a t e r  th a n  1 0 0 ,000/cu.mm a n d /o r  a  f a l l  i n  
W.B.G. o f 4 , 000/cu.mm b u t w ith in  th e  norm al range  r e s u l t e d  in  th e  
drug b e in g  w ith h e ld  u n t i l  a  r e p e a t  b lood  coun t was o b ta in e d , b u t f o r  
th e  purpose o f  th e  s tu d y , th e se  e v e n ts  were n o t re c o rd e d  a s  t o x i c i t i e s .
A m ajor t o x i c i t y  was re c o rd e d  a s  an ad v erse  e f f e c t  w hich was 
c o n s id e re d  se v e re  enough to  r e q u ir e  d is c o n t in u a t io n  o f  th e  d ru g . A ;I
m inor t o x i c i t y  was re c o rd e d  a s  an ad v e rse  e f f e c t  r e l a t e d  to  th e  d rug  
which d id  n o tn e c e s s i ta t e  t o t a l  i n t e r r u p t io n  o f  th e  co u rse  o f th e ra p y . I
STATESHGAL ANALYSIS:
S t a t i s t i c a l  a n a ly s i s  o f  p a t i e n t  d a ta  in  t a b le s  1 and 2 were 
perform ed u s in g  th e  s tu d e n ts  t  t e s t , 2 t a i l e d  f o r  u n p a ire d  d a ta .
V alues in  t a b l e s  3 , 4 , 5 and 6 were c a lc u la te d  u s in g  th e  c h i-s e q u a re
. V.!-
s t a t i s t i c  a n d /o r  th e  F i s h e r 's  E xact t e s t  where a p p r o p r ia te . A lo g
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Rank c h i-s q u a re  a n a ly s i s  was perform ed to  compare th e  w ithd raw al 
cu rv es  o f th e  young ( l e s s  th a n  60 y e a rs )  v e rsu s  th e  e ld e r ly  p a t i e n t s  
( g r e a t e r  th a n  60 y e a rs )  f o r  th e  summed e v e n ts  o f  m ajor t o x i c i t y  and
th ro u g h o u t r e f e r s  to  d e g re e s  o f  freedom .
th e r a p e u t ic  f a i l u r e .  An a lp h a  l e v e l  o f  0 ,0 5  was chosen f o r  ju d g in g  




O v e ra ll E f f ic a c y :
The o v e r a l l  c l i n i c a l  outcome f o r  each age g ro u p , group A 
(<  30 y e a r s ) , g roup  B (30-44  y e a r s ) , g roup G (45-59  y e a rs )  and 
group  D (> 60 y e a rs )  i s  i l l u s t r a t e d  in  T able 8 . T here was no s i g ­
n i f i c a n t  d i f f e r e n c e  among th e  g roups a t  any tim e p e r io d  examined 
i n  te rm s o f  " re m is s io n " , " b e t t e r " ,  "same" o r  "w orse" (T able 8 ) ,
The t o t a l  p a t i e n t s  in  A, B and G ( i . e .  a l l  p a t i e n t s  < 60 y e a rs )  
were compared to  group D (> 60 y e a r s ) . At any tim e p e r io d  examined 
up to  4  y e a r s ,  58^  o r  g r e a t e r  in  th e  e l d e r ly  g roup (> 60 y e a rs )  
and 74^  o r  g r e a t e r  o f  th e  young group  (< 60 y e a rs )  were c l a s s i f i e d  
a s  b e in g  b e t t e r  o r  in  re m is s io n . There was no s ig n i f i c a n t  d i f f e r e n c e  
in  teimis o f  " re m is s io n " , " b e t t e r " ,  "same" o r  "w orse" betw een th e  
young and th e  e l d e r ly  group a t  any tim e  p e r io d  (x^ = 1 .2 0 0 -5 .8 7 4 , 
p = 0 .7393”0*d l79) ex ce p t f o r  th e  f i r s t  p e r io d  (O -  < 3 months) 
when th e  young p a t i e n t s  had s i g n i f i c a n t l y  g r e a t e r  numbers in  th e  
re m is s io n  a n d /o r  b e t t e r  c a te g o ry  (x^ -  7*977, P = O.OI85 ) .  However, 
s in c e  th e  in j e c t a b l e  g o ld  compounds a r e  slow  a c t in g  compounds, t h i s  
r e s u l t  i s  o f  q u e s tio n a b le  s ig n i f i c a n c e .
Reasons f o r  D is c o n tin u a tio n  o f  T heranv .
R em ission .
Three p a t i e n t s  in  group B (30-44  y e a r s ) , 5 p a t i e n t s  in  group 
G (45-59  y e a rs )  and 4  p a t i e n t s  in  g roup D (> 60 y e a rs )  d is c o n tin u e d  
th e ra p y  because  th e y  were judged to  be in  s u s ta in e d  re m is s io n . These 
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These d i f f e r e n c e s  among th e  groups were n o t s ig n i f i c a n t  (T ab le  9 )
142 -
mean tim e a t  which re m is s io n  o c c u rre d  was re c o rd e d  a s  27 months ± 11 
SEM f o r  group B, 3I  months ± 4 .9  SEM f o r  group G and 52 months ± 4 .3
SEM f o r  g roup D. T here was no s ig n i f i c a n t  d i f f e r e n c e  i n  th e s e  tim es
betw een group B and G ( t  = 0 .3 5 , P > O.O5 ) b u t th e  d i f f e r e n c e s
betw een group  B and D ( t  = 2 .2 1 , p < 0 .0 5 , > 0 .0 2 ) and group G and
D ( t  = 3*16, p < 0 . 01 ) were s i g n i f i c a n t .  One fem ale p a t i e n t  in  group 
A (< 30 y e a rs )  developed  a  s u s ta in e d  re m is s io n  a f t e r  1 month o f  g o ld  
th e ra p y  fo llo w in g  th e  o ccu rren ce  o f  c h o le s t a t i c  ja u n d ic e .
The mean t o t a l  g o ld  compound re c e iv e d  a t  th e  tim e re m is s io n  
was re c o rd e d  was 2467 mg ± 8 .9  SEM f o r  group B, 2430 mg ± 265 SEM
f o r  g roup G and 2946 mg ± l4 0 5  SEM f o r  group D, There was no s ig n i ­
f i c a n t  d i f f e r e n c e  betw een th e  g roups i n  te rm s o f  t o t a l  g o ld  compound 
re c e iv e d  (B v e rsu s  G t  = 0 .4 l ,  p > 0 .0 5 ; B v e rsu s  D t  = 0 .2 9 , P > 0 .0 5 ; 
G v e rsu s  D t  = O.3 6 , p > O.O5 ) .
D e f a u l t .
Two p a t i e n t s  in  g roup A and 4  p a t i e n t s  in  group G dropped 
o u t because  o f d e f a u l t .  T h is  d id  n o t r e p r e s e n t  a  s ig n i f i c a n t  d i f f e r ­
ence betw een th e  g roups A, B, G n o r  D (T able 9 ) .  At th e  tim e o f 
d e f a u l t ,  2 p a t i e n t s  were re c o rd e d  a s  "w orse", 1 re c o rd e d  a s  "same" Iand 3 re c o rd e d  a s  " b e t t e r " .
No R esponse,
■illThree p a t i e n t s  in  group A, 3 p a t i e n t s  in  g roup B, 9 p a t i e n t s  
in  g roup G and 9 p a t i e n t s  i n  group  D dropped o u t because  o f f a i l u r e  
to  respond  to  th e  d rug  and were re c o rd e d  a s  hav ing  "No R esponse".
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T o x ic i ty .
E ig h t p a t i e n t s  in  group A, 11 p a t i e n t s  in  g roup B, 21 
p a t i e n t s  in  group G and 18 p a t i e n t s  in  group D d is c o n tin u e d  
th e ra p y  because o f a  m ajor t o x i c i t y .  These d i f f e r e n c e s  were n o t 
s i g n i f i c a n t  (T able 9 ) .
I n  o rd e r  to  compare th e  r a t e  o f  d ro p o u t from  th e ra p y  f o r  
th e  two most s ig n i f i c a n t  e v e n ts ,  w ith d raw al cu rv es  o f th e  young 
(g roup  A, B and G) v e rs u s  th e  e l d e r ly  (group D) were c a lc u la te d  
f o r  th e  summed e v e n ts  o f  m ajor t o x i c i t y  and th e r a p e u t ic  f a i l u r e .
As shown in  F ig u re  46^ th e re  was no s ig n i f i c a n t  d i f f e r e n c e  betw een 
th e  young and th e  e l d e r ly  g roup (Log Rank = 2 .4 1 9 , P >  O . l ) ,  
i n  te rm s o f  d ropou t from  th e ra p y  due to  t o x i c i t y  and d rug  f a i l u r e .
O v e ra ll T o x ic i ty .
The number o f e p iso d e s  o f  t o x i c i t y ,  m ajor and m inor, and 
m ajor a lo n e  o c c u rr in g  in  th e  young p a t i e n t s  l e s s  th a n  60 y e a rs  
(g roup  A, B and C) compared to  th e  number o f e p iso d e s  o c c u rr in g  in  
th e  e ld e r ly  group (g roup  D) a re  i l l u s t r a t e d  in  T able 10,. There were 
76 e p iso d e s  o f  m ajor p lu s  m inor t o x i c i t y  in  56 p a t i e n t s  from  th e  
young g roups (g roup  A, B and G) and 36 e p iso d e s  o f m ajor p lu s  m inor 
t o x i c i t y  i n  27 p a t i e n t s  from  th e  e ld e r ly  group (g roup  D ), The 
number o f p a t i e n t s  w ith  m ajor p lu s  m inor t o x i c i t y  was n o t s i g n i f i -
2 ^
1
p > 0 .0 5 ; F i s h e r 's  E xac t p = 0 .2 5 4 7 ) . T here were 49 e p iso d e s  o f
c a n t ly  d i f f e r e n t  betw een th e  young and th e  e l d e r ly ,  ( x j  = 1 .7 1 9 ,
m ajor t o x i c i t y  i n  39 p a t i e n t s  from  th e  young groups (g roup  A, B and 
G) and 20 e p iso d e s  o f  m ajor t o x i c i t y  i n  I 8 p a t i e n t s  from  th e  e ld e r ly  
g ro u p . The number o f  p a t i e n t s  d ev e lo p in g  m ajor t o x i c i t y  was n o t 
s ig n i f i c a n t l y  d i f f e r e n t  (x^ = 0 .4 8 5 , P > 0 .0 5 ; F i s h e r 's  E xact p 
= 0 .5688) .
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S k in  R ash.
There were 39 e p iso d e s  o f  sk in  r a s h  in  th e  young group and 
21 e p iso d e s  o f  s k in  r a s h  in  th e  e ld e r ly  g roup . There was no s i g n i ­
f i c a n t  d i f f e r e n c e  betw een th e s e  g roups (x? = 2 . 260 , p = 0 .133» 
F i s h e r 's  E x ac t p = O .I856) .  T w en ty -fiv e  p a t i e n t s  i n  th e  young group 
and 13 p a t i e n t s  i n  th e  e ld e r ly  g roup had a  s e r io u s  s k in  r a s h  and th u s  
r e q u ir e d  d is c o n t in u a t io n  o f  th e ra p y . These v a lu e s  were n o t s i g n i f i -
s i g n i f l e a n t  (x^= O .233 , p = 0.637» F i s h e r 's  E xact p = O.7786) .  Only 
2 e l d e r ly  p a t i e n t s  r e q u ir e d  d is c o n t in u a t io n  from  th e ra p y  due to  
p r o te in u r ia  a s  opposed to  9 o f th e  young p a t i e n t s ,  b u t t h i s  d i f f e r e n c e  
was n o t s i g n i f i c a n t  (x^ = O .609 , p = 0 .3147 ; F i s h e r 's  E xact p = 0 ,5147) 
(T ab le  10)
e p iso d e s  o f mouth u l c e r  o c c u rre d  in  th e  young p a t i e n t s .  These d i f f e ­
re n c e s  were n o t s i g n i f i c a n t  (x^ = 0,351» P "  0 ,5 5 4 ; F i s h e r 's  E x ac t
c a n t ly  d i f f e r e n t  betw een th e  two g ro u p s , (x = 0 .8 7 4 , p = 0,350»1
F i s h e r 's  E xac t p = 0 ,4 0 l4 ) .  (T ab le 1C)
E ig h teen  o f  th e  25 m ajor e p iso d e s  o f  r a s h  in  th e  young 
o c c u rre d  b e fo re  12 months and 11 o u t o f  I 3 m ajor e p iso d e s  of r a s h  
in  th e  e ld e r ly  o c c u rre d  b e fo re  12 m onths. Thus th e  d i s t r i b u t i o n  
p a t t e r n  f o r  tim e o f o ccu rren ce  o f  m ajo r sk in  r a s h  was s im i la r .  T h is  
was a l s o  t r u e  f o r  m inor r a s h .
P r o te in u r ia ,
T h ir te e n  e p iso d e s  o f  p r o te in u r i a  o ccu rred  i n  th e  young group 
and 4 e p iso d e s  in  th e  e ld e r ly  g ro u p , b u t th e se  d i f f e r e n c e s  were n o t
Mouth U lc e r .





















p = 0 . 6207) .  Three e ld e r ly  p a t i e n t s  and 9 young p a t i e n t s  had 
se v e re  mouth u lc e r s  and w ere d is c o n t in u e d  from  th e ra p y . There 
was no d i f f e r e n c e  betw een th e  numbers in  th e se  g roups (x^  "  0 . 073» 
p = 0 .787» F i s h e r 's  E xact p = l.OOOO). (T ab le 10)
Low P l a t e l e t s ,
Two e p iso d e s  o f low p l a t e l e t  c o u n ts  were re c o rd e d  in  th e  
e l d e r ly  g roup and 4 e p iso d e s  o f  low p l a t e l e t s  in  th e  younger group 
(x^ = 0 .0 7 3 » P = 0 . 783 ; F i s h e r 's  E xac t p = 1 ,0 0 0 0 ) . Only 1 e ld e r ly  
p a t i e n t  and 3 young p a t i e n t s  were re c o rd e d  a s  hav ing  a  m ajor t o x i ­
c i t y  due to  low p l a t e l e t s  and had to  be d is c o n tin u e d  from  th e ra p y
Low White Blood C e ll  C ount.
There was 1 ep iso d e  o f m ajor t o x i c i t y  due to  low  w h ite  b lood  
c e l l  count i n  e i t h e r  g roup (x^ = 0 .4 6 7 , P ™ 0 ,4 9 4 ; F i s h e r 's  E xac t 
p = 1 .0 0 0 0 , n o t s i g n i f i c a n t ) .  One o th e r  p a t i e n t  in  th e  young group 
had a  low w h ite  b lood  c e l l  coun t b u t t h i s  was n o t c o n s id e re d  s e r io u s  
enough to  r e q u i r e  d is c o n t in u a t io n  o f th e ra p y . (T ab le  10)
A cute A lle rg ic  R esponse.
Acute a l l e r g i c  re sp o n se  c h a ra c te r iz e d  by o n se t o f g e n e ra l is e d  
a c h in g , f e v e r ,  m a la ise  was n o te d  i n  two o f  th e  young g ro u p . These 
r e a c t io n s  were se v e re  enough to  r e q u ir e  d is c o n t in u a t io n  o f  th e  d ru g . 
None o f  th e  e l d e r ly  g roup ex p e rie n c e d  an a l l e r g i c  re sp o n se , how ever, 
th e s e  d i f f e r e n c e s  were n o t s i g n i f i c a n t l y  d i f f e r e n t  (m ajor and m inor, 
X^ = 0 ,8 0 3 , p = O .37O; F i s h e r 's  E xact p = 0 .5907) (T able 10)
-r:
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o f s e r io u s  mouth u lc e r  o c c u rre d  in  g roup D„ There was no s ig n i f i c a n t
I
M ajor T oxic E v en ts  in  Each Group.
I n  o rd e r  to  ex c lu d e  d i f f e r e n c e s  between th e  age groups 
th e  m ajo r a d v e rse  e f f e c t s  o c c u rr in g  in  group  A (< 30 y e a r s ) , g roup 
B (30  -  < 44 y e a r s ) , g roup G (45 -  <  60 y e a rs ) , and group  D (> 60 
y e a rs )  were a n a ly se d  and a r e  i l l u s t r a t e d  in  T able 1 1 ,
S k in  Hash
There were 5 e p iso d e s  o f  m ajor s k in  r a s h  in  g roup  A, 7 
e p iso d e s  in  group  B, 13 e p iso d e s  in  g roup  G and 13 in  g roup  D.
There was no s i g n i f i c a n t  d i f f e r e n c e  betw een th e  g roups (x^ = 2 .0 4 , 
p = 0 .5 6 , n o t s i g n i f i c a n t ) .  (T a b le l l )
P r o te in u r ia .
There were 3 e p iso d e s  o f  m ajo r p r o te in u r ia  in  Group A, 2 in
group  B, 4- in  g roup G and 2 i n  g roup D. These d i f f e r e n c e s  were n o t
s ig n i f i c a n t  (%  ^ = 3 «27, p = 0.34-96) (T ab le  i ] ) . The 4- p a t i e n t s  in  
3
group  G and th e  2 p a t i e n t s  i n  g roup D a l l  had n e p h ro tic  syndrome 
(>  3 grams o f p r o te in u r ia  p e r  24 h o u r s ) . A ll p a t i e n t s  w ith  n e p h ro tic  
syndrome were 52 y e a rs  o f  age o r  g r e a t e r .  A ll c a se s  r e s o lv e d  w ith in  
12 m onths.
Mouth U lc e r .
Four e p iso d e s  o f  m ajor mouth u l c e r  o ccu rred  in  group B,
5 e p iso d e s  o f m ajor mouth u lc e r  o ccu rred  in  group G and 3 e p iso d e s
I
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Low P l a t e l e t s .
Three e p iso d e s  o f  m ajor low  p l a t e l e t  coun t o ccu rred  in
group  G and 1 ep iso d e  o ccu rred  in  g roup  D. These d i f f e r e n c e s  were'
n o t s i g n i f i c a n t  (x^ = 2 .0 4 , p = O.561) (T able 11). A ll p a t i e n t s3
w ith  s e r io u s  low p l a t e l e t  coun t were 4? y e a rs  o f  age o r  g r e a t e r .
Low White Blood C e ll C ount.
One s e r io u s  e p iso d e  o f  low w h ite  b lood  c e l l  coun t o ccu rred  
in  a  57 y e a r  o ld  male i n  g roup  G and 1 s e r io u s  ep iso d e  o f low w h ite  
b lood  c e l l  coun t o ccu rred  i n  a  65 y e a r  o ld  male in  group D, There 
w as no s ig n i f i c a n t  d i f f e r e n c e  betw een th e  two g roups (x^ = 0 .9 1 , 
p = 0 .8224) (T ab le  1 ^  .
A cute A l le rg ic  R esponse.
One ep iso d e  o f  s e r io u s  a c u te  a l l e r g i c  re sp o n se  o ccu rred  in  
a  30 y e a r  o ld  fem ale i n  g roup  B fo llo w in g  h e r  second t e s t  dose o f
25 mg o f g o ld  sodium th io m a la te .  The r e a c t io n  was c h a r a c te r iz e d  
by th e  o n se t o f  u r t i c a r i a ,  w ith in  24 h o u rs  o f h e r  i n j e c t i o n .  One 
ep iso d e  o f  s e r io u s  a c u te  a l l e r g i c  re sp o n se  o ccu rred  in  a  57 y e a r  
o ld  fem ale  in  g roup G a f t e r  h e r  f i r s t  5G mg o f g o ld  sodium th io m a la te  
( i . e .  she had r e c e iv e d  10 mg and 25 mg r e s p e c t iv e ly  in  th e  two
p re v io u s  w eek s). The r e a c t io n  to  th e  d rug  was c h a r a c te r i s e d  by 
u r t i c a r i a ,  i t c h in g  and f e v e r  w ith in  24 h ou rs o f r e c e iv in g  th e  i n j e c ­
t i o n .  There was no s i g n i f i c a n t  d i f f e r e n c e  in  th e  numbers o f  a c u te
a l l e r g i c  re sp o n se s  betw een th e  g roups (x^ "  2 .2 1 , p = 0 . 5253)
3
(T ab le  l l )  .
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The p o ten tia l fo r  increased  drug to x ic ity  i s  w ell recognised  
in  the e ld e r ly  population ( l4 4 , l4 5 , l4 6 ) and although a ttr ib u ted  to  
d efec tiv e  m etabolic handling ( l 4 6 ) , p atien t and physician mal- 
compliance contribute to  the p o ten tia l development of adverse e f f e c t s .  
The use o f gold therapy in  the e ld e r ly  rheumatoid p a tien t has r e c e i-  
ved l i t t l e  a tten tio n  in  the rheum atological lite r a tu r e  and the few 
statem ents to  d a te , s ta te  th at in je c ta b le  gold i s  l e s s  e f f ic a c io u s  
(i 42) and more to x ic  (l4u ) in  the e ld e r ly  rheumatoid p a tien t than in  
the young group. This prospective a n a ly s is  comparing an e ld e r ly  to  
a young population did not confirm these statem ents but suggest to  
the contrary th at the e ld e r ly  rheumatoid should not be denied the
e ld e r ly  than in  the young ( l5 5 , 156, 157). This controversy w il l
p o ten tia l value o f in jec ta b le  gold therapy. This study demonstrates 
th at the e ld e r ly  are ju st as l ik e ly  to  b en efit from gold therapy as 
the younger population.
Several authors have reported th a t the prognosis o f rheuma­
to id  a r th r it is  in  the e ld e r ly  i s  e ith e r  ju st as favourable ( l4 7 , l4 8 ,  
l4 9 ) or b e tter  (15O, 151) than in  the younger age groups. A sudden 
onset severe form of rheumatoid a r th r it is  i s  found in  approximately
20- 30^ o f the e ld e r ly  ( l4 9 , 152, 153, 154) but i t  i s  u su a lly  s e l f  
l im it in g , can be rea d ily  con tro lled  during the acute phase and has 
a good prognosis (154). However, some authors do hold the ■'dew 
th at rheumatoid d isease  does fo llo w  a more severe course in  the
-  153
o n ly  be r e s o lv e d  by a  p ro s p e c tiv e  c o n t ro l le d  com para tive  a n a ly s i s  
o f f u n c t io n a l  outcome to  a s s e s s  d is e a s e  s e v e r i ty  in  an e ld e r ly  
p o p u la tio n  compared to  a  younger p o p u la tio n  who dev e lo p  rheum ato id  
a r t h r i t i s .
I n  o rd e r  to  d e te rm in e  e f f ic a c y  o r  t o x i c i t y  w ith in  o r 
betw een a  c e r t a in  age g ro u p , th e  d a ta  f o r  c l i n i c a l  outcome and 
t o x i c i t y  were a n a ly se d  f o r  f o u r  a r b i t r a r y  age g roups : g roup  A l e s s  
th a n  30 y e a r s ;  g roup B 30-44  y e a rs ;  g roup G 45-59 y e a rs  and group  D
th e  e ld e r ly  p o p u la tio n  g r e a t e r  th a n  60 y e a r s .  No d if f e r e n c e s  in
te rm s o f  e f f ic a c y  were found  among th e  g ro u p s . R em ission (see  
M ethods) was j u s t  a s  common i n  th e  e ld e r ly  a s  i n  th e  young g ro u p s .
I t  i s  o f i n t e r e s t  t h a t  th e  mean tim e  o f re m is s io n  was 27 m onths,
31 months and 52 months in  g roups B, G and D r e s p e c t iv e ly ,  and t h a t
th e  mean g o ld  dosage re c e iv e d  was g r e a t e r  th a n  2400 mg o f g o ld
■compound. T h is  su g g e s ts  t h a t  th e  20 week cou rse  o f  g o ld  th e ra p y  
o r  th e  a r b i t r a r y  1 gram o f  compound a d m in is te re d  (158) may be 
i n s u f f i c i e n t  to  a f f o r d  maximum b e n e f i t  to  th e  p a t i e n t s ,  e s p e c ia l ly
■-th e  e l d e r ly .
-S im i la r ly ,  a d v e rse  r e a c t io n s  were n o t more common in  th e
'
e l d e r ly  group  compared to  th e  young g ro u p s . A n a ly s is  o f  th e  i n d i v i -  
d u a l age g roups -  A, B, G and D d id  n o t uncover any h idden  s u s c e p t-  
i b i l i t y  to  t o x i c i t y  w ith in  a  g ro u p . I t  shou ld  be n o te d , how ever, 
t h a t  low p l a t e l e t  coun t and low w h ite  b lood  c e l l  c o u n t, a lth o u g h
in f r e q u e n t ,  o ccu rred  i n  p a t i e n t s  g r e a t e r  th an  47 y e a rs  and 57 y e a rs
-  154
r e s p e c t iv e ly  and th e  s ix  p a t i e n t s  w ith  n e p h ro tic  syndrome were 
o ld e r  th a n  52 y e a rs  o f  a g e .
e ld e r ly  p o p u la t io n . However, s in c e  th e  p ro g n o s is  f o r  a p l a s t i c  
anaem ia i s  e s p e c i a l l y  poor i n  th e  e l d e r ly  ( l6 0 )  I  s t r o n g ly  recom­
mend a  s t r i c t  m o n ito rin g  system  f o r  a l l  th e  haem at o lo g i c a l  in d ic e s  
in  any p a t i e n t  r e c e iv in g  g o ld  th e ra p y  ( l2 ? ) .
ilT h e re fo re , a lth o u g h  h a e m a to lo g ic a l t o x i c i t y  d id  n o t occu r 
w ith  in c re a s e d  freq u en cy  s t a t i s t i c a l l y  in  t h i s  e ld e r ly  p o p u la tio n  
(g roup  D ), s t r i c t  c r i t e r i a  f o r  r e c o rd in g  h a em a to lo g ica l ad v erse  
e f f e c t s  sh o u ld  be u se d . The g u id e l in e s  u sed  in  t h i s  s tu d y  o f  a  
low p l a t e l e t  coun t l e s s  th a n  1 5 0 ,000/mm^ and a  low  w h ite  b lood  c e l l  
coun t o f  l e s s  th a n  4 0 0 0 /mm-^  a s  w e ll a s  th e  d i f f e r e n t i a l  w h ite  b lood  
c e l l  coun t (se e  M ethods) a re  s t r i c t  by most s ta n d a rd s ,  b u t a re  
d es ig n ed  to  i d e n t i f y  h a e m a to lo g ic a l t o x i c i t y  a t  i t s  e a r l i e s t  s ta g e s ,
G aird  e t  a l  found t h a t  th e  ran g e  o f le u k o c y te  count in  th e  
norm al e l d e r ly  p e rso n  was 500 -  3,500/mm^ ( l5 9 ) ,  b u t in d eed  I
. ore c o rd e d  on ly  one m ajor r e d u c t io n  i n  W.B.G. below  4,000/mm'^ i n  t h i s
IÎ
5s
Skin  r a s h  was n o t in c re a s e d  i n  t h i s  e l d e r ly  group a lth o u g h  
s k in  r a s h  has been r e p o r te d  to  be in c re a s e d  in  th e  "norm al" e ld e r ly  
p o p u la tio n  in  a s  many a s  50-95^  o f  peo p le  ( l 6 l ,  l 6 2 , I 63 ) and was 
a ls o  in c re a s e d  in  th e  e l d e r ly  p o p u la tio n  re p o r te d  by me who re c e iv e d  
D -p e n ic illa m in e  th e ra p y  ( l 4 l , l 4 2 ) .
!
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I t  has been su g g e s te d  t h a t  th e  e ld e r ly  a re  a t  r i s k  o f :
d e v e lo p in g  th e  n i t r i t o i d  r e a c t io n  ( l 6 4 ) . The a u th o rs  base  t h e i r  
c o n v ic tio n  on th e  outcome o f  th r e e  c a s e s  ( l6 5 , l6 6 )  w hich r e f e r  to  
n i t r i t o i d  r e a c t io n s  o c c u rr in g  in  two p a t i e n t s  ov er 60 y e a rs  o f age 
and recommend th e  u se  o f g o ld  th io g lu c o s e  a s  an a l t e r n a t i v e . I t
th e ra p y  can be a d m in is te re d  to  th e  e ld e r ly  p o p u la tio n  p ro v id ed  th e  
same s t r i c t  g u id e l in e s  f o r  m o n ito rin g  t o x i c i t y  i s  a p p l ie d  to  th e  
young p o p u la tio n  a re  e n fo rc e d  ( l2 ? ) .
sh o u ld  be n o te d , how ever, t h a t  th e  t h i r d  p a t i e n t  r e p o r te d  was 
49 y e a rs  o f  a g e . I n  my own s tu d y  none o f  th e  e l d e r ly  p a t i e n t s  
d eveloped  an a l l e r g i c - l i k e  re sp o n se  o f  any k in d . Thus my s tu d y
■V;-d id  n o t uncover any p re d isp o se d  r i s k  o f  n i t r i t o i d  r e a c t io n  in  th e  
e ld e r ly  g ro u p . The p re d isp o se d  r i s k ,  i f  i t  i s  g en u in e , most l i k e l y  
e x i s t s  w ith  p a t i e n t s  o f  a l l  ag es  who have s e r io u s  c a rd io v a s c u la r  , ;
d i s e a s e .
The r e s u l t s  r e p o r te d  in  t h i s  c h a p te r  in d ic a te  t h a t  g o ld  
sodium th io m a la te  i s  e q u a l ly  e f f ic a c io u s  in  th e  e l d e r ly  rheum ato id  
p a t i e n t  a s  in  th e  young rheum ato id  p a t i e n t ,  and t h a t  th e  in c id e n c e Io f  ad v e rse  e f f e c t s  does n o t  ap p ea r to  be in c re a s e d ,  a lth o u g h  s e r io u s  
t o x i c i t y  such  a s  n e p h ro tic  syndrome and h aem a to lo g ic a l t o x i c i t y
.
o ccu rred  in  p a t i e n t s  47 y e a rs  o f age o r o ld e r .  There a r e  no a p p a r­
e n t  d i f f e r e n c e s  in  c l i n i c a l  outcome n o r  in  t o x i c i t y  due to  g o ld  
th e ra p y  among th e  age g ro u p s : l e s s  th a n  30 y e a rs ;  30-44 y e a rs ;
45-59  y e a rs  and g r e a t e r  th a n  60 y e a r s .  Thus g o ld  sodium th io m a la te
Ii
a r b i t r a r y  age g roups -  g roup A (< 30 y e a r s ) , g roup B (30-44  y e a r s ) , 
g roup G (45-59  y e a rs )  and group D (> 60 y e a r s ) ,
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SUMMARY;
F o r ty  e l d e r ly  p a t i e n t s  (> 60 y e a rs )  and 101 young p a t i e n t s  
(< 60 y e a rs )  w ith  rheum ato id  a r t h r i t i s  r e c e iv in g  in j e c ta b le  g o ld  
th e ra p y  were fo llo w ed  p ro s p e c t!v e ly  betw een A p r i l ,  1971 and A p r i l ,
1 982 , I n  th e  young g roup , th e r e  were 28 m ales and 73 fem a les  w ith  
a  mean age o f 44 y e a rs  (ran g e  1 0 -5 9 ) . The median f u n c t io n a l  c l a s s  
was 2, th e  d u ra tio n  o f  d is e a s e  p r i o r  to  th e ra p y  was 4 ,4  y e a r s ,  and
th e  d u ra t io n  o f  th e ra p y  w ith  i n j e c ta b le  g o ld  was I 5 .6  m onths. The 
mean t o t a l  g o ld  compound re c e iv e d  was 1392 mg. The e l d e r ly  grouj) 
com prised I 7 m ales and 23 fem a les  w ith  a  mean age o f  67 y e a rs  
(ran g e  6O-83) . The median f u n c t io n a l  c l a s s  was 2 , th e  d u ra t io n  o f  
d is e a s e  p r io r  to  th e ra p y  was 5 -7  y e a rs  and th e  mean d u ra t io n  o f
th e ra p y  was 21 m onths. The mean t o t a l  g o ld  compound a d m in is te re d  
was 1861 mg. As w e ll a s  age," th e  o n ly  s ig n i f i c a n t  d i f f e r e n c e  betw een
th e  two g roups was th e  in c re a s e d  g o ld  compound re c e iv e d  by th e  
e ld e r ly .  I n  o rd e r  to  d e te rm in e  e f f ic a c y  and t o x i c i t y  w ith in  and
betw een c e r t a in  g ro u p s , th e  l 4 l  p a t i e n t s  were d iv id e d  in to  fo u r ÎI
The e ld e r ly  responded  to  th e  g o ld  th e ra p y  j u s t  a s  w e ll a s  
th e  young p a t i e n t s  a t  any tim e fram e examined a f t e r  3 months o f 
th e ra p y .  There was no d i f f e r e n c e  in  te rm s o f  c l i n i c a l  b e n e f i t  
betw een groups A, B, G and D.
N ine p a t i e n t s  in  th e  e l d e r ly  g roup (> 60 y e a rs )  and 15 




becau se  o f  no re s p o n s e . T h is d i f f e r e n c e  was n o t s ig n i f i c a n t  between 
th e  g roups A, B, G and D (x^ = 1.4-17, p = O.7OI5 ) .
There was no d i f f e r e n c e  in  outcome o f in d iv id u a l  t o x i c i t y  
betw een th e  e l d e r ly  and th e  young g ro u p s , and th e r e  was no d if f e r e n c e  
i n  freq u en cy  o f  t o x i c i t y  betw een th e  age g roups A, B, G and D,
S e r io u s  h aem ato lo g ic  t o x i c i t y  o ccu rred  on ly  in  p a t i e n t s  ov er 4-7 y e a rs  
o f a g e , and n e p h ro tic  syndrome o ccu rred  on ly  in  p a t i e n t s  o ld e r  th a n  
52 y e a rs  o f a g e .
I n  t h i s  s tu d y , c l i n i c a l  b e n e f i t  from  g o ld  th e ra p y  was j u s t
a s  good i n  th e  e ld e r ly  a s  i n  th e  young p a t i e n t s ,  and th e  t o x i c i t y  r a t e  
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t h i s  compound i n  W ils o n 's  d is e a s e  in  1956 based  on th e  h y p o th e s is  
t h a t  th e  i n  v i t r o  c h e la t in g  p r o p e r t i e s  o f th e  p e n ic illa m in e  f o r
»
INTRODUCTION;
The t h i o l  compound p e n ic il la m in e  c u r r e n t ly  u sed  in  th e  
tre a tm e n t o f  rheum ato id  d is e a s e  ( l6 y ,  l6 8 ,  I 69 ) was f i r s t  u sed  
in  m edicine because o f i t s  p r o p e r t i e s  a s  a  c h e la t in g  a g e n t.
J .M . Walshe ( l7 0 ,  171 ) f i r s t  p u b lish e d  th e  b e n e f i c i a l  e f f e c t s  o f
copper was th e  mechanism o f a c t io n  o f th e  new d ru g . New knowledge
o f th e  many v a r ie d  a c t io n s  o f p e n ic il la m in e  su g g e s t t h a t  p o s s ib ly  
o th e r  mechanisms a re  a l s o  a c t iv e  in  i t s  b e n e f i c ia l  e f f e c t s  in  
W ilso n 's  d i s e a s e .  These a c t io n s  have been rev iew ed  i n  an a r t i c l e  
by me and my c o lle a g u e s  b u t t h e i r  f u r t h e r  d is c u s s io n  i s  o u tw ith  
th e  scope o f t h i s  t h e s i s  ( l 4 l ) . Many te x tb o o k s  su g g e s t t h a t  i f  
p a t i e n t s  r e c e iv in g  g o ld  compounds d ev e lo p  t o x i c i t y ,  a  c h e la t in g  
a g en t such  a s  D -p e n ic il la m in e  sh o u ld  be used  (172-175) w ith  th e  
c l e a r  im p l ic a t io n ,  o f te n  n o t s t a t e d ,  t h a t  th e  D -p e n ic illa m in e  may 
a c t  a s  a  c h e la t in g  a g e n t tow ards g o ld . Along w ith  my c o lle a g u e s  
P ro fe s s o r  G .J .L . Lock and D r. H elen E . Howard-Lock o f th e  D ep a rt­
ment o f M a te r ia ls  R esearch  and P ro fe s s o r  W. Watson Buchanan,
P ro fe s s o r  o f  M edicine a t  McMaster U n iv e r s i ty ,  I  ad d re sse d  th e
q u e s tio n  -  does p r io r  th e ra p y  w ith  g o ld  compounds in f lu e n c e  th e  
■ad v e rse  e f f e c t s  o f D -p e n ic illa m in e  in  rheum ato id  a r t h r i t i s ?
■The tre a tm e n t o f  rheum ato id  d is e a s e  w ith  g o ld  compounds 
i s  n o t e f f e c t iv e  in  a l l  p a t i e n t s  (IO8 -IIO ) and th e  r a t e  o f ad v erse
Ïr e a c t io n  i s  ap p ro x im ate ly  30^. T h e re fo re , an in c re a s in g  number
I
D -p e n ic i lla m in e , s e v e r a l  a u th o rs  have commented on. th e  outcome o f
i,.ï
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o f  p a t i e n t s  w ith  rheu m ato id  d is e a s e  a re  t r e a te d  w ith  D -p e n ic illa m in e  
su b seq u en t to  g o ld  th e ra p y . D e sp ite  t h e i r  w idely  d i s s im i l a r  
chem ical s t r u c t u r e s , th e  t h i o l  compounds go ld  sodium th io m a la te
and D -p e n ic illa m in e  have rem ark ab ly  s im i la r  c l i n i c a l  e f f e c t s .
Im proved p a t ie n t  w e ll-b e in g  and a  r e d u c t io n  in  e ry th ro c y te  sedim en­
t a t i o n  r a t e  o ccu r a f t e r  a p p ro x im a te ly  th r e e  months o f  tre a tm e n t 
(1O8 - I IO , 167) w ith  e i t h e r  d ru g , and th e re  i s  a  marked s i m i l a r i t y  
i n  in c id e n c e  and ty p e  o f  a d v e rse  e f f e c t s  (108-110, 124 , I 6 7 , I 68 ) ,
■ .I n  view o f t h i s  s i m i l a r i t y  o f g o ld  sodium th io m a la te  to
I '
rheum ato id  p a t i e n t s  who were t r e a t e d  w ith  D -p e n ic illa m in e  and who
p re v io u s ly  had re c e iv e d  go ld  th e ra p y  (1 6 8 , I 76- I 83 ) . I t  i s  n o t
:
s u r p r i s in g  t h a t  th e s e  a u th o rs  have d i f f e r e n t  o p in io n s  i n  re g a rd  to  
th e  t o x i c i t y  r a t e  o f  p a t i e n t s  who re c e iv e d  D -p e n ic illa m in e  a f t e r  
g o ld  th e ra p y , because  th e r e  have been no s ta n d a rd  c r i t e r i a  by w hich 
to  judge t o x i c i t y  in  th e  management o f  rheum ato id  d is e a s e .  The 
g ra d in g  and a ssessm en t o f  a d v e rse  e f f e c t s  o f  go ld  compounds and 
D -p e n ic illa m in e  have been m ere ly  a  c o l l e c t iv e  s e r i e s  o f p e rso n a l 
o b s e rv a tio n s ;  th e r e  have been  no common s ta n d a rd  d e f in i t i o n s  among 
th e  d i f f e r e n t  g roups (1O8 - I IO , 124, 167- I 6 9 , 17 6 -1 8 3 ). I n  p a r a l l e l  
c o n tro v e rsy  in  th e  l i t e r a t u r e ,  r e s e a r c h e r s  have asked  w hether 
p e n ic illa m in e  e f f e c t iv e l y  b in d s  to  go ld  and cou ld  in d eed  be re sp o n ­
s ib l e  f o r  th e  o ccu rren c e  o r  r e c u r re n c e  o f ad v e rse  e f f e c t s  in  
p a t i e n t s  who r e c e iv e  D -p e n ic illa m in e  and who have p re v io u s ly  had 







The o b je c t iv e  o f my s tu d y  was to  d e term ine  w hether th e re  
i s  a  d i f f e r e n c e  in  outcome in  p a t i e n t s  who re c e iv e  D -p e n ic illa m in e  
th e ra p y  and who have had p re v io u s  go ld  th e ra p y . I  a tte m p te d  to  
meet th e s e  o b je c t iv e s  by com paring : ( l )  o v e r a l l  outcom e, ( 2 ) e f f e c t  
of g o ld  d osage , (3 ) e f f e c t  o f  tim e betw een end o f  go ld  th e ra p y  and 
s t a r t  o f  D -p e n ic illa m in e . th e ra p y , (4 ) e f f e c t  o f tim e  betw een end 
o f  go ld  th e ra p y  and th e  o n se t o f  D -p e n ic illa m in e  t o x i c i t y ,  (5 ) th e  
tim e o f  o n se t o f  t o x i c i t y  to  D -p e n ic illa m in e  in  th o s e  p a t i e n t s  
hav in g  p re v io u s  g o ld  th e ra p y  compared w ith  th o se  h av in g  no p re v io u s  
g o ld  th e ra p y , and (6 ) th e  t o x i c i t y  p a t te r n  o f D -p e n ic illa m in e  w ith  
r e s p e c t  to  p re v io u s  go ld  th e ra p y .
'S
:
■ ' A :
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PATIENTS AND METHODS:
One hundred fo u r te e n  p a t i e n t s  w ith  d e f i n i t e  o r  c l a s s i c  
rheum ato id  a r t h r i t i s  (d iag n o sed  a c c o rd in g  to  c r i t e r i a  o f  American 
Rheumatism A ss o c ia tio n  ( i l l ) } w e r e  fo llo w ed  p ro s p e c t iv e ly  between 
J a n u a ry  1976 and A p r il  1981, in  o rd e r  to  m on ito r t h e i r  t o x i c i t y  
p a t t e r n  to  D -p e n ic illa m in e  th e ra p y . There were 34 male p a t i e n t s  
and 80 fem ale p a t i e n t s ;  th e  average ag es  were 54 y e a rs  (range 
10-79 y e a rs )  and 50 y e a rs  (ran g e  11-74  y e a r s ) , r e s p e c t iv e ly .  The 
mean f u n c t io n a l  c l a s s  was 2 , The d u ra t io n  o f  d is e a s e  b e fo re  th e ra p y  
was 6 ± 3 y e a r s ,  and th e  mean d u ra tio n  o f  th e ra p y  was 11 ± 8 m onths.
The average  dosage o f  D -p e n ic illa m in e  was 490 ± l6 0  m g/day. A ll 
p a t i e n t s  w ith  in flam m ato ry  rheum ato id  d is e a s e  n o t re sp o n s iv e  to  
n o n s te ro id a l  a n tiin f la m m a to ry  d ru g s  were c o n s id e re d  e l i g i b l e  f o r
■D -p e n ic illa m in e  th e ra p y . A co u rse  o f  D -p e n ic illa m in e  i s  d e f in e d  as  
d a i ly  o r  a l t e m a te - d a y  a d m in is t r a t io n  o f  th e  d ru g  f o r  an i n d e f i n i t e
'p e r io d  o f tim e . P a t i e n t s  who were ta k in g  th e  drug  f o r  th e  f i r s t
Itim e  were g iv en  250 mg/day f o r  a  minimum of 4 weeks, and in c rem en ts  
in  dosage were made a t  th e  d i s c r e t io n  o f th e  a t te n d in g  p h y s ic ia n  
and were based  on c l i n i c a l  outcom e. I f  D -p e n ic illa m in e  th e ra p y  
was s topped  f o r  6 months and th e n  s t a r t e d  a g a in , we d e f in e d  t h a t
Ia s  a  second co u rse  o f th e  d rug  f o r  t h a t  p a t i e n t .
Im m unosuppressive d ru g s , go ld  compounds, and ch lo ro q u in e  
were n o t g iv en  d u rin g  D -p e n ic illa m in e  th e ra p y .  A few  p a t i e n t s  were 




F or th e  pu rpose  o f th e  s tu d y , th e  p a t ie n ts  were d iv id e d
had a  mean age o f  55 ± 1 2  y e a rs  and who had r e c e iv e d  p re v io u s  g o ld
§
F i f ty - t h r e e  p a t i e n t s  had p re v io u s ly  r e c e iv e d  g o ld  sodium 
th io m a la te  th e ra p y . A s ta n d a rd  co u rse  o f go ld  sodium th io m a la te  
was a  w eekly i n j e c t i o n  o f  50 mg in t ra m u s c u la r ly  f o r  20 weeks, 
fo llo w ed  by 50 mg ev e ry  two to  fo u r  weeks f o r  an i n d e f i n i t e  p e r io d  
o f tim e . The tim e  betw een d is c o n t in u a t io n  of go ld  sodium th io m a la te  
th e ra p y  and th e  s t a r t  o f D -p e n ic i lla m in e  th e ra p y  ran g ed  from  0-84  
m onths. The p h y s ic ia n  who was managing th e  p a t i e n t 's  rheum ato id  
d is e a s e  d ec id ed  w hether to  s t a r t  D -p e n ic illa m in e  tre a tm e n t and when 
to  s t a r t  i t  f o r  each  p a t i e n t .
Ï
i n to  th r e e  g ro u p s . Group A c o n s is te d  o f 11 men and 19 women, who
sodium th io m a la te  th e ra p y  t h a t  had been d is c o n tin u e d  because of an 
a d v e rse  r e a c t io n .  Group B c o n s is te d  o f 21 women and two men who
had a  mean age o f 51 ± l6  y e a rs  and who had re c e iv e d  p r io r  g o ld  
sodium  th io m a la te  th e ra p y  th a t  was d is c o n tin u e d  becau se  o f no r e s ­
ponse . F o r one p a t i e n t  in  Group B, g o ld  sodium th io m a la te  th e ra p y  
was d is c o n tin u e d  because o f re m is s io n . When a  r e la p s e  o c c u rre d , she 
chose to  r e c e iv e  D -p e n ic i lla m in e  because  o f a  f e a r  o f  i n j e c t i o n s .  
Group G c o n s is te d  o f  40 women and 21 men who had a  mean age of 
49 -  15  y e a rs  and who had n e v e r  r e c e iv e d  p re v io u s  g o ld  sodium th i o ­
m ala te  .
The m ethods u sed  to  m easure e f f ic a o y  and t o x i c i t y  in  th e se  
p a t i e n t s  have been d e s c r ib e d  p re v io u s ly  ( l2 4 ,  l 6 8 ) , A m ajor t o x i ­
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n e c e s s i t a t e  d is c o n t in u a t io n  o f th e  d ru g . A m inor t o x i c i t y  was 
d e f in e d  a s  an a d v e rse  e f f e c t  r e l a t e d  to  th e  d rug  t h a t  d id  n o t 
n e c e s s i t a t e  t o t a l  i n t e r r u p t io n  o f th e  co u rse  o f th e ra p y .
F or th e  pu rpose o f t h i s  s tu d y , a  sk in  r a s h  was any sk in  
e ru p tio n  c o n s id e re d  to  he r e l a t e d  to  th e  tre a tm e n t d ru g . Mouth 
u lc e r s  were d e f in e d  a s  l e s i o n s  s im i la r  in  appearance  to  aph thous 
u lc e r s  o c c u rr in g  i n  th e  mucous membrane o f  th e  mouth. D ysgeusia  
was th e  lo s s  o r  a l t e r a t i o n  o f  t a s t e  p e rc e p tio n ,  and p r o te in u r ia  
was th e  p resen ce  o f 2+ on d ip s t i c k  on 1 o ccasio n  o r  1+ on 2 co n sec­
u t iv e  u r in e  specim ens 1 week a p a r t .  Abnormal u r in a r y  sed im ent was 
d e f in e d  a s  any o f th e  fo llo w in g : th e  p resen ce  o f  re d  c e l l s  > 10 p e r  
h ig h  power f i e l d ,  w h ite  c e l l s  > 10 p e r  h ig h  power f i e l d ,  r e d  c e l l  
c a s t s ,  w h ite  c e l l  c a s t s ,  o r  h y a lin e  c a s t s .  Throm bocytopenia was 
d e f in e d  a s  any d rop  in  p l a t e l e t  coun t below l50,000/m m ^. As p re v -  
io u s ly  re p o r te d  (124 ,168  ) ,  a  f a l l  in  polym orpholeukocyte coun t 
below 50^  a n d /o r  a  r i s e  i n  monocyte coun t above 10^ was re c o rd e d  
a s  a  w h ite  b lood  c e l l  (WBC) t o x i c i t y .  I f  th e re  was a  f a l l  in  p l a t e ­
l e t  coun t o f g r e a t e r  th a n  100,000/mm^ a n d /o r  a  f a l l  i n  WBC of 
g r e a t e r  th a n  4,000/mm^ b u t w ith in  th e  norm al ra n g e , th e  d rug  was 
w ith h e ld  u n t i l  a  r e p e a t  b lood  coun t was o b ta in e d , b u t ,  f o r  th e  
purpose of th e  s tu d y , th e s e  e v e n ts  were n o t re c o rd e d  a s  t o x i c i t i e s .  
I n  one r e p o r t  by Kay ( l 8 4 ) , th e  a u th o r  le n d s  su p p o rt to  th e  s t r i c t  
m easures we have i n s t i t u t e d  to  i n t e r c e p t  p o te n t i a l  hem ato log ic  
t o x i c i t y ,  by th e  o b s e rv a tio n  t h a t  bone marrow su p p re s s io n  may be 
p receded  by a  g ra d u a l f a l l  o f  p l a t e l e t s  and n e u t r o p h i l s ,  even w ith in  
th e  norm al ra n g e .
I
-  166
th e r a p y .
w ith  no D -p e n ic illa m in e  t o x i c i t y  had re c e iv e d  a  mean t o t a l  go ld  
dosage o f  920 mg, and th o s e  p a t i e n t s  who developed  t o x i c i t y  to
and th o se  p a t i e n t s  who d ev eloped  D -p e n ic illa m in e  t o x i c i t y  had
RESULTS ;
I n  T ab le 12„ th e  outcomes o f th e  114 p a t i e n t s  who re c e iv e d  
o r a re  r e c e iv in g  D -p e n ic illa m in e  a re  shown. F i f t y - t h r e e  p a t i e n t s  
(g roup  A and B) p re v io u s ly  r e c e iv e d  g o ld  th e ra p y . T h ir te e n  o f 
group A ( 4 ^ )  , 10 o f group B ( 4 ^ ) ,  and 25 o f g roup G (4 l^ )  had 
no t o x i c i t y  to  D -p e n ic i l la m in e . S even teen  o f group A {31%) t 13 o f 
group B {37%) f and 36 o f  g roup G ( 39%) had a  m ajor o r  m inor t o x i c i t y  
to  D -p e n ic i l la m in e . T h ir te e n  o f g roup A ( 4 ;^ ) ,  10 o f g roup B ( 4 ^ )  , 
and 24 o f group G { 39%) had a  m ajor t o x i c i t y  to  D -p e n ic illa m in e I
There was no s i g n i f i c a n t  d i f f e r e n c e  among p a t i e n t s  in
groups A, B, o r  G in  t h e i r  e v e n tu a l re sp o n se  to  D -p e n ic illa m in e  
w ith  r e s p e c t  to  t o x i c i t y  (x^ < 0 .0 8 , p > O.9 , n o t s i g n i f i c a n t ) .
I n  T ab le  13 , I  have compared th e  t o t a l  accum ulated  g o ld  
th e ra p y  a d m in is te re d  in  g roups A and B w ith  r e s p e c t  to  th e  d e v e l­
opment o f D -p e n ic i lla m in e  t o x i c i t y .  I n  group A, th o se  p a t i e n t s
D -p e n ic illa m in e  had r e c e iv e d  a  mean t o t a l  g o ld  dosage o f 777 mg.
A t - t e s t  f o r  com parison o f th e  mean v a lu e s  showed no s t a t i s t i c a l l y  
s ig n i f i c a n t  d i f f e r e n c e  betw een th e se  v a lu e s  ( t  = 0 .9 2 , p > 0 . 2 5 ,
'n o t s i g n i f i c a n t ) .  I n  group B, th o se  p a t i e n t s  w ith  no D - p e n ic i l la -  
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re c e iv e d  a  mean t o t a l  dose o f 1 ,778  mg o f g o ld . These v a lu e s  
were n o t s i g n i f i c a n t l y  d i f f e r e n t  ( t  = 0 .4 6 , p > 0 ,2 5 ) .  A Mann- 
W hitney Ü t e s t  ( f o r  s to c h a s t ic  conlparison o f  skewed d i s t r i b u t io n s )  
was a p p lie d  to  th e  r e s u l t s  o f T ab les  14 -17 .
The mean tim e in  months between d is c o n t in u a t io n  o f g o ld  
th e ra p y  and th e  s t a r t  o f D -p e n ic illa m in e  th e ra p y  w ith  r e s p e c t  to  
th e  developm ent o f  D -p e n ic illa m in e  t o x i c i t y  i s  shown in  Table l 4 .
I n  group A, th e  mean tim e  betw een d is c o n t in u a t io n  o f  g o ld  th e ra p y  
and th e  s t a r t  o f D -p e n ic illa m in e  th e ra p y  was 25 months in  th o se  
p a t i e n t s  who d id  n o t d ev e lo p  D -p e n ic illa m in e  t o x i c i t y  ( s u b s e t  A l)
The mean tim e  betw een th e  d is c o n t in u a t io n  o f  g o ld  th e ra p y  and th e  
s t a r t  o f D -p e n ic illa m in e  th e ra p y , how ever, was l 6  months in  th o se  
who developed  b o th  a  m ajor and m inor D -p e n ic illa m in e  to x i c i t y
I
(s u b s e t  A 2), and l6  months in  th o se  who developed  a  m ajor D -pen i­
c i l la m in e  t o x i c i t y  o n ly  ( s u b s e t  A 3). The d i f f e r e n c e  betw een th e s e 1
't im e s  approached  th e  l e v e l  o f  s t a t i s t i c a l  s ig n if ic a n c e  ^ “ 5 0 -5 »
0 .0 2  < p < 0 .0 5 ; = 3 6 .5 , 0 ,0 2  < p < 0 .05 ) . I
I n  g roup B, th e r e  was no s ig n i f i c a n t  d i f f e r e n c e  in  tim e 
betw een th e  d is c o n t in u a t io n  o f g o ld  th e ra p y  and th e  s t a r t  o f D -pen i­
c i l la m in e  th e ra p y  in  th o se  p a t i e n t s  who d id  n o t d ev e lo p  D - p e n ic i l l a -  
mine t o x i c i t y  ( s u b s e t  B l, mean = 15 m onths), th o se  who developed  
b o th  a  m ajor t o x i c i t y  ( s u b s e t  B2, mean = l6  m on ths), and th o se  who 




Table 14. Tim e in m onths betw een  the d iscontinuation o f gold 
therapy  and the s ta rt o f D -penicillam ine therapy*
T oxicity  to G roup A G roup B
Subset D -penicillam ine (n =  30)t (n = 23)t
1 N one
M ean 25 15
M edian 26 4
Range 3-53 0-72
2 M ajor and m inor
M ean 16 16
M edian 5 5
Range 0-84 0-72
3 M ajor
M ean 16 16
M edian 5 4
Range 0-84 0-72
* n =  num ber o f pa tien ts; M ann-W hitney U test fo r com parison of 
m edians o f subsets A l ,  2, 3 and B l, 2, 3 was used: U a i 2 =  50.5, 0.02 
<  P  <  0.05; U a i .3 =  36.5, 0.02 < P <  0.05; Ugi.z =  62.5, P > 0.10 
no t significant; 1) 31,3 =  47, P  >  0.10 no t significant; U a i,b i =  28, 
0.05 <  P  <  0.10; U a 2,b2 =  105, P  >  0.10 not significant; U a 3,b3 = 
60, P  >  0.10 no t significant, 
t  G roup A had toxicity  to previous gold therapy ; group B had no 
toxicity  to previous gold therapy . I
I
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I n  a  com parison betw een g roups A and B, th e re  was a  
s i g n i f i c a n t  d i f f e r e n c e  betw een s u b s e ts  Al and A2 b u t n o t  A2 and 
B2 o r  A3 and B3, in  r e g a rd  to  th e  tim e between d is c o n t in u a t io n  o f 
g o ld  th e ra p y  and th e  s t a r t  o f  D -p e n ic illa m in e  th e ra p y , r e g a r d le s s  
o f outcome on D -p e n ic illa m in e  = 28, 0 .0 5  < P < O.Ol)
(Ua2^B2 " 105, P > 0 .1 0 )  (Ua3,B3 = 60 , p > 0 .1 0 ) .
I n  T able 15 , th e  mean tim e  i n  months betw een d is c o n t in u a ­
t io n  o f  g o ld  th e ra p y  and th e  o n se t o f  D -p e n ic illa m in e  t o x i c i t y  in  
group A (mean = 22 m onths) and group B (mean = 20 m onths) i s  shown. 
T here was no s i g n i f i c a n t  d i f f e r e n c e  between th e se  tim es  (U = 104,
p > 0 .1 0 ) .
I n  group A, 13 p a t i e n t s  had a  m ajor t o x i c i t y  to  b o th  g o ld  
th e ra p y  and D -p e n ic illa m in e  (T ab le  l 6 ) . S ix  o f th e  13 p a t i e n t s  had 
th e  same m ajor t o x i c i t y  to  b o th  d ru g s  ( th r e e  r a s h ,  th r e e  p r o te in u r ia )  
The average  tim e betw een d is c o n t in u a t io n  o f go ld  th e ra p y  and th e  
developm ent o f  D -p e n ic i lla m in e  t o x i c i t y  was 17 months in  th o se  w ith  
th e  same t o x i c i t y  and 24 months i n  th o se  w ith  d i f f e r e n t  t o x i c i t i e s .  
These tim es  were n o t s i g n i f i c a n t l y  d i f f e r e n t  (U = 17 , P > 0 ,6 0 , 
2 - t a i l e d ) .
I n  T ab le 17 , th e  mean tim e o f  developm ent o f t o x i c i t y  to  
D -p e n ic illa m in e  i s  compared betw een group A + B and g roup  G ( i . e .  
p a t i e n t s  w ith  p re v io u s  g o ld  th e ra p y  and p a t i e n t s  w ith o u t p re v io u s  
g o ld  th e r a p y ) . The mean tim e a t  which D -p e n ic illa m in e  t o x i c i t y  
o ccu rred  was fo u r  months f o r  group A + B and s ix  months f o r  group C. 
These v a lu e s  a re  n o t s ig n i f i c a n t l y  d i f f e r e n t  (U = 129 , p > 0 .1 0 , 
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The t o x i c i t y  p a t te r n s  a r e  a l s o  shown in  T ab le  17 f o r  
two groups o f p a t i e n t s ,  th o se  w ith  p re v io u s  go ld  sodium th io ra a la te  
th e ra p y  (group A + B, n = 33) and th o se  w ith  no p re v io u s  go ld  
sodium th io m a la te  th e ra p y  (g roup  G, n = 6 l ) . There was no s ig n i ­
f i c a n t  d i f f e r e n c e  in  th e  number o f  e p iso d e s  o f in d iv id u a l  t o x i c i t y  
betw een th e  two g ro u p s . (See T able 17 f o r  and p v a lu e s ) .
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S e v e ra l a u th o rs  have commented on th e  outcome o f rheum a- 
t o i d  p a t i e n t s  t r e a t e d  w ith  D -p e n ic illa m in e  who had r e c e iv e d  
p re v io u s  g o ld  th e ra p y  ( l4 0 ,  l6 8 ,  176- I 83 ) - The M u ltic e n tre  T r i a l  
Group (176 ) ,  Tsang e t  a l  ( l 7 7 ) , Webley and Goomes (178 ) ,  and W eiss 
e t  a l  (179) d id  n o t  f in d  an in c re a s e d  ev idence o f  t o x i c i t y  in  t h e i r  
D -p e n ic i l la m in e - t r e a te d  p a t i e n t s  who had re c e iv e d  p re v io u s  g o ld  
th e ra p y . T h is  h as  been confirm ed  in  b o th  younger (<  60 y e a rs  o ld )
and e l d e r ly  (> 60 y e a rs  o ld )  p a t i e n t s  ( iW , l 4 l ) . Our f in d in g s  
a r e  c o n s is te n t  w ith  th e s e  r e p o r t s  and su g g e s t t h a t  o v e r a l l  d e v e l­
opment o f t o x i c i t y  i s  n o t in f lu e n c e d  by p re v io u s  g o ld  th e ra p y , s in c e  
th e  t o x i c i t y  p a t te r n  o f  group  A + B was n o t s i g n i f i c a n t l y  d i f f e r e n t  
from  th a t  o f g roup G and th e  tim e  o f o n se t o f D -p e n ic illa m in e  
t o x i c i t y  was n o t s i g n i f i c a n t l y  d i f f e r e n t  between group A + B and 




w ith  p ro te in -b o u n d  g o ld  and m o b iliz e  i t ,  so  t h a t  th e  g o ld  can a g a in  
cause ad v erse  r e a c t io n s ,  I  found  th a t  in  group A, th o se  p a t i e n t s  
who d id  n o t d ev e lo p  D -p e n ic illa m in e  t o x i c i t y  had a  l a r g e r  tim e 
i n t e r v a l  betw een th e  g o ld  t o x i c i t y  and th e  s t a r t  o f  D -p e n ic illa m in e  
th e ra p y  th a n  th o s e  p a t i e n t s  who developed  a  m ajor and m inor t o x i c i t y  
o r  th o se  who developed  a  m ajor t o x i c i t y  a lo n e  (T ab le  l 4 ) . A lthough 
th e s e  d i f f e r e n c e s  j u s t  reac h ed  s t a t i s t i c a l  s i g n i f i c a n c e , i t  i s  
d i f f i c u l t  to  draw a  c o n c lu s io n  t h a t  D -p e n ic illa m in e  t o x i c i t y  i s  l e s s
'common i f  th e  tim e betw een g o ld  t o x i c i t y  and D -p e n ic illa m in e  th e ra p y
177 -
i s  lo n g , because  th e  ran g e  o f  i n t e r v a l s  f o r  in d iv id u a l  p a t i e n t s  
o verlap p ed  among th e  3 s u b s e ts .  S im i la r ly ,  th e  tim e  between 
d is c o n t in u a t io n  o f g o ld  and th e  developm ent o f  D -p e n ic illa m in e  
t o x i c i t y  was no d i f f e r e n t  betw een group A and group  B (T able 1 5 ) .
t i o n  o f th e  2 d rugs i s  s h o r t .  I n  my s e r i e s ,  13 p a t i e n t s  had a
1
Dodd e t  a l  ( l8 0 )  a ls o  su g g e s te d  t h a t  ad v erse  r e a c t io n s  in  p a t i e n t s
r e c e iv in g  g o ld  th e ra p y  and su b se q u e n tly  D -p e n ic illa m in e  a re  com­
monly o f th e  same ty p e ,  i f  th e  tim e  i n t e r v a l  betw een a d m in is tr a -
m ajor r e a c t io n  to  b o th  d ru g s , b u t I  d id  n o t f in d  any s i g n i f i c a n t
■'.iV
d if f e r e n c e  in  th e  tim e betw een t o x i c i t y  to  th e  2 d ru g s  in  th e  6 
p a t i e n t s  who had th e  same a d v e rse  e f f e c t  compared w ith  th e  7 p a t i e n t s  
who had a  d i f f e r e n t  ad v e rse  e f f e c t .
Many a u th o rs  have commented t h a t  s p e c i f i c  ad v e rse  r e a c t io n s  
o ccu r more commonly in  p a t i e n t s  w ith  D -p e n ic illa m in e  t o x i c i t y  i f  
p re v io u s  g o ld  has been a d m in is te re d . Day and G old ing  ( l 8 l )  found 
an  in c re a s e  in  marrow h y p o p la s ia  i n  p a t ie n t s  who were r e c e iv in g  
D -p e n ic illa m in e  and who had  p re v io u s ly  re c e iv e d  g o ld  th e ra p y . 
B i l l in g s l e y  and S tev e n s  ( l8 2 )  r e p o r te d  an in c re a s e d  in c id e n c e  of 
p r o te in u r ia ,  and Webley and Goomes (183 ) r e p o r te d  an in c re a s e d
in c id e n c e  o f  s k in  r a s h  and p r o te in u r ia .  As in  Webley and Goomes'
o r ig in a l  r e p o r t  (178 ) , th e  M u ltic e n tre  T r i a l  Group (176) , Tsang
e t  a l  (177) ,  and W eiss e t  a l  ( l 7 9 ) , how ever, I  d id  n o t  f in d  any 
s ig n i f i c a n t  d i f f e r e n c e s  in  th e  in c id e n c e  o f s k in  r a s h ,  p r o te in u r ia ,  
low p l a t e l e t s ,  t a s t e  a b n o rm a lity , mouth u l c e r s ,  low  w h ite  c e l l  
c o u n t, o r  g a s t r o i n t e s t i n a l  u p s e t  when I  compared my p a t i e n t s  w ith
sI3i
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p re v io u s  g o ld  th e ra p y  (g roup  A + B) w ith  th o se  who had n e v e r 
r e c e iv e d  go ld  th e ra p y  (g roup  C) (T ab le 1 7 ) .
T o ta l go ld  dosage r e c e iv e d  d id  n o t in f lu e n c e  th e  outcome 
o f  D -p e n ic illa m in e  t o x i c i t y ,  r e g a r d le s s  o f p re v io u s  g o ld  t o x i c i t y .  
Dodd e t  a l  ( l8 0 )  m entioned t h a t  g o ld  i s  a  c h e la t in g  a g e n t f o r  
m e ta ls  and su g g es ted  t h a t  D -p e n ic illa m in e  may r e a c t  w ith  p r o te in -  
bound g o ld  and m o b iliz e  i t ,  th u s  making i t  a v a i la b le  to  cause 
ad v erse  r e a c t io n .  W hile D -p e n ic illa m in e -d o e s  c h e la te  Au ( i l l ) ,  
an o x id a tio n  s t a t e  o f g o ld  known to  bond to  fo u r  atom s a rra n g e d  
in  a  squ are  ab o u t i t ,  th e r e  i s  no ev idence t h a t  D -p e n ic illa m in e  
c h e la te s  A u ( l) ,  th e  o x id a tio n  s t a t e  o f  go ld  u sed  in  a n t i - a r t h r i t i c  
d ru g s  and t h a t  found in  v iv o . I  s u g g e s t,  t h e r e f o r e ,  t h a t  th e  
te rm in o lo g y  c h e la t io n  n o t be used  when r e f e r r in g  to  th e  in  vivo 
in t e r a c t io n  o f  go ld  and p e n ic i l la m in e .
A lthough p e n ic il la m in e  was o r ig in a l ly  in tro d u c e d  a s  a  
d ru g  in  th e  tre a tm e n t o f  W ilso n 's  d is e a s e  because  o f  th e  com­
p o u n d 's  c a p a c i ty  to  c h e la te  copper (17O, 171) ,  t h i s  knowledge t h a t  
p e n ic il la m in e  i s  a  m e ta l c h e la to r  has le d  to  th r e e  b a s ic  problem s 
in  th e  m ed ical l i t e r a t u r e : -
( i )  The assum ption  t h a t  p e n ic il la m in e  a c t s  a s  a  
c h e la to r  f o r  a l l  m e ta ls ,  in c lu d in g  th e  A u(l) 
a d m in is te re d  in  g o ld  t h i o l  com plexes, e .g .  
g o ld  sodium th io m a la te  (185 , I 86 ) .
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( i l )  The assum ption  t h a t  ad v e rse  e f f e c t s  o c c u rr in g  
in  p a t i e n t s  r e c e iv in g  D -p e n ic illa m in e  m ight be 
r e l a t e d  to  D -p e n ic illa m in e  " c h e la t in g "  p re v io u s ly  
a d m in is te re d  g o ld .
( i i i )  The p e rp e tu a t io n  o f  assum ptions ( i )  and ( i i )  in  
th e  m ed ica l l i t e r a t u r e  (172- 175)•
The f i r s t  c o n c e p t, t h a t  D -p e n ic illa m in e  c h e la te s  th e  A u(l) 
o f  g o ld  sodium th io m a la te  has r e c e n t ly  been d is p u te d  (187) , The 
r e s u l t s  o f  my f in d in g s  in  t h i s  c h a p te r  have d is p u te d  co n cep t ( i i )  
and in d ic a te  t h a t  th e r e  i s  no c l i n i c a l  c o r r e l a t io n  betw een p r io r  
g o ld  th e ra p y  (a d v e rse  e f f e c t s  o r  n o t)  and e v e n tu a l outcome on 
D -p e n ic illa m in e  th e ra p y  (188) .
I t  i s  e v id e n t t h a t  th e  te rm  c h e la t io n  i s  n o t co m p le te ly  
u n d e rs to o d  by some members o f th e  m edical f r a t e r n i t y .  A part from  
th e  co n fu s io n  m entioned  h e r e in ,  i t  has been s t a t e d  t h a t  D - p e n ic i l l ­
amine on o x id a tio n  to  D ,D -2 ,2 ,5 ,5 »  te tr a m e th y lc y s t in e  can n o t a c t  
a s  a  c h e la te  (189 ) , even though  t h i s  l ig a n d  h as  q u i te  c l e a r l y  been 
shown to  c h e la te  copper (19O) (F ig u re  4-7).
I n  view  o f  t h i s  a p p a re n t knowledge gap in  th e  m ed ical 
l i t e r a t u r e ,  P ro fe s s o r  G .J .L . Lock (D epartm ent o f M a te r ia ls  R esearch , 
McMaster U n iv e rs i ty )  and I  c o l la b o ra te d  to  p ro v id e  a  d e s c r ip t io n  o f 
th e  chem ical mechanism o f c h e la t io n ,  and to  i l l u s t r a t e  t h a t  a lth o u g h  
D -p e n ic illa m in e -A u (l)  b in d in g  may o ccu r, D -p e n ic illa m in e -A u (l)  
c h e la t io n  i s  an u n l ik e ly  ch em ica l r e a c t io n  in  v iv o . I t  seems
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r e le v a n t  t h a t  t h i s  d e s c r ip t io n  be added to  th e  d is c u s s io n  o f  
th e  c l i n i c a l  s tu d ie s  i n  t h i s  c h a p te r .
■s
.1C h e la tio n  (G reek: k h e le ,  L a t in :  c h e le ,  claw) i s  s a id  to  
occu r when two o r  more e l e c t r o n - p a i r  donor s i t e s  from  a  p o ly d en - 
t a t e  l ig a n d  a t ta c h  to  th e  same m e ta l io n  s im u lta n e o u s ly  and form  
a  r in g  s t r u c t u r e .
,3
A lig a n d  i s  any atom , io n  o r  m olecule which can form  a  
bond to  a n o th e r  atom , u s u a l ly  a  m e ta l atom o r  c a t io n ,  by d o n a tin g  
a  p a i r  o f e le c t r o n s  (F ig u re  4 8 a ) . P o ly d en t a te  l ig a n d s  have more 
th a n  one p o te n t i a l  donor s i t e  (F ig u re s  48b and 4 8 c ) . When two o r 
more donor e le c t r o n  s i t e s  o f  a  p o ly d e n ta te  l ig a n d  a t t a c k  to  th e  
same m e ta l s im u lta n e o u s ly , a  r in g  s t r u c tu r e  a s  i l l u s t r a t e d  in  
F ig u re  48d o ccu rs  and a  c h e la te  i s  s a id  to  be form ed.
:iD -p e n ic illa m in e  form s a t  l e a s t  one complex w ith  A u ( l) ,  1J'and a lth o u g h  th e  e x a c t s t r u c t u r a l  n a tu re  i s  unknown, i t  i s  assumed
—to  be a  l i n e a r  g o ld -c y s te in e  compound (RS-Au (I)-S R )  (191) a s  
,shown i n  F ig u re  4 9 a . T h is com plex, however, i s  r e a d i ly  o x id ise d  
in  a i r  to  th e  Au ( i l l ) - p e n i c i l l a m i n e  c h e la te  complex A u ( l l l ) -  
(NHgOH(00^")G(CH«)^)^ 3 "  a s  shown i n  F ig u re  49b ( l9 2 ) .
I t  was t h i s  l a t t e r  compound which E y rin g  and Engleman 
used  to  d e te rm in e  t h e i r  c h e la t io n  c o n s ta n ts  ( 185) and i t  i s  
a p p a re n tly  from  t h i s  work t h a t  th e  m isapp rehension  a ro se  t h a t  
D -p e n ic illa m in e  c h e la te s  g o ld  i n  a l l  i t s  o x id a tio n  s t a t e s .  I t  
sh o u ld  be n o te d , how ever, t h a t  g o ld  c o n ta in e d  in  i n j e c ta b le  go ld I"
182 -
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FIGURE 4 9 ; (a )  Two D -p e n ic i lla m in e  m olecu les bound to  
A u ( l) ,  b u t n o t a s  a  c h e la te .
(b ) Two D -p e n ic illa m in e  m olecu les bound to  
Au ( i l l  5 and c h e la t in g  th ro u g h  th e  S and 
N atom s.
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a n t i - a r t h r i t i c  g o ld  compounds.
l i n e  (196 ) .  I n  one ca se  a  su lp h u r  c o n ta in in g  lig a n d  form s a  c h e la te
compounds i s  A u(l) ( l 9 3 ) • I f  g o ld  sodium th io m a la te  i s  adm in i­
s te r e d  to  la b o ra to r y  a n im a ls , go ld  reco v e re d  in  t i s s u e  and u r in e  
e x i s t s  on ly  in  th e  A u (l)  o x id a tio n  s t a t e  a s  d e te rm in ed  by 
Extended X -ray  A b so rp tio n  A n a ly s is  o f  F in e  S tr u c tu r e  te c h n iq u e s  
(EXAFS) (193 ) .  R eduction  from  Au( i l l )  to  A u(l) i s  most l i k e l y  
caused  by th e  p o w erfu l su lp h u r  c o n ta in in g  re d u c in g  enzymes p re s e n t  
in  v iv o . Thus a lth o u g h  p e n ic i l la m in e  form s a  c h e la te  w ith  Au ( i l l ) ,
t h i s  o x id a tio n  s t a t e  i s  n o t  p r e s e n t  in  th e  commonly u sed  a n t i -  
a r t h r i t i c  compounds, g o ld  sodium th io m a la te ,  g o ld  th io g lu c o s e  
and g o ld  sodium th io s u lp h a te , and th e r e  i s  no ev idence t h a t  Au ( i l l ) -  
c o n ta in in g  m o lecu les  o ccu r in  v ivo  fo llo w in g  a d m in is t r a t io n  o f th e I
A u(l) compounds n o rm ally  have a  geom etry in  which th e  
A u(l) atom i s  a t ta c h e d  to  o n ly  two l ig a n d  atoms (x) such t h a t  th e  
X -A u(l)-X  an g le  i s  l8 0 °  (191 ) . L ess f r e q u e n t ly ,  and on ly  f o r
■
r a t h e r  s p e c i f i c  l ig a n d s ,  A u(l) b in d s  to  th r e e  (X -A u(l)-X =120°)
(194 ) o r  f o u r  (X -A u(l) -X=109.5^) ( l9 5 )  l ig a n d  a tom s. S c h a e f fe r  
e t  a l  (191) have p o in te d  o u t t h a t  c h e la t io n  o f  A u(l) by D -p e n ic i l -
lam ine i s  im p o ss ib le  i f  th e  two l ig a n d  bonds a re  a t  180^; th e
l ig a n d  i s  n o t la rg e  enough to  span th e  d is ta n c e  in v o lv e d . G hela-
.t i o n  can o n ly  o ccu r i f  th e  X -A u(l)-X  an g le  i s  l e s s  th a n  ro u g h ly  
1 2 0 ° . Complexes o f  A u(l) w ith  X -A u(l)-X  a n g le s  o f  <  120° a re
known and in d eed  some may in v o lv e  c h e la te  l ig a n d s .  These th r e e  
and fo u r -c o o rd in a te  com plexes a r e ,  w ith  one e x c e p tio n , on ly  found
w ith  o rg a n ic  phosphine l ig a n d s  and a ,a " - d ip y r id y l  o r  0 -p h e n a n th ro -
__
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to  A u ( l) .  T h is  i s  an e x c e p tio n a l  compound c o n ta in in g  th e  t e t r a -  
th io tu n g s ta te  io n  a s  a  l ig a n d  and a g a in  i s  s t a b i l i z e d  by an 
organophosphine ( l9 7 )«
There have been no d e s c r ip t io n s  o f  o th e r  su lp h u r  bound 
ligan(te form ing  more th a n  one bond to  a  A u(l) atom , so th e  complex 
c o n ta in s  two l ig a n d s  w ith  th e  bonds a t  180° to  each  o th e r ,  and 
th e re  have now been many such  s t r u c t u r e s  d e te rm in e d . Even when a  
l ig a n d  has two p o te n t i a l  s u lp h u r  bonding s i t e s ,  th e  l ig a n d  b in d s  
to  two d i f f e r e n t  go ld  atom s r a t h e r  th a n  form a  c h e la te  (F ig u re  50) 
(198 ) .  There i s  no a p p a re n t re a so n  why D -p e n ic illa m in e  sho u ld  
show e x c e p tio n a l  b e h a v io u r and th u s  one would ex p e c t D -p e n ic illa m in e  
to  b in d  to  A u(l) o n ly  th ro u g h  th e  su lp h y d ry l s i t e ,  ( in d ee d  th e re  
i s  good re a so n  why D -p e n ic il la m in e  shou ld  n o t c h e la te  A u ( l) ) ,
A u(l) p r e f e r s  to  b in d  to  p o la r iz a b le  ( s o f t )  l ig a n d  g roups such  
a s  su lp h u r  o r  p h osph ines ( l 9 9 ) • I t  does n o t b in d  r e a d i ly  to  weakly 
p o la r iz a b le  (h a rd )  l ig a n d  g roups ( l 9 9 ) • The am ine and c a rb o x y la te  
g roups o f  D -p e n ic illa m in e  a r e  " h a rd " . H igher o x id a tio n  s t a t e s  o f 
m e ta ls  p r e f e r  to  b in d  to  in c r e a s in g ly  h a rd e r  s i t e s  so th e  c h e la t io n  
observed  in  Au ( i l l )  to  th e  S and NH^ s i t e s  i s  n o t s u r p r i s in g .
The a b i l i t y  o f  p e n ic il la m in e  to  compete f o r  A u (l) a t ta c h e d  
to  p r o te in  i s  w e ll e s ta b l i s h e d  when a  la rg e  ex ce ss  o f  p e n i c i l l a ­
mine i s  p re s e n t  ( l9 2 ,  2 0 0 ), b u t th e  D -p e n ic illa m in e  i s  p ro b ab ly  
o n ly  bound th ro u g h  a  s im p le  Au-S bond. T h is  co m p e titio n  ap p ea rs  
n o t to  be im p o rta n t a t  s ta n d a rd  p h a rm aco lo g ica l d o se s .
These chem ica l c o n ce p ts  le n d  credence to  th e  r e s u l t s  o f 
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g o ld  th e ra p y  does n o t  in f lu e n c e  th e  c l i n i c a l  outcome o f p a t i e n t s  
w ith  rheum ato id  d is e a s e  r e c e iv in g  D -p e n ic illa m in e . I n  my o p in io n  
a  more l i k e l y  h y p o th e s is  re g a rd in g  th e  s im i l a r i t y  o f ad v e rse  
e f f e c t s  n o ted  f o r  g o ld  sodium th io m a la te  and D -p e n ic illa m in e  i s  
th e  f a c t  t h a t  b o th  r e a c t  w ith  t h i o l  compounds and w i l l  th u s  have 
s im i la r  chem ical i n t e r a c t io n  w ith  b io lo g ic a l ly  a c t iv e  compounds 
and s t r u c t u r e s .
■■ii
I n  c o n c lu s io n , th e  ev id en ce  i s  a g a in s t  t h i o l  bound l ig a n d s  
such  a s  th io m a la te ,  th io g lu c o s e ,  th io s u lp h a te  and D -p e n ic illa m in e  
fo rm ing  c h e la te s  to  A u(l) u n le s s  a  phosphine i s  p r e s e n t ,  and th u s  
m o b i l is a t io n  o f  bound g o ld  in  v iv o  by D -p e n ic illa m in e  th ro u g h  
th e  mechanism o f c h e la t io n  i s  u n l ik e ly  (2 0 0 ) .
T h e re fo re , th e  in  v ivo  in t e r a c t io n  of D -p e n ic illa m in e  and 
g o ld  in  th e  A u(l) o x id a tio n  s t a t e  shou ld  n o t be r e f e r r e d  to  a s  




The b in d in g  o f  t h i o l  c o n ta in in g  p o ly d e n ta te  l ig a n d s ,  
p a r t i c u l a r l y  D -p e n ic i l la m in e , to  A u(l) and Au( i l l ) , i s  d is c u s s e d .
SUMMARY;
One hundred and fo u r te e n  p a t i e n t s  w ith  d e f i n i t e  o r 
c l a s s i c a l  rheum ato id  a r t h r i t i s  were fo llo w ed  p ro s p e c t iv e ly  
betw een Jan u a ry  1976 and A p r il  198I  to  m on ito r t h e i r  t o x i c i t y  
p a t te r n  to  D -p e n ic i lla m in e . The in f lu e n c e  o f p re v io u s  go ld  
sodium th io m a la te  th e ra p y  on th e  t o x i c i t y  p a t te r n s  o f  D -p en ic -
Ii l la m in e  i s  d e s c r ib e d .  There was no s ig n i f i c a n t  d i f f e r e n c e  in  o v e r a l l  outcome o f  th e  p a t i e n t s  t r e a t e d  w ith  D -p e n ic illa m in e  
w ith  r e s p e c t  to  ad v e rse  e f f e c t s ,  w hether th e y  had p re v io u s  go ld  
t o x i c i t y ,  p re v io u s  g o ld  th e ra p y  b u t no t o x i c i t y ,  o r  no p re v io u s  
g o ld  th e ra p y .  The tim e from  g o ld  t o x i c i t y  to  th e  s t a r t  o f 
D -p e n ic illa m in e  th e ra p y  was g r e a t e r  in  th o se  who d id  n o t d ev e lo p  
D -p e n ic illa m in e  t o x i c i t y  compared w ith  th o se  who d id .  T h is  
d i f f e r e n c e  j u s t  re a c h e d  s t a t i s t i c a l  s ig n i f i c a n c e .  T o ta l g o ld  
th e ra p y  r e c e iv e d  had no e f f e c t  on e v e n tu a l outcome o f  D - p e n ic i l -  
lam ine  t r e a tm e n t ,  and th e  t o x i c i t y  p a t te r n  o f D -p e n ic illa m in e  in  
th o s e  p a t i e n t s  who had p re v io u s  g o ld  th e ra p y  was s im i la r  to  th o se  
p a t i e n t s  who had n e v e r re c e iv e d  g o ld  th e ra p y .
There a re  r e f e r e n c e s  i n  th e  m ed ical l i t e r a t u r e  which 
s t a t e  t h a t  D -p e n ic illa m in e  may be u sed  a s  a  c h e la t in g  a g e n t f o r  
g o ld  a d m in is te re d  in  th e  a n t i - a r t h r i t i c  i n j e c ta b le  g o ld  compounds. I
-  189 -
I t  i s  concluded  t h a t  w h ile  th e s e  l ig a n d s  b in d  to  b o th  A u(l) 
and Au( i l l )  th ro u g h  th e  su lp h u r  atom , c h e la t io n  o ccu rs  only  
to  Au( i l l ) .  C h e la tio n  o f t h i o l  l ig a n d s  to  A u(l) does n o t occur,




GOLD CHEMISTRY OF THE AU(l) ANTI-ARTHRITIC
INTRODUCTION 
GOLD CHEMCSTRY
THE ANIT-ARTHEEITC GOLD COMPLEXES 
AND RELATED STRUCTURES rl
SUMMARY
Matthew Green ( l6 9 6 - l? 3 7 )
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"By happy alchem y o f mind 
They tu r n  to  p le a s u re  a l l  th e y  f i n d . "
I
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S h o r t ly  a f t e r  b e in g  ap p o in te d  to  th e  F a c u lty  o f H ea lth
S c ie n c e s  a t  McMaster U n iv e r s i ty  my r e s e a r c h  i n t e r e s t s  became
in c re a s in g ly  d i r e c te d  tow ards th e  mechanism o f a c t io n  o f th e
a n t i - a r t h r i t i c  g o ld  com plexes. T his work has in v o lv ed  s tu d ie s,on th e  chem ical n a tu re  o f th e  g o ld  com plexes ( in  c o l la b o r a t io n  
w ith  P ro fe s s o r  C o lin  J .L .  Lock o f th e  D epartm ent o f  M a te r ia ls  
R e s e a rc h ) , th e  e f f e c t s  o f  g o ld  com plexes on lym phocytes ( in  
c o l la b o r a t io n  w ith  D r. Dharam S in g a l ,  P ro fe s s o r  o f  P a th o lo g y  and 
D ir e c to r  o f H is to c o m p a ta b i l i ty  S tu d ie s )  and p l a t e l e t s  (s u p e rv is e d  
by D r. J .  F r a s e r  M ustard , fo rm er Vice P r in c ip a l  o f  H ea lth  S c ie n c e s , 
D r. R aelene K in lough-R athbone, P ro fe s s o r  o f P a th o lo g y , D ire c to r  
o f P o s t-G ra d u a te  S tu d ie s ,  and D r. J a c k  H irsh , Chairman o f  th e
.
D epartm ent o f  M ed ic in e ). I n  I 98I  P ro fe s s o r  C o lin  J .L .  Lock and 
I  form ed th e  d i s c i p l in e  o f  B io - in o rg a n ic  M edicine a t  McMaster 
U n iv e r s i ty ,  which in  a d d i t io n  to  o u is e lv e s  a s  c o - d i r e c to r s  has 
f o u r  o th e r  f a c u l ty  members, a s  w e ll a s  one Ph. D. s tu d e n t ,  one 
r e s e a r c h  s c h o la r ,  one B .Sc . s tu d e n t ,  two la b o ra to ry  r e s e a r c h  a s s i s ­
t a n t s ,  and th r e e  t e c h n ic ia n s .  The m ajor r e s e a rc h  t h r u s t  o f t h i s
i-
b io - in o rg a n ic  m edicine team  i s  th e  s tu d y  o f th e  a n t i - a r t h r i t i c  
g o ld  com plexes and  r e l a t e d  compounds ( e .g .  D -p e n ic illa m in e )  in  
th e  c h a r a c te r i s a t io n  o f  t h e i r  s t r u c t u r e , th e  s t r u c t u r a l  r e l a t i o n -  
s h ip  o f th e  com plexes to  p e p tid e  and p r o te in  b in d in g  and th e
J
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sy s tem s . Some o f  th e s e  s tu d ie s  w i l l  be o u tl in e d  in  th e  su cceed in g  
c h a p te r s ,  b u t  th e  e n t i r e - s c o p e  o f  th e  r e s e a r c h  work i s  to o  v a r ie d  
and le n g th y  to  in c lu d e  i n  one t h e s i s .  I n  th e  n e x t two c h a p te r s ,
I  w i l l  a d d re ss  two avenues o f my own re s e a r c h  made i n  c o n ju n c tio n  
w ith  my c o lle a g u e s  over th e  p a s t  two y e a r s ,  which I  c o n s id e r  to  
have been s i g n i f i c a n t  o b s e rv a t io n s .  F i r s t l y ,  a  b r i e f  rev iew  o f 
th e  b a s ic  c h em is try  o f  g o ld  r e le v a n t  to  th e  compounds u sed  i s  g iv en
:
I
t o  f a c i l i t a t e  th e  u n d e rs ta n d in g  o f  th e  co n c lu d in g  c h a p te r s .  Four 
e x c e l le n t  e x te n s iv e  rev ie w s o f  g o ld  ch e m is try  a r e  a v a i la b le  which 
p ro v id e  a  more d e t a i l e d  acco u n t o f  th e  s t r u c t u r a l  a n a ly s i s  and 
b io lo g ic a l  a c t io n  o f  th e  g o ld  com plexes a s  a re  known to  d a te





Gold i s  a  s o f t ,  ye llow  lu s t r o u s  m e ta l. S in ce  i t  i s  
n o t a t ta c k e d  by e i t h e r  oxygen o r su lp h u r  a t  any te m p e ra tu re , i t  
h as  a  un ique s t a b i l i t y  in  i t s  e le m e n ta l form ( l ) , S o la r  s p e c t r a l  
a n a ly s is  confirm s t h a t  go ld  i s  p re s e n t  a t  0 .0 4  p a r t s  p e r  m illio n  
in  th e  sun ; i t  i s ,  how ever, o n ly  p re s e n t  a s  ap p ro x im a te ly  0 .0 0 4  
p a r t s  p e r  m il l io n  in  th e  E a r t h 's  c r u s t  ( 1 ) .  Gold d e p o s i t s  on 
E a r th  e x i s t  a s  th e  m e ta l l i c  form  o r  in  m in e ra l form , e i t h e r  as  
T e l lu r id e s  such  a s  c a l a v e r i t e  and k r e n n e r i te  ( d i f f e r e n t  c r y s t a l l i n e I
form s o f  AuTe2 ) , m o n tb ray ite  (Au^Te^) and mixed g o ld - s i l v e r  
t e l l u r i d e s  such  a s  s y lv o n i te  (Au Ag Te^) ( l ) . To a  l e s s e r  e x te n t  
m in e ra l form s o f  a u r i f e r o u s  s u lp h id e s  a ls o  e x i s t  ( s ) .  M e ta l l ic  
g o ld  and s i l v e r  m ix tu re s  a ls o  e x i s t ,  perhaps th e  m ost w ell-know n 
b e in g  e le c tru m , which c o n ta in s  20^ s i l v e r  ( l ) . Gold o re s  a ls o  
c o n ta in  sm a ll q u a n t i t i e s  o f  o th e r  v a lu a b le  m e ta ls  such as  i r id iu m , 
osmium, p la tin u m , rhodium , ru th en iu m , p a llad iu m , copper and n ic k e l  
( l ) .
Gold i s  ex tre m e ly  m a lle a b le  and h ig h ly  d u c t i l e ,  such  th a t  
one ounce can be b e a te n  to  an a r e a  o f 300 sq u are  f e e t .  Pure go ld  
m e ta l has a  d e n s i ty  o f  19*32g cm ^ a t  20°C; i t  m e lts  a t  1063°C and 
b o i l s  a t  2966°G. ( l )  Gold has an atom ic number o f  79 and an a tom ic 
w eigh t o f 1 9 6 . 9665 . The s ta b l e  is o to p e  ^^"^Au c o n ta in s  79 p ro to n s  
and 119 n e u tro n s . T here a r e  29 o th e r  is o to p e s  o f  g o ld  w ith  mass
n  q Onumbers in  th e  177 to  204 ra n g e . The most im p o rta n t o f  th e s e  i s  Au
-  195 -
w hich i s  p re p a re d  by n e u tro n  c a p tu re  by th e  r e a c t io n ;
^ 198^^
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^^^Au decays by 3 -em ission  accom panied by gamma r a d i a ­
t i o n  ( l ) .  The h a l f - l i f e  o f 2 .7  days makes i t  a  r e l a t i v e l y  s a fe  
and u s e f u l  to o l  in  m ed ica l s c ie n c e , in  ra d io th e ra p y ,  r a d io - d ia g n o s t ic  
and r a d io t r a c e r  s tu d ie s .
Gold i s  c l a s s i f i e d  a s  a  Group I .B ,  m eta l in  th e  p e r io d ic  
t a b le  w ith  an  e le c t r o n i c  c o n f ig u ra t io n  o f (Xe} 4 f^ ^ 5 d ^ ^ 6 s^ , The 
most commonly re c o g n ise d  o x id a tio n  s t a t e s  a re  I ,  I I ,  I I I  and V 
( r e f e r r e d  to  in  t h i s  t h e s i s  a s  A u(l) e t c . ) ,  a lth o u g h  a c c o rd in g  to  
P u d d ep h a tt ( l ) , m e ta l-m e ta l bonds do e x i s t  in  com plexes in  w hich i t  
i s  d i f f i c u l t  to  a s s ig n  a  fo rm a l o x id a tio n  s t a t e  to  th e  g o ld  atom . 
A u(l) has th e  c lo se d  s h e l l  e l e c t r o n i c  c o n f ig u ra tio n  {Xe } 4f^^5d^^ 
and th u s  l i k e  th e  i s o e l e c t r i c  m ercury (X I) form s tw o, th r e e  and 
f o u r  c o -o rd in a te  com plexes. The A u(l) com plexes a r e  d iam ag n e tic  
and ad o p t r e g u la r  s t r u c t u r e s  w hich a re  most commonly o f  th e  l i n e a r  
two c o -o rd in a te  ty p e .  The t r u e  s a l t s  o f A u(l) such  a s  th e  h a l id e s  
a r e  u n s ta b le  i n  th e  p re sen ce  o f  w a te r  and d is p ro p o r t io n a te  to  Au° 
(m e ta l l ic  g o ld )  and Au( i l l ) .  However, A u(l) can be s t a b i l i s e d  
by th e  fo rm a tio n  o f  com plexes w ith  " s o f t "  l ig a n d s  ( l9 9 )  such  a s  
th e  t h i o l a t e s  (204-206) and phosph ines (2 0 4 ,2 0 7 ,2 0 8 ). A ll c u r r e n t ly  
i s e d  a n t i - a r t h r i t i c  g o ld  com plexes e x i s t  a s  A u(l) t h i o l  o r phosphine 
compounds (2 0 9 ) . The Au( i l l )  com plexes a re  d iam ag n e tic  and have 
th e  lo w -sp in  e le c t r o n  c o n f ig u ra t io n .  The v a s t  m a jo r i ty  o f
-  196 -
th e s e  com plexes have a  fo u r  c o -o rd in a te  sq u are  p la n a r  s t e r o -  
ch e m is try  ( l ,  2 01 -203). The h ig h  t o x i c i t y  o f th e  Au( i l l )  
com plexes such  a s  c h lo ro a u r ic  a c id  (HAuGl^), makes them u n s u i t ­
a b le  f o r  human u se  (2 0 9 ) . As a l re a d y  r e f e r r e d  to  in  G hapter V, 
E ld e r  and c o l le a g u e s  have shown t h a t  i f  go ld  sodium th io m a la te
i s  a d m in is te re d  to  la b o ra to r y  a n im a ls , th e  go ld  re c o v e re d  from
'
th e  t i s s u e  and u r in e  e x i s t s  i n  th e  A u(l) o x id a tio n  s t a t e  ( i . e .
th e  same o x id a tio n  s t a t e  a s  th e  g o ld  in  go ld  sodium th io m a la te )  
and n o t th e  Au ( i l l )  o x id a tio n  s t a t e .  F u r th e r ,  i f  Au ( I I I )G 1„ 
i s  a d m in is te re d  to  la b o r a to r y  a n im a ls , g o ld  re c o v e re d  in  t i s s u e s
and u r in e  e x i s t s  on ly  i n  th e  A u (l) o x id a tio n  s t a t e  a s  d e te rm in ed  
by x - r a y  a b s o rp tio n  n e a r  edge sp e c tro sc o p y  (XANES) and ex tended  
x - ra y  a b s o rp tio n  f in e  s t r u c t u r e  sp e c tro sc o p y  (EXAFS) .  XANES 
d is t in g u is h e s  Au ( i l l )  from  A u (l)  and Au due to  a  2p-»5d t r a n s i ­
t i o n  which o ccu rs  o n ly  f o r  Au ( i l l ) .  E ld e r  and c o l le a g u e s  a ls o  
showed th a t  EXAFS w ith  a p p ro p r ia te  curve f i t t i n g  te c h n iq u e s  co u ld  
d e m o n stra te  t h a t  th e  go ld  atom s in  s o lu t io n  o f  g o ld  sodium t h i o ­
m a la te  ( i . e .  A u(l) o x id a tio n  s t a t e )  a re  c o -o rd in a te d  to  two
su lp h u r  atom s w ith  a  Au-S bond le n g th  o f  2 .2 9  A° ( l9 3 )  « T h is
'was c o n s is te n t  w ith  t h e i r  f in d in g  t h a t  in  r a t s  c h r o n ic a l ly  t r e a t e d Îw ith  g o ld  sodium th io m a la te ,  th e  g o ld  w ith in  p a r t i c l e s  o b ta in e d  
from  th e  r a t  k id n e y  c e l l s  was in  th e  A u(l) o x id a tio n  s t a t e  and was 
bound to  two su lp h u r  atom s w ith  a  Au-S bond le n g th  o f  2 .30  A° ( l 9 3 ) . 
The A u(l) o x id a tio n  s t a t e  th e r e f o r e  ap p ea rs  to  be th e  p rim ary  
o x id a tio n  s t a t e  in  a  b io lo g ic a l  m ilie u : re d u c t io n  from  AU( i l l )  to  
A u (l)  i s  most l i k e l y  caused  by th e  pow erfu l su lp h y d ry l c o n ta in in g  
re d u c in g  enzymes p r e s e n t  in  v iv o .
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A common m isco n cep tio n  among members o f th e  m ed ical 
p ro fe s s io n ,  i s  th e  id e a  t h a t  D -p e n ic illa m in e  may be u sed  a s  a  
c h e la t in g  a g e n t f o r  g o ld , i f  a  to x ic  r e a c t io n  o ccu rs  d u rin g  o r 
fo llo w in g  th e  a d m in is t r a t io n  o f th e  a n t i - a r t h r i t i c  g o ld  com plexes 
(172- 175) •  There i s  no t h e o r e t i c a l  (se e  C hapter V, D iscu ss io n ) 
n o r b io ch em ica l (187 ) ev idence  t h a t  D -p e n ic illa m in e  c h e la te s  
A u(l) in  v iv o . As r e f e r r e d  to  above and in  C hap ter V, A u(l) 
compounds n o rm ally  have a  l i n e a r  geom etry i n  which th e  A u(l) 
atom i s  a t ta c h e d  to  on ly  two l ig a n d  atoms (x) such t h a t  th e  
X -A u(l)-X  an g le  i s  180° ( l 9 l ) - L ess f r e q u e n t ly ,  and o n ly  f o r  
r a t h e r  s p e c i f i c  l ig a n d s ,  A u (l) b in d s  to  th r e e  (X -A u(l)-X  an g le  
eq u a l to  120°) (194) o r  f o u r  (X -A u(l)-X  an g le  eq u a l to  109 .5 )
(195) l ig a n d  a tom s. These th r e e  a n d fo u r-c o o rd in a te  com plexes 
a r e ,  w ith  one e x c e p tio n , o n ly  found  w ith  o rg a n ic  phosphine l ig a n d s  
and c ,a ^ - d ip y r id y l  o r  0 -p h e n a n th ro lin e  (196) . The o n ly  su lp h u r  
c o n ta in in g  compound to  form  a  c h e la te  and th u s  non l i n e a r  s t r u c ­
tu r e  to  A u(l) i s  an  e x c e p tio n a l compound c o n ta in in g  th e  t e t r a -
th io tu n g s ta te  io n  a s  a  l ig a n d .  I t  i s  s t a b i l i s e d  by an  o rganophos- 
p h ine  ( l9 7 ) .  Thus A u (l)-S  bonds a r e  a t  180° to  each  o th e r  ex cep t 
in  e x c e p tio n a l c irc u m s ta n c e s . Even when a  l ig a n d  h as  two p o te n t i a l
s u lp h u r  bonding  s i t e s ,  th e  l ig a n d  b in d s  to  two d i f f e r e n t  go ld
■atom s r a th e r  th a n  form  a  c h e la te  (1 9 8 ). There i s  no a p p a re n t 
re a so n  why D -p e n ic illa m in e  sh o u ld  show e x c e p tio n a l b e h a v io u r and 
th u s  one would e x p e c t D -p e n ic illa m in e  to  b in d  to  A u(l) o n ly  th ro u g h
th e  su lp h y d ry l s i t e .  F u rth e rm o re , A u(l) b in d s  more r e a d i ly  to
'
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p o la r iz a b le  ( s o f t )  l ig a n d  g ro u p s  such a s  su lp h u r  o r  phosph ines 
(199 ) a s  opposed to  w eakly p o la r iz a b le  (h ard ) l ig a n d  groups 
(199 ) ,  and th e  amine and c a rb o x y la te  groups o f D -p e n ic illa m in e  
a re  " h a rd " . Thus, a s  su p p o rted  by th e  s tu d ie s  o f  D avis and 
B arrao lough  (187 ) ,  th e r e  i s  no th e o r e t i c a l  re a so n  why D - p e n ic i l l ­








THE ANTE-ARTHHLTIG GOLD COMPLEXES AND RELATED STRUCTURES .
The c u r r e n t  commonly u sed  g o ld  com plexes in  th e  tre a tm e n t
r a te d  in  f ig u r e
:
I
o f rheum ato id  a r t h r i t i s  and in  r e l a t e d  re s e a rc h  work a r e  i l l u s t -
Gold sodium th io m a la te  ( f ig u r e  51sJ> has been u sed  in  th e  
tre a tm e n t o f rheum ato id  a r t h r i t i s  s in c e  th e  e a r ly  1930s (87 ) .  I t
i s  m arketed  by May and B aker (U .K .) , Rhone-Poulenc (Canada) and 
M erck, S harp  and Dhome (U .S .A .) a s  v i a l s  o f 50 mg/ml o f  compound
suspended in  s t e r i l e  w a te r  f o r  u se  a s  an in t ra m u s c u la r  i n j e c t i o n .  
The compound c o n ta in s  ap p ro x im a te ly  g o ld  and O.3  mois of 
g ly c e ro l  p e r  mol o f th io m a la te .  D uring th e  m an u fac tu rin g  p ro c e ss  
g ly c e ro l  i s  u sed  in  th e  f i n a l  p u r i f i c a t i o n  s te p  (21Ô ). The v i a l s
is;
o f  compound m arketed  f o r  human u se  a l s o  c o n ta in  th e  fo llo w in g  
p r e s e r v a t iv e s :  p h en y lm ercu rie  n i t r a t e  0 .002^  (May and B aker p rep ­
a r a t io n )  ; c h lo ro c re s c o l  0.05% (R hone-Poulenc p r e p a r a t io n ) ; 
b en zy l a lc o h o l 0 . ^  (Merck S harp  and Dhome p r e p a r a t io n ) .  May and 
Baker (U .K .) have k in d ly  a llo w ed  P ro fe s s o r  C o lin  J .L .  Lock and 
me a c c e s s  to  th e  d e t a i l s  o f t h e i r  p a te n te d  m anu fac tu rin g  p ro c e s s .
S in ce  a  s e c re c y  agreem ent e x i s t s ,  no d e t a i l s  o f t h i s  p ro c e s s  w i l l  
be g iv e n . The c u r r e n t ly  assumed m o lecu la r w eight o f  g o ld  sodium 
th io m a la te  i s  3 9 0 .1 2 , T h is v a lu e  i s  based  on th e  e m p ir ic a l  fo rm u la  
o f  th e  compound ( f ig u r e  52a) b u t c l e a r ly  t h i s  s t r u c t u r e  i s  in c o m p a tib le  
w ith  th e  known chem ica l p r o p e r t i e s  o f  A u(l) ( l ,  201-203) and a  more 
l i k e l y  e x p la n a tio n  o f  th e  s t r u c t u r e  i s  a  polym er o r  o ligom er a s  
g r a p h ic a l ly  d e p ic te d  in  f ig u r e  5I  ( a ) . A ccording to  Shaw (2 1 l)  
g o ld  sodium th io m a la te  e l u te s  from  Sephadex G-100 a s  a  po lym eric
I
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The fo rm u la  o f  g o ld  sodium th io m a la te  d e p ic te d  a s  a  po lym er.
The fo rm u la  o f  g o ld  th io g lu c o s e  d e p ic te d  a s  a  po lym er.
Gold sodium th i o s u l p h a te , s t r u c t u r a l  fo rm u la . The an io n  
c o n ta in s  two th io s u lp h a te  m o ie tie s  bound to  g o ld  th ro u g h  
th e  su lp h u r  a tom s.
Disodium  th io m a la te  fo rm u la . The d isodium  th io m a la te  s a l t  
i s  a  monomeric s p e c ie s .
2 , 3 ,4 , 6 -T e tr a -o ;- a c e ty l- I  - th io -g -D -g lu c o p y ra n o s a to -3 - ( t r ie th y l-  
p h o sp h in e )g o ld  i s  c h a r a c te r i s e d  a s  hav ing  a  g o ld -p h o sp h in e  
bond a s  w e ll a s  a  go ld  t h i o l  bond, and i s  a  monomeric s p e c ie s .
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Gold sodium th io s u lp h a te  ( f ig u r e  51c) i s  m arketed  a s
s t r u c t u r e .  U l t r a c e n t r i f u g e  and hydrogen-1  and carh o n -1 3  n u c le a r  
m agnetic  re so n an ce  s tu d ie s  by S a d le r  and c o lle a g u e s  (201 ,210 ,212 ) 
su p p o rt t h i s  co n cep t o f  th e  g o ld  sodium th io m a la te  s t r u c t u r e .
Based on model b u i ld in g ,  a  l i k e l y  s t r u c t u r a l  fo rm u la  i s  a  hexamer 
a s  i s  shown g r a p h ic a l ly  in  f ig u r e  52b C le a r ly  th e  d e a r th  o f 
in fo rm a tio n  o f th e  s t r u c t u r a l  fo rm u la tio n  o f go ld  sodium th io m a l­
a te  h as  c o n tr ib u te d  c o n s id e ra b ly  to  th e  la c k  o f knowledge a v a i la b le  
on th e  b io lo g ic a l  i n t e r a c t i o n  o f  t h i s  A u(l) a n t i - a r t h r i t i c  com plex.
iGold th io g lu c o s e  ( f ig u r e  51b) was m anufactured  in  th e  U n itedS ta t e s  by Merck S harp  and Dhome in  th e  e a r ly  1930s (87 ) and i s
c u r r e n t ly  m anufactu red  u n d er th e  b rand  name S o lg an o l by th e  S o b erin g
■C o rp o ra tio n  o f New J e r s e y  and i s  a d im in is te re d  a s  an in tra m u s c u la r
'i n j e c t i o n .  A lthough i t  i s  w a te r  s o lu b le ,  i t  i s  m arketed  a s  50 mg 
o f  g o ld  th io g lu c o s e  in  s t e r i l e  sesame o i l  w ith  2^ alum inium  mono­
s t e a r a t e  j 1 mg o f  P ro p y l p-H ydroxybenzoate i s  added a s  a  p r e s e r v a t iv e .
Gold c o n te n t i s  ap p ro x im a te ly  and th e  m o lecu la r w eigh t based
on th e  e m p ir ic a l fo rm u la  i s  3 9 2 .1 8 , bu t a s  w ith  g o ld  sodium t h i o ­
m a la te , th e  s t r u c t u r a l  fo rm u la tio n  o f go ld  th io lg u c o s e  b ased  on 
th e  known c h e m is try  o f  g o ld , i s  most l i k e l y  an o ligom er ( l ,  201- 203 ,
209) (F ig u re  5 1 b ) ,
S an o ch ry sin e  i n  Europe by F e rro  s e n , Sweden, in  v i a l s  o f  100 mg o f
compound/ml f o r  use  a s  an in tra v e n o u s  i n j e c t i o n .  I t  h as  been 
a v a i la b le  s in c e  1924 when i t  was f i r s t  in tro d u c e d  by M ^llgard  (7 5 )•
203
o f 1 5 0 .1 5 . The d isod ium  th io m a la te  s a l t  i n  equ im o lar c o n c e n tra t io n s  
o f th io m a la te  to  g o ld  sodium th io m a la te  i s  p rep a red  by th e  a d d i t io n
The compound has a  m o le c u la r  w eigh t o f 490 .21  and c o n ta in s  40.19% 
g o ld . The an ion  c o n ta in s  two th io s u lp h a te  m o ie tie s  bound to  g o ld  
th ro u g h  th e  su lp h u r  atom s. Gold sodium th io s u lp h a te  i s  one o f 
th e  few A u(l) compounds whose s t r u c t u r e  i s  known and w hich has 
been s tu d ie d  c r y s ta l lo g r a p h i c a l l y  ( 206) .
M ercap to sy c c in ic  a c id  i s  m anufactu red  in  th e  U n ite d  S ta te s  
by Sigma C hem icals, S t .  L o u is , M is so u rr i and h as  a  m o lecu la r w eigh t
o f  1 m olar sodium h yd rox ide  to  th e  m e rc ap to su cc in ic  a c id  s o lu t io n
(19  mg/ml) u n t i l  a  pH o f  7*75 i s  a c h ie v e d . The d isod ium  s a l t  i s  
a  monomeric s p e c ie s  ( f ig u r e  5 1 d ) .
2 , 3 ,4 , 6 - T e t r a - ^ a c e t y l - I  - th io - g -D - g lu c o p y r a n o s a to - 8 - ( t r ie th y l -  
phosph ine) g o ld  ( f ig u r e  51®) i s  m anufactu red  a s  Auranofin^jy^ by 
Sm ith K lin e  and F ren ch , P h i la d e lp h ia ,  U .S .A . I t  i s  c h a r a c te r i s e d  
a s  h av ing  a  g o ld -p h o sp h in e  bond a s  w e ll a s  a  go ld  t h i o l  bond and 
i s  a  monomeric s p e c ie s  ( f ig u r e  51® )* I t  i s  c u r r e n t ly  b e in g  t e s t e d  
in  numerous c l i n i c a l  t r i a l s  a s  a  3 mg t a b l e t  a d m in is te re d  o r a l l y .
The compound i s  a  w h ite , o d o u r le s s  c r y s t a l l i n e  s o l id  which i s  
in s o lu b le  i n  w a te r . The powder i s  u n s ta b le  and must be p ro te c te d  
from  l i g h t  and h e a t .  On a  w eigh t b a s is  i t  c o n ta in s  ap p ro x im ate ly  
29%'g o ld  and has a  m o lecu la r w eig h t o f  67 8 .5  w ith  a  m e ltin g  p o in t  
o f  112^-115*^0 (116- 121 ) .  I t  i s  c u r r e n t ly  on ly  a v a i la b le  f o r  r e s e a rc h  
s tu d ie s .
-  20.4
SUMMARY.
Fo llow ing  my appo in tm en t a s  a  f a c u l ty  member a t  McMaster 
U n iv e r s i ty ,  H am ilton , O n ta r io , I  e s ta b l i s h e d  th e  d i s c i p l i n e  o f 
B io - in o rg a n ic  m ed icine  a lo n g  w ith  P ro fe s s o r  G.J .L .  Lock o f 
M a te r ia ls  R esea rch . The p r in c ip le  a r e a s  o f r e s e a rc h  o f  t h i s  
group  a re  th e  in v e s t ig a t io n  o f  th e  s t r u c t u r a l  fo rm ulae  o f  th e  
a n t i - a r t h r i t i c  g o ld  com plexes, t h e i r  s t r u c t u r a l  i n t e r a c t io n  w ith  
p e p t id e s  and p r o te in s  and th e  mechanism o f  i n t e r a c t io n  o f  th e  
g o ld  com plexes w ith  c e l l  and enzyme system s such a s  o ccu r in  
lym phocytes and p l a t e l e t s .
Gold i s  a  v a lu a b le  m e ta l w ith  a  un ique s t a b i l i t y  in  i t s  
e le m e n ta l fo rm . I t  i s  p r e s e n t  i n  th e  E a r th ’s c r u s t  a s  a p p ro x i­
m a te ly  0 .0 0 4  p a r t s  p e r  m i l l io n  e i t h e r  in  th e  m e ta l l ic  s t a t e  o r  
in  m in e ra l form  u s u a l ly  a s  a  T e l lu r id e .
Gold has an atom ic  number o f 79 and i s  c l a s s i f i e d  a s  a
197IB  m e ta l in  th e  p e r io d ic  t a b l e .  I t s  s ta b l e  is o to p e  i s  Au
a lth o u g h  29 o th e r  i s o to p e s  e x i s t  w ith  mass numbers in  th e  177 to  
204 ra n g e . A u(l) i s  th e  o x id a tio n  s t a t e  o f th e  p r e s e n t ly  used  
a n t i - a r t h r i t i c  go ld  com plexes. A u(l) com plexes a re  d iam ag n e tic  
and ad o p t r e g u la r  s t r u c t u r e s  w hich a re  most commonly o f  th e  l i n e a r  
two c o -o rd in a te  ty p e .  E xtended x - ra y  a b s o rp tio n  f in e  s t r u c tu r e  
sp e c tro sc o p y  s tu d ie s  have shown t h a t  th e  A u(l) s t a t e  i s  th e  p rim ary  
o x id a tio n  s t a t e  p re s e n t  i n  a  b io lo g ic a l  m il ie u .  The l i n e a r  geom etry  




makes th e  co n cep t t h a t  D -p e n ic illa m in e  c h e la te s  A u(l) in  v ivo  
u n l ik e ly .  B iochem ical s tu d ie s  have a l s o  shown t h a t  D -p e n ic illa m in e  
does n o t c h e la te  A u ( l) ,  th e r e f o r e  D -p e n ic illa m in e  can n o t be used  
a s  an  in  v ivo  c h e la t in g  a g e n t f o r  g o ld  a d m in is te re d  a s  th e  a n t i -  
a r t h r i t i c  g o ld  com plexes.
The c u r r e n t  commonly u sed  a n t i - a r t h r i t i c  go ld  com plexes
'a r e  g o ld  sodium th io m a la te ,  g o ld  th io g lu c o s e ,  g o ld  th io s u lp h a te  
and 2 ,3 ,4 , 6- T e t r a - p _ - a c e ty l - l - th io -g -D -g lu c o p y ra n o s a to -S - ( t r ie th y l-  
phosph ine) g o ld . The s t r u c t u r e s  o f th e s e  com plexes d i f f e r  in  t h a t  
b o th  g o ld  sodium th io m a la te  and g o ld  th io g lu c o s e  a re  o lig o m e r,s  
g o ld  sodium th io s u lp h a te  c o n ta in s  one g o ld  m olecule and two t h i o ­
s u lp h a te  m o ie tie s  and 2 ,3 ,4 ,6 -T e tr a -o .- a c e ty l - l - th io -g -D -g lu c o p y ro -  
n o s a t0-8 - ( t r i e th y lp h o s p h in e ) g o ld  a s  a  monomer. Gold sodium  t h i o ­
m a la te  and g o ld  th io g lu c o s e  a re  a d m in is te re d  by th e  in t ra m u s c u la r  
r o u t in e  w hereas g o ld  sodium th io s u lp h a te  i s  a d m in is te re d  i n t r a ­
v en o u sly  . 2 , 3 ,4 , 6- T e t r a - 07a c e t y l - l - t h i o - 6-D -g lu co p y ran o sa to -S ” s
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"What one knows i s ,  i n  yo u th , 
o f l i t t l e  moment;
They know ( 
to  l e a m . "
Henry Brooks Adams (1838- I 918)
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INTRODUCTION
Gold sodium th io m a la te  has been used  in  th e  tre a tm e n t 
o f rh eu m a to id  a r t h r i t i s  f o r  a t  l e a s t  50 y e a rs  (87) ,  b u t to  d a te ,  
th e  d e f i n i t i v e  in  v ivo  a c t io n s  r e s u l t i n g  in  e f f ic a c y  and t o x i c i t y  
have n o t been i d e n t i f i e d .  As r e f e r r e d  to  in  C h ap te r VI th e  e x a c t 
chem ical s t r u c t u r e  o f g o ld  sodium th io m a la te  h as  n o t been d e s c r ib e d .
The sim ple  fo rm u la tio n  g iv e n  in  f ig u r e  52a, a s  Na2lAu8CH(G02)GH2C02} 
i s  in c o n s i s t e n t  w ith  th e  known c h em is try  o f g o ld  ( l ,  201- 203) .
P h y s ic a l and chem ica l s tu d ie s  su g g e s t t h a t  th e  s t r u c t u r e  i s  l i k e l y  
an o ligom er (201 , 210-212) and model b u i ld in g  shows a  hexamer i s  
p o s s ib le  ( 212) ( f ig u r e  5 2 b ) . The c o r r e c t  chem ical name f o r  g o ld  
sodium th io m a la te  b ased  on th e  s t r u c tu r e  g iv en  in  th e  M a r t in d a le 's  
E x tra  Pharm acopoeia ( 213) i s  sodium  ( d i th io m a la to - S ) a u r a t e ( l ) , b u t 
s in c e  th e  s t r u c tu r e  ( f ig u r e  52a) i s  a lm o st c e r t a in l y  i n c o r r e c t ,  I  
s h a l l  u se  th e  te rm  g o ld  sodium th io m a la te  th ro u g h o u t. I n  c o l l a t o r -
ia t io n  w ith  P ro fe s s o r  C o lin  J .L .  Lock ( i n s t i t u t e  f o r  M a te r ia ls  R esearch , 
McMaster U n iv e r s i ty )  I  have u n d e rta k e n  v a r io u s  chem ical and b io lo ­
g ic a l  exp erim en ts  i n  o rd e r  to  e s t a b l i s h  th e  e x a c t n a tu re  o f  th e  
compound, g o ld  sodium th io m a la te .  L ike D r. F rank  Shaw and c o lle a g u e s  
( 202) a t  Ann Arbor U n iv e r s i ty  in  M ichigan, U .S .A . and D r. P e te r  
S a d le r  and c o lle a g u e s  ( 201) , B irkbeck  C o lle g e , U n iv e r s i ty  o f  London, 
U .K ., we have had d i f f i c u l t y  in  c r y s t a l l i s i n g  g o ld  sodium th io m a la te  
and a g ree  t h a t  i t  i s  most l i k e l y  an o lig o m er. One im p o rta n t o b se r­
v a t io n  which we have d em o n stra ted  f o r  th e  f i r s t  tim e i s  t h a t  g o ld  
sodium th io m a la te  a s  c u r r e n t ly  m arketed  f o r  human u s e ,  i s  a  m ix tu re .
  ■ .....................................................
-  209 -
T his  im p o rta n t f in d in g  was th e  r e s u l t  o f a  s im p le  o b s e rv a tio n .
I n  1980 th e  p h a rm a c e u tic a l company R hone-Poulenc, Quebec, Canada
k in d ly  ag reed  to  su p p ly  g r a t i s  sam ples o f go ld  sodium th io m a la te  
f o r  my ex p e rim en ta l u s e .  I  n o te d  t h a t  s o lu t io n s  o f  th e  compound
s u p p lie d  f o r  human u se  were y e llo w , w hereas a  b a tc h  o f  compound
s u p p lie d  f o r  r e s e a r c h  p u rp o ses  was a  c o lo u r le s s  s o lu t io n .  I  made 
e n q u ir ie s  to  th e  company i n  M on trea l a s  to  th e  d i f f e r e n c e  in  th e
,1
Î
two s o lu t io n s  and was in fo rm ed  by t h e i r  c h ie f  p h a rm a c is t t h a t  
a lth o u g h  b o th  sam ples were p re p a re d  in  e x a c t ly  th e  same way, by 
d is s o lv in g  th e  s o l id  form  (w h ite  powder) in  s t e r i l e  w a te r , th e  
sam ples f o r  human u se  were f u r t h e r  s t e r i l i z e d  by h ea tin g , a t  100°G 
f o r  30 m in u te s . T h is  p ro ced u re  r e s u l t e d  in  th e  f a m i l i a r  yellow  
s o lu t io n  which i s  m arketed  by t h e i r  company, w hereas th e  s o lu t io n  
which was n o t exposed t o  100 G f o r  30 m inu tes was c o lo u r l e s s .
H„0 100°G
W hite Powder  ^ C o lo u rle s s    . Yellow
(Gold Sodium T h iom alatd ) S o lu tio n  «n • S o lu tio n30 mins
T h is  sim ple  experim en t was con firm ed  in  my la b o ra to r y .  S in ce  b o th
Ith e  c o lo u r le s s  and y e llo w  s o lu t io n  o f  g o ld  sodium th io m a la te  were 
o f  e x a c t ly  th e  same c o n c e n tr a t io n ,  c l e a r ly  th e  h e a t s t e r i l i z a t i o n  
p ro c e ss  had r e s u l t e d  in  some change in  o rd e r  to  produce th e  ye llow  
c o lo u r .  I n  c o n ju n c tio n  w ith  my c o lle a g u e s  in  th e  d i s c i p l in e  o f  
B io - in o rg a n ic  m ed ic in e , we u n d erto o k  p h y s ic a l ,  chem ical and b i o l ­
o g ic a l  in v e s t ig a t io n s  i n  o rd e r  to  compare and c o n t r a s t  th e  p ro p e r­
t i e s  o f  th e  c o lo u r le s s  and y e llo w  s o lu t io n s  o f g o ld  sodium th io m a la te .
-----
2 1 0  -
The p h y s ic a l  and chem ical s tu d ie s  r e f e r r e d  to  in  th e  
c h a p te r  were done by P ro fe s s o r  G .J .L . Look, D r. Helen Howard-Lock 
and M iss D ebra H arvey, a  Ph.D . s tu d e n t .  The b io lo g ic a l  ex p erim en ts  
in v o lv in g  lym phocytes were done in  c o l la b o r a t io n  w ith  D r. D. S in g a l ,  
D ir e c to r  o f H is to c o m p a ta b i li ty  S tu d ie s  and th e  ex p erim en ts  on p l a t e ­
l e t s ,  e le c t r o n  m icroscopy and energy  d is p e r s iv e  a n a ly s i s  were done 
s o le ly  by m y se lf . Lymphocytes were chosen f o r  s tu d y , a s  th e  e f f e c t  
o f g o ld  sodium th io m a la te  (y e llo w  s o lu t io n )  on lym phocyte fu n c tio n  
i s  w e ll e s ta b l i s h e d  (2 1 4 -2 1 7 ). P l a t e l e t s  were chosen a s  a  s tu d y  c e l l  
because  s e v e ra l  a s p e c ts  o f th e  in t e r a c t io n  o f  th e  y e llo w  s o lu t io n  o f  
g o ld  sodium th io m a la te  w ith  p l a t e l e t s  were a lre a d y  known to  me from  
my r e s e a rc h  s tu d ie s  on th e  i n t e r a c t i o n  o f  g o ld  com plexes w ith  throm bin  
and p l a t e l e t s . (These w i l l  be o u t l in e d  in  C hap ter V I I I ) .
The e x p e rim e n ta l q u e s tio n  a d d re sse d  in  t h i s  c h a p te r  was:
>Jhat i s  th e  p h y s ic a l ,  chem ica l and b io lo g ic a l  s ig n if ic a n c e  o f th e  
change from  th e  c o lo u r le s s  s o lu t io n  o f g o ld  sodium th io m a la te  to  th e  
y e llo w  s o lu t io n  o f  g o ld  sodium th io m a la te ,  e s p e c ia l ly  s in c e  th e  l a t t e r  
i s  m arketed  f o r  human u se?
-  2 1 1  -
MATERIALS AND METHODS
Gold Complexes and R e la te d  Compounds
Gold sodium th io m a la te  was s u p p lie d  g r a t i s  by R hone-Poulenc, 
Quebec a s :  (a )  th e  y e llow  s o lu t io n  in  v i a l s  a s  c u r r e n t ly  m arketed 
f o r  human u se ; and a s  (b) a  s t e r i l e  w h ite  powder w hich , when mixed I
w ith  s t e r i l e  w a te r , r e s u l t e d  i n  a  c o lo u r le s s  s o lu t io n  ( f ig u r e  53)» 
Both th e  ye llow  and th e  c o lo u r le s s  s o lu t io n  c o n ta in e d  eq u a l q u a n t i -
t i e s  o f  g ly c e ro l  (0 ,3  mois p e r  mol o f  th io m a la te )  and c h lo ro c re s o l
(0 .05%) a s  s t a t e d  in  C hap ter V I. Gold th io g lu c o s e  and th io m a lic  a c id
'were o b ta in e d  from  th e  Sigma Chem ical C o ., S t .  L o u is , M is s o u ri ,  U .S .A .
Gold sodium th io s u lp h a te  was p re p a re d  in  th e  B io - in o rg a n ic  m edicine 
l a b o r a to r i e s  a t  McMaster U n iv e r s i ty  a f t e r  th e  method o f  Brown (2 0 4 ) .
2 ,3 ,4 ,6 - t e t r a - o r t h o - a c e t y l - l  - t h i o -  d -D -g lucopyranosato -S  - ( t r i e t h y l ­
phosph ine) g o ld  (A uranofin™ ) was su p p lie d  g r a t i s  by Sm ith , K lin e  and 
F ren ch , P h i la d e lp h ia ,  U .S .A . D isodium  th io m a la te  i n  equ im o lar concen­
t r a t i o n  to  the. th io m a la te  in  g o ld  sodium th io m a la te  was p rep a red  by 
th e  a d d i t io n  o f 1 m olar sodium h yd rox ide  (NaOH) to  th io m a lic  a c id  
19 mg/ml u n t i l  a  pH o f  7•75 was o b ta in e d . A uranofin  i s  in s o lu b le  in
w a te r . F o r th e  p l a t e l e t  s tu d ie s  a  s to c k  s o lu t io n  was p rep a red  by 
d is s o lv in g  17 mg o f compound in  0 .5  ml o f  a b s o lu te  a lc o h o l (G„H-0H)2 5
fo llo w ed  by th e  a d d i t io n  o f  O.5  ml o f  w a te r to  ach iev e  a  c o n c e n tra t io n  
-4o f 5 .1x10  M a s  e le m e n ta l g o ld . S u i ta b le  a lc o h o l c o n t ro l  c o n c e n tra t io n s  
were u sed  f o r  each  d i l u t i o n  o f  A uranofin  added to  th e  p l a t e l e t  su spen ­
s io n s .
A ll go ld  compound c o n c e n tra t io n s  l i s t e d  in  t h i s  c h a p te r  a re  
ex p re ssed  a s  m olar q u a n t i t i e s  o f  e lem en ta l g o ld .
Î
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P h y s ic a l  and Chem ical S tu d ie s
N u c lea r M agnetic re so n an ce  sp e c tro sc o p y  (n .M .R.) s tu d ie s  
w ere c a r r i e d  ou t on a  V arian  EM-390 s p e c tro m e te r . The c o lo u r le s s  
s o lu t io n  o f  g o ld  sodium th io m a la te  was p rep a red  from  s o l id  in  
heavy w a te r  (D^O) to  a  c o n c e n tra t io n  o f  3*2x10 N.M.R, s tu d ie s
were a l s o  c a r r i e d  o u t on th e  c o lo u r le s s  s o lu t io n  o f g o ld  sodium 
th io m a la te  fo llo w in g  lo n g  te rm  u l t r a - v i o l e t  (U .V .) i r r a d i a t i o n  
ov er 750 m inu tes a t  300 nanom eter (nm) w aveleng th  in  a  R a y o n e t^  
Pho tochem ical R e a c to r ,
s
U l t r a - v i o l e t - v i s i b l e  s p e c t r a  were perform ed on a  Pye Unicam
'
SP8-100 u l t r a - v i o l e t  sp e c tro p h o to m e te r . S p ec tro sco p y  o f  th e  \ d s i b l e  
l i g h t  range  (350~^50 nm) was c a r r i e d  o u t u s in g  c o n c e n tra t io n s  o f 
c o lo u r le s s  and y e llow  g o ld  sodium th io m a la te  a t  3*2x10 S p e c tra
in  th e  u l t r a - v i o l e t  ran g e  (180-350 nm) were exam ined u s in g  concen- 
t r a t i o n s  o f  3*2x10 M f o r  th e  c o lo u r le s s  and yellow  s o lu t io n  o f  g o ld  
sodium th io m a la te ,
I n  o rd e r  t o  fo llo w  th e  c o lo u r  change from  c o lo u r le s s  to  
y e llow  by u l t r a - v i o l e t  i r r a d i a t i o n ,  3*2x10 ^  o f  th e  c o lo u r le s s  
s o lu t io n  o f  g o ld  sodium th io m a la te  i n  d i s t i l l e d  w a te r was i r r a d i a t e d  
w ith  350 nm w aveleng th  in  a  B a y o n e t^  P ho tochem ical R e a c to r . The 
v i s i b l e  spectrum  o f  th e  sample was observed  a t  s p e c i f i c  tim e i n t e r ­
v a ls  ov er 500 m inu tes a t  425 , 450 and 475 nm w aveleng th  and th e  
o p t i c a l  d e n s i ty  (a b s o rp tio n )  p lo t t e d .
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B io lo g ic a l  S tu d ie s
(a )  Mixed Lymphocyte C u ltu re  CMIG)
Lymphocytes w ere s e p a ra te d  from  f r e s h ly  drawn b lood  a s  
d e s c r ib e d  by Boyum (218) and suspended in  minimum e s s e n t i a l  m edia, 
supplem ented w ith  h e a t - in a c t iv a t e d  (56° f o r  30 m in .) poo led  AB
s t im u la to r  c e l l s  in  0 .1  ml volume in  f la t -b o t to m  m ic r o t i t r e  p la t e s  
( l in b r o  IS MRG96 ) . H e a t- in a c t iv a te d  poo led  AB serum was added in
*:.'I'I'
serum from  norm al h e a l th y  d o n o rs . The one way mixed lym phocyte
c u l tu r e  (MLG) t e s t  was perform ed  a s  d e sc r ib e d  by S in g a l e t  a l  ( 219)
3 3u s in g  100 X 10 re sp o n d e r  lym phocytes and 100 x 10 X - ir r a d ia te d
i
0 .0 5  ml volume p e r  c u l tu r e .  The c u l tu r e s  were in c u b a te d  a t  37°G in  
w a te r - s a tu ra te d  5% C O ^ -in -a ir  a tm o sp h ere . C u ltu re s  were la b e le d  
w ith  0 .5  uCi o f  ^H -thym idine (6 .7  Gi/mM, New England N u c lea r , B oston ,
M ass.) f o r  I 8 h o u rs . T o ta l c u l tu r e  tim e , in c lu d in g  thym id ine  p u ls e ,  
was 120 h o u rs . The c u l tu r e s  were h a rv e s te d  on to  g la s s  f i l t e r  p ap e rs  
by a  m u l t ip le  sam ple h a r v e s te r ,
MLG in h i b i t i o n  t e s t s  were c a r r ie d  ou t by add ing  a  ran g e  o f
c o n c e n tra t io n s  o f  th e  c o lo u r le s s  o r  yellow  s o lu t io n s  o f g o ld  sodium
th io m a la te  (O -  60 yg o f  Au /m l o f c u l tu r e )  a t  th e  i n i t i a t i o n  o f
c u l t u r e . P e rc e n t in h i b i t i o n  in  MLG in  g o ld  t r e a te d  c u l tu r e s  compared
to  c o n t ro ls  was c a lc u la te d  f o r  th e  c o n c e n tra t io n s  3 .8 x l0 " % , 7*6x10"-^M,
 ,
1 .5x10 M and 3*0x10 M (e x p re s se d  a s  e lem en ta l g o ld ) p e r  m i l l i ­
l i t e r  o f c u l tu r e ,
i%
__
-  215 -
PREPARATION OF WASHED HUMAN PLATELETS
%
i
(b ) P l a t e l e t  S tu d ie s  
M a te r ia ls
Adenosine d ip h o sp h a te  (ADP) and ad en o sin e  5 ^-monophosphate 
(amp) were o b ta in e d  from  th e  Sigma Chem ical C o ., S t .  L o u is , M is s o u rr i ,  
C re a tin e  phosphate  and c r e a t in e  phosphokinase were o b ta in e d  from  th e  
Sigma Chem ical C o ., S t .  L o u is , M is s o u rr i .  C re a tin e  p h o s p h a te /c re a t in e  
phosphokinase i s  p re p a re d  by th e  a d d i t io n  o f 5x10 ^  c r e a t in e  phos­
ph a te  to  0.85% sodium c h lo r id e  and m ixing t h i s  s o lu t io n  w ith  100 u n i t s /  
ml o f c r e a t in e  p h o sp h o k in ase . Bovine throm bin  was o b ta in e d  from  
M iles L a b o ra to r ie s ,  K ankakee, I l l i n o i s ,  U .S .A . R ad io a c tiv e  s e ro to n in
(^ ^ G -se ro to n in )  was o b ta in e d  from  A m ersham /Searle, A r lin g to n  H e ig h ts ,
l 4I l l i n o i s ,  U .S .A . a s  5“b y d ro x y try p tam in e -3 " -  G -c re a tin e  s u lp h a te ,
57 mCi/mmol. R a d io a c tiv e  chromium (-^G r) a s  Na^-^GrOn, 100-400 mCi 
p e r  mg o f  Gr was a l s o  o b ta in e d  from  A m ersham /Searle. R ad io ac tiv e  
co u n tin g  was perform ed on a  P h i l i p s  L iq u id  S c i n t i l l a t i o n  A n a ly se r 
(P.W. 4 5 1 0 ).
.If
Washed human p l a t e l e t  su sp e n s io n s  were p re p a re d  by th e  method 
o f M ustard e t  a l  (2 2 0 ) . B r ie f ly ,  129 ml o f  b lood  was o b ta in e d  by 
a n t e c u b i t a l  v e in  p u n c tu re  from  v o lu n te e r s .  V o lu n tee rs  were s e le c te d  
who were on no m e d ic a tio n s  and had ta k e n  no in d ic a t io n  f o r  two w eeks. 
The b lood  was im m ed ia te ly  t r a n s f e r r e d  in  eq u a l volumes to  3 p l a s t i c  
c e n tr i fu g e  tu b e s  (5  m l) , each  c o n ta in in g  7 ml o f  a c i d - c i t r a t e - d e x t r o s e  
(AGD) a n t ic o a g u la n t  s o lu t io n ,  a s  d e s c r ib e d  by A s te r  and J a n d l ( 2 2 l ) , 
The whole blood-ACD m ix tu re  was g e n t ly  b u t r a p id ly  mixed to  p re v e n t
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ic l o t t i n g .  The su sp e n sio n  was th e n  c e n tr i fu g e d  a t  37^0 in  an B .C .3 S o rv a l c e n t r i f u g e  a t  1200g f o r  3 m in u te s . The p la te l e t - p o o r  plasm a 
was d is c a rd e d  and th e  p l a t e l e t s  were suspended in  Tyrodes s o lu t io n  
c o n ta in in g  0,35% album in (2 2 0 ,2 2 2 ) , Apyrase p re p a re d  a c c o rd in g  to  
M olnar and Lorand (2 2 3 ) , w ith  a  n u c le o t id a s e  a c t i v i t y  o f  5*3 u n i t s  
o f ad en o sin e  d ip h o sp h a tase /m g  and 4 .2  u n i t s  o f  ad en o sin e  tr ip h o s p h ­
a tase /m g  was in c lu d e d  i n  th e  T yrodes album in s o lu t io n  a t  a  concen­
t r a t i o n  o f  10 y l/m l (220 , 2 2 4 ). P l a t e l e t s  were in c u b a te d  in  t h i s
l 4f i r s t  w ashing s o lu t io n  o f  T yrodes album in w ith  2 yCi o f  C -se ro to n in  
and 200 yCi o f  d isod ium  chrom âte/mg f o r  30 m in u te s . T h is  f i r s t  
w ashing s o lu t io n  was th e n  c e n tr i fu g e d  a t  1200g f o r  10 m in u te s , th e  
s u p e rn a ta n t d is c a rd e d  and th e  p l a t e l e t s  resuspended  in  T yrodes 
album in s o lu t io n  (second  w ashing s o lu t io n )  f o r  10 m in u te s . The second 
w ashing s o lu t io n  o f  p l a t e l e t s  was c e n tr i fu g e d  a t  1200g f o r  10 m inu tes 
and th e  s u p e rn a ta n t d is c a rd e d .  The p l a t e l e t s  were suspended in  a  
f i n a l  su sp e n sio n  o f  T yrodes album in and th e  p l a t e l e t  coun t a d ju s te d  
to  5 0 0 , 000/mm^. The p l a t e l e t  su sp e n sio n s  were s to r e d  a t  37^0 in  a  
w a te r  b a th  p r i o r  to  u s e .
P l a t e l e t  A ggregation  S tu d ie s
P l a t e l e t  a g g re g a tio n  was s tu d ie d  by a  m o d if ic a tio n  o f  a  t u r -  
b id im e tr ic  method a s  p re v io u s ly  d e s c r ib e d  (2 2 0 ) , B r ie f ly ,  l i g h t  
tra n s m is s io n  o f  1 ml su sp e n s io n s  o f washed p l a t e l e t s  was m easured 
on a  Payton  A ggregation  Module (P ay ton  A s s o c ia te s ,  S carbo rough , 
O n ta r io , Canada) and re c o rd e d  on a  R ikadenki Pen R ecorder (Kogyo, 
J a p a n ) , P l a t e l e t  shape change and a g g re g a tio n  were re c o rd e d  f o l l o ­
wing th e  i n t e r a c t io n  w ith  t e s t  compounds ( e .g .  g o ld  com plexes) and 
a g g re g a tin g  a g e n ts  ( e .g .  ADP).
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te t r o x id e  and b lo ck  s t a i n in g ,  w hich were o m itte d . The u n s ta in e d ,  
u l t r a t h i n  s e c t io n s  were co a ted  w ith  carbon and an a ly se d  in  a  P h i l ip s
E le c tro n  M icroscopy
Specim ens o f  p l a t e l e t s  t r e a t e d  w ith  th e  g o ld  compounds 
were s tu d ie d  by e le c t r o n  m icroscopy , 0 .5  ml sam ples of th e  p l a t e ­
l e t  su sp e n s io n s  were added to  0 .5m l o f 4% g lu te ra ld e h y d e  in  0.2M 
sodium c a c o d y la te  b u f f e r  (pH 7 .3 )*  The specim ens were f ix e d  f o r  
one hour a t  4^0 and th e n  c e n tr i fu g e d  a t  3200 r .p .m .  to  o b ta in  a  
p e l l e t  o f  p l a t e l e t s .  These p l a t e l e t s  were p o s t- f ix e d  in  1% osmium 
te t r o x id e  in  O.IM sodium c a c o d y la te  b u f f e r .  The p l a t e l e t s  were 
b lo c k  s ta in e d  w ith  2% aqueous u ra n y l a c e ta te  and d eh y d ra ted  in  
g rad ed  e th y l  a lc o h o l s o lu t io n s  and embedded in  S p u r r 's  r e s i n .  U l t r a -  
th i n  s e c t io n s  were s ta in e d  w ith  R e y n o ld 's  le a d  c i t r a t e .  E le c tro n  
m icroscopy was perform ed on a  P h i l i p s  301 m icroscope a t  McMaster 
U n iv e r s i ty  H ea lth  S c ien ce  C e n tre .
Energy D is p e rs iv e  S p e c tro sc o p ic  A n a ly s is
P l a t e l e t  specim ens were p rep a red  a s  d e s c r ib e d  f o r  conven-
t i o n a l  e le c t r o n  m icroscopy ex ce p t f o r  th e  p o s t - f ix a t io n  i n  osmium
400 tra n s m is s io n  e le c t r o n  m icroscope equipped w ith  an energy  d is p e r ­
s iv e  x - ra y  d e te c to r  and a n a ly s e r . Energy d is p e r s iv e  s p e c tro s c o p ic
a n a ly s is  was c a r r ie d  o u t a t  th e  O n ta rio  R esearch  F o u n d a tio n , M is s is ­
sauga, O n ta r io , Canada.
I
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RESULTS
P h y s ic a l and Chem ical S tu d ie s  
1H-N.M.R. s p e c t r a  o f  f r e s h ly  p rep a red  c o lo u r le s s  s o lu t io n
o f g o ld  sodium th io m a la te  made from  s o l id  (3*2x10 a re  shown in  
f ig u r e  5 4 a , There i s  no s i g n i f i c a n t  d i f f e r e n c e  in  th e  p a t te r n  o f 
t h i s  spectrum  when compared to  th e  yellow  s o lu t io n  o f go ld  sodium 
th io m a la te  (3*2x10 (h e a t  s t e r i l i s e d  f o r  human u se )  a s  shown in  
f ig u r e  54b. The e x t r a  peak in  f ig u r e  54a a s  marked by an arrow  i s  
a  m arker. 130 N.M.R. were n o t  m easured. The d i f f e r e n c e  in  i n t e n s i t y  
o f  th e  N.M.R. s p e c tr a  i s  because  th e y  were m easured a t  d i f f e r e n t  
g a in s .  The spectrum  o f  th e  y e llo w  was w e ll known, b u t th e  c o lo u r­
l e s s  was m easured a t  th e  h ig h e r  g a in  in  o rd e r  to  d e te rm in e  w hether 
th e r e  were any d i f f e r e n t  weak f e a t u r e s .
The u l t r a - v i o l e t - v i s i b l e  s p e c t r a  o f  th e  c o lo u r le s s  and 
y e llow  s o lu t io n s  a re  shown in  f ig u r e s  55 (1) and 5 5 (H )  * They i l l u ­
s t r a t e  t h a t  a lth o u g h  th e r e  i s  a  re d u c t io n  in  th e  peaks a t  230 and 
270 nm {see arrow s f ig u r e  5 5 ( l ) }  th e re  i s  much g r e a t e r  a b s o rp tio n  f o r  
th e  y e llo w  s o lu t io n  in  th e  350-450 nm range  { f ig u re  5 5 ( H ) } ,  c o n s is ­
t e n t  w ith  th e  c o lo u r  d i f f e r e n c e  o f  th e  two s o lu t io n s .
I n  o rd e r  to  fo llo w  th e  c o lo u r  change from  c o lo u r le s s  to  
y e llo w , th e  c o lo u r le s s  s o lu t io n  (3 * 2 x l0 ~ ^ )  was i r r a d i a t e d  w ith  U.V. 
l i g h t  a t  350 nm o v er a  p ro lo n g ed  tim e p e r io d , and o p t i c a l  o b se rv a ­
t i o n s  were made ov er 3 w aveleng ths in  th e  400-500 nm re g io n s ,  a s  
shown in  f ig u r e  5 6 . The cu rv es  a r e  c o n s is te n t  w ith  a  peak grow ing 
in  th e  450-475 nm ra n g e . A f te r  500 m inu tes o f  i r r a d i a t i o n  th e  c o lo u r ­
l e s s  s o lu t io n  had become d a rk  brown. Thus, th e  yellow  c o lo u r  of th e  
com m ercia lly  a v a i la b le  go ld  sodium th io m a la te  (m y o ch ris in e ) i s  




EIGUBE Hydrogen I  n u c le a r  m agnetic  reso n an ce  s p e c tr a  o f  (a ) 
a  f r e s h ly  p re p a re d _ c o lo u r le s s  s o lu t io n  o f g o ld  sodium 
th io m a la te  (3 .2x10  and (h) a  sample o f^ g ie  ye llow  
s o lu t io n  o f  g o ld  sodium  th io m a la te  ( 3 .2 x l 0 " '^ ) ,
T here i s  no s i g n i f i c a n t  d i f f e r e n c e  in  th e  p a t te r n s  o f  
th e s e  s p e c t r a .
g -  g ly c e ro l  p eak . arrow  -  i s  a  m arker
a b s c is s a  -  5 i s  th e  s h i f t  d ow nfie ld  from  te t r a m e th y l-  
s i l a n e  in  p .p .m . 
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B io lo g ic a l  S tu d ie s
(a )  Mixed Lvmt>hocvte C u ltu re
The a d d i t io n  o f  th e  c o lo u r le s s  and y e llow  s o lu t io n s  o f  
go ld  sodium th io m a la te  to  th e  M.L.G. c u l tu r e s  r e s u l t e d  in  s i g n i f i ­
c a n t (p  < .005) d e c re a se s  in  re s p o n s e . The d a ta  w ith  c o lo u r le s s  go ld  
sodium th io m a la te  s o lu t io n  a re  g iv e n  in  f ig u r e  32 and w ith  th e  
y e llow  s o lu t io n  o f  g o ld  sodium th io m a la te  a re  g iv en  in  f ig u r e  5 8 .
The av erag e  p e rc e n t in h i b i t i o n  in  s t im u la t io n  r a t i o s  (SR) w ith  th e  
c o lo u r le s s  s o lu t io n  were 29^  and w ith  8 .8x10 and w ith  
7 .6x10  r e s p e c t iv e ly .  The p e rc e n t i n h i b i t i o n  w ith  th e  y e llo w  s o lu ­
t i o n  were 18^ and 44^ a t  th e s e  c o n c e n tra t io n s .
The p e rc e n t in h i b i t i o n  in  M.L.G. w ith  v a ry in g  c o n c e n tra t io n s  
o f th e  c o lo u r le s s  and y e llo w  s o lu t io n  o f g o ld  sodium th io m a la te  
(3 .8x10"’-^  -  3 »03d.O”^M) a re  g iv e n  in  f ig u r e  59* I t  i s  e v id e n t t h a t  
th e  p e rc e n t i n h i b i t i o n  in c re a s e d  w ith  in c re a s e  in  amount o f  g o ld  in
—4c u l tu r e s  (e x c e p t f o r  c o lo u r le s s  g o ld  sodium th io m a la te  a t  3*0x10 M,
-4w hich produced a  lo w er p e rc e n ta g e  in h i b i t i o n  th a n  1 .5x10  M o f  th e  
c o lo u r le s s  so lu tio n * .{ f ig u ré ' ^ } )  .
(b ) P l a t e l e t  S tu d ie s
Thrombin I n h ib i t i o n
The s e r in e  e s te r a s e  th rom bin  which c o n v e rts  f ib r in o g e n  to
l 4f i b r i n  w i l l  cause p l a t e l e t  a g g re g a tio n  and r e le a s e  o f  G- s e r o to n in  
when added to  washed human p l a t e l e t s .  Both th e  c o lo u r le s s  and ye llo w  














3.8 X 10"®M (Elemental gold) 











FIGURE 5 ? ; The e f f e c t  o f  c o lo u r le s s  go ld  sodium th io m a la te  on 
th e  mixed lym phocyte c u l tu r e  (M .L.G.) r e a c t io n .
The d a ta  from  two ex p erim en ts  axe g iv e n  in  t h i s  f ig u re .  
The r e s u l t s  a re  e x p re sse d  a s  s t im u la t io n  r a t i o  (S .R .)  
on th e  o r d in a te .  The c o n c e n tra t io n s  axe ex p re ssed  a s  
















^  3.8 X  10'°M (Elemental gold) 
3  7.6 X  10"'M (Elemental gold)
EIGUEB S8: The e f f e c t  o f  ye llo w  g o ld  sodium th io m a la te  on
th e  mixed lym phocyte c u l tu r e  r e a c t io n .  Hie d a ta  
from  two ex p erim en ts  a re  g iven  in  t h i s  f ig u r e .  
The r e s u l t s  a r e  ex p re sse d  a s  s t im u la t io n  r a t i o s  
(S .R .)  on th e  o r d in a te .  The c o n c e n tra t io n s  a r e  






• Sol. 1 Colourless 
oSol. 2 Yellow
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FIGUHS 59; The e f f e c t  o f  v a ry in g  c o n c e n tr a t io n s  o f  g o ld  sodium 
th io m a la te  ( c o lo u r le s s  and yellow  s o lu t io n s )  on th e  
mixed lym phocyte c u l tu r e  r e a c t io n .  The d a ta  a re  
ex p re ssed  a s  p e rc e n t  in h i b i t i o n  on th e  o rd in a te  and 
a s  th e  c o n c e n tra t io n  o f  e le m e n ta l g o ld  p e r  m i l l i l i t r e  
o f  c u l tu r e  on th e  a b s c i s s a .
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—6 —91 .8 x 1 0  -  2.5x10 M in h i b i t e d  th e  a c t io n  o f bov ine throm bin
(0 .025- 0 .2 5  u n i t s /m l)  on 1 ml o f washed human p l a t e l e t s  i f  added 
to  th e  p l a t e l e t  su sp e n sio n  p r io r  to  th e  a d d i t io n  o f  th e  throm bin  
( f ig u r e  60) o r  s im u lta n e o u s ly  w ith  th e  th rom bin . (These e f f e c t s  
w i l l  be f u r t h e r  d is c u s s e d  in  C hap ter V II I ) .
P l a t e l e t  A ggregation  S tu d ie s
The y e llo w  s o lu t io n  o f  g o ld  sodium th io m a la te  ( l .3 x lO  ^ » 
6 .4x10  a s  e le m e n ta l g o ld ) added to  washed human p l a t e l e t s  r e s u l ­
te d  in  shape change, w ith in  30 seconds fo llo w ed  by p l a t e l e t  a g g re g a -
14t i o n  and r e le a s e  o f  i n t e r n a l  g ra n u le  c o n te n ts  a s  m easured by C-
s e ro to n in  r a d i o a c t i v i t y  ( f ig u r e  61 ) . De-a g g re g a tio n  o f  p l a t e l e t s
u s u a l ly  o c c u rre d  w ith in  2 to  4  m in u tes  ( f ig u r e  61 ) . Due to  th e
l 4wide b io lo g ic a l  v a r i a b i l i t y  d em o n stra ted  by th e  p l a t e l e t s ,  G- 
s e ro to n in  r e le a s e  v a lu e s  co u ld  n o t  be compared betw een in d iv id u a l
g o ld  sodium th io m a la te  (l.B x lO   ^ -  6 .4x10 ^M) was added to  washed 
human p l a t e l e t s  a b s o lu te ly  n r  r e a c t i v i t y  o f th e  p l a t e l e t s  was 
observed  ( f ig u r e  61 ) .
IÎ
sam ples o b ta in e d  from  d i f f e r e n t  v o lu n te e r s .  However, w ith in  sam p les, 
l4 G -se ro to n in  r e le a s e  v a lu e s ,  p a r a l l e l e d  th e  in c re a s e  in  c o n c e n tra t io n  
o f th e  ye llo w  s o lu t io n  o f g o ld  th io m a la te .  The u s u a l  v a lu e s  f o r  
^ ^ G -se ro to n in  r e le a s e  were betw een 5% and 205^  f o r  th e  g o ld  concen-
_ o  . 0t r a t i o n s ,  1 .3x10  -  6 .4x10  ( f ig u r e  61 ) . P l a t e l e t  l y s i s  a s
61m easured by Cr r e l e a s e  d id  n o t  o ccu r w ith in  t h i s  c o n c e n tra tio n  
range  o f g o ld . P l a t e l e t  a g g re g a tio n  was n o t observed  f o r  g o ld  co n - I
A:;:
c e n t r a t io n s  o f th e  y e llo w  s o lu t io n  o f  g o ld  sodium th io m a la te  l e s s  
th a n  1 . 3x10 ^M.
When a  range  o f c o n c e n tra t io n  o f  th e  c o lo u r le s s  s o lu t io n  o f
_
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SEROTONIN RELEASE 35-90%
PLATELET AGGREGATION
’-k: s e r o t o n in  r elea se  o%
GOLD SODIUM THIOMALATE 
(1 ,8x10 -' to  2 5 x 1 0 - 'M )
THROMBIN (O.Oæ-0.25 units/ml) THROMBIN (0.025-0.25 units/ml)
J  I I I I3 0 1 2  3
Thrombin (0.025-0.25 units/ml) added to washed human platelets causes 
platelet aggregation and release of ’-^-serotonin. Prior addition of 
Gold Sodium Thiomalate (1.8 x 10 ® to 2.5 x lO'^M)’'' inhibits the action of 
thrombin (0.025-0.25 units/ml) on w ashed human platelets.
* GOLD SODIUM THIOMALATE values are expressed as moles of elemental gold.
FIGUEE 6:0; Thrombin (0 .0 2 5 -0 .2 5  u n i ts /m l)  induced  p l a t e l e t
a g g re g a tio n , w ith  35^ - 90^  r e le a s e  o f  i ^ - s e r o t o n i n .  
P r io r  a d d i t io n  o f  e i t h e r  c o lo u r le s s  o r ye llow  go ld  
sodium th io m a la te  (1 .8x10   ^ -  2 ,5x10”3m a s  e le m e n ta l 
g o ld ) b lo c k s  th e  a g g re g a tio n  of washed human p l a t e l e t s  







C O L O U R L E S S  G ST
C“Serotonin Release 5-20%
YELLOW  GST
1 2 3 
TIME (minutes)
FIGURE 6 l : The a d d i t io n  o f  th e  y e llo w  s o lu t io n  o f go ld  sodium
th io m a la te  (y e llo w  G.S .T .)  ( l ,3 x l0 * ’3 -  6 .4x10“3m) to  
washed human p l a t e l e t s  c a u se s  p l a t e l e t  shape change 
w ith in  30 seconds fo llo w ed  by p l a t e l e t  a g g re g a tio n  
and r e le a s e  o f  l^ G -s e ro to n in .  .D eaggregation  o f p l a t e ­
l e t s  o ccu rs  w ith in  2 -4  m in u te s .
The a d d i t io n  o f  c o lo u r le s s  go ld  sodium th io m a la te  
( c o lo u r le s s  G .S .T .)  ( l . 8x10*3 _ 6<.4x10**3m) added to  
washed human p l a t e l e t s  does n o t r e s u l t  in  any ag g re ­
g a t io n  n o r  r e le a s e  r e a c t io n .
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(l.8 x iO ~ 3  _ 6.4x10 %[) d id  n o t cause  p l a t e l e t  a g g re g a tio n  n o r r e le a s e  
o f  i n t e r n a l  g ra n u le s .
( f ig u r e  62 ) .  When a  g o ld  c o n c e n tra t io n  o f A urano fin  (5 -1x10”^M)
II
S im i la r ly ,  g o ld  th io g lu c o s e  and g o ld  sodium th io s u lp h a te  
in  equ im o lar c o n c e n tra t io n s  o f e le m e n ta l g o ld  ( l . 8x l 0 ^ -  6 .4x10 ^M) 
and d isod ium  th io m a la te  in  eq u im o la r c o n c e n tra t io n s  o f th io m a la te
to  th e  c o n c e n tra t io n s  o f  th io m a la te  in  g o ld  sodium th io m a la te
■I
2 , 3 , 4 , 6 - te tra -q ,-a c e ty l- l- f th iO '~ j8-D -g lucopy rano8a to -S  - ( t r i e t h y l -
phosph ine) g o ld  (A u ra n o fir )  in  th e  c o n c e n tra t io n  ran g e  6 .4x10 ^ -  
-65 .1x10 M d id  n o t cause p l a t e l e t  a g g re g a tio n  n o r  r e le a s e  o f i n t e r n a l  
g ra n u le s  a s  m easured by ^ ^ G -se ro to n in  r a d io a c t iv e  c o u n tin g  ( f ig u r e  62 ) .
P l a t e l e t  shape change d id  o ccu r w ith in  30 seconds fo llo w in g  th e  a d d i -  
t i o n  o f  5 .1x10 o f  A u ran o fin , b u t no a g g re g a tio n  o r  r e le a s e  o ccu rred
which i s  g r e a t ly  in  e x c e ss  o f  th e  p h a rm aco lo g ica l serum c o n c e n tra t io n s
ach iev ed  d u r in g  g o ld  th e ra p y  (6 ,4x10  ^ -  4 .1x10 -%) was added to  th e
p l a t e l e t s ,  shape change to o k  p la c e  ov er 3 m in u te s , fo llo w ed  by a  l i g h t
tra n s m is s io n  p a t te r n  c o n s is te n t  w ith  p l a t e l e t  clum ping ( f ig u r e  62 ) ,
61Gr r e le a s e  d id  n o t  in d i c a te  any ev id en ce  o f  l y s i s .
Mechanism o f  P l a t e l e t  A g gregation  by th e
Yellow S o lu tio n  o f  Gold Sodium T hiom alate
C re a tin e  p h o s p h a te /c re a t in e  phosphokinase (GP/GPK) c o n v e r ts  
ad en o sin e  d ip h o sp h a te  (ADP) to  ad enosine  t r i - p h o s p h a te  (ATP) (225)*
P r io r  a d d i t io n  o f 100 y i  o f GP/CPK to  th e  washed human p l a t e l e t  s u s ­
p en sio n s  b lo c k s  th e  p l a t e l e t  a g g re g a tio n  in duced  by th e  ye llow  s o lu -
. . . .
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/ \m onophsphate (A .M .P.) I s  a  c o m p e tit iv e  i n h i b i t o r  o f  ADP induced  
p l a t e l e t  a g g re g a tio n  (2 2 6 ) . P r io r  a d d i t io n  o f  ad en o sin e  monophosphate 
( a .m .P .)  in  ex cess  (lO  ^M) to  a  washed human p l a t e l e t  su sp e n sio n  
b lo c k s  th e  e f f e c t  o f th e  y e llo w  s o lu t io n  o f g o ld  sodium th io m a la te  
( l .3x10 -  6 .4x10 on p l a t e l e t  a g g re g a tio n . Thus when A .D .P.
i s  e l im in a te d  by GP/CPK o r  c o m p e ti t iv e ly  b locked  from  i t s  p l a t e l e t  
su r fa c e  membrane r e c e p to r  by e x c e ss  A .M .P., p l a t e l e t  a g g re g a tio n  
in duced  by th e  y e llo w  s o lu t io n  o f  go ld  sodium th io m a la te  does n o t o c c u r .
A s y n e r g i s t i c  e f f e c t  on th e  a g g re g a tio n  o f  washed human p l a t e l e t s  was 
observed  f o r  su b a g g re g a tin g  c o n c e n tra t io n s  o f A .D .P . (5xlO " M) added 
to  su b a g g re g a tin g  c o n c e n tr a t io n s  o f  th e  yellow  s o lu t io n  o f  go ld  sodium 
th io m a la te  (2 .5 x l0 ”^  -  1 .3x10  ^M) ( f ig u r e  63 ) ,  No such s y n e r g i s t i c  
e f f e c t  was n o te d  f o r  th e  c o lo u r le s s  s o lu t io n  o f go ld  sodium th io m a la te  
and ADP.
Thus th e  y e l lo w .s o lu t io n  o f  g o ld  sodium th io m a la te  cau ses ■'.J
p l a t e l e t  a g g re g a tio n , w hereas th e  c o lo u r le s s  s o lu t io n  o f  g o ld  sodium 
th io m a la te  has no e f f e c t  on p l a t e l e t s .  S in ce  th e  p l a t e l e t  a g g re g a tio n  
and G -se ro to n in  r e le a s e  in d u ced  by th e  y e llo w  s o lu t io n  can be b lo ck ed  
by a g e n ts  which p re v e n t th e  a c t io n  o f ADP on p l a t e l e t s , and s in c e  ADP 
and th e  yellow  s o lu t io n  o f  go ld  sodium th io m a la te  a c t  s y n e r g i s t i c a l l y
on p l a t e l e t  a g r é g a t i o n ,  i t  a p p e a rs  t h a t  th e  a g g re g a tio n  o f  washed
.human p l a t e l e t s  by th e  y e llow  s o lu t io n  o f  g o ld  sodium th io m a la te  i s  
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a t  9 . 627- 9 .712  KEY and. th e  peak a t  2 .1 2 5 -2 .2 1 1  KEY. The. M peak
(c )  E le c tro n  M icroscopy and Energy D isp e rs iv e  A n a ly s is
E le c tro n  m icrog raphs o f p l a t e l e t s  t r e a t e d  w ith  yellow  g o ld
-3  -3sodium th io m a la te  s o lu t io n  ( l .3x10 -  6 .4x10 had numerous
pseudopod ia  and were c o n s is te n t  w ith  p l a t e l e t s  which had u n d e r­
gone a g g re g a tio n  ( f ig u r e  6 4 ) .  F i b r i l l a r  go ld  c o n ta in in g  p a r t i c l e s  
100-700  nm in  le n g th  were i d e n t i f i e d :  ( l )  in  th e  p ro c e s s  o f be in g  
p h ag o cy to sed ; ( 2 ) w ith in  i n t r a c e l l u l a r  v e s i c l e s ;  and (3 ) in  th e  
su rro u n d in g  medium. Energy d is p e r s iv e  s p e c tro s c o p ic  a n a ly s i s
re v e a le d  th e  p re sen ce  o f g o ld  and su lp h u r  w ith in  th e s e  p a r t i c l e s  
( f ig u r e  65) .  I n  f ig u r e  65 th e  g o ld  i s  i d e n t i f i e d  a s  th e  La peak
spans 1 .6 6 4 -2 .8 0 6  KEY w hich o v e r la p s  th e  phosphorous peak (K a t
2 .0 1 3 -2 .1 4 6  key) and th e  s u lp h u r  peak (K a t  2 .3 0 7 -2 .4 7 4  KEY).
Based on th e  i n t e n s i t y  o f x - r a y  co u n ts  o b ta in e d  o v er 445 l i v e -  
seconds i t  was shown t h a t  su lp h u r  was p re s e n t  i n  s ig n i f i c a n t  amounts 
above th e  background l e v e l ,  b u t no phosphorous. I n  c o n t r a s t ,  p l a t e -  
l e t s  t r e a t e d  w ith  th e  c o lo u r le s s  s o lu t io n  o f  g o ld  sodium th io m a la te  
( 1 .8x10   ^ -  6 ,4x10 % )  were o v a l in  shape and d id  n o t  ap p ea r to  
have a g g re g a te d . These p l a t e l e t s  c o n ta in e d  numerous s c a t t e r e d  
p a r t i c l e s  < 40 nm in  d ia m e te r  which were d i s t i n c t  from  glycogen 
g ra n u le s  ( f ig u r e  6 6 ) ,  O ccas io n a l p a r t i c l e s  were membrane bound.
Energy d is p e r s iv e  s p e c tro s c o p ic  a n a ly s is -c o n f irm e d  t h a t  th e se  p a r t i ­
c l e s  a l s o  c o n ta in e d  g o ld  and su lp h u r  ( f ig u re  67 ) .  No g o ld  was
'
d e te c te d  in  p l a t e l e t s  t r e a t e d  w ith  g o ld  th io g lu c o s e ,  g o ld  sodium 
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# 3 - M A R - 8 2  1 0 : 2 4 : 4 0  EDRX READY
PATE 01: P S T I N E
0 0 - 2 0 K  E V 1 0 E  V . • r H P P S I  
A B
FS= 3 9 5  MEM R




' " - •  P ' y E V ' = 0 5 .  6 4 0
AUROTHIOMALATE 
(yellow)
FIGURE 6 6 : Energy d isp e r s iv e  sp ec tro sco p ic  a n a ly s is  o f the  
p a r t ic u la te  m atter seen in  washed human p la t e le t s  trea ted  w ith  
the ye llow  s o lu t io n  o f  go ld  sodium th iom alate ( 2 , 5 x 1 0 “ 3 m  as  
elem ental g o ld ) ,  (se e  f ig u r e  6 4 ) .  The graphs show 2 gold  peaks, 
(a) La a t  9 .6 2 7 -9 .7 1 2  KEY and (b) Kbg a t 2 .1 2 5 -2 .2 1 1  KEY (N.B. 
the M peak spans 1 .6 6 4 -2 .8 0 6  KEY which overlaps th e  phosphorous 
peak (K a t  2 .0 1 3 -2 .1 4 6  KEY) and th e sulphur peak (K a t  2 .3 0 7 -  




1  / f  S c
FIGURE 6 6 ; E lectron  micrograph (m agn ifica tio n  x 11 ,000) o f
washed human p la t e l e t s  tr e a te d  w ith c o lo u r le s s  go ld  
sodium th iom alate ( 2 . 5 x1 0 "% as elem ental g o ld ) . 
Numerous sc a tte r e d  p a r t ic le s  l e s s  than 40 nm in  
diam eter are seen  w ith in  th e  p la t e l e t s .  Some of th ese  
p a r t ic le s  are membrane bound, (see  p la t e le t  in  cen tre  
o f  f ig u r e ) .
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# 3 - M m R - 8 2  1 1 : 4 6 : 1 6  EDRX READY
P O T E  0 C P S  T I M E  5 0 3 L S E L
# 0 - 2 6 1  E V  1 0  E  V  . ■ r  H  P  R  S  T  : O F F
A 8 2 0 8 8 1  B:
F S =  7 0 1  M E M  A F S =  2  5
| 0  2  | 0  4  | 0  6  j 0 S i  | 1 0
S SC c
I L A
I. U  p  S  0  P  • I  E  V ' = 0 5
A U R O T H IO M A L A T E  
(colourless)
FIGURE 67 : Energy d isp e r s iv e  sp ec tro sco p ic  a n a ly s is  o f  the
p a r t ic u la te  m atter (< 40 nm) seen w ith in  washed human p la t e le t s  
tr e a te d  w ith  c o lo u r le s s  go ld  sodium ttiiom alate ( 2 . 5 x 1 0 ~ 3 m  as 
elem ental g o ld ) ,  (se e  f ig u r e  6 6 ) .  The graph shows two go ld  peaks, 
(a ) La a t  9 .6 2 7 -9 .7 1 2  KEY and (b) Ma3 a t  2 ,1 2 5 -2 ,2 1 1  KEY,
(N,B,  the M peak spans 1 ,6 6 4 -2 ,8 0 6  KEY which overlap s the  
phosphorous peak (K a t  2 ,0 1 3 -2 ,1 4 6  KEY) and the sulphur peak 
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I 3 - H R R - 8 2  1 2 : 3 7 : 0 0  EDf lX READY
RATE 0 C P S  T I M E  1 2 6 L S E I
M - 2 0 K E  V ; 1 0 E  V / C H  P R S T ;  OFI
A 8 9 0 8 8 1  B
S SC c
I L A
CUPSOP Ç F EV > = 0 5 .  4 4 0
F I L E NAME  - MR X P r H A R S > [' P G s ;
AUROTHIOGLUCOSE
FIGURE 6 9 ; Energy d is p e r s iv e  sp ec tro sco p ic  a n a ly s is  o f  the  
o r g a n e lle s  o f washed human p la t e le t s  tr e a te d  w ith go ld  
th io g lu c o se  ( 2 . 5 x 1 0 ” 3 m  as elem en ta l g o ld , se e  f ig u r e  6 8 ) .  
The presence o f  gold was not d e tec ted  w ith in  any o f  the  
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I 3 - H R R - 8 2  1 3  4  3 0 4  EDAX READY
R A T E  5  7 C P S  T I ME  1 5 5 LSEC
# 8 - 2 8 K  E V 1 0 E V . ‘CH P P S T  OFF
A  8 4 0 8 8 1  B L I S T
F S =  1 0 3 2  MEM B F S =  2 5
|0 2 |0 4 |0 h J 0  8 | i  0
S SC c 
I L A
r n p s o p  ' y EV ■ = 0 5 .  4 8 0
AU ROTH lOSU LPHATE
FIGURE 7 1 : Energy d is p e r s iv e  s p e c tro s c o p ic  a n a ly s i s  o f th e  
o rg a n e l le s  of washed human p l a t e l e t s  t r e a t e d  w ith  g o ld  sodium 
th io s u lp h a te  (2 ,5x 10“3m , a s  e le m e n ta l g o ld , see  f ig u r e  70 ) . 
The p re sen ce  o f  g o ld  was n o t d e te c te d  w ith in  any o f  th e se  
p l a t e l e t s .
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FIGURE 7 3 : Energy d isp e r s iv e  sp ec tro sco p ic  a n a ly s is  o f  the  
o r g a n e lle s  o f  washed human p la t e l e t s  trea ted  w ith  2 , 3 , 4 , 6 -t e t r a —o ^ a ce ty l—1 —6 —D—glucopyranosato—6 —(tr ie th y lp h o sp h in e)
go ld  (A uranofin, 5x10”-% as e lem en ta l g o ld , see  f ig u r e  72) 
The presence o f go ld  was n ot d e tec ted  w ith in  any o f th ese  
p la t e l e t s .
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DISCUSSION
For ap p ro x im ate ly  seven y e a r s ,  I  have, in  common w ith  
most rh e u m a to lo g is ts ,  f r e q u e n t ly  a d m in is te re d  go ld  sodium t h i o ­
m ala te  in t r a m u s c u la r ly  to  p a t i e n t s  w ith  rheum ato id  a r t h r i t i s .
I  was th u s  w e ll a c q u a in te d  w ith  th e  f a m i l i a r  yellow  c o lo u r  of 
th e  go ld  sodium th io m a la te  s o lu t io n  a s  s u p p lie d  co m m erc ia lly .
I t  was th u s  s u r p r is in g  t h a t ,  i n  th e  cou rse  of my la b o ra to r y  
r e s e a r c h  work, I  n o te d  t h a t  th e  go ld  sodium th io m a la te  s o lu t io n  
su p p lie d  from  th e  same com m ercial sou rce  (R hone-Poulenc, Quebec) 
was c o lo u r le s s .  E n q u ir ie s  re v e a le d  th a t  th e  yellow  c o lo u r  r e s u l t e d  
from  th e  h e a t s t e r i l i s a t i o n  p ro c e ss  used  to  p re p a re  th e  s o lu t io n  
f o r  human c l i n i c a l  u s e ,  and t h a t  th e  p h a rm a ceu tica l in d u s t r y ,  
a lth o u g h  aware o f  t h i s  p h y s ic a l  change, d id  n o t have any chem ical 
e x p la n a tio n  f o r  i t .  I  d e te rm in ed  to  in v e s t ig a te  th e  chem ica l b a s is  
f o r  t h i s  change. I  was f o r tu n a t e ,  t h a t  in  th e  r e s u l t a n t  re s e a rc h e s  
I  had th e  e x p e r t  gu idance  o f  P ro fe s s o r  C o lin  J .L .  Lock and th e  
te c h n ic a l  e x p e r t is e  o f  h i s  c o lle a g u e s  and s t a f f .
When s o l id  (w h ite  powder) g o ld  sodium th io m a la te  i s  added 
to  s t e r i l e  w a te r ,  to  a  c o n c e n tra t io n  o f 0.13M (a s  e le m e n ta l go ld ) 
a  c o lo u r le s s  s o lu t io n  i s  p ro duced . I f  t h i s  s o lu t io n  i s  h e a te d  a t  
100°G f o r  30 m inu tes a s  i n  th e  s ta n d a rd  s t e r i l i s a t i o n  p rocedu re  
f o r  m a rk e tin g , a  yellow  s o lu t io n  r e s u l t s .  I t  i s  t h i s  ye llow  s o lu ­
t i o n  which i s  a v a i la b le  f o r  human use  in  th e  tre a tm e n t o f  rheum ato id  
a r t h r i t i s .  The ex p erim en ts  r e p o r te d  in  t h i s  c h a p te r  have e s ta b l is h e d
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t h a t  n o t o n ly  h e a t in g  a t  100°G f o r  30 m in u tes , b u t u l t r a - v i o l e t
i r r a d i a t i o n  w ith  a  350 nm w aveleng th  r e s u l t s  in  th e  change from
a  c o lo u r le s s  to  a  y e llo w  s o lu t io n  f o r  g o ld  sodium th io m a la te  in
s t e r i l e  w a te r .  The change i s  accom panied by a  d e c re a se  in  in te n s e
u l t r a - v i o l e t  a b s o rp tio n s  a t  230 nm and 270 nm ( f ig u r e  55) and
th e  fo rm a tio n  o f  a  v e ry  weak peak  in  th e  v i s i b l e  re g io n  a t  450 nm
( f ig u r e  56 ) a s  a  sh o u ld e r  on th e  u l t r a - v i o l e t  b and . The y e llow
sp e c ie s  ap p ea rs  to  be a  m inor component s in c e  no s i g n i f i c a n t  change
can be d e te c te d  in  th e  H s p e c t r a .  However, lo n g  te rm  u l t r a - v i o l e t
i r r a d i a t i o n  o f  th e  c o lo u r le s s  s o lu t io n  f o r  e i t h e r  500 m in u tes  a t
350 nm o r  750 m inu tes w ith  s h o r te r  w aveleng th  l i g h t  ( 3OO nm)
1r e s u l t s  i n  a  d a rk  brown s o lu t io n .  The H ÏÏ.M.R. s p e c t r a  o f th e  
sam ple a f t e r  750 m inu tes of u l t r a - v i o l e t  i r r a d i a t i o n  a t  3OO nm a re  
d i f f e r e n t  ( f ig u r e  74) and c o n s is te n t  w ith  a  s ig n i f i c a n t  change in  
th e  l ig a n d .
D r. P e te r  S a d le r  o f  B irkbeck  C o lle g e , U n iv e r s i ty  o f London, 
U.K. has r e p o r te d  (210) th e  s e p a ra t io n  o f  a  ye llow  s o lu t io n  phase 
made by t r e a t i n g  g o ld  sodium th io m a la te  s o lu t io n  w ith  sodium c h lo r id e  
W hile v i s i t i n g  McMaster U n iv e r s i ty  l a s t  y e a r .  D r. S a d le r  o f fe re d  
s e v e r a l  p o in ts  o f good ad v ice  and su g g es ted  p r iv a t e ly  t h a t  h i s  
y e llo w  s o lu t io n  may be i d e n t i c a l  t o  th e  yellow  m a te r ia l  p roduced 
by h e a t  and u l t r a - v i o l e t  l i g h t .  So f a r  I  have been  u n ab le  to  r e ­
produce th e  s e p a ra t io n  p ro c e s s  d e s c r ib e d  in  h is  r e p o r t  (210) and 




^GURE 7 4 : H ydrogen -1 -n u c lea r m agnetic  reso n an ce  s p e c t r a  o f 
(a )  c o lo u r le s s  g o ld  sodium  th io m a la te  (0,13M) and (h ) th e  same 
sample a f t e r  u l t r a - v i o l e t  i r r a d i a t i o n  (300 nm) f o r  750 m inu tes,
I n t e n s i t y  i s  m easured on th e  o r d in a te .  5, th e  d o w n fie ld  s h i f t  
in  p .p .m . from  te t r a m e th y l s i l a n e , i s  m easured on th e  a b s c is s a .  
The d i f f e r e n c e  in  th e  p a t te r n s  ojp th e s e  s p e c t r a  a re  c o n s is te n t  
w ith  a  s ig n i f i c a n t  change in  th e  l ig a n d .
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Gold sodium th io m a la te  h as  been  m arketed  com m ercially  
f o r  c l i n i c a l  u se  f o r  more th a n  50 y e a rs  (87 ) . At th e  tim e o f  i t s  
in t r o d u c t io n ,  a lth o u g h  t h i s  c o lo u r  change in  go ld  sodium th io m a la te  
must have been o b se rv ed , a v a i la b le  chem ica l e x p e r t is e  was p ro b ab ly  
i n s u f f i c i e n t  to  e x p la in  th e  m o lecu la r  b a s i s  f o r  th e  change. I t  
can o n ly  be presum ed t h a t  f a m i l i a r i t y  w ith  t h i s  c o lo u r  change 
e x p la in s  th e  f a i l u r e  o f  th e  c h em is ts  in  th e  p h a rm a c e u tic a l in d u s tr y  
to  in v e s t ig a t e  t h i s  f u r t h e r  u n t i l  th e  p r e s e n t  tim e . The r e s e a r c h  
work in  t h i s  c h a p te r  h as  r e k in d le d  t h e i r  i n t e r e s t  and in  a d d i t io n  
to  th e  r e s u l t s  r e p o r te d  h e re ,  many f u r t h e r  e x te n s io n s  o f  t h i s  work 
a r e  p lanned  o r  a r e  in  an e a r ly  s ta g e  o f developm ent. These f u r t h e r  
s tu d ie s  have shown t h a t  in d e ed  n o t o n ly  i s  th e  yellow  s o lu t io n  o f 
g o ld  sodium th io m a la te  a  m ix tu re  b u t  t h a t  th e  o r ig in a l  s o l id  (w h ite  
powder) can be s e p a ra te d  in t o  two com ponents; one which r e s u l t s  in  
a  c o lo u r le s s  s o lu t io n  when mixed w ith  s t e r i l e  w a te r and one which 
r e s u l t s  in  a  y e llo w  s o lu t io n  when mixed w ith  s t e r i l e  w a te r . I f  b o th  
o f  th e s e  s o lu t io n s  a re  h e a te d , th e  c o lo u r le s s  s o lu t io n  rem ains 
c o lo u r le s s  and th e  ye llow  s o lu t io n  becomes a  d e e p e r y e llo w . F u l l  
r e p o r t in g  o f  th e s e  d e t a i l s  a r e  o u ts id e  th e  scope o f  t h i s  t h e s i s  
p a r t i c u l a r l y  a s  th e  chem ica l e x t r a c t io n  p ro c e s s e s  in v o lv ed  a re  th e  
s u b je c t  o f  a  p a te n t  a p p l ic a t io n  by McMaster U n iv e r s i ty  on b e h a lf  o f 
P ro fe s s o r  C o lin  J .L .  Lock, M iss D ebra A. Harvey (Ph.D . s tu d e n t)  
and m y se lf .
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I n  th e  b io lo g ic a l  s tu d ie s  th e  e f f e c t  o f th e  c o lo u r le s s  
and y e llow  s o lu t io n  o f g o ld  sodium th io m a la te  on th e  mixed lympho­
c y te  c u l tu r e  were c o n s is te n t  w ith  th e  f in d in g s  o f p re v io u s  a u th o rs  
( 2 l4 - 2 iy ) ,  nam ely t h a t  g o ld  sodium th io m a la te  ov er a  range o f 
c o n c e n tra t io n s  added on day one o f  th e  mixed lym phocyte c u l tu r e ,  
r e s u l t e d  in  i n h i b i t i o n  o f th e  mixed lym phocyte re sp o n se . Thus, 
th e  ye llow  component p r e s e n t  i n  th e  com m ercia lly  a v a i la b le  g o ld  
sodium th io m a la te  p r e p a ra t io n  i s  n o t th e  a c t iv e  component re sp o n ­
s i b l e  f o r  th e  in h i b i t i o n  o f th e  mixed lym phocyte resp o n se  and c l e a r ly  
any o th e r  changes induced  by th e  h e a t  s t e r i l i s a t i o n  p ro c e ss  d u rin g  
m arke ting  (lOO°G f o r  30 m in u tes) a r e  n o t n e c e ssa ry  f o r  th e  in h ib ­
i t i n g  e f f e c t  o f  g o ld  sodium th io m a la te  on lym phocy tes.
Both th e  c o lo u r le s s  and ye llow  s o lu t io n s  o f g o ld  sodium 
th io m a la te  in h ib i te d  th e  e f f e c t  o f  th e  s e r in e  e s te r a s e  throm bin  on 
washed human p l a t e l e t s .  (T h is  w i l l  be f u r t h e r  d is c u s se d  in  C hap ter 
V I I I ) .  As w ith  th e  i n h i b i t i o n  o f  th e  mixed lym phocyte re sp o n se , i t  
i s  e v id e n t t h a t  th e  y e llo w  component i s  n o t  n e c e ssa ry  f o r  th e  
in h i b i t i o n  o f  th e  s e r in e  e s te r a s e  th ro m b in .
E le c tro n  m icroscopy and p l a t e l e t  a g g re g a tio n  s tu d ie s  i l l u s ­
t r a t e d  t h a t  a t  l e a s t  one d if f e r e n c e  betw een th e  c o lo u r le s s  and 
y e llo w  s o lu t io n s  o f  go ld  sodium th io m a la te  was t h a t  th e  ye llo w  s o lu ­
t i o n  c o n ta in e d  a  p a r t i c u l a t e  component IOO-7OO nm in  d ia m e te r , w here­
a s  th e  c o lo u r le s s  s o lu t io n  c o n ta in e d  p a r t i c l e s  o f  l e s s  th a n  40 nm. 
Energy d is p e r s iv e  a n a ly s i s  re v e a le d  t h a t  t h i s  p a r t i c u l a t e  m a te r ia l  
found in  p l a t e l e t s  t r e a t e d  w ith  b o th  c o lo u r le s s  and yellow  s o lu t io n s
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o f  go ld  sodium th io m a la te  c o n ta in e d  g o ld  and su lp h u r  in  q u a n t i ­
t i e s  g r e a t e r  th a n  ex p ec ted  f o r  a  norm al p l a t e l e t  n o t t r e a t e d  w ith  
g o ld  sodium th io m a la te .  The g o ld  and su lp h u r a r e  most l i k e l y  from 
th e  g o ld  sodium th io m a la te  a s  has  p re v io u s ly  been su g g e s te d , and 
th e  m orphology o f membrane bound, r o d - l ik e  p a r t i c l e s  i s  a l s o  
s im i la r  to  t h a t  d e s c r ib e d  in  th e  r a b b i t  sy n o v ia l t i s s u e  by G h a d la lly
( 227) .  I t  i s  a l s o  a p p a re n t t h a t  th e  ye llow  s o lu t io n  cau ses  an ADP 
dependent p l a t e l e t  a g g re g a tio n . T h is  ADP dependent a g g re g a tio n  i s  
analogous t o , t h e  e f f e c t  o f  l a t e x  p a r t i c l e s  on p l a t e l e t s  a s  observed  
by Movat e t  a l  (2 2 8 ) . P l a t e l e t  p h a g o c y to s is  o f  l a t e x  p a r t i c l e s
i s  accom panied by ADP r e le a s e  which le a d s  to  p l a t e l e t  a g g re g a tio n
( 228) s im i la r  to  t h a t  observed  f o r  th e  y e llo w  s o lu t io n  o f g o ld  sodium 
th io m a la te .  The l o c a l i s a t i o n  o f  th e  p a r t i c u l a t e  component o f  th e  
y e llo w  s o lu t io n  o f go ld  sodium th io m a la te  in  phagolysosom es i s  n o t 
s u r p r i s in g ,  s in c e  i t  i s  an a lo g o u s to  th e  f in d in g s  o f  Lewis and c o -  
w orkers who showed t h a t  p l a t e l e t s  ta k e  up p a r t i c l e s  in to  v acu o les  
w hich c o n ta in  a c id  p h o sp h a tase  ( i . e .  phagolysosom es) ( 229) and th a t  
th e  e le c t r o n  m ic ro sco p ic  morphology i s  s im i la r  to  th a t  d e s c r ib e d
f o r  o th e r  p h ag o cy tic  c e l l s  w hich have been exposed to  g o ld  sodium 
th io m a la te ,  e i t h e r  in  v i t r o  o r  in  v ivo  ( 227 , 230- 232) .
I t  i s  e v id e n t t h a t  th e  th e rm a l s t e r i l i s a t i o n  o f  go ld  sodium 
th io m a la te  s o lu t io n  cau ses  a  chem ical change and th e  r e s u l t a n t  form a­
t io n  o f  a new s p e c ie s  w ith  d i f f e r e n t  b io lo g ic a l  a c t i v i t y  from  th e  
s t a r t i n g  compound, a t  l e a s t  in  i t s  in t e r a c t io n  w ith  th e  p l a t e l e t .
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The e x a c t chem ical s t r u c tu r e  o f  g o ld  sodium th io m a lte  i s  unknown, 
h u t i s  presum ed to  be a  polym er (201 , 2 02 ). My c o lle a g u e s  and I  
do n o t know th e  e x a c t n a tu re  o f e i t h e r  th e  c o lo u r le s s  o r y e llo w  
form o f th e  compound a t  p r e s e n t  b u t one cou ld  p o s tu la te  t h a t  th e y  
a re  b o th  polym ers o f d i f f e r e n t  s i z e .  I t  h as  been su g g es ted  t h a t  
th e  new s p e c ie s  may be an o x id a tio n  p ro d u c t s in c e  Au( S O N ) h a s  
an a b s o rp tio n  a t  4^0 nm (2 3 3 ). T h is  e x p la n a tio n  i s  u n l ik e ly  a s  
a t te m p ts  to  cause o x id a tio n  w ith  d ioxygen (O^) were u n s u c c e s s fu l 
and P ro fe s s o r  C o lin  J .L ,  Lock and h i s  c o lle a g u e  D r. Adam H itchcock  
( i n s t i t u t e  f o r  M a te r ia ls  R esea rch , McMaster U n iv e rs ity )  have shown 
t h a t  by X -ray  A bso rp tio n  N ear Edge S p ec tro sco p y  (XANES) ( a t  th e  
C o rn e ll High Energy S y n ch ro tro n  S ource) ( f ig u r e  75) t h a t  th e  upper 
l i m i t  f o r  Au( i l l )  in  th e  ye llow  g o ld  sodium th io m a la te  sam ple i s  2^.
A com parison o f c o rre sp o n d in g  XANES and U.V. v i s i b l e  s p e c t r a  ( f ig u re  
75 and 56 ) o f  a  sam ple o f  c o lo u r le s s  g o ld  sodium th io m a la te  (3*2x10 %  
a s  e le m e n ta l g o ld ) iz rra d ia te d  f o r  5OO m inu tes a t  350 nm shows th a t  
Au ( i l l )  can n o t be th e  cause  o f  th e  c o lo u ra tio n  o f go ld  sodium th i o ­
m a la te . The XANES s p e c t r a  o f  H Au(XIl)Cl^ and g o ld  sodium th io m a la te  
i r r a d i a t e d  w ith  350 nm l i g h t  f o r  500 m inu tes a re  shown in  f ig u r e  75* 
A llow ing f o r  th e  e r r o r  caused  by n o is e ,  i t  i s  p o s s ib le  to  e s t a b l i s h  
t h a t  th e  g o ld  sodium th io m a la te  sam ples has an u pper l i m i t s  o f  2^ o 
Au ( i l l )  i f  th e  a b s o rp tio n  a t  11 .915  KEV ( e le c t r o n  v o l t s )  i s  caused  
by Au ( h i ) .  The U.V. v i s i b l e  s p e c ta  ( f ig u r e  56 ) shows t h a t  th e  same 
sample a t  5OO m inu tes h as  an abso rb an ce  ( o p t i c a l  d e n s i ty )  a t  450 nm 
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an abso rbance o f  0,055 a.t th e  same w avelength  and c o n c e n tra tio n  
( f ig u r e  55 i t ) • I f  we assume t h a t  th e  peak a t  450 nm i s  caused 
by Au ( h i )  we can e s t im a te  th e  minimum c o n c e n tra t io n  o f Au ( i l l )  
n e c e ssa ry  to  cause  a b s o rp t io n .  The a b so rp tio n  a t  455 nm in  th e  
U.V. v i s ib l e  spectrum  of Au(SCïï) ^  (m easured a t  3OOK) (233) has 
a  m olar e x t in c t io n  c o e f f i c i e n t  ( e )  of 5^1 and o th e r  Au( i l l )  com­
p lex es  have s im i la r  v a lu e s  f o r  th e  same a b s o rp tio n . S in ce  a b so r­
bance = GC&, where c i s  th e  c o n c e n tra tio n  in  mole L  ^ and i  i s  
th e  p a th  in  c e n t im e tre s  (one cm c e l l s  were u sed ) we can w r ite
3 ,0  = 361 X c X 1 
Thus th e  minimum c o n c e n tra t io n  of Au ( i l l )  i s  g iv en  b y : -
c = 3 .0  mole L” ^
561
However, th e  t o t a l  g o ld  p r e s e n t  i s  1 2 .5  mole L ^, th e r e f o r e  th e
390
p e rc e n ta g e  o f Au ( I I I )  i s : -
5^1 ^ 12^5 ^ “ 1 6 . 7^
A maximum Au( i l l )  c o n te n t o f 2% a s  de term ined  by XANES ( f ig u r e  75)
i s  th e r e f o r e  in c o n s i s t e n t  w ith  a  minimum Au ( i l l )  c o n te n t o f  l 6 .7 ^ .  
T h e re fo re  th e  b a s ic  a ssu m p tio n , nam ely th a t  th e  change in  th e  
c h a r a c t e r i s t i c s  p r e s e n t  in  th e  ye llow  s o lu t io n  o f  go ld  sodium t h i o ­
m ala te  i s  due to  Au (h i ) ,  i s  wrong. I n  c o n c lu s io n , in  th e se  e x p e r i­
m ents in v o lv in g  U.V. v i s ib l e  i r r a d i a t i o n ,  ( f ig u re  5^) A u(l) i s  n o t 
o x id ise d  to  Au( i l l ) .
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The exp erim en ts  r e p o r te d  in  t h i s  c h a p te r ,  d e s c r ib e  th e  
s o lu t io n s  o f go ld  sodium th io m a la te :  a  y e llo w  s o lu t io n  which i s  
c u r r e n t ly  m arketed and a v a i la b l e  f o r  human u s e ;  and a  c o lo u r le s s  
s o lu t io n  p re p a re d  by d is s o lv in g  O.IJM of s o l id  (w h ite  powder) in  
s t e r i l e  w a te r . D if fe re n c e s  betw een th e s e  two s o lu t io n s  were 
observed  f o r :  s p e c t r a l  a b s o rp tio n  v i s i b i l i t y ;  p l a t e l e t  a g g re g a tio n ; 
and e le c t r o n  m icroscopy . S im i la r  r e a c t io n s  f o r  th e  two s o lu t io n s  
were i d e n t i f i e d  by : mixed lym phocyte c u l tu r e  i n h i b i t i o n ;  throm bin  
enzyme in h i b i t i o n  and; n u c le a r  m agnetic  re so n an ce  ( f ig u r e  5 ^ ) . 
These f in d in g s  in d i c a te  th a t  g o ld  sodium th io m a la te  a s  c u r r e n t ly  
m arketed  f o r  human u se  i s  a  m ix tu re . I t  i s  p o s s ib le  th a t  th e  
r e s u l t s  o f  th e s e  s tu d ie s  have im p o rta n t c l i n i c a l  co nsequences. 
About 60- 70% o f p a t i e n t s  w ith  rheum ato id  a r t h r i t i s  respond  to  
t r e a tm e n t w ith  g o ld  sodium th io m a la te  (1 0 8 , 109 , llO )  and 10% show 
com plete re m is s io n  ( l 2 4 ) . U n fo r tu n a te ly  a  s e r io u s  l i m i t i n g  f a c t o r  
to  th e  c o n t in u a tio n  o f therapy a re  th e  ad v erse  e f f e c t s  w hich occur 
in  a s  many a s  3f% o f p a t i e n t s  ( l 2 4 ) . I f  th e  component o f  th e  
s o lu t io n  o f  g o ld  sodium  th io m a la te  which cau ses  th e  to x ic  resp o n se  
i s  d i f f e r e n t  from  th e  component w hich cause th e  d e s i r a b le  re sp o n s e , 
s e p a ra t io n  o f  th e  com ponents o f  th e  o r ig in a l  s o l id  g o ld  sodium  
th io m a la te  may y ie ld  a  d rug  w ith  more d e s i r a b le  p r o p e r t i e s .
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SUMMARY
The chem ical s t r u c t u r e  o f  th e  most commonly u sed  a n t i -  
a r t h i d t i c  g o ld  compound i s  unknown d e s p i te  th e  f a c t  t h a t  go ld  
sodium th io m a la te  has  been u sed  i n  c l i n i c a l  p r a c t ic e  f o r  50 y e a rs  
in  th e  tre a tm e n t o f  rheu m ato id  a r t h r i t i s .  A ttem pts to  d e te rm in e  
th e  s t r u c t u r e  by X -ray  c r y s ta l lo g ra p h y  have r e s u l t e d  in  a  f a i l u r e  
because  o f  th e  d i f f i c u l t y  in  o b ta in in g  c r y s t a l s  and i t  i s  on ly  
by in fe re n c e  based  on th e  p r o p e r t i e s  o f  g o ld  compounds t h a t  
ch em ists  have su g g e s te d  t h a t  g o ld  sodium th io m a la te  may be a  sm all 
po lym er, f o r  example a  hexam er. A pproxim ately  th r e e  y e a rs  ago I  
n o te d  t h a t  sam ples o f  g o ld  sodium th io m a la te  su p p lie d  by Rhone- 
P o u le n c , Quebec, f o r  my re s e a r c h  p u rp o ses  were c o lo u r le s s  and n o t 
th e  f a m i l i a r  y e llo w  s o lu t io n  known to  rh e u m a to lo g is ts  who t r e a t  
p a t i e n t s  w ith  i n j e c t a b l e  g o ld  sodium th io m a la te .  I  e n q u ire d  o f  
th e  company a s  to  th e  c o lo u r  d is c re p a n c y  and was in fo rm ed  t h a t  
b o th  th e  c o lo u r le s s  and ye llow  s o lu t io n  a re  p rep a red  i d e n t i c a l l y  
ex cep t f o r  one s te p .  I f  th e  o z d g in a l s o l id  g o ld  sodium th io m a la te  
(w h ite  powder) i s  d is s o lv e d  in  s t e r i l e  w a te r to  50 mg o f compound 
p e r  m l, a  c o lo u r le s s  s o lu t io n  r e s u l t s .  However, a s  a  f i n a l  s t e r i ­
l i s a t i o n  s te p  in  th e  p re p a ra t io n  f o r  human u s e , th e  c o lo u r le s s  
s o lu t io n  i s  h e a te d  a t  100°G f o r  30 m inu tes and a  ye llow  s o lu t io n  
r e s u l t s .  S in ce  th e s e  compounds have id e n t i c a l  c o n c e n tra t io n s ,  
c l e a r ly  some change had o c c u rre d  d u r in g  th e  h e a t  s t e r i l i s a t i o n  
p ro c e d u re . I n  o rd e r  to  d e te rm in e  any p h y s ic a l ,  chem ical o r  b io ­
lo g i c a l  changes which m ight have o c c u rre d , th e  compound was th e n
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su b je c te d  to  a  s e r i e s  o f  e x p e rim e n ts : n u c le a r  m agnetic  re so n a n c e , 
u l t r a - v i o l e t  v i s ib l e  i r r a d i a t i o n ,  x - r a y  a b s o rp tio n  n e a r  edge 
sp e c tro sc o p y  to  d e te rm in e  any p h y s ic a l  and chem ical change; mixed 
lym phocyte c u l tu r e  re sp o n se  to  d e te rm in e  e f f e c t  on one arm o f  th e  
immune mechanism; and p l a t e l e t s  in  o rd e r  to  d e te rm in e  any i n t e r ­
a c t io n  w ith  th e  th rom bin  enzyme and th e  p h ag o cy tic  c a p a c ity  o f 
th e  p l a t e l e t .
N u c lea r m agnetic  re so n an ce  s tu d ie s  (N.M .R.) dem on stra ted  
t h a t  th e re  was no s i g n i f i c a n t  d i f f e r e n c e  in  th e  s p e c t r a  o f th e  
c o lo u r le s s  and yellow  s o lu t io n ,  b u t u l t r a - v i o l e t  v i s ib l e  i r r a d i a ­
t i o n  s p e c tr a  in d ic a te d  t h a t  th e r e  was a  g r e a t e r  a b s o rp tio n  f o r  
th e  yellow  s o lu t io n  in  th e  350-^50 nm ra n g e . I n  o rd e r  to  fo llo w  
th e  c o lo u r  change from  c o lo u r le s s  to  y e llo w , th e  c o lo u r le s s  
s o lu t io n  (3*2x10 ^  a s  e le m e n ta l g o ld )  was i r r a d i a t e d  w ith  u l t r a ­
v i o l e t  l i g h t  (350 nm) o v er a  p ro lo n g ed  tim e p e r io d .  O p tic a l o b se r­
v a tio n  made in  th e  400-500 nm r e g io n s  dem on stra ted  t h a t  th e  yellow  
c o lo u r  was caused  b y ,a n  a b s o rp tio n  a t  450 nm.
P rev io u s  a u th o rs  have shown t h a t  go ld  sodium th io m a la te  
i n h i b i t s  th e  mixed lym phocyte re s p o n s e . I n  my ex p e rim en ts , a d d i t io n  
o f  b o th  th e  c o lo u r le s s  and y e llo w  s o lu t io n s  of go ld  sodium t h i o ­
m ala te  i n  th e  c o n c e n tra t io n  ran g e  3*8x10  ^ -  3*OxlO"^ (a s  e le m e n ta l 
g o ld )  i n h ib i t e d  th e  mixed lym phocyte re sp o n se . Thus th e  changes 
w hich o ccu r d u rin g  th e  h e a t  s t e r i l i s a t i o n  p ro c e ss  a re  n o t n e c e ss a ry  
f o r  t h i s  p ro p e r ty  o f g o ld  sodium th io m a la te .
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In  p l a t e l e t  s tu d ie s ,  b o th  th e  c o lo u r le s s  and ye llow  
s o lu t io n s  o f  go ld  sodium th io m a la te  were shown to  i n h i b i t  p l a t e ­
l e t  a g g re g a tio n  by th e  s e r in e  e s te r a s e  th rom bin . T h e re fo re , th e  
h e a t s t e r i l i s a t i o n  p ro c e s s  (lOO^G f o r  30 m inu tes) was n o t e s s e n t i a l  
t o  produce t h i s  p ro p e r ty .  However, a  d if f e r e n c e  was observed  when 
th e  c o lo u r le s s  and y e llo w  s o lu t io n s  o f  go ld  sodium th io m a la te  
(1 . 3x10”^ -  6.4x10"^M a s  e le m e n ta l g o ld ) were added to  washed human 
p l a t e l e t s .  The c o lo u r le s s  s o lu t io n  had no e f f e c t  on p l a t e l e t s ,  b u t 
th e  y e llo w  s o lu t io n  produced  an ADP dependent p l a t e l e t  a g g re g a tio n .
When th e s e  p l a t e l e t s  were exam ined by e le c t r o n  m icroscopy , an 
i r r e g u l a r  p a r t i c u l a t e  component IOO-7OO nm in  d ia m e te r  was i d e n t i ­
f i e d  in  p l a t e l e t s  t r e a t e d  w ith  y e llo w  go ld  sodium th io m a la te .  I n  
p l a t e l e t s  t r e a t e d  w ith  c o lo u r le s s  g o ld  sodium th io m a la te ,  a  p a r t i ­
c u la te  component m easuring  l e s s  th a n  40 nm was o b se rv ed . Energy 
d is p e r s iv e  a n a ly s i s  d em o n stra ted  t h a t  th e s e  p a r t i c l e s  from  b o th  
so u rc e s  co n ta in e d  g o ld  and s u lp h u r .  Gold th io g lu c o s e ,  g o ld  t h i o -  
s u lp h a te ,  A u ra n o f in ^  and d isodium  th io m a la te  in  eq u im o lar concen­
t r a t i o n s  had no e f f e c t  on p roducing  p l a t e l e t  a g g re g a tio n  n o r  was 
any p a r t i c u l a t e  component i d e n t i f i e d  in  p l a t e l e t s  t r e a t e d  w ith  th e s e  
compounds.
The d i f f e r e n t i a l  p r o p e r t i e s  o f  th e  c o lo u r le s s  and y e llo w  
s o lu t io n  o f g o ld  sodium th io m a la te  f o r  some in v e s t ig a t io n s ,  d e s c r ib e d  
ab o v e , c o n tra s te d  by p e r s is te n c e  o f  c e r t a in  p r o p e r t i e s  fo llo w in g  
h e a t s t e r i l i s a t i o n  ( e .g .  i d e n t i c a l  e f f e c t  on mixed lym phocyte c u l tu r e ) ,  
c l e a r l y  in d ic a te  t h a t  go ld  sodium th io m a la te  a s  c u r r e n t ly  m arketed 
f o r  human use  i s  a  m ix tu re .
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T h is  o b s e rv a tio n  h as  p o s s ib le  im p o rta n t consequences.
The b e n e f i c i a l  re sp o n se  to  g o ld  sodium th io m a la te  i s  seen  in  
60- 70% o f p a t i e n t s  w ith  rheum ato id  a r t h r i t i s  b u t 35% o f  p a t i e n t s  
e x p e rie n c e  a  t o x i c i t y .  I f  th e  component o f th e  compound which 
cau ses  some o r  a l l  o f th e  ad v erse  e f f e c t s  i s  d i f f e r e n t  from  t h a t  
which r e s u l t s  in  th e  b e n e f i c i a l  e f f e c t s ,  s e p a ra t io n  o f  th e  
com ponents o f th e  s o lu t io n  may y ie ld  a  d rug  w ith  more d e s i r a b le  
p r o p e r t i e s .
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"Ah, h u t a  m an 's re a c h  
shou ld  exceed  h i s  g ra s p , 
Or w h a t 's  a  heaven f o r . "
R obert Browning ( l 8 l 2-1889)
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INTRODUCTION
The o b se rv a tio n  th a t  g o ld  sodium th io m a la te ,  a s  c u r r e n t ly  
m arke ted , i s  a  m ix tu re  has been a  m ajor fo c u s  o f my re s e a r c h  i n t e r e s t  
and t h a t  o f  my c o lle a g u e s  ov er th e  p a s t  y e a rs  b u t i t  i s  n o t th e  
o n ly  m ajor o b se rv a tio n  w hich has been en co u n te red  in  th e  co u rse  o f 
my re s e a rc h  on th e  a n t i - a r t h r i t i c  go ld  com plexes. I n  1980 w hile  
i n v e s t ig a t in g  th e  i n t e r a c t io n  o f v a r io u s  g o ld  compounds w ith  human 
p l a t e l e t s ,  I  d is c o v e re d  t h a t ,  o f a l l  th e  a n t i - a r t h r i t i c  g o ld  com plexes 
c u r r e n t ly  a v a i la b l e ,  o n ly  go ld  sodium th io m a la te  i n h ib i t e d  th e  throm ­
b in  enzyme. I t  was im m ed ia te ly  obv ious t h a t  t h i s  e f f e c t  o f th e  go ld  
sodium th io m a la te  had p o s s ib le  f a r  re a c h in g  im p lic a t io n s  and c e r t a in ly  
re q u ire d  f u r t h e r  in v e s t ig a t io n .  I n  th e  p u r s u i t  o f th e s e  in v e s t ig a t io n s  
I  am in d e b te d  to  th e  fo llo w in g  peop le  f o r  t h e i r  ad v ice  and c r i t i c i s m ;  
P ro fe s s o r  J ,  F r a s e r  M ustard , p ro fe s s o r  o f pa th o lo g y  (fo rm er V ice- 
P re s id e n t  o f  H ea lth  S c ie n c e s ) ;  P ro fe s s o r  R aelene K in lough-R athbone, 
p ro fe s s o r  o f p a th o lo g y ; P ro fe s s o r  Jack  H irsh , Chairman o f  th e  D e p a rt­
ment o f M edicine; P ro fe s s o r  W. Watson Buchanan, R eg ional C o -o rd in a to r  
o f  Rheum atology, and P ro fe s s o r  C o lin  J .L .  Lock, I n s t i t u t e  f o r  M a te r ia ls  
R esearch , a l l  o f  McMaster U n iv e r s i ty .  I  am a ls o  in d e b te d  to  Mrs. D iana 
Somers (Ph.D . s tu d e n t ,  D epartm ent o f P a tho logy ) who ta u g h t me th e  
s u r g ic a l  te c h n iq u e  f o r  my an im al ex p e rim en ts .
A lthough g o ld  sodium th io m a la te  has been u sed  in  th e  tre a tm e n t 
o f  rheum ato id  a r t h r i t i s  s in c e  th e  e a r ly  1930 ' s  (87 ) i t s  d e f in i t i v e  
mechanism o f a c t io n  i s  unknown. Numerous mechanisms so f a r  i d e n t i ­
f i e d  b o th  in  v i t r o  and in  v ivo  have been p o s tu la te d  a s  b e in g  c o n t r i ­
b u to ry  to  th e  mode o f a c t io n  o f  th e  g o ld  compounds in  a c u te  in flam m ato ry  
rheum ato id  a r t h r i t i s .  Among th e se  a c t io n s  a re  th e  in h i b i to r y  e f f e c t s
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o f  th e  g o ld  t h i o l  com plexes on th e  h y d ro ly t ic  enzymes (234, 235) 
such  a s  th e  s e r in e  e s te r a s e  enzymes e la s t a s e  and c a th e p s in  G ( 236 ,
237) .  Thus my i n i t i a l  f in d in g s  t h a t  go ld  sodium th io m a la te  in h ib i te d  
th e  a c t io n  o f th rom bin  in  v i t r o  shou ld  n o t have come a s  a  s u r p r is e  
s in c e  throm bin  i s  a ls o  a  s e r in e  e s t e r a s e ,  b u t I  have a s  y e t found 
no r e fe re n c e s  in  th e  m edial l i t e r a t u r e  o th e r  th a n  my own (238  -  240) 
t h a t  g o ld  sodium th io m a la te  i n h i b i t s  th e  a c t io n  o f th rom bin  in  v i t r o  
and in  v iv o . T h is  c h a p te r  o u t l in e s  some o f  th e  r e s u l t s  and r e s e a rc h  
te c h n iq u e s  used  in  th e  in v e s t ig a t io n  o f  th e  a c t io n  o f  th e  a n t i - a r t h r i t i c  
go ld  com plexe# on th e  th rom bin  enzyme.
^ D e ta i l s  o f  th e  e f f e c t  o f th e  s e p a ra te d  components o f o r ig in a l  go ld  
sodium th io m a la te  s o l id  (a s  a l re a d y  d is c u s s e d  in  c h a p te r  V II) on 
th e  th rom bin  enzyme can n o t be g iv e n  a s  th e se  d e t a i l s  a re  th e  s u b je c t  
o f a  p a te n t  a p p l ic a t io n  in  Canada and th e  U .S .A . by McMaster U n iver­
s i t y ,  on b e h a lf  o f  P ro fe s s o r  C o lin  J .L .  Lock, M iss D ebra A. H arvey, 
(Ph.D . s tu d e n t)  and th e  a u th o r  o f  t h i s  t h e s i s .
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MATERIALS
Gold sodium th io m a la te  (M y o c h r is in e ^ )  was su p p lie d  g r a t i s  
by R hone-Poulenc, Quebec, a s  th e  y e llo w  s o lu t io n  in  v ia l s  a s  c u r r e n t ly  
m arketed f o r  human u s e . Gold th io g lu c o s e  and th io m a lic  a c id  were 
o b ta in e d  from  th e  Sigma Chem ical C o ., S t .  L o u is , M is so u ri, U .S .A .
Gold sodium th io s u lp h a te  was p re p a re d  in  th e  B io - in o rg a n ic  m edicine 
l a b o r a to r i e s  a t  McMaster U n iv e r s i ty  a f t e r  th e  method o f  Brown (2 0 4 ).
2 ,3 ,4 ,6 - t e t r a - o r t h o - a c e t y l - 1 - t h i  o -g -D -g lu co p y ran o sa t o-S- ( t r i  e th y l -  
phosph ine) g o ld (A u ra n o f in ^ )  was su p p lie d  g r a t i s  by S m ith , K lin e  and 
F ren ch , P h i la d e lp h ia ,  U .S .A . D isodium  th io m a la te  was p re p a re d  by th e  
a d d i t io n  o f  1 m olar sodium h yd rox ide  (NaOH) to  th io m a lic  a c id  19 mg/ml 
u n t i l  a  pH o f 7*75 was o b ta in e d , A uranofin  i s  in s o lu b le  in  w a te r .
F o r th e  p l a t e l e t  s tu d ie s  a  s to c k  s o lu t io n  was p re p a re d  by d is s o lv in g  
17 mg o f  compound in  0 .5  ml o f  a b s o lu te  a lc o h o l (G^H^OH) fo llo w ed  by
-4th e  a d d i t io n  o f  0 .5  ml o f w a te r to  ach ie v e  a  c o n c e n tra tio n  o f  5*1x10 M 
ex p re sse d  a s  e lem en ta l g o ld . S u i ta b le  a lc o h o l c o n t ro l  c o n c e n tra t io n s  
were u sed  f o r  each d i l u t i o n  o f  A urano fin  added to  th e  p l a t e l e t  su spen ­
s io n s  .
A ll go ld  compounds l i s t e d  in  t h i s  c h a p te r  a re  ex p re sse d  a s  
m olar q u a n t i t i e s  o f e le m e n ta l g o ld .
Bovine th rom bin  was o b ta in e d  from  M iles L a b o ra to r ie s ,  Kankakee, 
I l l i n o i s ,  U .S .A . A tro p in e  was o b ta in e d  from  Aleon L a b o ra to r ie s ,  
M is s is sa u g a , O n ta r io . Ketam ine h y d ro c h lo r id e  was o b ta in e d  from  P arke-  
D av is , S carbo rough , O n ta rio  and p e n to b a rb i to l  sodium was o b ta in e d  from  
A bbott L a b o ra to r ie s ,  Don M il l s ,  O n ta r io .  Bovine album in (P en tax  
F ra c tio n  V) was o b ta in e d  from  M iles L a b o ra to r ie s ,  Kankakee, I l l i n o i s ,
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U .S .A . R a d io a c tiv e  s e ro to n in  - s e ro to n in )  was o b ta in e d  from 
A m ersham /Searle, A r lin g to n  H e ig h ts , I l l i n o i s  a s  5 -h y d ro x y try p ta -  
mine-3'^-^^G- c r e a t in e  s u lp h a te ,  57 mCi/mmol, and r a d io a c t iv e  
chromium (^^G r) a re  Na^'^GrO ^, 100-400 mCi/mg o f Or was o b ta in e d  
from  New England N u c le a r , L ac h in e , Quebec. Sodium h e p a r in  was 
o b ta in e d  from  H a r r is  L a b o ra to r ie s ,  West H i l l ,  O n ta r io . P l a s t i c  
c a th e te r s  u sed  in  an im al s tu d i e s ,  P .E .90  and P .E .19O p o ly e th y le n e , 
were o b ta in e d  from  C lay  Adams C o ., New York, U .S .A .
METHODS ; IN VITRO STUDIES 
PREPARATION OF WASHED HUMAN PLATELETS
Washed human p l a t e l e t  su sp e n s io n s  were p re p a re d  by th e  
method o f  M ustard e t  a l  (2 2 0 ) . B r ie f l y ,  129 ml o f  b lo o d  was 
o b ta in e d  by a n t i - c u b i t a l  v e in  p u n c tu re  from v o lu n te e r s .  V o lu n te e rs  
were s e le c te d  who were on no m e d ica tio n s  and had ta k e n  no m e d ica tio n  
f o r  two w eeks. The b lood  was im m ed ia te ly  t r a n s f e r r e d  in  eq u a l 
volumes to  3 p l a s t i c  c e n t r i f u g e  tu b e s  (50 m l) , each  c o n ta in in g
7 ml o f  a c i d - c i t r a t e - d e x t r o s e  (ACD) a n t ic o a g u la n t  s o lu t io n ,  a s  
d e s c r ib e d  by A s te r  and H andle ( 2 2 l ) , The whole blood-ACD m ix tu re  
was g e n t ly  b u t r a p id ly  mixed to  p re v e n t c l o t t i n g .  The su sp e n sio n  was 
th e n  c e n tr i fu g e d  a t  37°G in  an R .G .3 S o rv a l c e n t r i f u g e  a t  1200g f o r
8 m in u te s . The p l a t e l e t - p o o r  p lasm a was d is c a rd e d  and th e  p l a t e ­
l e t s  were suspended in  T yrodes s o lu t io n  c o n ta in in g  0.35% album in and 
50 u n i t s /m l  o f h e p a r in  (2 2 0 ,2 2 2 ) , Apyrase p re p a re d  ac c o rd in g  to  
M olnar and L or and ( 223) ,  w ith  a  n u c le o tid a s e  a c t i v i t y  o f  5*3 n n i t s  
o f  ad en o sin e  d iphosphate /m g  and 4 .2  u n i t s  o f ad en o sin e  t r ip h o s p h a te /  
mg was in c lu d e d  in  th e  T yrodes album in s o lu t io n  a t  a  c o n c e n tra tio n  o f
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10 p l/m l ( 220 , 224) .  P l a t e l e t s  were in c u b a te d  in  t h i s  f i r s t
l 4w ashing s o lu t io n  o f T yrodes album in w ith  2 yCi of G-s e ro to n in  
and 200 yCi o f  d isodium  chrom ate/m g f o r  30 m in u te s . T h is  f i r s t  
w ashing s o lu t io n  was th e n  c e n tr i fu g e d  a t  1200g f o r  10 m in u tes , th e  
su p e rn a ta n t d is c a rd e d  and th e  p l a t e l e t s  resu sp en d ed  in  Tyrodes 
album in  s o lu t io n  (second  w ashing s o lu t io n )  f o r  10 m in u te s . The 
second w ashing s o lu t io n  o f  p l a t e l e t s  was c e n tr ifu g e d  a t  1200g f o r  
10 m inu tes and th e  s u p e rn a ta n t d is c a rd e d .  The p l a t e l e t s  were su s ­
pended in  a  f i n a l  su sp e n s io n  o f  T yrodes album in and th e  p l a t e l e t  
coun t a d ju s te d  to  500,000/mm^. The p l a t e l e t  su sp e n sio n s  were 
s to r e d  a t  37°G in  a  w a te r b a th  p r io r  to  u s e .
P l a t e l e t  A ggregation  S tu d ie s
P l a t e l e t  a g g re g a tio n  was s tu d ie d  by a  m o d if ic a tio n  o f a  
tu r b id im e tr ic  method a s  p re v io u s ly  d e s c r ib e d  (2 2 0 ) . B r ie f ly ,  l i g h t  
tra n s m is s io n  o f  1 ml su sp e n s io n s  o f  washed p l a t e l e t s  was m easured 
on a  Payton A ggregation  Module (P ay ton  A sso c ia te s , S carborough , 
O n ta r io , Canada) and re c o rd e d  on a  R ikadenki Pen R ecorder (Kogyo, 
J a p a n ) . P l a t e l e t  shape change and a g g re g a tio n  were reco rd ed  
fo llo w in g  th e  i n t e r a c t io n  w ith  t e s t  compounds ( e .g .  go ld  com plexes) 
and a g g re g a tin g  a g e n ts  ( e .g .  ADP).
P l a t e l e t  R ich Plasm a and P l a t e l e t  Poor Plasm a
Whole b lood  (9 p a r t s )  a n t ic o a g u la te d  w ith  3*8% sodium 
c i t r a t e  ( l  p a r t )  was c e n tr i fu g e d  a t  1200g f o r  3 m inu tes in  an 
R.G.3 S o rv a l C e n tr ifu g e  in  o rd e r  t o  o b ta in  p l a t e l e t  r i c h  plasm a. 
P l a t e l e t  poor plasm a was o b ta in e d  by c e n t r i f u g in g  p l a t e l e t  r i c h  
plasm a a t  1200g f o r  10 m in u tes .
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Thrombin C lo t t in g  Time
Thrombin c l o t t i n g  tim e o f  p l a t e l e t  r i c h  plasm a and 
p l a t e l e t  poor plasm a were m easured i n  a  Hyland G lo tek  System  
(Hyland L a b o ra to r ie s ,  M aiton , O n ta r io ) .  T h is  i s  an a u to m a tic a l ly  
tim ed  in s tru m e n t w hich o p e ra te s  by cau s in g  a  s t e e l  b a l l  b e a r in g  
(6 mm d ia m e te r)  to  o s c i l l a t e  i n  a  g la s s  t e s t  tu b e  (6x75mm) 
c o n ta in in g  300 p i o f  p lasm a. F o llo w in g  th e  a d d i t io n  o f  th rom bin  
(5  u n i t s /m l  f i n a l  c o n c e n tra t io n )  a  f i b r i n  c l o t  form s which c o a ts  
th e  b e a r in g  and s to p s  th e  f r e e  o s c i l l a t i o n  o f th e  b a l l ,  th u s  
s to p p in g  th e  t im e r .  I n  th e  s ta n d a rd  throm bin  c l o t t i n g  tim e  u s in g  
th e  Hyland G lo tek  System , ca lc ium  c h lo r id e  i s  u se d . S in c e  th e  
g o ld  sodium th io m a la te  and th e  ca lc iu m  c h lo r id e  form  a  p r e c i p i t a t e ,  
th e  ca lc iu m  c h lo r id e  h as  been o m itte d  from  th e s e  e x p e rim e n ts .
Under th e s e  c o n d it io n s  th e  c o n t ro l  th rom bin  c l o t t i n g  tim e was in  
th e  o rd e r  o f  17 s e c s ,  (s e e  t a b l e  l 8 ) .
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RESULTS: IN VITRO STUDIES
Bovine throm bin  (0 .0 2 5 -0 .2 5  u n i t s /m l)  added to  washed human
l4p l a t e l e t s  caused  p l a t e l e t  a g g re g a tio n  and r e le a s e  o f G -se ro to n in  
from  p l a t e l e t  g ra n u le s  ( f ig u r e  6o). P r io r  a d d i t io n  (O .5-240 m inu tes) 
o r  s im u ltan e o u s  a d d i t io n  o f go ld  sodium  th io m a la te  (1 .8x10  ^ -  2.5x10 
a s  e le m e n ta l g o ld ) to  th e  1 ml p l a t e l e t  su sp e n sio n  in h ib i te d  th e  e f f e c t  
o f th e  th rom bin  enzyme on th e  washed human p l a t e l e t s  ( f ig u r e  6 0 ) . As 
seen  from  th e  f ig u r e  6 0 , th e  d i f f e r e n c e s  observed  were d ra m a tic  and 
s in c e  th e  o b s e rv a tio n  was c o n s is te n t  w ith  30 s e p a ra te  e x p e rim en ts , 
s t a t i s t i c a l  a n a ly s i s  was n o t r e q u i r e d .  I f  th e  go ld  sodium th io m a la te  
was added a f t e r  th e  a d d i t io n  o f th e  th rom bin  to  th e  p l a t e l e t  s u sp e n s io n , 
in h i b i t i o n  d id  n o t o c c u r . The i n h i b i to r y  e f f e c t  o f g o ld  sodium t h i o ­
m ala te  on th e  throm bin  induced  a g g re g a tio n , was in d ep en d en t o f  th e  
d u ra tio n  o f  in c u b a tio n  o f  th e  g o ld  sodium th io m a la te  w ith  th e  p l a t e ­
l e t s  .
Gold th io g lu c o s e  and g o ld  sodium th io s u lp h a te  in  eq u im o lar 
c o n c e n tra t io n s  o f e le m e n ta l g o ld  and equ im o lar d isodium  th io m a la te  
( i . e .  eq u im o la r c o n c e n tra t io n  o f  th io m a la te  to  th e  th io m a la te  i n  go ld  
sodium th io m a la te )  d id  n o t  i n h i b i t  th e  e f f e c t  o f throm bin  induced  
a g g re g a tio n  on washed human p l a t e l e t s .  A uranofin^^  in  th e  c o n c e n tra ­
t i o n  ran g e  1 .3x10 -  5-lxlO~^M , a s  e le m e n ta l g o ld , d id  n o t i n h i b i t
th e  a c t io n  o f  th rom bin  on washed human p l a t e l e t s .
The e f f e c t  o f  g o ld  sodium th io m a la te  on th e  th rom bin  (5 u n i t s /  
ml) c l o t t i n g  tim e o f p l a t e l e t  r i c h  plasm a and p l a t e l e t  poor plasm a a re
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shown in  T ab le  18 (A r e p r e s e n ta t iv e  experim ent has been shown a s  
an exam ple). A ll c o n c e n tra t io n s  o f  g o ld  sodium th io m a la te  2.1xlO~^M 
(a s  e le m e n ta l g o ld ) and g r e a t e r , induced  p ro lo n g a tio n  o f th e  throm bin 
tim e  o f b o th  p l a t e l e t  r i c h  plasm a and p l a t e l e t  poor p lasm a. Concen­
t r a t i o n s  o f  go ld  sodium th io m a la te  o f  2x10 ^  (a s  e le m e n ta l go ld ) 
and g r e a t e r ,  ex tended  th e  th rom bin  c l o t t i n g  tim e to  i n f i n i t y  (T ab le  
l 8 ) . Gold th io g lu c o s e  and g o ld  sodium th io s u lp h a te  in  eq u im o lar 
c o n c e n tra t io n s  o f e le m e n ta l g o ld  and equ im o lar d isodium  th io m a la te  
( i . e .  a s  equ im o lar c o n c e n tr a t io n s  o f th io m a la te  to  th e  th io m a la te  in  
g o ld  sodium th io m a la te )  d id  n o t p ro lo n g  th e  throm bin c l o t t i n g  tim e 
o f p l a t e l e t  r i c h  p lasm a o r  p l a t e l e t  poor p lasm a. S im i la r ly  A u ra n o f in ^  
in  th e  c o n c e n tra t io n  ran g e  ( l .3x10 ^ -  5* lx lO ”^M a s  e le m e n ta l go ld ) 
d id  n o t p ro lo n g  th e  th rom bin  c l o t t i n g  tim e o f p l a t e l e t  r i c h  plasm a o r 
p l a t e l e t  p o o r p lasm a. The p ro lo n g a tio n  o f th e  throm bin  c l o t t i n g  tim e 
o f p l a t e l e t  r i c h  plasm a and p l a t e l e t  poor plasm a by g o ld  sodium th i o ­
m ala te  was in d ep en d en t o f th e  d u ra t io n  o f in c u b a tio n  o f th e  compound 
w ith  th e  plasm a su sp e n sio n  b u t was r e l a t e d  to  th e  c o n c e n tra tio n  o f th e  
g o ld  sodium  th io m a la te  u se d , a s  shown i n  T able 18 ,
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METHODS! IN VIVO STUDIES
Male New Z ealand  r a b b i t s  ( 2 .5  -  3*5 k ilo g ram s) used  in  
th e  s tu d y  were housed s in g ly  and m a in ta in ed  a t  McMaster U n iv e rs i ty  
an im al f a c i l i t i e s  in  a  c o n t ro l le d  tem p era tu re  and h u m id ity  e n v i r ­
onment and fe d  r a b b i t  chow and w a te r  a d lib itu m .
I n  o rd e r  to  s tu d y  th e  e f f e c t  o f go ld  compounds on th e  a c t io n  
o f  th rom bin  in  v iv o , ex p erim en ts  to  measure p l a t e l e t  s u r v iv a l  and 
th e  w eigh t o f  throm bus fo rm a tio n , were s tu d ie d  in  an e x p e rim en ta l 
model o f i n t r a  a o r t i c  th ro m b o sis  by an in d w e llin g  a o r t i c  c a th e te r  
method ( f ig u r e  7 6 ) .  The experim en t was c a r r ie d  ou t ov er 12 d ay s . 
A nim als were g iv en  d a l ly  i n j e c t i o n s  o f d rug  on days 1 to  5 ar.d th e  
in d w e llin g  a o r t i c  c a th e te r  was s u r g ic a l ly  in s e r t e d  on day 8 . .Animals 
were s a c r i f i c e d  on day  1 2 . I n  o rd e r  to  o b ta in  a  r e l a t i v e  u n ifo rm ity  
o f  serum g o ld  by day 8 ( i . e .  day o f  c a th e te r  in s e r t io n )  f o r  each 
go ld  complex a d m in is te re d , p i l o t  dosage s tu d ie s  w ith  8 r a b b i t s  in  
each  group were u n d e r ta k e n . U sing equ im o lar c o n c e n tra t io n  o f  th e  
g o ld  compounds a t  0 .13M a s  e le m e n ta l g o ld  in  0 .5  ml o f  s t e r i l e  w ate r 
g iv en  in t r a m u s c u la r ly  d a i l y  from  day 1 to  5» th e  fo llo w in g  mean 
serum go ld  l e v e l s  (± SEM) co u ld  be ach iev ed : g o ld  sodium th io m a la te  
t r e a t e d , 1 .0 x l0 ”^M ± 6 .7 x lO ”^M; g o ld  th io g lu c o se  t r e a t e d  l . l x l O ”^M 
± 4.7xlO"^M ' go ld  sodium th io s u lp h a te  t r e a te d  1.6xlO"^M ± 5»8xlO”^M, 
C o n tro l an im als  were g iv e n  0 .5  ml o f  s t e r i l e  w a te r in t ra m u s c u la r ly  
d a i ly  f o r  5 d a y s . D isodium  th io m a la te  was a d m in is te re d  a s  0.13M 
th io m a la te  i n  0 .5  ml o f  s t e r i l e  w a te r .  F ive i d e n t i c a l  experim en ts  
w ith  a p p ro p r ia te  c o n t ro l  groups were c a r r ie d  ou t a s  fo llo w s :
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(a )  4 g o ld  sodium th io m a la te  t r e a t e d  and 4  w a te r t r e a t e d ,  (h)
4  g o ld  sodium th io m a la te  t r e a t e d  and 4 w a te r t r e a t e d ,  (c )  5 g o ld  
sodium th io m a la te  t r e a t e d  and 5 w a te r  t r e a te d  (d) 5 w a te r  t r e a t e d ,
5 g o ld  th io g lu c o s e  t r e a t e d  and 5 g o ld  th io s u lp h a te  t r e a t e d ,  (e )
5 w a te r t r e a t e d  and 5 d isod ium  th io m a la te  t r e a t e d .  Some an im als  
succumbed to  a n a e s th e s ia  in d u c tio n  le a v in g  19 w a te r  t r e a t e d ,  12 
g o ld  sodium th io m a la te  t r e a t e d ,  5 g o ld  th io g lu c o s e  t r e a t e d ,  5 go ld  
th io s u lp h a te  t r e a t e d  and 4  d isod ium  th io m a la te  t r e a t e d  a v a i la b le  
f o r  a n a ly s i s  to  d a t e .  Serum g o ld  was m easured on day 12 . P la t e ­
l e t  co u n ts  were m easured on days 1 , 8 ,  9» 10 , 11 and 1 2 . Haemo­
g lo b in  and w h ite  b lood  c e l l  coun t were m easured on day 1 and day 8 
i n  exp erim en ts  ( a ) , (b) and (c ) and on day 12 in  ex p erim en ts  (d) 
and ( e ) .
I n  a l l  ex p erim en ts  p l a t e l e t  s u rv iv a l  s tu d ie s  were s t a r t e d  
on day 8 im m ed ia te ly  a f t e r  c a th e te r  i n s e r t i o n .  B r ie f ly ,  washed 
r a b b i t  p l a t e l e t s  were p re p a re d  from  s to c k  New Z ealand  r a b b i t s  by 
th e  method o f A rd lie  e t  a l  (220) r a d io la b e l le d  in  th e  f i r s t  wash 
w ith  150 ]iGi o f Na^-^GrOj^ p e r  50 ml o f r a b b i t  w hole b lood  and in c u ­
b a te d  f o r  1 hour a t  20°C. The p l a t e l e t s  were resu sp en d ed  in  r a b b i t  
p l a t e l e t  poor plasm a (2x l0 ^ /cu ,m m ). Four ml (75 pG i) o f  th e  l a b e l ­
le d  p l a t e l e t  su sp e n sio n  was in j e c te d  in to  th e  m arg in a l e a r  v e in  o f  
e x p e rim e n ta l r a b b i t s  f o r  p l a t e l e t  s u rv iv a l  and throm bus w eigh t 
s tu d ie s .  P l a t e l e t s  were a llow ed  to  c i r c u la t e  f o r  2 h o u rs , a t  which 
tim e a  b lood  sam ple was ta k en  to  d e te rm in e  re c o v e ry  o f r a d io a c t i v i t y  
in  th e  c i r c u l a t i o n .  The r a d i o a c t i v i t y  o f t h i s  sam ple was a ss ig n e d  
a  v a lu e  o f 100% f o r  th e  pu rpose  o f  p l a t e l e t  s u r v iv a l  d e te rm in a tio n .
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A d d it io n a l  r a b b i t  whole b lood  sam ples were ta k en  a t  2 , 19 , 22,
4 3 , 67 and 91 ho u rs  a f t e r  th e  2 hour re c o v e ry  sam ple. R adio­
a c t i v i t y  in  th e s e  sam ples was ex p re ssed  a s  a  p e rce n tag e  o f th e  
r a d i o a c t i v i t y  in  th e  i n i t i a l  2 hou r re c o v e ry  sam ple. Mean 
p l a t e l e t  s u rv iv a l  was c a lc u la te d  u s in g  th e  gamma fu n c t io n  d e v e l­
oped by Murphy e t  a l  ( 2 4 l ) .
At tim e  zero  (im m ed ia te ly  a f t e r  re c o v e ry  sam ples were 
ta k e n )  th e  r a b b i t s  were a n a e s th e t i s e d  w ith  p e n to b a rb i to l  sodium 
{35-^5 mg/Kg) in t r a v e n o u s ly .  Twenty c e n tim e tre s  (cm) p o ly e th y ­
le n e  c a th e te r s  (P .E , I 90 Glay-Adams, New Y ork), s e a le d  a t  b o th  
en d s , were s u r g ic a l ly  in s e r t e d  in to  th e  a o r ta  in  a l l  an im als  v ia  
th e  r i g h t  fem o ra l a r t e r y .  The d i s t a l  end ex tended  to  1 cm above 
th e  d iaphragm  where i t  was f r e e  to  o s c i l l a t e  w ith  th e  a r t e r i a l  
b lood  p u ls a t io n  (F ig u re  76 ) .  A co n tin u o u s  v e s s e l  w a ll in ju r y  
r e s u l t s  from  t h i s  p ro ced u re  and e x p e rim en ta l th rom bi form  a lo n g  
th e  le n g th  o f th e  v e s s e l  (F ig u re  7 7 )• The c a th e te r s  were l e f t  in  
s i t u  u n t i l  day 12 , when th e  an im als  were th e n  k i l l e d  by p e r fu s io n  
f i x a t i o n .  F o r p e r fu s io n  th e  an im a ls  were a n a e s th e t i s e d  w ith  
Ketam ine h y d ro c h lo r id e  100 mg in t r a m u s c u la r ly ,  p e n to b a rb i to l  sodium 
20 mg/Kg and a t ro p in e  0 .1  mg su b c u ta n e o u s ly . The l e f t  fem o ra l and 
l e f t  c a r o t id  a r t e r i e s  were i s o l a t e d  and a  s a l i n e  f i l l e d  p o ly e th y ­
le n e  c a th e te r  (P .E .90 ) was in s e r t e d  in  each  (F ig u re  7 8 , 79 ) ,  The 
a n im a ls  were h e p a r in iz e d  w ith  1000 u n i t s  o f  sodium h e p a r in  and 
th e n  p e rfu se d  w ith  oxygenated  L o c k e 's  R inger c o n ta in in g  h e p a rin  
1 u n i t /m l  v ia  th e  l e f t  c a r o t id  a r t e r y  and ex san g u in a ted  v ia  th e
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FIGURE 7 6 : Twenty cen tim etre p o lyeth y len e c a th e ter  (P .E .190) 
in se r te d  in to  a rab b it a orta  v ia  th e r ig h t  fem oral a r te r y .  
The d i s t a l  end extends to  1 centim etre above th e diaphragm 
where i t  i s  fr e e  to  o s c i l l a t e  w ith  the a r t e r ia l  p u lsa t io n .
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FIGURE 77 : 'Transverse s e c t io n  o f  ra b b it a orta  w ith  
20 cm in d w ellin g  p o ly eth y len e  c a th e ter  (P .E .1 9 0 ) in  s i t u .  
Organised thrombus i s  seen attach ed  to  th e v e s s e l  
w a ll and around th e  c a th e te r  ( s e c t io n  s ta in ed  w ith  
Lendrum’s m artius s c a r le t  b lu e ) .
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FIGURE 7 9 ; S a lin e  f i l l e d  p o lyeth y len e  c a th e ter  (P .E . 9 0 ) 
in se r te d  in to  th e  l e f t  fem oral a r tery  o f  a r a b b it .
The animal i s  exsanguinated v ia  t h i s  c a th e te r .
(See te x t  and f ig u r e  7 8 ) .
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l e f t  fem o ra l a r t e r y  (F ig u re  8 0 ) .  When th e  s o lu t io n  d ra in in g  
from  th e  fem o ra l a r t e r y  was v i r t u a l l y  c l e a r  o f re d  b lood  c e l l s  
th e  L o ck e 's  R inger s o lu t io n  was r e p la c e d  by 4% paraform aldehyde 
in  phosphate  b u f f e r .  The a o r ta e  w ith  in d w e llin g  c a t h e te r  and 
throm bi were removed i n t a c t  by c a r e f u l  d i s s e c t io n .  S ix  s e c t io n s  
o f  th e  a o r t a  (2 ,5  cm p e r  s e c t io n )  w ith  c a th e te r  and throm bus in  
s i t u  were ta k en  from  th e  a o r t i c  b i f u r c a t io n  upw ards, The throm bi 
were th e n  d is s e c te d  f r e e  o f  th e  v e s s e l  w a ll and c a t h e t e r ,  and a i r  
d r ie d  a t  room te m p e ra tu re  f o r  1 -2  hours b e fo re  w eigh ing .
Whole Blood F ib r in o ly s i s  A ssay
I n  o rd e r  to  d e te rm in e  th e  e f f e c t  o f g o ld  sodium th io m a la te  
on whole b lood f i b r i n o l y s i s ,  th e  fo llo w in g  exp erim en t was u n d ertak en
Ten New Z ealand  W hite r a b b i t s  (2 .5  -  3*5 k ilo g ra m s) were 
g iv e n  g o ld  sodium th io m a la te  0.13M in  0 .5  ml o f s t e r i l e  w a te r 
in t r a m u s c u la r ly  f o r  5 d a y s . Ten c o n t ro l  an im als  were g iv e n  0 .5  ml 
s t e r i l e  w a te r  in t r a m u s c u la r ly  f o r  5 d a y s . On day 8 serum go ld  
sam ples were ta k e n  and 2 ml o f whole b lood  was w ithdraw n f o r  f i b r ­
in o l y s i s  a s s a y , ^ ^ -^ o d in e  l a b e l l e d  human f ib r in o g e n  (g rad e  L,
Kabi L a b o ra to r ie s ,  S tockholm , Sweden) was u sed  to  p re p a re  
f i b r i n  c o a te d  t e s t  tu b e s  a s  d e s c r ib e d  by Moroz and G ilm ore (2 4 2 ), 
W hile b lood  f i b r i n o l y s i s  was d e te rm in ed  u s in g  a  ^ ^ - ^ - f ib id n  r a d io -  
m e tr ic  a s s a y . B r ie f ly ,  0 .9  ml o f  r a b b i t  whole b lood  was c o l le c te d  
in  0 .1  ml o f h e p a r in  ( f i n a l  c o n c e n tra t io n  10 u n i t s /m l)  and in c u ­
b a te d  (37^C) in  a  - f i b r i n  c o a te d  t e s t  tu b e  ( tu b e  A) f o r  one
h o u r. P la in  Tyrodes s o lu t io n  (2  ml) c o n ta in in g  10 u n i t s /m l  o f 
h e p a r in  was th e n  added and th e  whole sam ple t r a n s f e r r e d  to  a  c le a n
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u n co a ted  12 x 75 mm p o ly s ty re n e  tu b e  (tu b e  B) . The - f i b r i n  
c o a te d  tu b e  ( tu b e  A) was th e n  r in s e d  w ith  a  f u r th e r  1 ml o f 
Tyrodes s o lu t io n  c o n ta in in g  10 u n i t s /m l  o f h e p a r in  and t h i s  
was a l s o  t r a n s f e r r e d  to  tu b e  B. Both th e  - f i b r i n  co a ted  
tu b e  ( tu b e  a ) and th e  12 x 75 mm u n co a ted  p o ly s ty re n e  tu b e  
( tu b e  B) w ere th e n  coun ted  in  a  gamma c o u n te r .  F ib r in o ly s i s  
was ex p re sse d  a s  a  p e rc e n ta g e  by d e te rm in in g  th e  r a d i o a c t i v i t y  
in  th e  u n co a ted  tu b e  ( tu b e  B) d iv id e d  by th e  sum o f  th e  r a d io ­
a c t i v i t y  in  th e  ^ ^ ^ I - f i b r in  c o a te d  tu b e  (tu b e  A) and th e  u n co a ted  
tu b e  ( tu b e  B ) : -
% F ib r in o ly s i s  = 100 X Tube B
Tube A + Tube B
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RESULTS t IN VIVO STUDIES
H aem oglobin, w h ite  b lood  c e l l  coun t and p l a t e l e t  cou n ts  
f o r  a l l  s tu d y  an im a ls  were norm al on day 1 . No change was 
d e te c te d  in  haem oglobin n o r w h ite  b lood  c e l l  v a lu e s  m easured on 
day  8 {experim en ts  ( a ) ,  (b ) and (c )}  o r  on day 12 {ex perim en ts  (d) 
and (e )}  compared to  b a s e l in e  v a lu e s  observed  on day  1 .
The mean serum g o ld  l e v e l s  m easured on day 12 ( i . e .  day 
o f  s a c r i f i c e )  a re  i l l u s t r a t e d  i n  t a b l e  1 9 j go ld  sodium th io m a la te  
-  4 .9x10  ± 1 .4 x lO ”^M; g o ld  th io g lu c o s e  -  4 .2x10 ± 3.8xlO"^M;
and g o ld  sodium th io s u lp h a te  4 .4x10  ± 2.8x10 There was no
s i g n i f i c a n t  d i f f e r e n c e  betw een th e s e  v a lu e s  a s  c a lc u la te d  by th e  
s t u d e n t 's  t  t e s t  assum ing an a lp h a  l e v e l  o f  0 .0 5  ( t  = 1 .8 - 0 .4 ,  
p >  0 ,0 5  n o t s i g n i f i c a n t ) .
The av erag e  p l a t e l e t  coun t i n  norm al New Z ealand  White 
r a b b i t s  i s  a p p ro x im a te ly  500»000 to  700,000/mm^. The lo w er p l a t e ­
l e t  v a lu e s  i l l u s t r a t e d  i n  t a b le  19 (mean v a lu e s  f o r  days 8 to  12) 
a re  c o n s is te n t  w ith  th e  p re se n c e  o f an in d w e llin g  a o r t i c  c a th e te r  
r e s u l t i n g  i n  v e s s e l  w a ll damage (F ig u re s  7 6 , 77) and subseq u en t 
reduced  p l a t e l e t  s u r v iv a l  (se e  t a b l e  2 0 ) . P l a t e l e t  s u r v iv a l  
( ta b le  20) was n o t s i g n i f i c a n t l y  d i f f e r e n t  in  any g o ld  t r e a te d  
g roup compared to  c o n t ro l s  a s  c a lc u la te d  by th e  s tu d e n t 's  t  t e s t .  
Thus th e  e f f e c t  o f  g o ld  sodium th io m a la te  on throm bus w eigh t was 
n o t  r e l a t e d  to  an a l t e r a t i o n  in  p l a t e l e t  s u r v iv a l .
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Thrombi do n o t in c re a s e  in  s iz e  in  a  n o rm ally  d i s t r i ­
b u te d  f a s h io n ,  th e r e f o r e  s t a t i s t i c a l  a n a ly s i s  o f throm bus w eight 
r e s u l t s  was done on th e  lo g  tra n s fo rm e d  d a ta .  A c tu a l mean 
throm bus w eig h ts  a re  shown in  t a b l e  21 a s  w e ll a s  th e  a n t i lo g  
o f th e  mean v a lu e  o f th e  sum o f  lo g  throm bus w e ig h ts  from  which 
th e  s t a t i s t i c a l  a n a ly s e s  were p erfo rm ed . One way a n a ly s i s  of 
v a r ia n c e  confirm ed  t h a t  a  d i f f e r e n c e  d id  e x i s t  among th e  5 g roups, 
A p p lic a tio n  o f D u n n e tt 's  t e s t  (243) confirm ed t h a t  th e  mean 
throm bus w eigh t in  th o se  an im a ls  t r e a te d  w ith  g o ld  sodium t h i o ­
m a la te  was s ig n i f i c a n t l y  l e s s  th a n  th e  mean throm bus w eigh t in  
a l l  o th e r  g ro u p s (p  = O.O35) .
Whole Blood F ib r in o ly s i s  S tudy
The mean serum g o ld  l e v e l  (±  SEM) in  th e  10 r a b b i t s  
t r e a t e d  w ith  go ld  sodium th io m a la te  O.13M a s  e le m e n ta l g o ld  in  
s t e r i l e  w a te r in t r a m u s c u la r ly  was 8,4xl0"^'^M ± 5*9x10 The
p e rc e n ta g e  f i b r i n o l y s i s  f o r  in d iv id u a l  r a b b i t s  and th e  group 
mean a re  shown in  t a b l e  22. There was no s i g n i f i c a n t  d i f f e r e n c e  
betw een th e  p e rc e n ta g e  f i b r i n o l y s i s  in  th e  10 an im a ls  t r e a t e d  
w ith  g o ld  sodium th io m a la te ,  compared to  th e  p e rc e n ta g e  f i b r i n o ­
l y s i s  observed  in  th e  10 c o n t ro l  an im als g iv e n  s t e r i l e  w a te r 
( ta b le  22) .
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TABLE 21
THE WEIGHT (mg) OF EXPERIMENTALLY INDUCED THROMBUS 
FROM RABBITS WITH INDWELLING AORTIC CATHETERS
TREATMENT
HgO GOLD SO D IU M  THIOM ALATE
GOLD
TH IO GLU CO SE
GOLD
THIOSULPHATE
SO D IU M
THIOM ALATE






















In view of skewed data due to biological variation, statistical 
analysis was calculated using log thrombus weight values.
TREATMENT





SO D IU M
THIOM ALATE
ANTILOG OF 
M EAN VALUE 
O F SU M  OF LOG 
TH R O M B U S 
W EIG H TS




15.03-48.03 4.88-25.46 14.37-33.55 14.40-27.09 19.43-33.55
Statistical comparison of antilogs of mean value of sum of 
log thrombus weights were calculated by one way analysis 
of variance and Dunnett's test. The thrombus weight of gold 
sodium thiomalate treated animals was significantly less 
than all other treatm ent groups. (p = 0.035)
N = Number of rabbits in each category
mg = Milligrams
SD" Standard deviation
S.E.M.° Standard error of the mean
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TABLE 2 2 ; P ercen t F ib r in o ly s is  of Whole Blood from R abbits 
T reated  w ith  Gold Sodium Thiom alate, Compared to  
C ontrol Animals T reated  w ith S te r i l e  Water,
Group T reated  w ith Gold Sodium 
Thiom alate 25mg in  0 .5ml s t e r i l e  
w ater ( l ,M .) fo r  5 days
C ontrol Group T reated  w ith 
0 .5ml s t e r i l e  w ater ( l.M .) 
f o r  5 days
Rabbit No. % F ib r in o ly s is  * R abbit No, % F ib r in o ly s is
1 3.20 11 3.33
2 3.04 12 3.31
3 4.87 13 2.61
4 3.60 14 5.18
5 3.59 15 4.10
6 3.87 16 3.25
7 3.43 17 3.19
8 5.07 18 2.37
9 3.40 19 4.44
10 4 .03 20 2.77
MEAN ± SEM 3.81 ± 0 .16 MEAN 3.45 ± 0 . 2 0
t  = i . 40j  
P > 0 . 0 5 Not s ig n if ic a n t
* Each sample measured in  d u p lic a te  
S.E,M. = S tandard  e r r o r  of mean 
S t a t i s t i c a l  a n a ly s is  was by s tu d e n t 's  t  t e s t  
I .M.  -  In tram u scu la r ly
-  2 8 5
DISCUSSION
Gold sodium th io m a la te  h as  p re v io u s ly  been shown to  i n h i b i t  
s e r in e  e s te r a s e  enzymes i s o l a t e d  from  th e  lyosom es o f  w h ite  c e l l s  
( 234- 237) .  T h is  s tu d y  d em o n stra te s  f o r  th e  f i r s t  tim e to  my know­
le d g e  t h a t  g o ld  sodium th io m a la te  i s  in h i b i to r y  to  th e  s e r in e  e s te r a s e  
th rom bin  in  i t s  i n t e r a c t io n  w ith , washed human p l a t e l e t s ,  human p l a t e ­
l e t  r i c h  p lasm a, human p l a t e l e t  poo r p lasm a, and on th e  fo rm a tio n  o f 
ex p e rim e n ta l th ro m b o sis  i n  New Z ealand  White r a b b i t s . S in ce  throm bin  
i s  a  s e r in e  e s t e r a s e ,  p h y lo g e n e t ic a l ly  r e l a t e d  to  th e  s e r in e  e s t e r a s e s ,  
e l a s t a s e  and c a th e p s in  G, th e  most l i k e l y  mechanism o f  a c t io n  i s  an 
i n t e r a c t io n  o f th e  g o ld  t h i o l  complex w ith  one o r  a l l  o f  th e  fo u r  
c y s te in e - c y s te in e  d is u lp h id e  b r id g e s  o f th e  th rom bin  m olecu le  (2 4 4 ).
The serum g o ld  l e v e l s  a ch iev ed  in  p a t i e n t s  r e c e iv in g  go ld  
sodium th io m a la te  f o r  rh eu m ato id  a r t h r i t i s  a re  u s u a l ly  in  th e  range 
1 .5 x lO ”-^ M -  4 .1x10"-% , and v a lu e s  a s  h ig h  a s  7 .6x10 %  may be ach iev ed  
im m ed ia te ly  a f t e r  an in t ra m u s c u la r  i n j e c t i o n .  The c o n c e n tra t io n  o f 
g o ld  sodium th io m a la te  (a s  e le m e n ta l g o ld ) which i n h i b i t  th e  a c t io n  
o f  th rom bin  ( 0 .025- 0 .2 5  u n i t s /m l)  on washed human p l a t e l e t s  was 
c l e a r l y  w ith in  t h i s  r a n g e . The g o ld  sodium th io m a la te  c o n c e n tra t io n s  
which r e s u l t e d  in  p ro lo n g a t io n  o f th e  throm bin  c l o t t i n g  tim e  o f p l a t e -
/ -4l e t  r i c h  plasm a and p l a t e l e t  poor plasm a were much h ig h e r  (2 .1x10  M 
and g r e a te r )  th a n  g o ld  v a lu e s  u s u a l ly  ach ieved  in  p a t i e n t s  b u t th e  
throm bin  c o n c e n tra t io n  u sed  was 20 tim e s  h ig h e r  th a n  th e  c o n c e n tra ­
t i o n  used  in  th e  washed human p l a t e l e t  s tu d ie s .  I n  th e  dosage sch ed u le
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used  in  th e  an im als  e x p e r im e n ts , th e  serum go ld  v a lu e s  on day 8
were in  th e  range  l,OxlO~^M -  1 . 6 x 1 0 and by day 12 had f a l l e n
to  4 .2 x l0 ”%  -  4 .9x10"’%  ( i . e .  com parable to  v a lu e s  ach iev ed  in  
p a t i e n t s  w ith  rheu m ato id  a r t h r i t i s ) . C ontinuous v e s s e l  w a ll 
in ju r y  h as  been shown by p re v io u s  w orkers from  th e  l a b o r a to r i e s  o f 
P ro fe s s o r  F ra s e r  M ustard and P ro fe s s o r  Jack  H irsh , McMaster U niv­
e r s i t y ,  to  r e s u l t  in  th e  fo rm a tio n  o f th rom bi in  th e  r a b b i t  a o r t a  
and a l s o  to  sh o r te n  p l a t e l e t  s u r v iv a l  ( 2 4 5 - 2 4 7 ) .  As r e p o r te d  in  
t h i s  c h a p te r ,  th e  p l a t e l e t  s u r v iv a l  was s im i la r  in  g o ld  t r e a te d  
an im als  and in  c o n t ro l  g ro u p s; th e r e f o r e  in d ic a t in g  t h a t  th e  
re d u c t io n  in  throm bus w e ig h t in  th e  g o ld  sodium th io m a la te  t r e a t e d  
an im als  was n o t due to  changes i n  p l a t e l e t  s u r v iv a l .  The c o n t in ­
uous v e s s e l  w a ll i n j u r y  in  th e  r a b b i t ,  a s  used  i n  th e  s tu d y ,
r e s u l t s  in  e n d o th e l ia l  damage and p l a t e l e t s  adhere  to  th e  damaged 
s u r f a c e .  The lo c a l i s e d  g e n e ra tio n  o f  throm bin  r e s u l t s  i n  a c t iv a ­
t i o n  o f  o th e r  p l a t e l e t s  to  change shape and s t i c k  to g e th e r  (2 4 8 ), 
Thrombin cau ses  f ib r in o g e n  in  and around  th e  p l a t e l e t  a g g re g a te s  
to  p o ly m e rise , th u s  c r e a t in g  a  p l a t e l e t  mass s t a b i l i s e d  w ith  f i b r i n  
( 249) .  S tu d ie s  to  m easure th e  f i b r i n o l y t i c  a c t i v i t y  o f g o ld  sodium 
th io m a la te  were th e r e f o r e  n e c e ss a ry  to  de term ine  w hether t h i s  g o ld  
complex red u ced  throm bus w eigh t by enhancing  th e  f i b r o l y t i c  p ro c e s s , 
The r e s u l t s  shown in  t a b l e  22 d em o n stra te  t h a t  i n  th e  whole b lood  
o f  New Z ealand  White r a b b i t s ,  g o ld  sodium th io m a la te  had no e f f e c t  
on f i b r i n o l y s i s  when compared to  c o n t ro l  a n im a ls . T his f in d in g  i s  
s im i la r  to  th e  r e s u l t s  r e p o r te d  by Moroz ( 250) , nam ely th a t  g o ld
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j fsodium th io m a la te  10 to  10"^M had no e f f e c t  on th e  f i b r i n o ­
l y t i c  a c t i v i t y  o f human whole b lo o d . The s i g n i f i c a n t  re d u c t io n  
in  throm bus w eigh t found in  th e  an im als  t r e a te d  w ith  go ld  sodium
th io m a la te  i s  l i k e l y  due to  th e  i n h i b i t i o n  o f  th rom bin  a c t io n  a t  
th e  s i t e  o f  v e s s e l  w a ll i n j u r y .  The re d u c t io n  in  throm bus 
w eigh t observed  in  my ex p erim en ts  i s  th u s  most l i k e l y  due to  
red u ced  f i b r i n  fo rm a tio n .
Thrombus fo rm a tio n  due to  v e s s e l  w a ll i n j u r y  i s  analogous 
t o  th e  p ro c e s s  which o ccu rs  in  a c u te  v a s c u l i t i s  ( 251) o r glom eru­
l o n e p h r i t i s  ( 232- 254) ,  s p e c i f i c a l l y  th e  d i f f u s e  and f o c a l  p r o l i f ­
e r a t iv e  v a r i e ty  o f lu p u s  n e p h r i t i s  (253, 2 5 4 ). The e n d o c a p il la ry  
damage seen  in  a c u te -g lo m e ru lo -n e p h r i t is  h as  been p o s tu la te d  to  be 
due to  th e  p re sen ce  o f  s o lu b le  immune com plexes ( 252) .  W hether 
o r  n o t t h i s  i s  a  p rim ary  e v e n t ,  s u b e n d o th e l ia l  damage does o ccu r 
w hich r e s u l t s  in  a c t iv a t io n  o f  p l a t e l e t s  to  adhere  to  th e  damaged 
e n d o th e l ia l  t i s s u e ,  r e le a s e  t h e i r  i n t e r n a l  g ra n u le s  and p e rp e tu a te  
l o c a l  p l a t e l e t  a g g re g a tio n  (248, 255)• C le a r ly  an a g en t which 
re d u c e s  th e  d e p o s i t io n  o f  f i b r i n  and hence m icro -th ro m b i (252-254) 
co u ld  be a  m ajor b reak th ro u g h  in  th e  management o f g lom eru lo ­
n e p h r i t i s  ( 252) and a c u te  v a s c u l i t i s  ( 251) .
T hat g o ld  sodium  th io m a la te  i n h i b i t s  th e  a c t io n  o f  throm bin  
in  v i t r o  and in  v ivo  po ses  a  number o f  problem s f o r  f u tu r e  s tu d y . 
V ascu la r throm bo-em bolic d is o r d e r s  c o n s t i tu te  one o f  th e  m ajor 
cau ses  o f d e a th  in  W estern s o c ie ty  to d a y . I t  has  been su g g es ted  p r e ­
v io u s ly  t h a t  p a t i e n t s  w ith  rheum ato id  a r t h r i t i s  a re  in  some way
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p r o te c te d  from  such d is o r d e r s  a s  m y ocard ia l i n f a r c t i o n  ( 256) 
and a ls o  deep venous th ro m b o sis  a f t e r  s u r g ic a l  traum a ( 257 ,
258) .  I t  has been assumed t h a t  somehow t h i s  i s  r e l a t e d  to  th e  
pharm acotherapy  o f  th e  in flam m ato ry  j o i n t  d is e a s e  and e s p e c ia l ly  
to  n o n - s te r o id a l  a n t i- in f la m m a to ry  d ru g s . However, no c o n c lu s iv e  
ev id en ce  t h a t  th e s e  a g e n ts  a re  r e s p o n s ib le  i s  a v a i la b le  and t h i s  
may be due to  th e  f a i l u r e  to  c o n s id e r  g o ld  sodium th io m a la te  
tr e a tm e n t e i t h e r  a s  th e  m ajor a g e n t in v o lv ed  o r a s  a  m ajor a d ju n c t 
to  t h i s  e f f e c t .  I t  would c e r t a i n l y  be w orthw hile  c a r ry in g  ou t 
s tu d ie s  in  th e  f u tu r e  to  a s s e s s  such  a  p o s s i b i l i t y .  As n o te d  
above, e q u a l ly  im p o rta n t in  th e  a r e a  o f  in flam m ato ry  j o i n t  d i s ­
e a s e ,  would be th e  c o n s id e ra t io n  o f  th e  e f f e c t  o f g o ld  sodium 
th io m a la te  on a c u te  g lo m e ru lo n e p h r i t i s . G lo m e ru lo n e p h ritis  i s  
w id e ly  c o n s id e re d  to  be due in  many c a se s  to  v a s c u la r  m icro throm bi 
caused  by immune complex d e p o s i t io n  (251-253)• I f  such throm bi 
cou ld  be avo ided  th e r e  may be c o n s id e ra b le  p r o te c t io n  a g a in s t  
r e n a l  f u n c t io n a l  d e t e r i o r a t i o n .
R esearch  in  throm bo-em bolism  has been s lo w ly  p ro g re s ­
s in g  f o r  many y e a rs  b u t no one has y e t reac h ed  "E l D orado", 
p erh ap s  th e  s ig n  p o s t  to  t h e i r  g o a l i s  a l s o  "g o ld " I
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SUMMARY
Gold sodium th io m a la te  ( l .8 x lO  %  -  2.5x10 %  as  
e le m e n ta l g o ld ) i n h i b i t e d  th e  e f f e c t  o f  bov ine  th rom bin  ( 0 , 025-
0 .2 5  u n i t s /m l)  on washed human p l a t e l e t s  suspended in  T yrodes 
album in 0 .3 5 ^ . The throm bin  c l o t t i n g  tim e o f  human p l a t e l e t  r i c h  
p lasm a and p l a t e l e t  poo r p lasm a was p ro longed  in  a  dose r e l a t e d
"4manner by g o ld  sodium th io m a la te  in  c o n c e n tra t io n s  o f 2 .1x10 M 
(a s  e le m e n ta l g o ld )  and g r e a t e r .  Gold th io g lu c o s e ,  g o ld  sodium 
th io s u lp h a te ,  A u ra n o fin , and d i s odium th io m a la te  had no e f f e c t  
on th rom bin  in  th e  above t e s t  p ro c e d u re s .
I n  o rd e r  to  s tu d y  th e  e f f e c t  o f g o ld  compounds on th e  
a c t io n  o f  th rom bin  i n  v iv o , ex p erim en ts  to  m easure p l a t e l e t  s u r ­
v iv a l  and th e  w ^ g h t  o f throm bus fo rm a tio n , were s tu d ie d  in  an 
e x p e rim en ta l model o f  i n t r a  a o r t i c  th ro m b o sis  by an in d w e llin g  
a o r t i c  c a th e te r  m ethod. P l a t e l e t  s u rv iv a l  was reduced  in  a l l  
g o ld  compound t r e a t e d  and c o n t ro l  an im als  w ith  in d w e llin g  a o r t i c  
c a t h e t e r s .  Thrombus w eigh t was reduced  in  an im als  t r e a t e d  w ith  
g o ld  sodium th io m a la te  compared to  an im als  t r e a t e d  w ith  s t e r i l e  
w a te r , g o ld  th io g lu c o s e ,  g o ld  sodium th io s u lp h a te ,  and disodium  
th io m a la te , v iv o  s tu d ie s  d em o n stra ted  t h a t  g o ld  sodium th i o ­
m ala te  had no e f f e c t  on whole b lood  f i b r i n o l y s i s .
These s tu d ie s  in d i c a te  t h a t  go ld  sodium th io m a la te  i s  
th e  on ly  g o ld  complex which in h i b i t e d  throm bin  in  v i t r o . Gold 
sodium th io m a la te  t r e a t e d  r a b b i t s  had a  reduced  w eigh t o f 
e x p e r im e n ta lly  induced  i n t r a - a o r t i c  throm bi compared to  an im als
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t r e a t e d  w ith  s t e r i l e  w a te r o r eq u im o la r c o n c e n tra t io n s  o f  
go ld  th io g lu c o s e ,  g o ld  sodium th io s u lp h a te  and d isodium  t h i o ­
m a la te . F in a l ly ,  th e  r e d u c t io n  in  throm bus w eigh t in  th e  an im als 
t r e a t e d  w ith  go ld  sodium th io m a la te  was n o t r e f l e c t e d  by changes 
i n  p l a t e l e t  s u r v iv a l  n o r f i b r i n o l y s i s .
The serum go ld  l e v e l s  a ch iev ed  in  th e  in  v ivo  ex p erim en ts  
was in  th e  range  5x10 M to  1 .0x10  M. These v a lu e s  a re  compa­
r a b le  to  l e v e l s  w hich can be a ch iev ed  in  human s u b je c ts  immedia­
t e l y  a f t e r  a  g o ld  i n j e c t i o n .  C le a r ly  an a g e n t such  a s  g o ld  sodium 
th io m a la te  which i s  cap a b le  o f th rom bin  in h i b i t i o n  r e q u i r e s  f u r th e r  
s tu d y  a s  to  i t s  v a lu e  in  th e  management o f th rom bo-em bolic  d is e a s e s  
and c o n d i t io n s  such  a s  v a s c u l i t i s  and a c u te  lu p u s  n e p h r i t i s  where 
m icro throm bi p la y  a  r o l e .
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